
<html lang="en"     class="pb-page"  data-request-id="da7150f5-64de-4032-a787-dc1bac4515ac"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.1c00555;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-13;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists" /></meta><meta name="dc.Creator" content="David  Sedlák" /></meta><meta name="dc.Creator" content="Tyler A.  Wilson" /></meta><meta name="dc.Creator" content="Werner  Tjarks" /></meta><meta name="dc.Creator" content="Hanna S.  Radomska" /></meta><meta name="dc.Creator" content="Hongyan  Wang" /></meta><meta name="dc.Creator" content="Jayaprakash Narayana  Kolla" /></meta><meta name="dc.Creator" content="Zbigniew J.  Leśnikowski" /></meta><meta name="dc.Creator" content="Alena  Špičáková" /></meta><meta name="dc.Creator" content="Tehane  Ali" /></meta><meta name="dc.Creator" content="Keisuke  Ishita" /></meta><meta name="dc.Creator" content="Liva Harinantenaina  Rakotondraibe" /></meta><meta name="dc.Creator" content="Sandip  Vibhute" /></meta><meta name="dc.Creator" content="Dasheng  Wang" /></meta><meta name="dc.Creator" content="Pavel  Anzenbacher" /></meta><meta name="dc.Creator" content="Chad  Bennett" /></meta><meta name="dc.Creator" content="Petr  Bartunek" /></meta><meta name="dc.Creator" content="Christopher C.  Coss" /></meta><meta name="dc.Description" content="Selective agonism of the estrogen receptor (ER) subtypes, ERα and ERβ, has historically been difficult to achieve due to the high degree of ligand-binding domain structural similarity. Multiple eff..." /></meta><meta name="Description" content="Selective agonism of the estrogen receptor (ER) subtypes, ERα and ERβ, has historically been difficult to achieve due to the high degree of ligand-binding domain structural similarity. Multiple eff..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 28, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00555" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00555" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00555" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00555" /></link>
        
    
    

<title>Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00555" /></meta><meta property="og:title" content="Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0016.jpeg" /></meta><meta property="og:description" content="Selective agonism of the estrogen receptor (ER) subtypes, ERα and ERβ, has historically been difficult to achieve due to the high degree of ligand-binding domain structural similarity. Multiple efforts have focused on the use of classical organic scaffolds to model 17β-estradiol geometry in the design of ERβ selective agonists, with several proceeding to various stages of clinical development. Carborane scaffolds offer many unique advantages including the potential for novel ligand/receptor interactions but remain relatively unexplored. We synthesized a series of para-carborane estrogen receptor agonists revealing an ERβ selective structure–activity relationship. We report ERβ agonists with low nanomolar potency, greater than 200-fold selectivity for ERβ over ERα, limited off-target activity against other nuclear receptors, and only sparse CYP450 inhibition at very high micromolar concentrations. The pharmacological properties of our para-carborane ERβ selective agonists measure favorably against clinically developed ERβ agonists and support further evaluation of carborane-based selective estrogen receptor modulators." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00555"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00555">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00555&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00555&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00555&amp;href=/doi/10.1021/acs.jmedchem.1c00555" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 9330-9353</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00539" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00561" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship of <i>para</i>-Carborane Selective Estrogen Receptor β Agonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">David Sedlák</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Sedlák</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Sedl%C3%A1k">David Sedlák</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-0074-335X" title="Orcid link">https://orcid.org/0000-0003-0074-335X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tyler A. Wilson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tyler A. Wilson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tyler+A.++Wilson">Tyler A. Wilson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Werner Tjarks</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Werner Tjarks</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medicinal Chemistry and Pharmacognosy College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Werner++Tjarks">Werner Tjarks</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hanna S. Radomska</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hanna S. Radomska</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hanna+S.++Radomska">Hanna S. Radomska</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongyan Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongyan Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongyan++Wang">Hongyan Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jayaprakash Narayana Kolla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jayaprakash Narayana Kolla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jayaprakash+Narayana++Kolla">Jayaprakash Narayana Kolla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zbigniew J. Leśnikowski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zbigniew J. Leśnikowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry, Institute of Medical Biology PAS, 106 Lodowa Street, 93-232 Lodz, Poland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zbigniew+J.++Le%C5%9Bnikowski">Zbigniew J. Leśnikowski</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-3158-5796" title="Orcid link">https://orcid.org/0000-0003-3158-5796</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alena Špičáková</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alena Špičáková</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Faculty of Medicine, Palacky University, Hněvotínská 3, 77515 Olomouc, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alena++%C5%A0pi%C4%8D%C3%A1kov%C3%A1">Alena Špičáková</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tehane Ali</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tehane Ali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medicinal Chemistry and Pharmacognosy College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tehane++Ali">Tehane Ali</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Keisuke Ishita</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Keisuke Ishita</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medicinal Chemistry and Pharmacognosy College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Keisuke++Ishita">Keisuke Ishita</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Liva Harinantenaina Rakotondraibe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Liva Harinantenaina Rakotondraibe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Medicinal Chemistry and Pharmacognosy College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Liva+Harinantenaina++Rakotondraibe">Liva Harinantenaina Rakotondraibe</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-2166-4992" title="Orcid link">https://orcid.org/0000-0003-2166-4992</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandip Vibhute</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandip Vibhute</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandip++Vibhute">Sandip Vibhute</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dasheng Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dasheng Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dasheng++Wang">Dasheng Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pavel Anzenbacher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pavel Anzenbacher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Faculty of Medicine, Palacky University, Hněvotínská 3, 77515 Olomouc, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pavel++Anzenbacher">Pavel Anzenbacher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chad Bennett</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chad Bennett</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</div><div class="loa-info-affiliations-info">Drug Development Institute, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chad++Bennett">Chad Bennett</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Petr Bartunek</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Petr Bartunek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#dab8bba8aeafb4bfb19ab3b7bdf4b9bba9f4b9a0"><span class="__cf_email__" data-cfemail="284a495a5c5d464d436841454f064b495b064b52">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Petr++Bartunek">Petr Bartunek</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Christopher C. Coss</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher C. Coss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</div><div class="loa-info-affiliations-info">Drug Development Institute, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#56353925257867601639252378333223"><span class="__cf_email__" data-cfemail="43202c30306d7275032c30366d262736">[email protected]</span></a>. Tel: 614-688-1309.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+C.++Coss">Christopher C. Coss</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8184-9190" title="Orcid link">https://orcid.org/0000-0002-8184-9190</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00555&amp;href=/doi/10.1021%2Facs.jmedchem.1c00555" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 9330–9353</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 28, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 March 2021</li><li><span class="item_label"><b>Published</b> online</span>28 June 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00555" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00555</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by-nc"><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_nc-1612971093307.svg" alt="NC: Only noncommercial uses of the work are permitted" /></img><span><strong>NC: </strong>Only noncommercial uses of the work are permitted</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_nd-1612971093637.svg" alt="ND: No derivatives or adaptations of the work are permitted" /></img><span><strong>ND: </strong>No derivatives or adaptations of the work are permitted</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00555"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">849</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00555" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Sedlák&quot;},{&quot;first_name&quot;:&quot;Tyler&quot;,&quot;last_name&quot;:&quot;A. Wilson&quot;},{&quot;first_name&quot;:&quot;Werner&quot;,&quot;last_name&quot;:&quot;Tjarks&quot;},{&quot;first_name&quot;:&quot;Hanna&quot;,&quot;last_name&quot;:&quot;S. Radomska&quot;},{&quot;first_name&quot;:&quot;Hongyan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jayaprakash&quot;,&quot;last_name&quot;:&quot;Narayana Kolla&quot;},{&quot;first_name&quot;:&quot;Zbigniew&quot;,&quot;last_name&quot;:&quot;J. Leśnikowski&quot;},{&quot;first_name&quot;:&quot;Alena&quot;,&quot;last_name&quot;:&quot;Špičáková&quot;},{&quot;first_name&quot;:&quot;Tehane&quot;,&quot;last_name&quot;:&quot;Ali&quot;},{&quot;first_name&quot;:&quot;Keisuke&quot;,&quot;last_name&quot;:&quot;Ishita&quot;},{&quot;first_name&quot;:&quot;Liva&quot;,&quot;last_name&quot;:&quot;Harinantenaina Rakotondraibe&quot;},{&quot;first_name&quot;:&quot;Sandip&quot;,&quot;last_name&quot;:&quot;Vibhute&quot;},{&quot;first_name&quot;:&quot;Dasheng&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Pavel&quot;,&quot;last_name&quot;:&quot;Anzenbacher&quot;},{&quot;first_name&quot;:&quot;Chad&quot;,&quot;last_name&quot;:&quot;Bennett&quot;},{&quot;first_name&quot;:&quot;Petr&quot;,&quot;last_name&quot;:&quot;Bartunek&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;C. Coss&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;9330-9353&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00555&quot;},&quot;abstract&quot;:&quot;Selective agonism of the estrogen receptor (ER) subtypes, ERα and ERβ, has historically been difficult to achieve due to the high degree of ligand-binding domain structural similarity. Multiple efforts have focused on the use of classical organic scaffolds to model 17β-estradiol geometry in the design of ERβ selective agonists, with several proceeding to various stages of clinical development. Carborane scaffolds offer many unique advantages including the potential for novel ligand/receptor interactions but remain relatively unexplored. We synthesized a series of para-carborane estrogen receptor agonists revealing an ERβ selective structure–activity relationship. We report ERβ agonists with low nanomolar potency, greater than 200-fold selectivity for ERβ over ERα, limited off-target activity against other nuclear receptors, and only sparse CYP450 inhibition at very high micromolar concentrations. The pharmacological properties of our para-carborane ERβ selective agonists measure favorably against clinically d&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00555&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00555" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00555&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00555" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00555&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00555" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00555&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00555&amp;href=/doi/10.1021/acs.jmedchem.1c00555" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00555" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00555" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00555%26sid%3Dliteratum%253Aachs%26pmid%3D34181409%26genre%3Darticle%26aulast%3DSedl%25C3%25A1k%26date%3D2021%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2Bof%2Bpara-Carborane%2BSelective%2BEstrogen%2BReceptor%2B%25CE%25B2%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D13%26spage%3D9330%26epage%3D9353%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Selective agonism of the estrogen receptor (ER) subtypes, ERα and ERβ, has historically been difficult to achieve due to the high degree of ligand-binding domain structural similarity. Multiple efforts have focused on the use of classical organic scaffolds to model 17β-estradiol geometry in the design of ERβ selective agonists, with several proceeding to various stages of clinical development. Carborane scaffolds offer many unique advantages including the potential for novel ligand/receptor interactions but remain relatively unexplored. We synthesized a series of <i>para</i>-carborane estrogen receptor agonists revealing an ERβ selective structure–activity relationship. We report ERβ agonists with low nanomolar potency, greater than 200-fold selectivity for ERβ over ERα, limited off-target activity against other nuclear receptors, and only sparse CYP450 inhibition at very high micromolar concentrations. The pharmacological properties of our <i>para</i>-carborane ERβ selective agonists measure favorably against clinically developed ERβ agonists and support further evaluation of carborane-based selective estrogen receptor modulators.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="fncc"><span><h4></h4></span><span><p class="last">Preparation of 5-Methylhexan-1-al: PCC (3.71 g, 17.21 mmol) was suspended in dry methylene chloride (40 mL). A solution of 5-methyl-1-hexanol (1 g, 8.61 mmol) in methylene chloride (15 mL) was then added in one portion to the stirred suspension to give a dark reaction mixture, which was stirred at room temperature overnight. Dry ether (60 mL) was added and then molecular sieve followed by stirring for 1 h. The supernatant liquid was decanted, and the insoluble residue was washed with dry ether (3 × 20 mL). The combined organic phases were passed through a short florisil column, and the solvent was removed in vacuo providing 370 mg (38%) of product, which was used without further purification and analysis in the next step.</p></span></div><div class="fnGroupItem" id="fnd"><span><h4></h4></span><span><p class="last">Preparation of 6-Methylheptan-1-al: PCC (2.89 g, 13.44 mmol) was suspended in dry methylene chloride (40 mL). A solution of 6-methyl-1-heptanol (1 g, 7.68 mmol) in methylene chloride (15 mL) was then added in one portion to the stirred suspension to give a dark reaction mixture, which was stirred at room temperature overnight. Dry ether (60 mL) was added and then molecular sieve followed by stirring for 1 h. The supernatant liquid was decanted, and the insoluble residue was washed with dry ether (3 × 20 mL). The combined organic phases were passed through a short florisil column, and the solvent was removed in vacuo providing 750 mg (76%) of product, which was used without further purification and analysis in the next step.</p></span></div></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although the physiologic functions of estrogens have been recognized as clinically important for roughly a century,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> the underlying mechanisms of estrogen action were largely unknown prior to the discovery of a high-affinity estrogen receptor (estrogen receptor α, or ERα) in 1958 and subsequent cloning of its gene in 1985.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Nonetheless, residual effects of exogenous estrogens in ERα knockout (ERα-KO) mice<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> were not readily explained until the surprising discovery of the second estrogen receptor (estrogen receptor β, or ERβ).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Mechanistically, ERα and ERβ function as transcription factors, which upon estrogen stimulation, translocate to the cell nucleus, homo- or hetero-dimerize, and bind to specific DNA sequences present in regulatory elements of target genes.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Adding to the complexity of estrogen signaling, a G protein-coupled transmembrane receptor, GPER1 (GPR30) localized to endoplasmic reticulum has been recently identified and demonstrated to be involved in acute estrogen-mediated responses.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> ERα, ERβ, and GPER1 are widely expressed in diverse tissues but have distinct distribution patterns, and even opposing functions, which creates a complex picture of composite estrogen action.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a></div><div class="NLM_p">All three receptor isoforms bind to the predominate circulating endogenous estrogen 17β-estradiol (E2) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) with very similar high affinities<a onclick="showRef(event, 'ref9 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref12 ref13">(9,12,13)</a> such that genetic approaches are required to deconvolute the contributions of each receptor to whole animal estrogen response. Characterization of ERα,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> ERβ,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and GPER1<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> genetically null mice supports distinct biological functions of each receptor including a very limited role for ERβ in control of steroidogenesis and homeostasis of uterine and breast tissues.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Estrogen receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One considerable challenge in understanding ERβ biology are the well-known differences in phenotypes between the multiple ERβKO mice that have been thus far developed.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> However, when KO mice are simultaneously treated with ERβ selective (diarylpropionitrile<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> [DPN]) or ERα selective (propylpyrazole triol<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> [PPT]) tool compounds, a clearer role for ERβ emerged.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The improved understanding of ERβ’s role in nonreproductive tissues and inflammatory response resulted in a heightened interest in developing ERβ-targeted therapeutics that could minimize unwanted ERα-mediated side effects classically associated with estrogen administration.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Structurally, both ERα and ERβ are composed of three major domains: N-terminal transactivation domain, central DNA-binding domain (DBD), and C-terminal ligand-binding domain (LBD). There is 97% amino acid sequence identity between DNA-binding domains and 54% between LBDs of human ERα and ERβ.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Given the high structural similarity in human and preclinical species LBDs,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> selective targeting of ERβ over ERα is challenging. Despite this, numerous chemically diverse selective ERβ agonists have been described with several compounds reporting low nanomolar ERβ activity and ≥100-fold selectivity over ERα.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Clinical development of ERβ agonists has thus far been limited to two agents. ERB-041<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (prinaberel), a selective agonist with a benzoxazole scaffold, was the first clinical candidate described and was developed to treat rheumatoid arthritis and other inflammatory diseases including Crohn’s disease, endometriosis, and interstitial cystitis, but ultimately failed to demonstrate efficacy in phase II trials.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> LY500307 (SERBA-1, erteberel), a selective agonist with a benzopyran core,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> was later advanced for the treatment of symptoms associated with benign prostatic hypertrophy but similarly failed to demonstrate efficacy in phase II trials.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Though development of ERB-041 has been terminated, LY500307 has recently been evaluated for symptoms associated with schizophrenia<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (NCT01874756) and for estrogen withdrawal-induced mood symptoms in women with past perimenopausal depression<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (NCT03689543). The continued description of novel, isoform-selective, estrogen receptor ligands suggests interest in the development of therapeutic estrogens remains high.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">While many groups have focused on “classical” organic scaffolds to develop potent ER modulators, in 1999, Endo and colleagues reported the estrogen receptor activity of a series of novel 17β-estradiol bioisosteres<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> belonging to a structurally unique class of molecules known as dicarba-<i>closo</i>-dodecaboranes (carboranes). Carboranes are perhaps best known for their use in boron-neutron capture therapy<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33−35)</a> (BNCT) and also possess multiple attractive features for use in non-BNCT-based medicinal chemistry including, but not limited to, their highly hydrophobic nature, spherical shape, which provides three-dimensional flexibility for target–ligand interactions compared to their two-dimensional benzene counterpart, and their resistance toward conventional enzymatic degradation.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a></div><div class="NLM_p">To explore the possibility to control ligand selectivity for ERα and ERβ, we prepared a series of 17β-estradiol derivatives substituted by different <i>ortho</i>-<i>, meta-</i>carboranes and metallacarboranes in the 17α-position.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Although these compounds acted as partial ER agonists, the selectivity for either isoform was achieved only to a limited extent in contrast to similar efforts carried out with perfluoroalkyl- or aryl-substituted 17β-estradiols.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a></div><div class="NLM_p last">Endo and colleagues explored a different route. Through comprehensive docking studies, they noted that carboranylphenols provided the proper molecular geometry and hydrophobicity to fit within the ERα LBD while maintaining key hydrogen bonds required for high affinity.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> From this work, the <i>para</i>-carborane <b>BE120</b> was shown to be an effective 17β-estradiol mimic with sufficient druglike properties to provide in vivo estrogenic effects following daily parenteral dosing in rats.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> By comparing <b>BE120</b> to ERB-041, this same group more recently reported <i>para</i>-carboranylcyclohexanol derivatives with ERβ selective activity.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Herein, we describe a novel series of <b>BE120</b>-based <i>para</i>-carborane derivatives demonstrating highly selective ERβ agonist activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84815" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84815" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The intermediate hydrocarbon- (pathway 1) or α-hydroxy-hydrocarbon-substituted <i>para</i>-carboranes <b>2a</b>–<b>x</b> (pathway 2) were prepared by lithiation of <b>1</b><a onclick="showRef(event, 'ref43 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref45">(43,45)</a> with <i>n</i>-butyllithium in 1,2-dimethoxyethane followed by alkylation with different alkyl halides or treatment with various aldehydes, respectively, as seen in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Subsequent demethylation with boron tribromide in methylene chloride furnished the target carboranes <b>BE120</b> and <b>3b</b>–<b>x</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Alkyl- and Hydroxyalkyl-Substituted Carboranes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) <i>n</i>-BuLi, dimethoxyethane (1,2-DME), −78 or 0 °C; (b) BBr<sub>3</sub>, CH<sub>2</sub>CI<sub>2</sub>, 0 °C to room temperature (RT).</p></p></figure><div class="NLM_p">The synthesis of each enantiomer of chiral alcohol <b>3k</b> and ketone <b>9</b> was carried out as described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Oxidation of <b>2k</b> using pyridinium chlorochromate (PCC) in methylene chloride provided ketone <b>4</b>, which was selectively reduced to the corresponding <i>S</i> and <i>R</i> enantiomers <b>5</b> and <b>6</b> using Corey–Bakshi–Shibata (CBS) conditions<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> as seen in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Subsequent demethylation using boron tribromide in methylene chloride furnished the target <i>S</i> and <i>R</i> enantiomers (<b>7</b> and <b>8</b>) and ketone <b>9</b>. The enantiomeric excesses (ee) of chiral alcohols <b>7</b> and <b>8</b> were determined to be >80 and >75%, respectively, through chiral high-performance liquid chromatography (HPLC) of intermediates <b>5</b> and <b>6</b>. The absolute configuration of chiral alcohol <b>8</b> was established by Mosher ester analysis.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Ketone <b>9</b> and <i>S</i> and <i>R</i> Enantiomers <b>7</b> and <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) PCC, CH<sub>2</sub>Cl<sub>2</sub>; (b) BH<sub>3</sub>·THF, (<i>S</i>)-2-Me-CBS, RT; (c) BH<sub>3</sub>·THF, (<i>R</i>)-2-Me-CBS, RT; (d) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to RT.</p></p></figure><div class="NLM_p">To determine the importance of the <i>para</i>-carborane core to the ERβ activity and selectivity, we made several analogues in which the <i>para</i>-carborane core was replaced with bioisosteric phenyl, cyclohexyl, and [2.2.2]-bicyclo groups. The syntheses of these non-carborane-containing compounds are detailed below.</div><div class="NLM_p">Commercially available biphenyl aldehyde <b>10</b> was treated with <i>n</i>-hexylmagnesium bromide, and then the resulting racemic alcohol was oxidized with PCC, as seen in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> to afford ketone <b>11</b>. Reduction of ketone <b>11</b> using borane–tetrahydrofuran (THF) complex and the (<i>R</i>)-2-Me-CBS reagent under CBS conditions yielded chiral alcohol <b>12</b>. Demethylation of the methyl phenyl ether moiety of <b>12</b> afforded bioisosteric phenyl analogue <b>13</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Phenyl Compound <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) <i>n</i>-Hexylmagnesium bromide, Et<sub>2</sub>O, 0 °C; (b) PCC, CH<sub>2</sub>CI<sub>2</sub>; (c) BH<sub>3</sub>·THF, (<i>R</i>)-2-Me-CBS, 0 °C; (d) 1-dodecanethiol, <i>N</i>-methylpyrrolidinone (NMP), NaOH, 100 °C.</p></p></figure><div class="NLM_p">Synthesis of the cyclohexyl-containing analogue <b>17</b> is depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Commercially available phenol <b>14</b> was methylated with iodomethane using cesium carbonate as the base in refluxing acetone to furnish intermediate <b>15</b>. Ketone <b>15</b> was subjected to (methoxymethyl)triphenylphosphonium chloride and lithium hexamethyldisilazane (LiHMDS) followed by subsequent acid hydrolysis. The resulting aldehyde was treated with <i>n</i>-hexylmagnesium bromide, followed by oxidation with PCC to afford ketone <b>16</b>. Reduction of ketone <b>16</b> using borane–THF complex and the (<i>R</i>)-2-Me-CBS reagent under CBS conditions yielded the chiral alcohol, which was subjected to demethylation of the methyl phenyl ether moiety to afford the bioisosteric cyclohexyl analogue <b>17</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Cyclohexyl Compound <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>I, acetone, reflux; (b) (methoxymethyl)triphenylphosphonium chloride, LiHMDS, THF; 2 N HCI; (c) hexylmagnesium bromide, Et<sub>2</sub>O, 0 °C; (d) PCC, CH<sub>2</sub>CI<sub>2</sub>; (e) BH<sub>3</sub>·THF, (<i>R</i>)-2-Me-CBS, 0°C; (f) 1-dodecanethiol, NMP, NaOH, 100 °C.</p></p></figure><div class="NLM_p">Synthesis of compound <b>26</b> started with the asymmetric [2.2.2]-bicyclocarboxylic acid <b>18</b>, as depicted in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Mercuric oxide-catalyzed bromination provided [2.2.2]-bicyclobromide <b>19</b>, which was then allowed to alkylate benzene via aluminum trichloride-catalyzed Friedel–Crafts alkylation to provide ester <b>20</b>. Lithium aluminum hydride reduction of ester <b>20</b>, followed by PCC promoted oxidation afforded aldehyde <b>21</b>. Treatment of this aldehyde with <i>n</i>-hexylmagnesium bromide gave racemic alcohol <b>22</b>, which was then brominated to provide alcohol <b>23</b>. PCC oxidation followed by reduction of the resulting ketone <b>24</b> using borane–THF complex and the (<i>R</i>)-2-Me-CBS reagent under CBS conditions<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> yielded chiral alcohol <b>25</b>. Palladium-catalyzed substitution of the aryl bromide of <b>25</b> to a hydroxyl group by utilizing benzaldehyde oxime afforded the desired [2.2.2]-alcohol <b>26</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of [2.2.2]Bicyclic Compound <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Br<sub>2</sub>, dichloromethane (DCM), HgO; (b) AICI<sub>3</sub>, benzene, (c) LiAIH<sub>4</sub>, Et<sub>2</sub>O; (d) PCC, NaHCO<sub>3</sub>, NaOAc, CH<sub>2</sub>CI<sub>2</sub>; (e) hexylmagnesium bromide, Et<sub>2</sub>O; (f) AgOAc, Br<sub>2</sub>, CHCI<sub>3</sub>; (g) PCC, CH<sub>2</sub>CI<sub>2</sub>; (h) BH<sub>3</sub>·THF, (<i>R</i>)-2-Me-CBS 0 °C; (i) benzaldehyde oxime, Cs<sub>2</sub>CO<sub>3</sub>, RockPhos Pd G3.</p></p></figure><div class="NLM_p">Finally, to better understand the importance of the para-substituted phenol in relation to its ERβ agonism activity, a series of analogues were prepared in which the aryl group attached directly to the carborane core was replaced with various substituents as seen <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Briefly, carboranes <b>27</b> and <b>29</b> were lithiated with <i>n</i>-butyllithium in 1,2-dimethoxyethane followed by the addition of the resulting lithiated species into 1-heptanal to afford the target phenyl-substituted carborane <b>28</b> and intermediate <b>30</b>, respectively. Intermediate <b>30</b> was demethylated utilizing boron tribromide in dichloromethane to furnish the target meta-substituted phenol compound <b>31</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>28</b> and <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) <i>n</i>-BuLi, 1,2-DME, −78 or 0 °C, 1-heptanal; (b) BBr<sub>3</sub>, CH<sub>2</sub>CI<sub>2</sub>, 0 °C to RT.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Structure–Activity Relationship (SAR) Study</h3><div class="NLM_p">The target compounds were analyzed for their ability to interact with ERα and ERβ by two approaches. We determined binding affinity to both receptors using a competitive biochemical polarized fluorescence-based assay with a fluorescent tracer. We also measured the consequence of receptor binding using luciferase cell-based ER transactivation functional assays in human embryonic kidney (HEK) cells expressing full-length ERα or ERβ. Our results are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The modulation of ER biological activity is a result of an orchestrated series of ligand–receptor, receptor–DNA, and receptor–transcriptional machinery interactions ultimately concluding in the modulation of transcription from the ER-regulated promoters. Considering this complex mechanism of ligand-induced transactivation, our SAR was driven using cellular transactivation data and binding affinities were primarily used to confirm the specificity of the interaction and observed activity trends.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure and Biological Activities of Novel <i>para</i>-Carborane-Based Estrogen Receptor Modulators</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Each compound was tested for ERα and ERβ agonism in luciferase transactivation assay and compared to 17β-estradiol. The EC<sub>50</sub> values are shown in nanomolar. Agonism is reported as full (≥67%) colored in green, partial (34−66%) colored in yellow, weak partial (10−33%) colored in red, and no agonism (<10%) not colored. To determine the ranking of agonism, percent agonism was calculated using <i>E</i><sub>max</sub> for each compound and comparing to the activity of 100 nM 17β-estradiol set to 100%.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">ERβ selectivity was calculated as the ratio of EC<sub>50</sub> for ERα/EC<sub>50</sub> for ERβ.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Compound cytotoxicity from parallel experiment to reporter assays determined by measurement of intracellular adenosine 5′-triphosphate (ATP) levels. IC<sub>50</sub> values are expressed in micromolar.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Compound affinities for ERα or ERβ proteins were evaluated in polarized fluorescence-based competitive binding assay PolarScreen ER α/β. Compounds were allowed to compete with Fluormone EL Red ligand for the binding to the receptor in a dose response experiment, and <i>K</i><sub>d</sub> values were calculated from IC<sub>50</sub> values using the Cheng−Prusoff equation.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">n.a., not active.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">n.c., not calculated.</p></div></div><div></div></div><div class="NLM_p">PPT was used as a positive control for ERα-selective agonism, and DPN was used as a positive control for ERβ-selective agonism. 17β-Estradiol (E2) was used as an endogenous ligand benchmark, and it is potent against both isoforms with only 1.3-fold selectivity for ERβ over ERα. For the purposes of this paper, maximal agonism is defined by E2, and all other agonistic effects are reported as either full agonism (≥67%, highlighted in green), partial agonism (34–66%, highlighted in yellow), weak partial agonism (10–33%, highlighted in red), or no agonism (<10%, not highlighted) relative the observed response of E2. Initially, we demonstrated that the highly potent agonist (<b>BE120</b>), originally reported by Endo and colleagues,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> was nonselective with equimolar potency and full agonism activity for both ERα and ERβ isoforms. In an effort to design a more selective ERβ agonist, we set out to investigate the structure–activity relationship at the R<sup>3</sup> position. Interestingly, compound <b>3b</b>, with a methyl group replacing the hydroxyl group of <b>BE120</b>, reduced the agonist potency for ERα by ∼1000-fold and ERβ by ∼30-fold, resulting in 36-fold selectivity for ERβ over ERα. Reintroducing a hydroxyl at the carbon closest to the carborane cage (compound <b>3c</b>) restored most of the potency of <b>BE120</b> but also reduced the selectivity to 8-fold. Based on these analogues, we designed a series of molecules extending and modifying the alkyl chain with and without a hydroxyl adjacent to the carborane core. The addition of one and then two more methylene units (compounds <b>3d</b>–<b>g</b>) resulted in reduced potencies, similar in magnitude between the isoforms with a modest preference for ERβ (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). By extending by one more methylene to an <i>n</i>-pentyl side chain (<b>3h</b> and <b>3i</b>), these two series now began to diverge more significantly. Compound <b>3h</b> retained a very similar profile to that of the <i>n</i>-butyl analogue <b>3f</b> with good potency but modest selectivity. However, α-hydroxy compound <b>3i</b> demonstrated a much larger drop in potency for ERα, leading to 92-fold selectivity for ERβ over ERα. Compound <b>3j</b> with an <i>n</i>-heptyl side chain continued the trend of reduced potency and modest selectivity, while the corresponding α-hydroxylated molecule <b>3k</b> had improved ERβ potency and selectivity. Importantly, <b>3k</b> was the first molecule demonstrating full agonism for ERβ, but partial agonism for ERα. Extending the chain length further to <i>n</i>-decyl in <b>3l</b> and <b>3m</b> eroded the ERβ potency displayed by <b>3j</b> and <b>3k</b>, respectively.</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Ligand selectivity for ERβ increases with elongation of the side hydrocarbon chain. <b>BE120</b>, <b>3g</b>, and <b>8</b> were tested in ERα (dashed line) and ERβ (solid line) transactivation assays in the concentration range between 10 μM and 1 pM, in triplicates and activities were expressed relative to 100 nM 17β-estradiol set to 100%. Increasing length of the carboranes’ side hydrocarbon chain is accompanied with decreasing potency in both ERα and ERβ reporter assays and by increasing selectivity for ERβ (blue: nonselective, green: 10–100× selective, red: selectivity >100×).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Adding a branching methyl at the end of the alkyl chain (<b>3n</b>–<b>q</b>) followed the SAR described above, with modest decreases in potency (ca. 2- to 10-fold) but with minimal effect on selectivity (compare <b>3n</b> with <b>3i</b>, <b>3p</b> with <b>3j</b>, and <b>3q</b> with <b>3k</b>, <b>7</b>, and <b>8</b>.) The single indane-containing molecule (<b>3r</b>) did not exhibit high selectivity. Several molecules were made to explore the effects of replacing the terminal isopropyl substituent of <b>3n</b>–<b>q</b> with a terminal phenyl ring. Overall, the SAR for these analogues is less consistent with regard to potency, selectivity, and agonism. However, it does appear that the α-hydroxylated molecules (<b>3t</b>, <b>3v</b>, and <b>3x</b>) are less selective for ERβ than their nonhydroxylated counterparts (<b>3s</b>, <b>3u</b>, and <b>3w</b>). Notably, one of the highest ERβ selective activities we observed belonged to this class. Compound <b>3u</b> showed an EC<sub>50</sub> = 87 nM on ERβ and no detectable activity on ERα up to 100 μM, therefore demonstrating selectivity of more than 3 orders of magnitude. This divergence implies that there are favorable aromatic interactions occurring in the binding site and that an α-hydroxyl group reorients the phenyl ring away from these hypothesized favorable interactions. In the future, additional analogues will be needed to better understand this portion of the SAR.</div><div class="NLM_p">As seen in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, compounds <b>7</b> and <b>8</b>, the individual <i>S</i> and <i>R</i> enantiomers of <b>3k</b>, each retained good ERβ potency and high selectivity, as well as partial agonism for ERα. While the presence α-hydroxyl group clearly improves ERβ potency and selectivity, its stereo configuration does not seem to meaningfully impact ER-isoform selectivity. Since both enantiomers of <b>3k</b> are similarly active and selective, it is interesting to note that corresponding ketone <b>9</b> displays reduced ERβ potency and selectivity. Based on the overall structure–activity relationship described, compounds <b>7</b>, <b>8</b>, and <b>3q</b> demonstrate a good balance between selectivity and potency for ERβ, warranting additional biological profiling, which will be the subject of future reports.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Activity of Enantiomers of <b>3k</b> and Its Ketone Precursor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Each compound was tested for ERα and ERβ agonism in luciferase transactivation assay and compared to 17β-estradiol. The EC<sub>50</sub> values are shown in nanomolar. Agonism is reported as full (≥67%) colored in green, partial (34−66%) colored in yellow, weak partial (10−33%) colored in red, and no agonism (<10%) not colored. To determine the ranking of agonism, percent agonism was calculated using <i>E</i><sub>max</sub> for each compound and comparing to the activity of 100 nM 17β-estradiol set to 100%.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">ERβ selectivity was calculated as the ratio of EC<sub>50</sub> for ERα/EC<sub>50</sub> for ERβ.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Compound cytotoxicity from parallel experiment to reporter assays determined by measurement of intracellular adenosine 5′-triphosphate (ATP) levels. IC<sub>50</sub> values are expressed in micromolar.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Compound affinities for ERα or ERβ proteins were evaluated in polarized fluorescence-based competitive binding assay PolarScreen ER α/β. Compounds were allowed to compete with Fluormone EL Red ligand for the binding to the receptor in a dose response experiment, and <i>K</i><sub>d</sub> values were calculated from IC<sub>50</sub> values using the Cheng−Prusoff equation.</p></div></div><div></div></div><div class="NLM_p">Next, we wanted to evaluate the importance of the <i>para</i>-carborane core to the biological activity of these molecules. To do so, a series of molecules were made in which the <i>para</i>-carborane core was replaced while retaining the left-hand side phenol and the right-hand side 1-hydroxy-<i>n</i>-heptyl side chain of compound <b>8</b>. The results are detailed in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Replacing the carborane with either <i>para</i>-phenyl or 1,4-cyclohexyl rings resulted in analogues <b>13</b> and <b>17</b> that displayed no measurable agonist activity at either ERα or ERβ. We then used a [2.2.2] bridged bicycle <b>26</b> as an isostere that would better mimic the three-dimensional shape of the carborane. Bridged bicycle <b>26</b> lost ∼100-fold activity for ERβ compared to the benchmark of <b>8</b> and had no measurable agonism for ERα. From these data, it seems clear that the carborane core structure plays a unique role in affording ER agonist activity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Activity of Bioisosteric Replacements of <i>para</i>-Carborane Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0013.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Each compound was tested for ERα and ERβ agonism in luciferase transactivation assay and compared to 17β-estradiol. The EC50 values are shown in nanomolar. Agonism is reported as full (≥67%) colored in green, partial (34−66%) colored in yellow, weak partial (10−33%) colored in red, and no agonism (<10%) not colored. To determine the ranking of agonism, percent agonism was calculated using <i>E</i><sub>max</sub> for each compound and comparing to the activity of 100 nM 17β-estradiol set to 100%.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">ERβ selectivity was calculated as the ratio of EC<sub>50</sub> for ERα/EC<sub>50</sub> for ERβ.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Compound cytotoxicity from parallel experiment to reporter assays determined by measurement of intracellular adenosine 5′-triphosphate (ATP) levels. IC<sub>50</sub> values are expressed in micromolar.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Compound affinities for ERα or ERβ proteins were evaluated in polarized fluorescence-based competitive binding assay PolarScreen ER α/β. Compounds were allowed to compete with Fluormone EL Red ligand for the binding to the receptor in a dose response experiment, and <i>K</i><sub>d</sub> values were calculated from IC<sub>50</sub> values using the Cheng−Prusoff equation.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">n.c., not calculated.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">n.d., not determined.</p></div></div><div></div></div><div class="NLM_p">Finally, we were interested in probing the importance of the para-substituted phenol in relation to ERβ selectivity and agonism activity. The hydroxyheptyl side chain was kept constant while the phenol moiety was replaced with various aryl groups as seen in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Replacement of the para-substituted phenol with a phenyl (compound <b>28</b>) resulted in complete loss of activity. Similarly, methylation of the phenol (compound <b>2k</b>) resulted in complete loss of activity as well. Interestingly, the meta-substituted phenol compound <b>31</b> displayed modest ERβ agonism activity and excellent ERβ selectivity suggesting that there is flexibility in the binding pocket for accommodating phenols with different substitution patterns.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Modification of the Phenol</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0014.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Each compound was tested for ERα and ERβ agonism in luciferase transactivation assay and compared to 17β-estradiol. The EC<sub>50</sub> values are shown in nanomolar. Agonism is reported as full (≥67%) colored in green, partial (34–66%) colored in yellow, weak partial (10–33%) colored in red, and no agonism (<10%) not colored. To determine the ranking of agonism, percent agonism was calculated using <i>E</i><sub>max</sub> for each compound and comparing to the activity of 100 nM 17β-estradiol set to 100%.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">ERβ selectivity was calculated as the ratio of EC<sub>50</sub> for ERα/EC<sub>50</sub> for ERβ.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Compound cytotoxicity from parallel experiment to reporter assays determined by measurement of intracellular adenosine 5′-triphosphate (ATP) levels. IC<sub>50</sub> values are expressed in micromolar.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Compound affinities for ERα or ERβ proteins were evaluated in polarized fluorescence-based competitive binding assay PolarScreen ER α/β. Compounds were allowed to compete with Fluormone EL Red ligand for the binding to the receptor in a dose response experiment, and <i>K</i><sub>d</sub> values were calculated from IC<sub>50</sub> values using the Cheng–Prusoff equation.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">n.a., not active.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">n.c., not calculated.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Interactions with Other Nuclear Receptors (NRs)</h3><div class="NLM_p">In addition to the successful preparation of different <i>para-</i>carborane series as ligands for ERα and ERβ, Endo and colleagues showed that structurally similar <i>para-</i>carboranes can bind to androgen receptor (AR) and show full antagonistic activities in the micromolar range.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> To investigate the possibility that ERβ and ERα, to a certain extent, are not the sole binding targets of these compounds, we systematically profiled the compound library in a panel of selective luciferase transactivation assays for 20 different nuclear receptors (NRs). All compounds were tested at 1 μM in both agonist and antagonist modes to identify all possible effects mediated through these receptors. Besides ERα and ERβ, we tested the library in the assays for remaining steroid receptors (SRs): androgen (AR), progesterone (PR), glucocorticoid (GR), and mineralocorticoid receptor (MR). These assays consist of clonal lines expressing individual human full-length steroid receptors in U2OS osteosarcoma cells. The reporter luciferase expression is controlled by viral long terminal repeat (LTR) promoter isolated from mouse mammary tumor virus (MMTV) harboring response elements for different SRs. Data summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Supporting Information</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Tables S1 and S2</a>) clearly show the prominent agonist activity on ERβ and, to less extent, on ERα. These data also confirm that chemical diversity represented in the library modulated ERβ selectivity and potency but never switched ER activity into antagonism as we did not detect any ER antagonist activity at 1 μM. Further, we did not find any activity on remaining SRs in any of the tested activity modes. This outcome accents the selectivity of <i>para</i>-carborane derivatives for ERβ.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Activities of the carboranes’ compound library on steroid receptors. (A) Compounds were profiled at 1 μM in the selective luciferase reporter assays for the agonistic and (B) antagonistic activities for steroid receptors. The activity is expressed relative to maximal activity induced by reference compound or as a fold induction compared to untreated cells for control assay (MMTV reporter alone, dark red dots). Cell viability in U2OS cells was used as a control experiment for the antagonistic activities and is expressed in a scale of 0–100% relative to dimethyl sulfoxide (DMSO)-treated cells (green dots).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Then, we extended the profiling further to other members of NR family: ERRγ, farnesoid X receptor (FXR), liver X receptor (LXR)α and β, peroxisome proliferator-activated receptor (PPAR)α, β/δ and γ, vitamin D receptor (VDR), retinoic acid receptor (RAR) α and γ and retinoid X receptor (RXR) α, β and γ. To maintain indispensable selectivity in these assays for individual receptors while keeping unified cellular background of U2OS cells expressing many NRs, we used a Ga4/upstream activating sequences (UAS) reporter system for luciferase transactivation assays. These assays are based on human chimeric NRs generated by the replacement of the N-terminally located DNA-binding domain (DBD) by a DBD from the yeast transcription factor Gal4. The chimeric receptor Gal4-DBD/NR-LBD binds to multiple upstream activating sequences (UAS) in the promoter controlling the expression of the firefly luciferase. The results shown in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Supporting Information</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Tables S1 and S2</a>) reveal only a few individual interactions with some receptors. Agonist activity exceeding 25% of the receptor activation was detected only for <b>3w</b> and <b>3x</b> in the ERRγ reporter assay (46.1 and 30.8%, respectively). Both efficacy and potency of these compounds are rather low for considering them as true ERRγ ligands, but this finding can be explored in depth in the future. In the antagonist mode, we found only a few compounds with inhibitory activity approaching, but never exceeding 50%. However, these activities appear sporadically in the library and do not show SAR pattern.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Inhibition of Cytochrome 450 Isoforms</h3><div class="NLM_p">As the majority of small molecule drugs (as well as compounds foreign to the organism) are metabolized by liver microsomal cytochromes P450 (CYPs), it is necessary to study interactions of promising active compounds with these enzymes.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> We characterized five compounds of interest (<b>BE120</b>, <b>3g</b>, <b>7</b>, <b>8</b>, and <b>3u</b>) showing different levels of ERβ selectivity, with nine forms of CYPs known to participate in drug metabolism to verify whether these compounds may interfere with drug metabolism in human and pose a potential risk for unwanted drug–drug interactions (DDI).</div><div class="NLM_p">The results summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> indicate a relatively potent inhibition of CYP activities by compound <b>BE120</b>, which has the lowest molecular weight (MW) from the prepared derivatives and highest estrogenic activity with no ER selectivity. This compound interferes most strongly with activity of CYP3A4 exhibiting inhibition in micromolar range (IC<sub>50</sub> = 0.5 μM). This observation is in line with study of Lee et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> showing that CYP3A4 enzymes are the major CYPs isoforms responsible for E2 metabolism. Increasing structural complexity and selectivity for ERβ is accompanied with weakening of the CYP inhibition which can be interpreted in light of the structure of CYP3A4’s active site. CYP3A4 has a rather open and flexible active site which allows promiscuous interactions with diverse drugs and xenobiotics as well as endogenous small molecules including steroids<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> Overall, our data support limited risk of DDIs with this new class of ERβ agonists.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibition of CYP450 Enzyme Isoforms by <i>para</i>-Carboranes Selected for Their Structural Diversity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0015.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Inhibitory activities of compounds were tested in dose response experiment with specific substrates for individual CYP forms. The enzyme activity was detected by HPLC Prominence system (Shimadzu; Kyoto, Japan) with a UV/fluorescence detection.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">n.a., not active.</p></div></div><div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Herein, we describe novel ERβ selective <i>para</i>-carborane agonists with in vitro isoform selectivity and potency that compare favorably to previously described ERβ agonist clinical candidates. <b>ERB-041</b> was reported to have striking 222-fold ERβ selective binding to recombinant human ERβ over ERα LBD, with a potency 5.4 nM, which is only 1.5-fold reduced potency compared with 17β-estradiol.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> However, in a functional assay evaluating the transcription of an ER target gene in cells transformed with either full-length human ERβ or ERα, selectivity was reduced to 14.3-fold with an ERβ potency of 20.0 nM. Similarly, <b>LY500307</b> has been previously reported to have 0.19 nM <i>K</i><sub>i</sub> for full-length recombinant human ERβ with 14-fold selective ERβ binding in a radio-ligand binding assay.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Using a similar reporter gene assay system to the activity data we present, <b>LY500307</b> was shown to be 30-fold ERβ selective with an EC<sub>50</sub> 0.66 nM for ERβ. Direct comparisons of <b>LY500307</b> to 17β-estradiol are not readily ascertained from published data. Though we acknowledge the various assay systems employed limit the utility of directly comparing our data, the potency of compounds <b>7</b>, <b>8</b>, and <b>3q</b> (27, 19, and 61 nM, respectively) and ERβ selectivity (191-, 201-, and 296-fold, respectively) suggest that these ligands may have therapeutically relevant ERβ pharmacological properties and warrant further investigation.</div><div class="NLM_p last">Finally, the general suitability of carboranes’ druglike properties is yet to be described. It is promising that in vivo estrogen effects have been reported following multiple subcutaneous doses of <b>BE120</b>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> However, to our knowledge, no comprehensive evaluation of carborane tolerability or drug disposition exists. It has been previously hypothesized that carboranes would likely undergo limited metabolism based on their inorganic nature.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In agreement with this, our CYP inhibition data suggests carboranes in our series are poor CYP substrates. We hypothesized that the hydrophobic character of the carboranes may result in problematic solubility and plasma protein binding limitations. To this end, the druglike properties of <b>7</b>, <b>8</b>, and <b>3q</b> were further profiled. The results of these experiments will be the subject of future reports.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemicals, Materials, and Methods</h3><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at The Ohio State University College of Pharmacy using a Bruker AVIII400HD NMR spectrometer or a Bruker DRX400 NMR spectrometer, or at The Ohio State University Campus Chemical Instrumentation Center using a Bruker Ascend 700 MHz NMR. Chemical shifts (δ) are reported in parts per million (ppm) from chemical reference shifts for internal deuterated chloroform or deuterated acetone reported previously by Fulmer et al.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Coupling constants are reported in hertz. <sup>13</sup>C NMR spectra are fully decoupled. NMR spectra were analyzed with Mnova Lite SE (Mestrelab Research, Bajo, Spain) or TopSpin. Melting points were obtained on a Thomas Hoover “UNI-MELT” capillary melting apparatus. Optical rotation was measured on a JASCO J-810 spectropolarimeter. Accurate- and high-resolution mass spectra were obtained from Ohio State University Campus Chemical Instrumentation Center using a Waters Micromass LCT mass spectrometer or a Waters Micromass Q-TOF II mass spectrometer, from The Ohio State University College of Pharmacy using a Waters Micromass Q-TOF micro mass spectrometer or a Thermo LTQ Orbitrap mass spectrometer, or from the University of Illinois Urbana–Champaign Mass Spectrometry Laboratory using a Waters Micromass 70-VSE mass spectrometer, or at the University of Michigan College of Literature, Science and the Arts Mass Spectrometry Technical Services on a Micromass Autospec Ultima Magnetic Sector mass spectrometer (HR-EI). For all carborane-containing compounds, the found mass corresponding to the most intense peak of the theoretical isotopic pattern was reported. Measured patterns agreed with calculated patterns.</div><div class="NLM_p">Silica gel 60 (0.063–0.200 mm), used for gravity column chromatography. Reagent-grade solvents were used for silica gel column chromatography. Precoated glass-backed thin-layer chromatography (TLC) plates with silica gel 60 F254 (0.25-mm layer thickness) from Dynamic Adsorbents (Norcross, GA) were used for TLC. General compound visualization for TLC was achieved by UV light. Carborane-containing compounds were selectively visualized by spraying the plate with a 0.06% PdCl<sub>2</sub>/1% HCl solution and heating at 120 °C, which caused the slow (15–45 s) formation of a gray spot due to the reduction of Pd<sup>2+</sup> to Pd<sup>0</sup>.</div><div class="NLM_p last">All HPLC studies were carried out using a Hitachi HPLC system (L-2130) equipped with a Windows-based data acquisition and Hitachi Diode array detector (L-2455). HPLC-grade solvents, purchased from Fisher Scientific (Waltham, MA), Acros Organics (Morris Plains, NJ), or Sigma-Aldrich (Milwaukee, WI), were used. The following columns were used: column (I) SMT SAM Analytical Column (250 × 4.6 mm<sup>2</sup>, particle size: 5 μm, 60 Å pore, normal phase silica, Si, Ref#: 2003P-C0076) from Analtech, Inc., Newark, DE. Column (II) CHIRAL PAK IB-3 column (250 × 4.6 mm<sup>2</sup>, 3 μm particle size) supplied by Chiral Technologies, PA. Purities of final compounds were determined by HPLC to be >95%. Anhydrous solvents were purchased from Fisher Scientific (Waltham, MA), Acros Organics (Morris Plains, NJ) or Sigma-Aldrich (Milwaukee, WI). <i>closo</i>-<i>p</i>-Carborane was purchased from Katchem Ltd. (Prague, Czech Republic). Other solvents and chemicals were obtained from standard vendors. Compounds <b>1</b>,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><b>BE120</b>,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a><b>3p</b>,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a><b>27</b>,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and <b>29</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> were synthesized as described previously. Unless specified otherwise, all reactions were carried out under argon atmosphere.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-(4-Methoxyphenyl)-12-ethyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2b</b>)</h4><div class="NLM_p last">To a solution of <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol) in anhydrous dimethoxyethane (DME, 40 mL) was added <i>n</i>-butyllithium (1 mL, 2.5 mmol, 2.5 M solution in hexanes) at −78 °C. The reaction mixture was stirred for 1.5 h at −78 °C. A quantity of 0.25 mL (3.0 mmol) of bromoethane, precooled to −78 °C, was added at −78 °C. Following stirring at room temperature overnight, the reaction mixture was carefully poured into 150 mL of 1 M HCl and extracted with ethyl acetate. The organic phase was washed with brine and dried over MgSO<sub>4</sub>. The solvents were evaporated, and the residue was purified by silica gel column chromatography to yield a white solid. Yield: 520 mg (93%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.78 (hexanes/EtOAc, 49/1, v/v), m.p.: 70–80 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.81 (t, 3H, CH<sub>3</sub>), 1.73 (q, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.67 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.00, 31.31, 55.38, 80.85, 81.60, 113.36, 128.50, 128.96, 159.62. Accurate mass high-resolution mass spectrometry (HRMS) (EI+): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>22</sub>B<sub>10</sub>O (M)<sup>+</sup> 278.2680, found 278.2675.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]ethan-1-ol (<b>2c</b>)</h4><div class="NLM_p last">To a solution of <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol) in anhydrous dimethoxyethane (DME, 40 mL) was added <i>n</i>-butyllithium (1 mL, 2.5 mmol, 2.5 M solution in hexanes) at −78 °C. The reaction mixture was stirred for 1.5 h at −78 °C. A quantity of 0.17 mL (3.0 mmol) of acetaldehyde, precooled to −78 °C, was added at −78 °C. Following stirring at room temperature overnight, the reaction mixture was carefully poured into 150 mL of 1 M HCl and extracted with ethyl acetate. The organic phase was washed with brine and dried over MgSO<sub>4</sub>. The solvents were evaporated, and the residue was purified by silica gel column chromatography to yield a white solid. Yield: 450 mg (76%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.24 (hexanes/EtOAc, 14/1, v/v), m.p.: 118–119 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.11 (d, 3H, CH<sub>3</sub>), 1.66 (d, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.74 (m, 4H, CH and OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 8.9 Hz), 7.12 (d, 2H, arom., <i>J</i> = 8.9 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 23.09, 55.40, 69.50, 83.36, 86.26, 113.43, 128.42, 128.80, 159.74. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>22</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 294.2629, found 294.2632.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-(4-Methoxyphenyl)-12-propyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2d</b>)</h4><div class="NLM_p last">To a solution of <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol) in anhydrous dimethoxyethane (DME, 40 mL) was added <i>n</i>-butyllithium (1 mL, 2.5 mmol, 2.5 M solution in hexanes) at 0 °C. The reaction mixture was stirred at room temperature for 1.5 h. A quantity of 0.237 mL (3.0 mmol) of 1-bromopropane was added at 0 °C. Following stirring at room temperature for 4 h, the reaction mixture was carefully poured into 60 mL of 1 M HCl and extracted with ethyl acetate. The organic phase was washed with a 10% aqueous sodium thiosulfate solution and brine and dried over MgSO<sub>4</sub>. The solvents were evaporated, and the residue was purified by silica gel column chromatography to yield a white solid. Yield: 510 mg (87%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.78 (hexanes/EtOAc, 49/1, v/v), m.p.: 95–96 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.77 (t, 3H, CH<sub>3</sub>), 1.20 (m, 2H, CH<sub>2</sub>), 1.63 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.67 (d, 2H, arom., <i>J</i> = 8.9 Hz), 7.12 (d, 2H, arom., <i>J</i> = 8.9 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.82, 22.96, 40.12, 55.38, 80.79, 80.96, 113.36, 128.49, 128.97, 159.62. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>24</sub>B<sub>10</sub>O (M)<sup>+</sup> 292.2837, found 292.2842.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]propan-1-ol (<b>2e</b>)</h4><div class="NLM_p last">To a solution of <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (0.5 g, 2 mmol) in anhydrous dimethoxyethane DME (40 mL) was added <i>n</i>-butyllithium (1.0 mL, 2.5 mmol, 2.5 M solution in hexanes) at 0 °C. The reaction mixture was stirred at room temperature for 1.5 h. A quantity of 0.22 mL (3 mmol) of 1-propanal was added at 0 °C. Following stirring at room temperature overnight, the reaction mixture was carefully poured into 150 mL of 1 M HCl and extracted with ethyl acetate. The organic phase was washed with brine and dried over MgSO<sub>4</sub>. The solvents were evaporated, and the residue was purified by column chromatography. Yield: 360 mg (58%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.32 (hexanes/EtOAc, 14/1, v/v), m.p.: 116–117 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.91 (t, 3H, CH<sub>3</sub>), 1.17–1.48 (m, 2H, CH<sub>2</sub>), 1.61 (d, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.39 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 8.9 Hz), 7.13 (d, 2H, arom., <i>J</i> = 8.9 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 11.29, 29.99, 55.39, 74.56, 83.56, 86.24, 113.42, 128.42, 128.84, 159.73. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>24</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 308.2786, found 308.2765.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(4-Methoxyphenyl)-12-butyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2f</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2d</b> was adapted to synthesize <b>2f</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), 1-Iodobutane (0.34 mL, 3.0 mmol). Yield: 400 mg (65%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.77 (hexanes/EtOAc, 49/1, v/v), m.p.: 55–56 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.83 (t, 3H, CH<sub>3</sub>), 1.14–1.17 (m, 4H, 2 × CH<sub>2</sub>), 1.65 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.67 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.84, 22.41, 31.76, 37.79, 55.38, 80.93, 113.36, 128.49, 128.97, 159.62. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>26</sub>B<sub>10</sub>O (M)<sup>+</sup> 306.2993, found 306.2992.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]butan-1-ol (<b>2g</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2g</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), 1-butanal (0.27 mL, 3.0 mmol). Yield: 500 mg (78%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.33 (hexanes/EtOAc, 19/1, v/v), m.p.: 96–97 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.16–1.27 (m, 2H, CH<sub>2</sub>), 1.35–1.52 (m, 2H, CH<sub>2</sub>), 1.59 (br. s, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.49 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.75, 19.82, 38.94, 55.40, 72.84, 83.54, 86.34, 113.42, 128.43, 128.84, 159.73. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>26</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 322.2943, found 322.2929.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(4-Methoxyphenyl)-12-pentyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2h</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2d</b> was adapted to synthesize <b>2h</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), 1-Iodopentane (0.392 mL, 3.0 mmol). Yield: 520 mg (81%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.46 (hexanes/EtOAc, 99/1, v/v), m.p.: 64–65 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.84 (t, 3H, CH<sub>3</sub>), 1.08–1.26 (m, 6H, 3 × CH<sub>2</sub>), 1.64 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.67 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.03, 22.39, 29.32, 31.40, 38.00, 55.38, 80.92, 113.36, 128.49, 128.97, 159.62. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>28</sub>B<sub>10</sub>O (M)<sup>+</sup> 320.3151, found 320.3147.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]pentan-1-ol (<b>2i</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2i</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), 1-pentanal (0.32 mL, 3 mmol). Yield: 540 mg (80%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.24 (hexanes/EtOAc, 19/1, v/v), m.p.: 92–93 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.15–1.34 (m, 4H, 2 × CH<sub>2</sub>), 1.39–1.46 (m, 2H, CH<sub>2</sub>), 1.59 (br. d, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.07, 22.40, 28.75, 36.60, 55.40, 73.09, 83.54, 86.39, 113.42, 128.43, 128.84, 159.73. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>28</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 336.3100, found 336.3116.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-(4-Methoxyphenyl)-12-heptyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2j</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2d</b> was adapted to synthesize <b>2j</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), 1-Iodoheptane (0.49 mL, 3.0 mmol). Yield: 550 mg (79%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.38 (hexanes), m.p.: 45–46 °C. Analytical HPLC: column I, solvent system: hexanes (100) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 5.11 min, purity 100.0% <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.08–1.28 (m, 10H, 5 × CH<sub>2</sub>), 1.64 (m, 2H, C<sub>carborane</sub>–CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.67 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.11 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.21, 22.73, 29.02, 29.24, 29.67, 31.82, 38.05, 55.39, 80.92, 113.36, 128.49, 128.97, 159.61. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>32</sub>B<sub>10</sub>O (M)<sup>+</sup> 348.3465, found 348.3461.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>2k</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2k</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (2.5 g, 10 mmol), 1-heptanal (1.83 mL, 13 mmol). Yield: 3.0 g (82%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.43 (hexanes/EtOAc, 19/1, v/v), m.p.: 104–105 °C. Analytical HPLC: column I, solvent system: hexanes/isopropyl alcohol (<i>i</i>-PrOH) (99/1) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 5.32 min, purity 99.87%, analytical HPLC: column II, solvent system: hexanes/CH<sub>2</sub>Cl<sub>2</sub> (9/1) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 9.67 min (area %: 49.99), 10.47 (area %: 49.0). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.88 (t, 3H, CH<sub>3</sub>), 1.15–1.30 (m, 8H, 4 × CH<sub>2</sub>), 1.38–1.47 (m, 2H, CH<sub>2</sub>), 1.59 (br. s, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.20, 22.71, 26.59, 28.98, 31.83, 36.92, 55.39, 73.10, 83.53, 86.39, 113.41, 128.43, 128.84, 159.73. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>32</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 364.3414, found 364.3423.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(4-Methoxyphenyl)-12-decyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2l</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2d</b> was adapted to synthesize <b>2l</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), 1-Iododecane (0.64 mL, 3.0 mmol). Yield: 420 mg (54%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.31 (hexanes), m.p.: 45–46 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.88 (t, 3H, CH<sub>3</sub>), 1.08–1.31 (m, 16H, 8 × CH<sub>2</sub>), 1.64 (m, 2H, C<sub>carborane</sub>–CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.67 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.28, 22.84, 29.29, 29.36, 29.44, 29.62, 29.68, 30.04, 38.06, 55.39, 80.93, 113.37, 128.50, 128.99, 159.63. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>38</sub>B<sub>10</sub>O (M)<sup>+</sup> 390.3936, found 390.3954.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]decyl-1-ol (<b>2m</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2m</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (0.5 g, 2 mmol), 1-decanal (0.57 mL, 3 mmol). Yield: 680 mg (86%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.31 (hexanes/EtOAc, 19/1, v/v), m.p.: 68–69 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.88 (t, 3H, CH<sub>3</sub>), 1.13–1.32 (m, 14H, 7 × CH<sub>2</sub>), 1.37–1.46 (m, 2H, CH<sub>2</sub>), 1.58 (d, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.46 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.26, 22.82, 26.63, 29.31, 29.42, 29.63, 29.65, 32.02, 36.92, 55.40, 73.10, 83.53, 86.39, 113.42, 128.43, 128.85, 159.73.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-4-methylpentan-1-ol (<b>2n</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2n</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (0.5 g, 2 mmol), 4-methylpentan-1-al (250 mg, 2.5 mmol). Yield: 580 mg (83%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.27 (hexanes/EtOAc, 19/1, v/v), m.p.: 111–112 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.84 (d, 3H, CH<sub>3</sub>), 0.85 (d, 3H, CH<sub>3</sub>), 1.06–1.19 (m, 2H, CH<sub>2</sub>), 1.30–1.45 (m, 2H, CH<sub>2</sub>), 1.46–1.52 (m, 1H, CH), 1.58 (d, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.45 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 8.9 Hz), 7.12 (d, 2H, arom., <i>J</i> = 8.9 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 22.36, 22.91, 27.88, 34.84, 35.72, 55.40, 73.10, 83.54, 86.43, 113.42, 128.43, 128.84, 159.74. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>30</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 350.3257, found 350.3260.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-5-methylhexan-1-ol (<b>2o</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2o</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (0.5 g, 2 mmol), 5-methylhexan-1-al<a class="ref internalNav" href="#fncc" aria-label="a">a</a> (370 mg, 3.25 mmol). Yield: 250 mg (34%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.32 (hexanes/EtOAc, 14/1, v/v), m.p.: 64–65 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.85 (d, 3H, CH<sub>3</sub>), 0.86 (d, 3H, CH<sub>3</sub>), 1.08–1.28 (m, 4H, 2 × CH<sub>2</sub>), 1.36–1.46 (m, 2H, CH<sub>2</sub>), 1.46–1.52 (m, 1H, CH), 1.60 (d, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 22.61, 22.76, 24.45, 28.04, 37.15, 38.58, 55.39, 73.11, 83.54, 86.38, 113.42, 128.43, 128.84, 159.73. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>32</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 364.3414, found 364.3426.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-6-methylheptan-1-ol (<b>2q</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2q</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (1.0 g, 4 mmol), 6-methylheptan-1-al<a class="ref internalNav" href="#fnd" aria-label="b">b</a> (750 mg, 5.85 mmol). Yield: 1.16 g (77%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.43 (hexanes/EtOAc, 19/1, v/v), m.p.: 95–96 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.85 (d, 6H, 2 × CH<sub>3</sub>), 1.11–1.29 (m, 6H, 3 × CH<sub>2</sub>), 1.39–1.44 (m, 2H, CH<sub>2</sub>), 1.47–1.53 (m, 1H, CH), 1.60 (br. s, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (br. d, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 22.71, 22.78, 26.89, 27.08, 28.04, 36.94, 38.95, 55.40, 73.10, 83.54, 86.39, 113.42, 128.43, 128.84, 159.73. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>34</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 378.3571, found 378.3576.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>RS</i>)-(2,3-Dihydro-1<i>H</i>-inden-5-yl)-[1-(4-methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]methanol (<b>2r</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2r</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (450 mg, 1.8 mmol), 5-formylindane (100 mg, 0.69 mmol). Yield: 240 mg (34%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.28 (hexanes/EtOAc, 19/1, v/v), m.p.: 123-124 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.85–3.0 (br. m, 10H, BH), 2.06–2.10 (m, 3H, CH<sub>2</sub>, OH), 2.89 (m, 4H, 2 × CH<sub>2</sub>), 3.74 (s, 3H, OCH<sub>3</sub>), 4.46 (s, 1H, CH), 6.66 (d, 2H, arom., <i>J</i> = 9.0 Hz), 6.92 (d, 1H, arom.), 7.03 (s, 1H, arom.), 7.09 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.15 (d, 2H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 25.56, 32.77, 32.95, 55.39, 76.11, 83.65, 85.84, 113.39, 122.74, 123.95, 124.92, 128.41, 128.86, 138.24, 144.29, 144.95, 159.71. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>28</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 396.3102, found 396.3096.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-(4-Methoxyphenyl)-12-(3-phenylpropyl)-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2s</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2d</b> was adapted to synthesize <b>2s</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), 1-bromo-3-phenylpropane (0.46 mL, 3.0 mmol). Yield: 530 mg (72%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.64 (hexanes/EtOAc, 49/1, v/v), m.p.: 93–94 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.50 (m, 2H, CH<sub>2</sub>), 1.98 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.57 (app. t, 2H, CH<sub>2</sub>), 3.72 (s, 3H, OCH<sub>3</sub>), 6.66–7.25 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 31.16, 35.38, 37.52, 55.38, 80.42, 81.09, 113.37, 126.12, 128.36, 128.47, 128.53, 128.90, 141.38, 159.63. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>28</sub>B<sub>10</sub>O (M)<sup>+</sup> 368.3152, found 368.3153.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-3-phenylpropan-1-ol (<b>2t</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2t</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (250 mg, 1 mmol), of 3-phenyl-1-propanal (0.17 g, 1.5 mmol). Yield: 344 mg (90%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.27 (hexanes/EtOAc, 19/1, v/v), m.p.: 123–124 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 01.49–1.77 (m, 2H, CH<sub>2</sub>), 1.69 (br. s, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 2.51–2.83 (m, 2H, CH<sub>2</sub>), 3.48 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68–7.28 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 32.69, 38.29, 55.39, 72.31, 83.64, 86.02, 113.42, 126.19, 128.41, 128.52, 128.61, 128.77, 141.15, 159.74. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>28</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 384.3102, found 384.3101.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(4-Methoxyphenyl)-12-(4-phenylbutyl)-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2u</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2u</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (350 mg, 1.4 mmol), 1-bromo-4-phenylbutane (450 mg, 2.1 mmol). Yield: 490 mg (91%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.57 (hexanes/EtOAc, 49/1, v/v), m.p.: 102–103 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.22 (m, 2H, CH<sub>2</sub>), 1.44 (m, 2H, CH<sub>2</sub>), 1.68 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.52 (app. t, 2H, CH<sub>2</sub>), 3.73 (s, 3H, OCH<sub>3</sub>), 6.67–7.27 (m, 9H, arom.). NMR (CDCl<sub>3</sub>): δ 29.27, 31.06, 35.62, 37.78, 55.38, 80.62, 81.01, 113.37, 125.92, 128.44, 128.46, 128.48, 128.92, 142.19, 159.63. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>30</sub>B<sub>10</sub>O (M)<sup>+</sup> 382.3309, found 382.3302.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-4-phenylbutan-1-ol (<b>2v</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2v</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), of 4-phenyl-1-butanal (0.46 mL, 3 mmol). Yield: 620 mg (78%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.27 (hexanes/EtOAc, 14/1, v/v), m.p.: 123–125 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.21–1.48 (m, 2H, CH<sub>2</sub>), 1.51–1.82 (m, 2H, CH<sub>2</sub>), 1.60 (br. d, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 2.52–2.61 (m, 2H, CH<sub>2</sub>), 3.50 (m, 1H, CH), 3.73 (s, 3H, OCH<sub>3</sub>), 6.67–7.28 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 28.38, 35.51, 36.40, 55.39, 72.87, 83.58, 86.21, 113.42, 125.97, 128.41, 128.48, 128.79, 142.05, 159.74. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>30</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 398.3259, found 398.3255.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(4-Methoxyphenyl)-12-(5-phenylpentyl)-1,12-dicarba-<i>closo</i>-dodecaborane (<b>2w</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2d</b> was adapted to synthesize <b>2w</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (440 mg, 1.77 mmol), 1-bromo-5-phenylpentane (600 mg, 2.65 mmol). Yield: 620 mg (88%) of white solid, <i>R</i><sub><i>f</i></sub>: 0.62 (hexanes/EtOAc, 49/1, v/v), m.p.: 70-71 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.17 (m, 4H, 2 × CH<sub>2</sub>), 1.53 (m, 2H, CH<sub>2</sub>), 1.63 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.52 (app. t, 2H, CH<sub>2</sub>), 3.73 (s, 3H, OCH<sub>3</sub>), 6.66–7.27 (m, 9H, arom.). NMR (CDCl<sub>3</sub>): δ 28.83, 29.50, 31.15, 35.89, 37.91, 55.38, 80.74, 80.97, 113.36, 125.83, 128.41, 128.48, 128.50, 128.93, 142.54, 159.62. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>32</sub>B<sub>10</sub>O (M)<sup>+</sup> 396.3466, found 396.3483.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-5-phenylpentan-1-ol (<b>2x</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>2x</b>. Starting materials: <b>1</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (500 mg, 2 mmol), of 5-phenyl-1-pentanal (0.52 mL, 3 mmol). Yield: 480 mg (58%) of a glasslike compound, <i>R</i><sub><i>f</i></sub>: 0.32 (hexanes/EtOAc, 14/1, v/v). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.18–1.28 (m, 2H, CH<sub>2</sub>), 1.41–1.63 (m, 5H, OH and 2 × CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.54–2.62 (m, 2H, CH<sub>2</sub>), 3.46 (m, 1H, CH), 3.77 (s, 3H, OCH<sub>3</sub>), 6.68–7.28 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 26.27, 31.13, 35.94, 36.71, 55.40, 72.96, 83.57, 86.26, 113.42, 125.85, 128.43, 128.51, 128.81, 142.48, 159.74. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>32</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 412.3416, found 412.3417.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(4-Hydroxyphenyl)-12-ethyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3b</b>)</h4><div class="NLM_p last">To a solution of <b>2b</b> (460 mg, 1.65 mmol) in anhydrous DCM (15 mL) was added boron tribromide (3.3 mL, 3.3 mmol, 1 M solution in DCM) at 0 °C. The reaction mixture was stirred at room temperature overnight, poured carefully into icecold 1 M HCl (15 mL), and extracted with EtOAc. The organic phase was washed with brine and dried over MgSO<sub>4</sub>. The solvents were evaporated, and the residue was purified by silica gel column chromatography. Further purification was achieved by recrystallization from heptane. The formed crystals were filtered at −20 °C and then washed with heptane cooled to −78 °C followed by pentane cooled to −78 °C. Yield: 360 mg (83%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.38 (hexanes/EtOAc, 6/1, v/v), m.p.: 125-126 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 12.09 min, purity 99.61%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.81 (t, 3H, CH<sub>3</sub>), 1.73 (q, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 4.79 (br. s, 1H, OH), 6.60 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.99, 31.30, 81.21, 80.73, 81.66, 114.84, 128.77, 129.28, 155.58. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>20</sub>B<sub>10</sub>O (M)<sup>+</sup> 264.2523, found 264.2525.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]ethan-1-ol (<b>3c</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3c</b>. Starting materials: <b>2c</b> (400 mg, 1.36 mmol); boron tribromide (4.0 mL, 4 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane precooled to −78 °C followed by pentane, precooled to −78 °C. Yield: 300 mg (79%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.35 (hexanes/EtOAc, 4/1, v/v), m.p.: 176–177 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 15.97 min, purity 99.33%. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): δ 1.07 (d, 3H, CH<sub>3</sub>), 1.85–3.0 (br. m, 10H, BH), 3.74 (m, 1H, CH), 4.39 (d, 1H, OH), 6.67 (d, 2H, arom., <i>J</i> = 8.9 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.9 Hz), 8.51 (s, 1H, OH). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): δ 23.74, 69.28, 84.18, 88.18, 115.65, 128.24, 129.09, 158.55. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>10</sub>H<sub>20</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 280.2472, found 280.2471.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(4-Hydroxyphenyl)-12-propyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3d</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3d</b>. Starting materials: <b>2d</b> (450 mg, 1.54 mmol); boron tribromide (3.0 mL, 3 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from heptane. The formed crystals were filtered at −20 °C and then washed with heptane cooled to −78 °C followed by pentane cooled to −78 °C. Yield: 390 mg (91%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.34 (hexanes/EtOAc, 6/1, v/v), m.p.: 139-140 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 11.87 min, purity 99.29%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.77 (t, 3H, CH<sub>3</sub>), 1.20 (m, 2H, CH<sub>2</sub>), 1.62 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 4.78 (br. s, 1H, OH), 6.60 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.82, 22.95, 40.11, 80.84, 114.84, 128.76, 129.29, 155.58. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>22</sub>B<sub>10</sub>O (M)<sup>+</sup> 278.2680, found 278.2684.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]propan-1-ol (<b>3e</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3e</b>. Starting materials: <b>2e</b> (250 mg, 0.81 mmol); boron tribromide (2.5 mL, 2.5 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane cooled to −78 °C followed by pentane, cooled to −78 °C. Yield: 180 mg (75%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.35 (hexanes/EtOAc, 4/1, v/v), m.p.: 206–207 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 13.42 min, purity 99.29%. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.15–1.45 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 3.39 (m, 1H, CH), 4.40 (d, 1H, OH), 6.67 (d, 2H, arom., <i>J</i> = 8.9 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.9 Hz), 8.52 (s, 1H, OH). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): δ 11.52, 30.63, 74.49, 84.41, 88.35, 115.68, 128.30, 129.12, 158.59. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>21</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 293.2545, found 293.2544.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-(4-Hydroxyphenyl)-12-butyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3f</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3f</b>. Starting materials: <b>2f</b> (300 mg, 0.97 mmol); boron tribromide (2.0 mL, 2 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from heptane. The formed crystals were filtered at −20 °C and then washed with heptane precooled to −78 °C followed by pentane precooled to −78 °C. Yield: 190 mg (64%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.35 (hexanes/EtOAc, 6/1, v/v), m.p.: 124–126 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 11.733 min, purity 98.83%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.82 (t, 3H, CH<sub>3</sub>), 1.15 (m, 4H, 2 × CH<sub>2</sub>), 1.65 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 4.78 (br. s, 1H, OH), 6.60 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.83, 22.41, 31.76, 37.78, 80.82, 80.91, 114.83, 128.76, 129.29, 155.59. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>23</sub>B<sub>10</sub>O (M – 1)<sup>−</sup> 291.2752, found 291.2751.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]butan-1-ol (<b>3g</b>)</h4><div class="NLM_p last">To a solution of <b>2g</b> (450 mg, 1.4 mmol) in anhydrous DCM (40 mL) was added boron tribromide (4.2 mL, 4.2 mmol, 1 M solution in DCM) at 0 °C. The reaction mixture was stirred at room temperature overnight, poured carefully into icecold 1 M HCl (60 mL), and extracted with DCM. The organic phase was washed with a 10% sodium thiosulfate solution and brine and dried over MgSO<sub>4</sub>. The solvents were evaporated, and the residue was purified by silica gel column chromatography (hexanes/EtOAc, 9/1, v/v) to yield a white solid. Further purification was achieved by recrystallization from hexanes/ isopropanol (24:1) and washing the obtained residue with icecold pentane. Yield: 265 mg (62%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.22 (hexanes/EtOAc, 9/1, v/v), m.p.: 184–185 °C. Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 9.87 min, purity 98.10%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.15–1.26 (m, 2H, CH<sub>2</sub>), 1.33–1.51 (m, 2H, CH<sub>2</sub>), 1.55 (br. s, ∼2H, OH and H<sub>2</sub>O), 1.85–3.0 (br. m, 10H, BH), 3.48 (m, 1H, CH), 4.69 (br. s, ∼1H, OH), 6.61 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.75, 19.82, 38.95, 72.86, 83.41, 86.39, 114.90, 128.71, 129.15, 155.75. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>12</sub>H<sub>23</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 307.2701, found 307.2700.</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-(4-Hydroxyphenyl)-12-pentyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3h</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3h</b>. Starting materials: <b>2h</b> (460 mg, 1.44 mmol); boron tribromide (2.8 mL, 2.8 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from heptane. The formed crystals were filtered at −20 °C and then washed with heptane cooled to −78 °C followed by pentane cooled to −78 °C. Yield: 370 mg (84%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.34 (hexanes/EtOAc, 6/1, v/v), m.p.: 99–100 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 11.37 min, purity 97.39%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.84 (t, 3H, CH<sub>3</sub>), 1.08–1.25 (m, 6H, 3 × CH<sub>2</sub>), 1.64 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 4.78 (br. s, 1H, OH), 6.60 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.03, 22.38, 29.32, 31.39, 37.99, 80.81, 80.97, 114.83, 128.76, 129.30, 155.57. Accurate mass HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>26</sub>B<sub>10</sub>O (M)<sup>+</sup> 306.2993, found 306.3001.</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>RS</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]pentan-1-ol (<b>3i</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3i</b>. Starting materials: <b>2i</b> (480 mg, 1.43 mmol); boron tribromide (4.3 mL, 4.3 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane cooled to −78 °C followed by pentane, cooled to −78 °C. Yield: 300 mg (65%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.36 (hexanes/EtOAc, 4/1, v/v), m.p.: 156-157 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 11.83 min, purity 99.77%. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): δ 0.85 (t, 3H, CH<sub>3</sub>), 1.16–1.46 (m, 6H, 3 × CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 3.48 (m, 1H, CH), 4.41 (d, 1H, OH), 6.67 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): δ 14.24, 22.85, 29.42, 37.33, 72.92, 84.38, 88.49, 115.68, 128.28, 129.12, 158.61. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>25</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 321.2858, found 321.2858.</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(4-Hydroxyphenyl)-12-heptyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3j</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3g</b> was adapted to synthesize <b>3j</b>. Starting materials: <b>2j</b> (600 mg, 1.72 mmol); boron tribromide (3.4 mL, 3.4 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from hexane. The formed crystals were filtered at −20 °C and then washed with pentane precooled to −78 °C. Yield: 380 mg (66%) of a white solid after column chromatograpy, <i>R</i><sub><i>f</i></sub>: 0.36 (hexanes/EtOAc, 9/1, v/v), m.p.: 114–115 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) (97/3) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 6.860 min, purity 99.52%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.08–1.29 (m, 10H, 5 × CH<sub>2</sub>), 1.64 (m, 2H, C<sub>carborane</sub>–CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 4.68 (br. s, 1H, OH), 6.60 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.20, 22.73, 29.02, 29.23, 29.67, 31.87, 38.04, 81.21, 80.82, 80.98, 114.83, 128.76, 129.30, 155.59. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>29</sub>B<sub>10</sub>O (M – 1)<sup>−</sup> 333.3216, found 333.3213.</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>3k</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3g</b> was adapted to synthesize <b>3k</b>. Starting materials: <b>2k</b> (570 mg, 1.57 mmol); boron tribromide (4.7 mL, 4.7 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from hexanes/<i>i</i>-PrOH (24/1). The formed crystals were filtered at −20 °C and then washed with pentane precooled to −78 °C. Yield: 400 mg (73%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.23 (hexanes/EtOAc, 9/1, v/v), m.p.: 129–130 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 9.52 min, purity 99.94%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.14–1.30 (m, 8H, 4 × CH<sub>2</sub>), 1.38–1.45 (m, 2H, CH<sub>2</sub>), 1.62–163 (m, ∼2H, OH and H<sub>2</sub>O), 1.8.5–3.0 (br. m, 10H, BH), 3.46 (m, 1H, CH), 4.96 (br. s, 1H, OH), 6.61 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.19, 22.71, 26.58, 28.97, 31.82, 36.91, 73.14, 83.57, 86.37, 114.90, 128.68, 129.06, 155.82. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>31</sub>B<sub>10</sub>O<sub>2</sub> (M + 1)<sup>+</sup> 351.3329, found 351.3322.</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-(4-Hydroxyphenyl)-12-decyl-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3l</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3l</b>. Starting materials: <b>2l</b> (360 mg, 0.92 mmol); boron tribromide (2.0 mL, 2 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from heptane. The formed crystals were filtered at −20 °C and then washed with heptane precooled to −78 °C followed by pentane precooled to −78 °C. Yield: 270 mg (78%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.38 (hexanes/EtOAc, 6/1, v/v), m.p.: 83–84 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 10.23 min, purity 100.0%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.88 (t, 3H, CH<sub>3</sub>), 1.08–1.23 (m, 16H, 8 × CH<sub>2</sub>), 1.64 (m, 2H, C<sub>carborane</sub>–CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 4.77 (br. s, 1H, OH), 6.60 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.27, 22.82, 29.27, 29.34, 29.43, 29.60, 29.67, 32.03, 38.04, 80.81, 80.97, 114.83, 128.76, 129.30, 155.59. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>35</sub>B<sub>10</sub>O (M – 1)<sup>−</sup> 375.3725, found 375.3723.</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]decan-1-ol (<b>3m</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3m</b>. Starting materials: <b>2m</b> (610 mg, 1.49 mmol); boron tribromide (4.5 mL, 4.5 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane cooled to −78 °C followed by pentane, cooled to −78 °C. Yield: 480 mg (82%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.42 (hexanes/EtOAc, 4/1, v/v), m.p.: 130–131 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 9.41 min, purity 99.73%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.88 (t, 3H, CH<sub>3</sub>), 1.15–1.46 (m, 16H, 7 × CH<sub>2</sub>), 1.38–1.45 (m, 2H, CH<sub>2</sub>), 1.58 (m, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 4.70–4.81 (br. d, 1H, OH), 6.61 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.26, 22.82, 26.63, 29.30, 29.42, 29.62, 29.65, 32.02, 36.91, 73.14, 83.45, 86.39, 114.90, 128.70, 129.13, 155.76. Accurate mass HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>36</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 392.3728, found 392.3750.</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-4-methylpentan-1-ol (<b>3n</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3n</b>. Starting materials: <b>2n</b> (510 mg, 1.44 mmol); boron tribromide (4.4 mL, 4.4 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane cooled to −78 °C followed by pentane, cooled to −78 °C. Yield: 370 mg (76%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.37 (hexanes/EtOAc, 4/1, v/v), m.p.: 175–176 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 11.07 min, purity 99.60%. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): δ 0.83 (d, 3H, CH<sub>3</sub>), 0.85 (d, 3H, CH<sub>3</sub>), 1.07–1.45 (m, 4H, 2 × CH<sub>2</sub>), 1.47–1.52 (m, 1H, CH), 1.85–3.0 (br. m, 10H, BH), 3.46 (m, 1H, CH), 4.41 (d, 1H, OH), 6.67 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz), 8.53 (s, 1H, OH). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): δ 22.51, 23.15, 28.38, 35.59, 36.44, 73.11, 84.39, 88.54, 115.59, 128.28, 129.11, 158.60. Accurate mass HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>28</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 336.310, found 336.3112.</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-5-methylhexan-1-ol (<b>3o</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3o</b>. Starting materials: <b>2o</b> (200 mg, 0.55 mmol); boron tribromide (1.7 mL, 1.7 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane cooled to −78 °C followed by pentane, cooled to −78 °C. Yield: 125 mg (65%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.36 (hexanes/EtOAc, 4/1, v/v), m.p.: 130–131 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 10.63 min, purity 98.39%. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): δ 0.84 (d, 3H, CH<sub>3</sub>), 0.85 (d, 3H, CH<sub>3</sub>), 1.07–1.52 (m, 6H, 3 × CH<sub>2</sub>, CH), 1.85–3.0 (br. m, 10H, BH), 3.49 (m, 1H, CH), 4.41 (d, 1H, OH), 6.67 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz), 8.52 (s, 1H, OH). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): δ 22.67, 22.93, 25.06, 28.62, 37.89, 39.17, 72.96, 84.40, 88.48, 115.68, 128.30, 129.13, 158.61. Accurate mass HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>30</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 350.3257, found 350.3268.</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-6-methylheptan-1-ol (<b>3q</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3g</b> was adapted to synthesize <b>3q</b>. Starting materials: <b>2q</b> (550 mg, 1.46 mmol); boron tribromide (4.4 mL, 4.4 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from hexanes/<i>i</i>-PrOH (24/1). The formed crystals were filtered at −20 °C and then washed with pentane precooled to −78 °C. Yield: 340 mg (72%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.23 (hexanes/EtOAc, 9/1, v/v), m.p.: 120–121 °C. Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (97/3) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 12.65 min, purity 99.99%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.85 (d, 6H, CH<sub>3</sub>), 1.14–1.43 (m, 8H, 4 × CH<sub>2</sub>), 1.46–1.52 (m, 1H, CH), 1.61 (m, ∼2H, OH and H<sub>2</sub>O), 1.85–3.0 (br. m, 10H, BH), 3.47 (d, 1H, CH), 4.88 (br. s, 1H, OH), 6.61 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.8 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 22.71, 22.78, 26.88, 27.07, 29.67, 28.04, 36.93, 38.94, 73.13, 83.47, 86.38, 114.90, 128.69, 129.09, 155.80. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>31</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 363.33217, found 363.33305.</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>RS</i>)-(2,3-Dihydro-1<i>H</i>-inden-5-yl)-[1-(4-hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]methanol (<b>3r</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3g</b> was adapted to synthesize <b>3r</b>. Starting materials: <b>2r</b> (280 mg, 0.63 mmol); boron tribromide (2.0 mL, 2 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from hexanes/<i>i</i>-PrOH (24/1). The formed crystals were filtered at −20 °C and then washed with pentane precooled to −78 °C. Yield: 240 mg (89%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.19 (hexanes/EtOAc, 9/1, v/v), m.p.: 231 °C (decomp.). Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 10.20 min, purity 99.69%. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): δ 1.9–3.0 (br. m, 10H, BH), 2.06 (m, ∼2H, CH<sub>2</sub>), 2.88 (m, ∼4H, 2 × CH<sub>2</sub>), 4.68 (s, H, OH), 4.99 (m, 1H, CH), 6.66 (d, 2H, arom., <i>J</i> = 8.6 Hz), 6.97 (d, 1H, arom.), 7.05 (d, 2H, arom., <i>J</i> = 8.9 Hz), 7.08 (s, 1H, arom.), 7.13 (d, 2H, arom.), 8.51 (s, 1H, OH). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): δ 26.41, 33.09, 33.31, 75.96, 84.58, 88.01, 115.65, 123.59, 124.21, 125.86, 128.30, 129.09, 140.63, 144.24, 144.71, 158.58. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>25</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 381.2852, found 381.2855.</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(4-Hydroxyphenyl)-12-(3-phenylpropyl)-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3s</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3s</b>. Starting materials: <b>2s</b> (470 mg, 1.28 mmol); boron tribromide (2.6 mL, 2.6 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from heptane. The formed crystals were filtered at −20 °C and then washed with heptane cooled to −78 °C followed by pentane cooled to −78 °C. Yield: 370 mg (84%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.32 (hexanes/EtOAc, 6/1, v/v), m.p.: 143–144 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 12.47 min, purity 99.77%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.50–1.55 (m, 2 H, CH<sub>2</sub>), 1.67–1.76 (m, 2H, OH and CH<sub>2</sub>) 1.85–3.0 (br. m, 10H, BH), 2.46 (t, 2H, CH<sub>2</sub>), 4.91 (br. s, 1H, OH), 6.59 – 7.29 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 31.15, 35.36, 37.50, 80.47, 81.00, 114.84, 126.12, 128.36, 128.53, 128.73, 129.16, 141.38, 155.64. Accurate mass HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>26</sub>B<sub>10</sub>O (M)<sup>+</sup> 354.2996, found 354.2975.</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-3-phenylpropan-1-ol (<b>3t</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3g</b> was adapted to synthesize <b>3t</b>. Starting materials: <b>2t</b> (250 mg, 0.65 mmol); boron tribromide (2.0 mL, 2 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from hexanes/<i>i</i>-PrOH (24/1). The formed crystals were filtered at −20 °C and then washed with pentane precooled to −78 °C. Yield: 200 mg (83%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.15 (hexanes/EtOAc, 9/1, v/v), m.p.: 135-136 °C. Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (97/3) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 12.87 min, purity 100.00%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.49–1.77 (m, 3 H, OH and CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.50–2.82 (m, 2H, CH<sub>2</sub>), 1.46–1.52 (m, 1H, CH), 3.47 (d, 1H, CH), 4.81 (br. s, 1H, OH), 6.60–7.29 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 30.68, 36.29, 70.35, 81.56, 83.85, 112.90, 124.20, 126.52, 126.61, 126.68, 127.04, 139.12, 153.78. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>25</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 369.28522, found 369.28508.</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-(4-Hydroxyphenyl)-12-(4-phenylbutyl)-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3u</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3u</b>. Starting materials: <b>2u</b> (550 mg, 1.44 mmol); boron tribromide (2.9 mL, 2.9 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from heptane. The formed crystals were filtered at −20 °C and then washed with heptane cooled to −78 °C followed by pentane cooled to −78 °C. Yield: 340 mg (64%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.32 (hexanes/EtOAc, 6/1, v/v), m.p.: 132–133 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 12.64 min, purity 99.93%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.24 (m, 2 H, CH<sub>2</sub>), 1.46 (m, 2H, CH<sub>2</sub>), 1.69 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.53 (t, 2H, CH<sub>2</sub>), 4.73 (br. s, 1H, OH), 6.59–7.29 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 29.26, 31.05, 35.62, 37.77, 80.68, 80.90, 114.84, 125.93, 128.45, 128.46, 128.75, 129.23, 142.20, 155.60. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>27</sub>B<sub>10</sub>O (M – 1)<sup>−</sup> 367.3074, found 367.3065.</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-4-phenylbutan-1-ol (<b>3v</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3v</b>. Starting materials: <b>2v</b> (550 mg, 1.38 mmol); boron tribromide (4.2 mL, 4.2 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane cooled to −78 °C followed by pentane, cooled to −78 °C. Yield: 400 mg (75%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.35 (hexanes/EtOAc, 4/1, v/v), m.p.: 161–162 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 12.65 min, purity 99.78%. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): δ 1.22–1.47 (m, 2 H, CH<sub>2</sub>), 1.52–1.81 (m, 2 H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.52–2.63 (m, 2H, CH<sub>2</sub>), 3.54 (m, 1H, CH), 4.48 (d, 1H, OH), 6.67–7.27 (m, 9H, arom.), 8.52 (s, 1H, OH). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): δ 29.21, 35.87, 37.14, 72.73, 84.42, 88.38, 115.68, 126.51, 128.28, 129.08, 129.12, 128.17, 143.14, 158.60. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>27</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 384.3102, found 384.3102.</div></div><div id="sec4_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 1-(4-Hydroxyphenyl)-12-(-phenylpentyl)-1,12-dicarba-<i>closo</i>-dodecaborane (<b>3w</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3w</b>. Starting materials: <b>2w</b> (430 mg, 1.08 mmol); boron tribromide (2.2 mL, 2.2 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from heptane. The formed crystals were filtered at −20 °C and then washed with heptane cooled to −78 °C followed by pentane cooled to −78 °C. Yield: 340 mg (64%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.36 (hexanes/EtOAc, 6/1, v/v), m.p.: 77–78 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 11.80 min, purity 99.24%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.18 (m, 4 H, 2 × CH<sub>2</sub>), 1.54 (m, 2H, CH<sub>2</sub>), 1.64 (m, 2H, CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.55 (t, 2H, CH<sub>2</sub>), 4.73 (br. s, 1H, OH), 6.59– 7.28 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 28.83, 29.50, 31.14, 35.88, 37.90, 80.79, 80.86, 114.83, 125.83, 128.41, 128.50, 128.75, 129.24, 142.55, 155.61. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>29</sub>B<sub>10</sub>O (M – 1)<sup>−</sup> 381.3256, found 381.3257.</div></div><div id="sec4_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>RS</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]-5-phenylpentan-1-ol (<b>3x</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>3x</b>. Starting materials: <b>2x</b> (50 mg, 0.122 mmol); boron tribromide (0.4 mL, 0.4 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane cooled to −78 °C followed by pentane, cooled to −78 °C. Yield: 24 mg (49%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.15 (hexanes/EtOAc, 9/1, v/v), m.p.: 119-120 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 11.89 min, purity 98.56%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.18–1.64 (m, 7 H, OH and 3 × CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.58 (m, 2H, CH<sub>2</sub>), 3.47 (d, 1H, CH), 4.81 (br. s, 1H, OH), 6.60–7.29 (m, 9H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 26.25, 31.10, 35.91, 36.69, 70.02, 83.51, 86.21, 114.90, 125.86, 128.43, 128.51, 128.67, 129.04, 142.46, 155.79. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>30</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 398.3259, found 398.3233.</div></div><div id="sec4_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-one (<b>4</b>)</h4><div class="NLM_p last">Pyridinium chlorochromate (PCC, 2.0 g, 9.34 mmol) was suspended in anhydrous DCM (50 mL). A solution of (<i>RS</i>)-1-[1-(4-methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>2k</b>) (1.7 g, 4.67 mmol) in anhydrous DCM (15 mL) was then added to give a dark reaction mixture, which was stirred at room temperature overnight. Diethyl ether (60 mL) was added and then molecular sieve followed by stirring for 1 h. The supernatant was decanted, and the insoluble residue was washed with dry ether (3 × 20 mL). The combined organic phases were passed through a short column of florisil followed by evaporation. The residue was purified by silica gel column chromatography to yield a white waxlike solid. Yield: 1.6 g (95%), <i>R</i><sub><i>f</i></sub>: 0.13 (hexanes), m.p.: 36–37 °C (waxlike). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.14–1.46 (m, 8H, 4 × CH<sub>2</sub>), 1.85–3.0 (br. m, 10H, BH), 2.39 (m, 2H, C(O)–CH<sub>2</sub>), 3.74 (s, 3H, OCH<sub>3</sub>), 6.69 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.10 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.14, 22.58, 23.60, 28.51, 31.60, 39.39, 55.41, 83.75, 85.64, 113.50, 128.28, 128.73, 159.92, 195.48. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>30</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 362.3257, found 362.3254.</div></div><div id="sec4_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>S</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>5</b>)</h4><div class="NLM_p last">Borane–tetrahydrofuran complex [16.5 mL, 16.5 mmol, 1.0 M solution in THF, stabilized with 0.005 M <i>N</i>-isopropyl-<i>N</i>-methyl-<i>tert</i>-butylamine (NIMBA)] followed by (<i>S</i>)-2-methyl-CBS-oxazaborolidine [(<i>S</i>)-MeCBS] (1.65 mL, 1.65 mmol, 1.0 M solution in toluene) were added to 15 mL of anhydrous THF. The reaction mixture was stirred at room temperature for 10 min and 1-[1-(4-methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-one (<b>4</b>) (600 mg, 1.65 mmol) in 15 mL of anhydrous THF was added slowly over a period of 2 h at 25 °C. The reaction mixture was stirred for additional 6 h at room temperature and then carefully quenched by the addition of 2.0 M HCl (30 mL) in small portions to control H<sub>2</sub> development. Diethyl ether (50 mL) was added, and the organic phase was washed with brine and saturated NaHCO<sub>3</sub>. The organic phase was dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by silica gel column chromatography to yield a white solid. Based on chiral HPLC, the enantiomeric excess (ee) of chiral alcohol <b>5</b> was estimated to be >80% (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Supporting Information</a>). Yield: 440 mg (73%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.43 (hexanes/EtOAc, 19/1, v/v), m.p.: 95–96 °C, [α]<sub>D</sub><sup>20 °C</sup> = +27° (0.1, DCM). Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 5.43 min, purity 100.0%, analytical HPLC: column II, solvent system: hexanes/CH<sub>2</sub>Cl<sub>2</sub> (9/1) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 10.01 min (area %: 8.74), 10.52 (area %: 91.26). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.15–1.31 (m, 8H, 4 × CH<sub>2</sub>), 1.38–1.48 (m, 2H, CH<sub>2</sub>), 1.58 (br. s, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.20, 22.72, 26.60, 28.98, 31.83, 36.92, 55.40, 73.10, 83.53, 86.39, 113.42, 128.43, 128.85, 159.73. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>32</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 364.3414, found 364.3417.</div></div><div id="sec4_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (<i>R</i>)-1-[1-(4-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>6</b>)</h4><div class="NLM_p last">For the synthesis of <b>6</b>, the procedure and conditions described for the synthesis of <b>5</b> were adapted using 500 mg (1.38 mmol) of <b>4</b> and 1.38 mL (1.38 mmol, 1.0 M solution in toluene) of (<i>R</i>)-2-methyl-CBS-oxazaborolidine [(<i>R</i>)-MeCBS]. The residue was purified by silica gel column to yield a white solid. Based on chiral HPLC, the enantiomeric excess (ee) was estimated to be >75% (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Supporting Information</a>). Yield: 400 mg (80%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.43 (hexanes/EtOAc, 19/1, v/v), m.p.: 95–96 °C, [α]<sub>D</sub><sup>20 °C</sup> = −24° (0.1, DCM). Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (99/1) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 5.55 min, purity 99.81%, analytical HPLC: column II, solvent system: hexanes/CH<sub>2</sub>Cl<sub>2</sub> (9/1) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 9.99 min (area %: 87.90), 10.97 (area %: 12.10) <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.15–1.31 (m, 8H, 4 × CH<sub>2</sub>), 1.38–1.47 (m, 2H, CH<sub>2</sub>), 1.57 (br. s, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 3.74 (s, 3H, OCH<sub>3</sub>), 6.68 (d, 2H, arom., <i>J</i> = 9.0 Hz), 7.12 (d, 2H, arom., <i>J</i> = 9.0 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.20, 22.72, 26.60, 28.99, 31.83, 36.92, 55.40, 73.10, 83.54, 86.39, 113.42, 128.43, 128.85, 159.73. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>32</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 364.3414, found 364.3406.</div></div><div id="sec4_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (<i>S</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>7</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3g</b> adapted to synthesize <b>7</b>. Starting materials: <b>5</b> (300 mg, 0.825 mmol); boron tribromide (2.5 mL, 2.5 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from hexanes/isopropyl alcohol [24:1]. The formed crystals were filtered at −20 °C and then washed with pentane precooled to −78 °C. Yield: 220 mg (76%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.23 (hexanes/EtOAc, 9/1, v/v), m.p.: 120–121 °C, [α]<sub>D</sub><sup>20 °C</sup> = +23° (0.1, DCM). Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (97/3) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 9.67 min, purity 100%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.15–1.30 (m, 8H, 4 × CH<sub>2</sub>), 1.39–1.45 (m, 2H, CH<sub>2</sub>), 1.66–1.71 (m, ∼2H, OH and H<sub>2</sub>O), 1.85–3.0 (br. m, 10H, BH), 3.46 (m, 1H, CH), 5.08 (br. s, 1H, OH), 6.61 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.9 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.19, 22.70, 26.58, 28.97, 31.81, 36.90, 73.16, 83.49, 86.33, 114.90, 128.67, 129.03, 155.84. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>29</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 349.3165, found 349.3162.</div></div><div id="sec4_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>R</i>)-1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>8</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3g</b> was adapted to synthesize <b>8</b>. Starting materials: <b>6</b> (300 mg, 0.825 mmol); boron tribromide (2.5 mL, 2.5 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from hexanes/isopropyl alcohol [24:1]. The formed crystals were filtered at −20 °C and then washed with pentane precooled to −78 °C. The enantiomeric excess of chiral alcohol <b>8</b> was enriched to >99% by chiral SFC separation, and then the absolute configuration of resulting enriched chiral alcohol <b>8</b> was determined via analysis of the corresponding bis-Mosher esters (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Supporting Information</a>). Yield: 180 mg (62%), <i>R</i><sub><i>f</i></sub>: 0.23 (hexanes/EtOAc, 9/1, v/v), m.p.: 120–121 °C, [α]<sub>D</sub><sup>20 °C</sup> = −28° (0.1, DCM). Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (97/3) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 9.52 min, purity 99.84%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.15–1.30 (m, 8H, 4 × CH<sub>2</sub>), 1.39–1.45 (m, 2H, CH<sub>2</sub>), 1.68–1.76 (m, ∼2H, OH and H<sub>2</sub>O), 1.9–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 5.17 (br. s, 1H, OH), 6.61 (d, 2H, arom., <i>J</i> = 8.8 Hz), 7.07 (d, 2H, arom., <i>J</i> = 8.9 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.19, 22.70, 26.58, 28.96, 31.81, 36.90, 73.17, 83.50, 86.31, 114.90, 128.67, 129.01, 155.86. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>29</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 349.3165, found 349.3158.</div></div><div id="sec4_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-[1-(4-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-one (<b>9</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3g</b> was adapted to synthesize <b>9</b>. Starting materials: <b>4</b> (630 mg, 1.74 mmol); boron tribromide (5.2 mL, 5.2 mmol, 1 M solution in DCM). Further purification was achieved by recrystallization of the residue obtained after column chromatography from hexanes. The formed crystals were filtered at −20 °C and then washed with pentane precooled to −78 °C. Yield: 520 mg (86%) of white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.31 (hexanes/EtOAc, 9/1, v/v), m.p.: 79–80 °C. Analytical HPLC: column I, solvent system: hexanes/<i>i</i>-PrOH (97/3) [isocratic], flow rate: 1 mL, wavelength: 254 nm, retention time: 8.89 min, purity 100.00%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.86 (t, 3H, CH<sub>3</sub>), 1.12–1.27 (m, 6 H, 3 × CH<sub>2</sub>), 1.39–1.46 (m, 2 H, CH<sub>2</sub>), 1.55–3.40 (br. m, 10H, BH), 2.39 (t, 2H, C(O)–CH<sub>2</sub>), 5.11 (br. s, 1H, OH), 6.62 (d, 2H, arom., <i>J</i> = 8.7 Hz), 7.05 (d, 2H, arom., <i>J</i> = 8.7 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.09, 22.52, 23.53, 28.44, 31.54, 39.40, 83.61, 85.83, 114.95, 128.49, 128.87, 155.99, 195.87. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>27</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 347.3001, found 347.3014.</div></div><div id="sec4_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-(4′-Methoxy-[1,1′-biphenyl]-4-yl)heptan-1-one (<b>11</b>)</h4><div class="NLM_p last">To a solution of commercially available 4′-methoxy-[1,1′-biphenyl]-4-carbaldehyde (<b>10</b>) (0.69 g, 3.25 mmol) in anhydrous diethyl ether (25 mL) was added dropwise hexylmagnesium bromide (2 M in diethyl ether, 1.95 mL, 3.9 mmol) at 0 °C. The reaction mixture was stirred for another hour after addition and quenched by adding 0.1 N HCl (10 mL), the organic layer was separated, and the aqueous layer was extracted with diethyl ether (2 × 20 mL). The combined organic layers were washed with water, NaHCO<sub>3</sub>, and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield a yellow solid (0.85 g), which was taken forward to the next step. Pyridinium chlorochromate (PCC, 0.9 g, 4.1 mmol) was suspended in anhydrous DCM (25 mL). A solution of the yellow solid from the previous step (0.8 g, 2.68 mmol) in DCM (10 mL) was then added, and the reaction mixture was stirred at room temperature overnight. Diethyl ether (25 mL) was added followed by molecular sieves, and then stirred for 1 h. The supernatant was decanted, and the insoluble residue was washed with dry ether (3 × 20 mL). The combined organic phases were passed through a short column of Celite followed by evaporation. The residue was purified by Teledyne Isco (RediSep Rf column) to yield 0.64 g (71% over two steps) of pure product as a white waxlike solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 0.94 (t, 3H), 1.34–1.45 (m, 6H), 1.74–1.80 (m, 2H), 3.00 (t, 2H), 3.89 (s, 3H), 7.02 (d, 2H), 7.60 (d, 2H), 7.66 (d, 2H), 8.03 (d, 2H).</div></div><div id="sec4_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>S</i>)-1-(4′-Methoxy-[1,1′-biphenyl]-4-yl)heptan-1-ol (<b>12</b>)</h4><div class="NLM_p last">Borane–tetrahydrofuran complex (10 mL, 10 mmol, 1.0 M solution in THF, stabilized with 0.005 M <i>N</i>-isopropyl-<i>N</i>-methyl-<i>tert</i>-butylamine (NIMBA)) followed by (<i>R</i>)-2-methyl-CBS-oxazaborolidine [(<i>R</i>)-MeCBS] (1.0 mL, 1.0 mmol, 1.0 M solution in toluene) were added to 10 mL of anhydrous THF. The reaction mixture was stirred at room temperature for 15 min, and 1-(4′-methoxy-[1,1′-biphenyl]-4-yl)heptan-1-one (<b>11</b>) (0.29 g, 1.0 mmol) in 10 mL of anhydrous THF was added slowly over a period of 2 h at 0 °C. The reaction mixture was stirred overnight at room temperature and then carefully quenched by the addition of 2.0 M HCl (15 mL) in small portions to control H<sub>2</sub> development. Diethyl ether (15 mL) was added, and the organic phase was washed with brine and saturated NaHCO<sub>3</sub>. The organic phase was dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by Teledyne Isco (RediSep Rf column) to yield 0.21 g (70%) of pure product as a white waxlike solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.90 (t, 3H), 1.26–1.87 (m, 11H, overlap with H<sub>2</sub>O), 3.88 (s, 3H), 4.71–4.74 (m, 1H), 7.00 (d, 2H), 7.41 (d, 2H), 7.54–7.57 (m, 4H).</div></div><div id="sec4_2_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>S</i>)-4′-(1-Hydroxyheptyl)-[1,1′-biphenyl]-4-ol (<b>13</b>)</h4><div class="NLM_p last">To a mixture of (<i>S</i>)-1-(4′-methoxy-[1,1′-biphenyl]-4-yl)heptan-1-ol (<b>12</b>) (72 mg, 0.24 mmol), 1-dodecanethiol (75 mg, 89 μL, 0.37 mmol) in <i>N</i>-methylpyrrolidinone (NMP, 2 mL), NaOH (29 mg, 0.73 mmol) was added, and the reaction mixture was heated up to 100 °C overnight; cooled to room temperature; diluted with ethyl acetate (15 mL); washed with 1 N HCl (10 mL), water, and brine; and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 42 mg (62%) of pure product as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 0.90 (t, 3H), 1.25–1.50 (m, 8H), 1.70–1.82 (m, 3H) 4.74 (m, 2H), 6.92 (d, 2H), 7.41 (d, 2H), 7.48–7.56 (m, 4H). HRMS calcd 283.17708 (M – 1), obsv. 283.17184.</div></div><div id="sec4_2_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 4-(4-Methoxyphenyl)cyclohexan-1-one (<b>15</b>)</h4><div class="NLM_p last">The reaction mixture of commercially available 4-(4-hydroxyphenyl)cyclohexan-1-one (<b>14</b>) (2.4 g, 12.62 mmol), Cs<sub>2</sub>CO<sub>3</sub> (6.16 g, 18.91 mmol), and iodomethane (6 mL, 18.91 mmol) in acetone (50 mL) was heated to reflux for 3 h, cooled to room temperature, filtered, and washed with acetone (2 × 20 mL). The combined acetone filtrates were concentrated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 2.58 g (quant.) of pure product as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.88–1.99 (m, 2H), 2.19–2.25 (m, 2H), 2.49–2.54 (m, 4H), 2.98–3.04 (m, 1H), 3.80 (s, 3H), 6.89 (d, 2H), 7.19 (d, 2H).</div></div><div id="sec4_2_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-(4-(4-Methoxyphenyl)cyclohexyl)heptan-1-one (<b>16</b>)</h4><div class="NLM_p last">To a solution of (methoxymethyl)triphenylphosphonium chloride (3.8 g, 11 mmol) in anhydrous THF (95 mL), lithium bis(trimethylsilyl)amide (1.0 M in THF, 11 mL) was added dropwise at −78 °C. The reaction mixture was stirred for 1 h, and a solution of 4-(4-methoxyphenyl)cyclohexan-1-one (<b>15</b>) (2.04 g, 10 mmol) was added dropwise. This reaction mixture was stirred 30 min after addition, warmed up to room temperature, and stirred overnight. HCl (50 mL, 2N) was added and stirred for 2 h. The reaction mixture was extracted with ethyl acetate (3 × 30 mL), and the combined organic layers were washed with water, NaHCO<sub>3</sub>, and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 1.25 g of a yellow solid, which was taken forward to the next step. To a solution of this yellow solid (0.86 g, 3.94 mmol) in anhydrous diethyl ether (50 mL), hexylmagnesium bromide (2 M in diethyl ether, 2.46 mL, 4.52 mmol) was added dropwise at 0 °C. The reaction mixture was stirred for another hour after addition and quenched by adding 0.1 N HCl (20 mL), the organic layer was separated, and the aqueous layer was extracted with diethyl ether (2 × 25 mL). The combined organic layers were washed with water, NaHCO<sub>3</sub>, and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 0.99 g of a yellow solid, which was taken forward to the next step. Pyridinium chlorochromate (PCC, 0.97 g, 4.42 mmol) was suspended in anhydrous DCM (25 mL). A solution of the yellow solid from the previous step (0.88 g, 2.89 mmol) in DCM (10 mL) was then added, and the reaction mixture was stirred at room temperature overnight. Diethyl ether (25 mL) was added and followed by molecular sieves, and then stirred for 1 h. The supernatant was decanted, and the insoluble residue was washed with dry ether (3 × 20 mL). The combined organic phases were passed through a short column of Celite followed by evaporation. The residue was purified by Teledyne Isco (RediSep Rf column) to yield 0.72 g (40% over three steps) of pure product as a white waxlike solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.91 (t, 3H), 1.30–1.62 (m, 12H, overlap with H<sub>2</sub>O), 1.98–2.02 (m, 4H), 2.39–2.51 (m, 4H), 3.81 (s, 3H), 6.87 (d, 2H), 7.14 (d, 2H).</div></div><div id="sec4_2_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>S</i>)-4-(4-(1-Hydroxyheptyl)cyclohexyl)phenol (<b>17</b>)</h4><div class="NLM_p last">Borane–tetrahydrofuran complex (21.5 mL, 21.5 mmol, 1.0 M solution in THF, stabilized with 0.005 M <i>N</i>-isopropyl-<i>N</i>-methyl-<i>tert</i>-butylamine (NIMBA)) followed by (<i>R</i>)-2-methyl-CBS-oxazaborolidine [(<i>R</i>)-MeCBS] (2.15 mL, 2.15 mmol, 1.0 M solution in toluene) were added to 20 mL of anhydrous THF. The reaction mixture was stirred at room temperature for 15 min, and 1-(4-(4-methoxyphenyl)cyclohexyl)heptan-1-one (<b>16</b>) (0.65 g, 2.15 mmol) in 15 mL of anhydrous THF was added slowly over a period of 2 h at 0 °C. The reaction mixture was stirred overnight at room temperature and then carefully quenched by the addition of 2.0 M HCl (25 mL) in small portions to control H<sub>2</sub> development. Diethyl ether (25 mL) was added, and the organic phase was washed with brine and saturated NaHCO<sub>3</sub>. The organic phase was dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by Teledyne Isco (RediSep Rf column) to yield 0.50 g of a white waxlike solid, which was taken forward to the next step. To a mixture of the above solid (0.25 g, 0.82 mmol) and 1-dodecanethiol (0.26 g, 0.3 mL, 1.26 mmol) in <i>N</i>-methylpyrrolidinone (NMP, 5 mL), NaOH (100 mg, 2.48 mmol) was added, and the reaction mixture was heated up to 100 °C overnight; cooled to room temperature; diluted with ethyl acetate (15 mL); washed with 1 N HCl (10 mL), water, and brine; and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 96 mg (31% over two steps) of pure product as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.91 (t, 3H), 1.18–1.60 (m, 16H, overlap with H<sub>2</sub>O), 1.79–1.87 (m, 1H), 1.93–2.01 (m, 3H), 2.41–2.47 (m, 1H), 3.42–3.46 (m, 1 H), 4.54 (s, 1H), 6.78 (d, 2H), 7.10 (d, 2H). Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>29</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 289.21621, found 289.21902.</div></div><div id="sec4_2_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Methyl 4-Bromobicyclo[2.2.2]octane-1-carboxylate (<b>19</b>)</h4><div class="NLM_p last">To a solution of bromine (3.3 g, 20.6 mmol) in dichloromethane (20 mL) was added dropwise over 10 min into a heterogeneous refluxing mixture of commercially available 4-(methoxycarbonyl)bicyclo[2.2.2]octane-1-carboxylic acid (3.0 g, 14.13 mmol) and mercuric oxide (5.12 g) in dichloromethane (60 mL), and heating was continued for 3.5 h. After the reaction mixture was allowed to cool to room temperature, it was filtered, and the resulting light orange filtrate was treated with MgSO<sub>4</sub> and filtered again. The volatiles were removed, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 1.93 g (55%) of pure product as a white waxlike solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.86–1.91 (m, 6H), 2.17–2.23 (m, 6H), 3.56 (s, 3H).</div></div><div id="sec4_2_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Methyl 4-Phenylbicyclo[2.2.2]octane-1-carboxylate (<b>20</b>)</h4><div class="NLM_p last">A benzene (30 mL) solution of methyl 4-bromobicyclo[2.2.2]octane-1-carboxylate (<b>19</b>) (1.90 g, 7.7 mmol) was added dropwise to a cooled (ca. −12 °C) mixture of benzene (100 mL) and aluminum chloride (5.0 g, 35 mmol) over 15 min. The heterogeneous mixture was stirred for 1 h while allowing the cooling bath to warm gradually to 3 °C, and then stirred at room temperature overnight; diluted with diethyl ether (100 mL); washed with 1 N HCl, water, and brine; and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 1.6 g (85%) of pure product as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.89–1.96 (m, 12H), 3.70 (s, 3H), 7.15–7.25 (m, 1H), 7.33–7.34 (m, 4H).</div></div><div id="sec4_2_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-Phenylbicyclo[2.2.2]octane-1-carbaldehyde (<b>21</b>)</h4><div class="NLM_p last">Methyl 4-phenylbicyclo[2.2.2]octane-1-carboxylate (<b>20</b>) (0.51 g, 2.1 mmol) was dissolved in anhydrous diethyl ether (25 mL), treated with LAH (159 mg, 4.2 mmol) at 0 °C for 2 h. NaOH (2 N) was added dropwise until form white precipitation, filtered, washed with diethyl ether (3 × 30 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 0.45 g of a white solid. To a mixture of this white solid (0.43 g, 1.99 mmol), NaHCO<sub>3</sub> (166 mg, 1.99 mmol), NaOAc (163 mg, 1.99 mmol) in anhydrous DCM, pyridinium chlorochromate (PCC, 0.43 g, 1.99 mmol) was added. The reaction mixture was stirred at room temperature for 3 h and filtered. The filtrate was washed with 1 N HCl, water, NaHCO<sub>3</sub>, and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 405 mg (52% over two steps) of pure product as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.79–1.83 (m, 6H), 1.91–1.95 (m, 6H), 7.19–7.24 (m, 1H), 7.31–7.36 (m, 4H), 9.55 (s, 1H).</div></div><div id="sec4_2_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 1-(4-Phenylbicyclo[2.2.2]octan-1-yl)heptan-1-ol (<b>22</b>)</h4><div class="NLM_p last">To a solution of 4-phenylbicyclo[2.2.2]octane-1-carbaldehyde (<b>21</b>) (0.4 g, 1.87 mmol) in anhydrous diethyl ether (25 mL), hexylmagnesium bromide (2 M in diethyl ether, 2.0 mL, 4.0 mmol) was added dropwise at 0 °C. The reaction mixture was stirred for another hour after addition and quenched by adding 0.1 N HCl (10 mL), the organic layer was separated, and the aqueous layer was extracted with diethyl ether (2 × 20 mL). The combined organic layers were washed with water, NaHCO<sub>3</sub>, and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 0.48 g (85%) of pure product as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.92 (t, 3H), 1.26–1.32 (m, 9H), 1.53–1.68 (m, 8H overlap with H<sub>2</sub>O), 1.84–1.88 (m, 6H), 3.20–3.24 (m, 1H), 7.17–7.21 (m, 1H), 7.29–7.36 (m, 4H).</div></div><div id="sec4_2_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 1-(4-(4-Bromophenyl)bicyclo[2.2.2]octan-1-yl)heptan-1-ol (<b>23</b>)</h4><div class="NLM_p last">To a mixture of 1-(4-phenylbicyclo[2.2.2]octan-1-yl)heptan-1-ol (<b>22</b>) (0.28 g, 0.94 mmol) and silver acetate (0.24 g, 1.09 mmol) in chloroform (25 mL), a solution of bromine (0.16 g, 0.99 mmol) in chloroform (10 mL) was added dropwise at 0 °C and stirred for 3 h; warmed up to room temperature; washed with NaHCO<sub>3</sub>, water, and brine; and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvents were evaporated, and the residue was purified by Teledyne Isco (RediSep Rf column) to yield 0.28 g (79%) of pure product as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.92 (t, 3H), 1.26–1.34 (m, 9H, overlap with grease), 1.51–1.64 (m, 8H, overlap with H<sub>2</sub>O), 1.80–1.84 (m, 6H), 3.20–3.22 (m, 1H), 7.21 (d, 2H), 7.42 (d, 2H).</div></div><div id="sec4_2_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 1-(4-(4-Bromophenyl)bicyclo[2.2.2]octan-1-yl)heptan-1-one (<b>24</b>)</h4><div class="NLM_p last">Pyridinium chlorochromate (PCC, 0.27 g, 1.27 mmol) was suspended in anhydrous DCM (25 mL). A solution of 1-(4-(4-bromophenyl)bicyclo[2.2.2]octan-1-yl)heptan-1-ol (<b>23</b>) (0.16 g, 0.42 mmol) in DCM (10 mL) was then added, and the reaction mixture was stirred at room temperature overnight. Diethyl ether (25 mL) was added and followed by molecular sieves, and then stirred for 1 h. The supernatant was decanted, and the insoluble residue was washed with dry ether (3 × 20 mL). The combined organic phases were passed through a short column of Celite followed by evaporation. The residue was purified by Teledyne Isco (RediSep Rf column) to yield 135 mg (85%) of pure product as a white waxlike solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.92 (t, 3H), 1.29–1.30 (m, 6H), 1.50–1.60 (m, 2H, overlap with H<sub>2</sub>O), 1.86–1.89 (m, 12H), 2.45–2.49 (m, 2H), 7.21 (d, 2H), 7.44 (d, 2H).</div></div><div id="sec4_2_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (<i>S</i>)-1-(4-(4-Bromophenyl)bicyclo[2.2.2]octan-1-yl)heptan-1-ol (<b>25</b>)</h4><div class="NLM_p last">Borane–tetrahydrofuran complex (3.2 mL, 3.2 mmol, 1.0 M solution in THF, stabilized with 0.005 M <i>N</i>-isopropyl-<i>N</i>-methyl-<i>tert</i>-butylamine (NIMBA)) followed by (<i>R</i>)-2-methyl-CBS-oxazaborolidine [(<i>R</i>)-MeCBS] (0.32 mL, 0.32 mmol, 1.0 M solution in toluene) were added to 20 mL of anhydrous THF. The reaction mixture was stirred at room temperature for 15 min, and 1-(4-(4-bromophenyl)bicyclo[2.2.2]octan-1-yl)heptan-1-one (<b>24</b>) (0.12 g, 0.32 mmol) in 10 mL of anhydrous THF was added slowly over a period of 2 h at 0 °C. The reaction mixture was stirred overnight at room temperature and then carefully quenched by the addition of 2.0 M HCl (25 mL) in small portions to control H<sub>2</sub> development. Diethyl ether (25 mL) was added, and the organic phase was washed with brine and saturated NaHCO<sub>3</sub>. The organic phase was dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by Teledyne Isco (RediSep Rf column) to yield 98 mg (81%) of product as a white waxlike solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.92 (t, 3H), 1.26–1.34 (m, 9H), 1.51–1.64 (m, 8H, overlap with H<sub>2</sub>O), 1.80–1.84 (m, 6H), 3.20–3.22 (m, 1H), 7.21 (d, 2H), 7.42 (d, 2H).</div></div><div id="sec4_2_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (<i>S</i>)-4-(4-(1-Hydroxyheptyl)bicyclo[2.2.2]octan-1-yl)phenol (<b>26</b>)</h4><div class="NLM_p last">A mixture of (<i>S</i>)-1-(4-(4-bromophenyl)bicyclo[2.2.2]octan-1-yl)heptan-1-ol (<b>25</b>) (72 mg, 0.19 mmol), benzaldehyde oxime (30 mg, 0.25 mmol), Cs<sub>2</sub>CO<sub>3</sub> (136.2 mg, 0.42 mmol), and RockPhos Pd G3 (8 mg) in DMF (1 mL) was degassed with Ar for 15 min. Then, the mixture was heated to 80 °C for 18 h. The mixture was then cooled down to room temperature; diluted with ethyl acetate (10 mL); washed with 1 N HCl (10 mL), water, and brine; dried over Na<sub>2</sub>SO<sub>4</sub>; filtered; and evaporated. The residue was purified by Teledyne Isco (RediSep Rf column) to yield a white solid, 98 mg. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.92 (t, 3H), 1.26–1.34 (m, 9H, overlap with grease), 1.51–1.64 (m, 8H, overlap with H<sub>2</sub>O), 1.80–1.84 (m, 6H), 3.20–3.22 (m, 1H), 4.60 (br. s, 1H), 6.78 (d, 2H), 7.21 (d, 2H). Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>31</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 315.23186, found 315.23676.</div></div><div id="sec4_2_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (<i>RS</i>)-1-[(1-Phenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>28</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>28</b>. Starting materials: <b>27</b><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> (0.27 g, 1.3 mmol), 1-heptanal (0.28 mL, 2 mmol). Yield: 280 mg (64%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.74 (hexanes/EtOAc, 49/1, v/v), m.p.: 106–107 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (99.7/0.3) [isocratic], flow rate: 1 mL, wavelength: 260 nm, retention time: 12.09 min, purity 99.61%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.88 (t, 3H, CH<sub>3</sub>), 1.16–1.32 (m, 8H, 4 × CH<sub>2</sub>), 1.40–1.47 (m, 2H, CH<sub>2</sub>), 1.59 (d, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 7.16- 7.23 (m, 5H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.20, 22.72, 26.59, 28.98, 31.83, 36.91, 55.38, 73.13, 83.63, 87.02, 127.26, 128.18, 128.47, 136.37. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>30</sub>B<sub>10</sub>O (M)<sup>+</sup> 334.3307, found 334.3302.</div></div><div id="sec4_2_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (<i>RS</i>)-1-[1-(3-Methoxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>30</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>2e</b> was adapted to synthesize <b>30</b>. Starting materials: <b>29</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (0.5 g, 2 mmol), 1-heptanal (0.42 mL, 3 mmol). Yield: 580 mg (80%) of a white solid, <i>R</i><sub><i>f</i></sub>: 0.39 (hexanes/EtOAc, 14/1, v/v), m.p.: 62–63 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.15–1.30 (m, 8H, 4 × CH<sub>2</sub>), 1.38–1.47 (m, 2H, CH<sub>2</sub>), 1.59 (br. s, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.47 (m, 1H, CH), 3.75 (s, 3H, OCH<sub>3</sub>), 6.75–7.09 (m, 4H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.20, 22.71, 26.59, 28.98, 31.83, 36.91, 55.38, 73.12, 83.43, 87.02, 113.52, 113.80, 119.73, 129.14, 128.84, 137.77, 159.21. Accurate mass HRMS (EI+): <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>32</sub>B<sub>10</sub>O<sub>2</sub> (M)<sup>+</sup> 364.3414, found 364.3412.</div></div><div id="sec4_2_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> (<i>RS</i>)-1-[1-(3-Hydroxyphenyl)-1,12-dicarba-<i>closo</i>-dodecaborane-12-yl]heptan-1-ol (<b>31</b>)</h4><div class="NLM_p last">The method described for the synthesis of <b>3b</b> was adapted to synthesize <b>31</b>. Starting materials: <b>30</b> (500 mg, 1.37 mmol); boron tribromide (4.1 mL, 4.1 mmol, 1 M solution in DCM). Further purification was achieved by suspending the residue obtained after column chromatography in boiling heptane. The suspension was then cooled to −78 °C, filtered, and the solid residue was washed with heptane cooled to −78 °C followed by pentane, cooled to −78 °C. Yield: 270 mg (56%) of a white solid after column chromatography, <i>R</i><sub><i>f</i></sub>: 0.48 (hexanes/EtOAc, 4/1, v/v), m.p.: 99–100 °C. Analytical HPLC: column I, solvent system: isooctanol/EtOH (95/5) [isocratic], flow rate: 1 mL, wavelength: 280 nm, retention time: 10.27 min, purity 100.00%. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.87 (t, 3H, CH<sub>3</sub>), 1.16–1.39 (m, 8H, 4 × CH<sub>2</sub>), 1.40–1.45 (m, 2H, CH<sub>2</sub>), 1.67 (br. s, 1H, OH), 1.85–3.0 (br. m, 10H, BH), 3.48 (m, 1H, CH), 4.98 (s, 1H, OH), 6.68–7.04 (m, 4H, arom.). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.19, 22.70, 26.57, 28.96, 31.80, 36.89, 73.21, 83.13, 86.96, 114.71, 115.45, 119.90, 129.38, 138.02, 155.17. Accurate mass HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>29</sub>B<sub>10</sub>O<sub>2</sub> (M – 1)<sup>−</sup> 349.31653, found 349.31686.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Plasmids and Transfection</h3><div class="NLM_p last">Human ERα and ERβ expression vectors (pcDNA3-hERα and pcDNA3-hERβ, respectively), as well as the luciferase reporter vector (pGL4.26-3xERE) were described previously.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> HEK-293 cells (ATCC CRL-1573) were seeded on 100 mm dishes and grown in Dulbecco’s modified Eagle’s medium (DMEM)/10% fetal bovine serum (FBS) to about 80% confluency. One day before transfection, growth medium was replaced by phenol-red-free DMEM/5% Hyclone charcoal stripped FBS (CS-FBS, GE Healthcare Life Sciences) without penicillin–streptomycin (starvation medium). DNA/polyethylenimine complexes were made by mixing 1.8 μg of pcDNA3-hERα or pcDNA3-hERβ with 3.6 μg of pGL4.26-3xERE and 9.6 μg of pBluescript in 500 μL of DMEM and adding to 30 μL of 1 mg/mL polyethylenimine (linear, MW ∼ 25 000, Cat #23966, Polysciences, Inc., PA) diluted in 500 μL of DMEM. Cells were further cultivated for 24 h and harvested for reporter luciferase assay.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Reporter Luciferase Assays for Steroid Receptors AR, PR, GR, and MR</h3><div class="NLM_p last">These assays were performed as described previously<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and consist of clonal lines created in U2OS cells with stably integrated expression constructs for individual full-length steroid receptors together with reporter vector pGL4.36[luc2P/MMTV/Hygro] (Promega) containing a viral LTR isolated from MMTV. This promoter harbors multiple binding sites for different steroid receptors that regulate the expression of firefly luciferase as a reporter enzyme.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Ga4/UAS Reporter Luciferase Assays for Nuclear Receptors</h3><div class="NLM_p last">The panel of selective cell-based luciferase reporter assays is based on chimeric NRs created by the replacement of the N-terminally located DBD by a DBD from the yeast transcription factor Gal4. The chimeric Gal4-DBD/NR-LBD binds to UAS elements in the promoter of the reporter construct controlling the expression of the firefly luciferase from the pGL4.35 reporter vector (Promega). Most of the assays are available in form of clonal stable cell lines established on the unified cellular background in U2OS osteosarcoma cells. These lines were prepared by introducing the expression vector encoding for NR and pGL4.35 reporter vector. Cells that stably integrated both constructs into the genome were isolated with selection medium containing hygromycin and G418 (Geneticin). From these cell cultures, clones of cells were further isolated and screened for optimal response in assays with reference ligands. All lines were extensively validated with a collection of reference ligands for individual NRs.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Luciferase Reporter Assays</h3><div class="NLM_p">Transcription response of different NRs to test compounds was evaluated using transiently transfected HEK293 (ERα and ERβ) or clonal stable reporter U2OS lines (remaining NRs). Cells were cultivated for 24 h in the starvation medium and were harvested, counted, and seeded to cell culture-treated, white, solid 384-well plates (Corning, Inc., NY) 12 h before compound addition. A total of 6000 transiently transfected HEK293 cells (ERα, ERβ reporter assay, dose response compound profiling) or 10 000 U2OS cells (compound selectivity profiling at 1 μM for NR activity) were dispensed in 20 μL of total starvation media volume to 384-well plates (Corning Costar) by Multidrop Combi (Thermo Fisher Scientific) or Tempest (Formulatrix, Inc.).</div><div class="NLM_p">Test compounds were diluted in DMSO and transferred to cells using contact-free acoustic transfer by ECHO 550 (Labcyte, Inc.) integrated in the fully automated robotic HTS station cell::explorer (PerkinElmer). In ERα and ERβ reporter assays, compounds were tested at 15 concentration points extending from 100 μM to 1 pM, in duplicates. In the Gal4/UAS NR profiling for compound selectivity, they were tested at a single concentration point: 1 μM, in quadruplicates. In the antagonist mode, 30 min incubation of cells with compounds was followed by the addition of 10-fold concentrated agonist to each well on the plate. The concentration of the agonist for the antagonist mode was chosen to induce 80% of the maximal reporter response and specific conditions for all assays are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Table S3</a> (Supporting Information). Luciferase activity was measured 20 h (ERα, ERβ reporter assay, dose response compound profiling) or 14 h (compound selectivity profiling at 1 μM for NR activity) after compound addition, with Bright-Glo Luciferase Assay System (Promega) on the multimode plate reader Envision (PerkinElmer) equipped with enhanced luminescence module. Data were collected, normalized, and processed using proprietary LIMS system ScreenX.</div><div class="NLM_p last">Luciferase activities were normalized for each assay independently in the scale of 0–100%: agonist mode: 0% = activity of untreated cells, 100% = maximal reporter activity achieved with reference agonist ligand (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Table S3</a>, Supporting Information). Antagonist mode: 0% = untreated cells, 100% = reporter activity obtained by treating cells with the agonist at concentration inducing 80% of the maximal reporter activity.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Cell Viability Assay</h3><div class="NLM_p last">Cells were propagated in the cell growth medium to the amount needed for the experiment. Cells were harvested, counted, and dispensed to 384-well plates at the same number/well as in the reporter assays and were treated with compounds identically as in the reporter assays. Cell viability was assessed after 20 h (ERα, ERβ reporter assay, dose response compound profiling) or 14 h (compound selectivity profiling at 1 μM for NR activity) of incubation with compounds by determining the level of intracellular ATP using CellTiter-Glo (Promega) luminescent assay. Luciferase signal was measured on the multimode plate reader Envision (PerkinElmer). Data were collected, normalized, and processed using proprietary LIMS system ScreenX.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> PolarScreen ERα and ERβ Competitor Binding Assay</h3><div class="NLM_p last">Compound affinities for ERα and ERβ proteins were assessed in commercial, homogeneous, polarized fluorescence-based PolarScreen ER α/β Competitor Assays, Red (Life Technologies) according to manufacturer′s protocols. First <i>K</i><sub>d</sub> for the competitor ligand Fluormone EL Red was determined in a saturation binding experiment for each receptor independently: <i>K</i><sub>d</sub> (ERα) = 12.4 nM and <i>K</i><sub>d</sub> (ERβ) = 16.7 nM. Then, competitive binding assays with carborane compounds were carried out in a total volume of 5 μL in nontreated, black polystyrene 1536-well plates (Corning, cat. no. 3936). First, 3 μL of reaction buffer was dispensed to each well by a Tempest (Formulatrix) dispenser. Then, dilution series of test compounds prediluted in DMSO in the acoustic dispensing-compliant polypropylene plates (Labcyte) were transferred to the assay plates using contact-free acoustic transfer by ECHO 550 (Labcyte, Inc.) integrated in the fully automated robotic HTS station cell::explorer (PerkinElmer). Compounds were tested in triplicates at 16 different concentration points between 100 μM and 100 pM. The plates were spun down and vigorously shaken for 5 min after which a mixture of 2 μL of ERα (final concentration = 48 nM) or ERβ (final concentration = 138 nM) proteins with Fluormone EL Red (final concentration = 1.4 nM) were dispensed to assay plates. Plates were shaken for 5 min again, spun down, and incubated for 3 h. Fluorescence polarization value (mP) was recorded using a multimode plate reader Envision (PerkinElmer) with optimized set of filters: excitation filter 531/25 nm and two emission filters 595/60 nm (S/P). Data were collected, normalized by proprietary LIMS system ScreenX. Dose response curves were obtained by fitting data with nonlinear regression function and <i>K</i><sub>d</sub> values for each compound were calculated from obtained IC<sub>50</sub> values by Cheng–Prusoff equation.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Cytochrome P450 Enzymatic Assays</h3><div class="NLM_p last">Enzyme activities of individual CYP forms were measured according to established protocols. The following microsomal CYP activities were tested: CYP1A2, 7-ethoxyresorufin O-deethylation;<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> CYP2A6, coumarin 7-hydroxylation;<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> CYP2B6, 7-ethoxy-4-(trifluoromethyl)coumarin 7-deethylation;<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> CYP2C8, paclitaxel 6α-hydroxylation;<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> CYP2C9, diclofenac 4′-hydroxylation;<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> CYP2C19, mephenytoin 4′-hydroxylation;<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> CYP2D6, bufuralol 1′-hydroxylation;<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> CYP2E1, chlorzoxazone 6-hydroxylation,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and CYP3A4, midazolam 1′-hydroxylation.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> Incubation mixtures contained 100 mM potassium phosphate buffer (pH 7.4), reduced nicotinamide adenine dinucleotide phosphate (NADPH)-generating system (0.8 mM NADP<sup>+</sup>, 5.8 mM isocitrate, 0.3 unit/mL of isocitrate dehydrogenase, and 8 mM MgCl<sub>2</sub>), human liver microsomes and individual probe substrate. Compounds tested were dissolved in DMSO to a concentration of 200 mM, then diluted with the same phosphate buffer. Compounds were tested at concentrations between 0.01 and 100 μM. Assay conditions are listed in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Supporting Information</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">Table S4</a>). The concentration of probe substrates for individual CYP forms was chosen in the range of the respective <i>K</i><sub>M</sub> determined separately as described previously for each CYP and for its respective substrate. Activities were measured using HPLC Prominence system (Shimadzu; Kyoto, Japan) with a UV/fluorescence detection. Data were analyzed using Sigma Plot v.12.0 graphing software (Jandel Scientific, Chicago, IL).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00555" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00555?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00555</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Activity profiles of library compounds in cell-based reporter assays for nuclear receptors; methods and experimental conditions for cytochrome P450 enzyme assays; and NMR and MS spectra and HPLC chromatograms (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf">jm1c00555_si_001.pdf (9.81 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_002.csv">jm1c00555_si_002.csv (9.79 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00555" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Petr Bartunek</span> - <span class="hlFld-Affiliation affiliation">CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy
of Sciences, Vídeňská
1083, 142 20 Prague, Czech Republic</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#97f5f6e5e3e2f9f2fcd7fefaf0b9f4f6e4b9f4ed"><span class="__cf_email__" data-cfemail="1270736066677c7779527b7f753c7173613c7168">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher C. Coss</span> - <span class="hlFld-Affiliation affiliation">Division
of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Development Institute, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8184-9190" title="Orcid link">https://orcid.org/0000-0002-8184-9190</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ff9c908c8cd1cec9bf908c8ad19a9b8a"><span class="__cf_email__" data-cfemail="2e4d415d5d001f186e415d5b004b4a5b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Sedlák</span> - <span class="hlFld-Affiliation affiliation">CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy
of Sciences, Vídeňská
1083, 142 20 Prague, Czech Republic</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-0074-335X" title="Orcid link">https://orcid.org/0000-0003-0074-335X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tyler A. Wilson</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Werner Tjarks</span> - <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanna S. Radomska</span> - <span class="hlFld-Affiliation affiliation">Division
of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongyan Wang</span> - <span class="hlFld-Affiliation affiliation">Division
of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayaprakash Narayana Kolla</span> - <span class="hlFld-Affiliation affiliation">CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy
of Sciences, Vídeňská
1083, 142 20 Prague, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zbigniew J. Leśnikowski</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry, Institute of Medical
Biology PAS, 106 Lodowa Street, 93-232 Lodz, Poland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-3158-5796" title="Orcid link">https://orcid.org/0000-0003-3158-5796</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alena Špičáková</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Faculty of Medicine, Palacky
University, Hněvotínská 3, 77515 Olomouc, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tehane Ali</span> - <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keisuke Ishita</span> - <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liva Harinantenaina Rakotondraibe</span> - <span class="hlFld-Affiliation affiliation">Division
of Medicinal Chemistry and Pharmacognosy College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-2166-4992" title="Orcid link">https://orcid.org/0000-0003-2166-4992</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandip Vibhute</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dasheng Wang</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pavel Anzenbacher</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Faculty of Medicine, Palacky
University, Hněvotínská 3, 77515 Olomouc, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chad Bennett</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Development Institute, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>D.S., T.A.W., W.T., P.B., and C.C.C. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6796-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Ministry of Education, Youth and Sports grant: RVO: 68378050-KAV-NPUI, LM2015063, LM2018130, NSC 2014/13/B/NZ1/03989 at IMB PAS, institutional support RVO: 68378050 at IMG and RVO: 61989592 at UPOL. This work was further supported by the College of Pharmacy at The Ohio State University, its instrumentation core and director Dr. Craig McElroy. This study made use of the Campus Chemical Instrument Center NMR facility at The Ohio State University. Compounds <b>13</b>, <b>17</b>, and <b>26</b> were synthesized by the Medicinal Chemistry Shared Resource, and the corresponding mass spectral data were obtained by the Proteomics Shared Resource, both of which are part of The Ohio State University Comprehensive Cancer Center and supported by NCI/NIH Grant P30CA016058. This work was also supported by the Drug Development Institute within The Ohio State University Comprehensive Cancer Center and Pelotonia. The authors thank the University of Illinois Urbana–Champaign Mass Spectrometry Laboratory and the University of Michigan College of Literature, Science and the Arts Mass Spectrometry Technical Services for instrumentation support. They also thank Olga Martínková for support in cell culture work and transfection experiments, Dr. Martin Popr for support in compound management, Tomas Langammer for automating the experiments on HTS robotics, and Dr. Samuel Kulp for his help in formatting the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">androgen receptor</p></td></tr><tr><td class="NLM_term">BNCT</td><td class="NLM_def"><p class="first last">boron-neutron capture therapy</p></td></tr><tr><td class="NLM_term">CBS</td><td class="NLM_def"><p class="first last">Corey–Bakshi–Shibata</p></td></tr><tr><td class="NLM_term">CDCl<sub>3</sub></td><td class="NLM_def"><p class="first last">deuterated chloroform</p></td></tr><tr><td class="NLM_term">DBD</td><td class="NLM_def"><p class="first last">DNA-binding domain</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">DPN</td><td class="NLM_def"><p class="first last">diarylpropionitrile</p></td></tr><tr><td class="NLM_term">E2</td><td class="NLM_def"><p class="first last">17β-estradiol</p></td></tr><tr><td class="NLM_term">ERRγ</td><td class="NLM_def"><p class="first last">estrogen receptor-related receptor γ</p></td></tr><tr><td class="NLM_term">ERα</td><td class="NLM_def"><p class="first last">estrogen receptor α</p></td></tr><tr><td class="NLM_term">ERβ</td><td class="NLM_def"><p class="first last">estrogen receptor β</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethyl alcohol</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">FXR</td><td class="NLM_def"><p class="first last">farnesoid X receptor</p></td></tr><tr><td class="NLM_term">GPER1</td><td class="NLM_def"><p class="first last">G protein-coupled transmembrane receptor</p></td></tr><tr><td class="NLM_term">GR</td><td class="NLM_def"><p class="first last">glucocorticoid receptor</p></td></tr><tr><td class="NLM_term"><i>i</i>-PrOH</td><td class="NLM_def"><p class="first last">isopropyl alcohol</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knock-out</p></td></tr><tr><td class="NLM_term">LTR</td><td class="NLM_def"><p class="first last">long terminal repeat</p></td></tr><tr><td class="NLM_term">LXR</td><td class="NLM_def"><p class="first last">liver X receptor</p></td></tr><tr><td class="NLM_term">MMTV</td><td class="NLM_def"><p class="first last">mouse mammary tumor virus</p></td></tr><tr><td class="NLM_term">MR</td><td class="NLM_def"><p class="first last">mineralocorticoid receptor</p></td></tr><tr><td class="NLM_term">NaOAc</td><td class="NLM_def"><p class="first last">sodium acetate</p></td></tr><tr><td class="NLM_term">NIMBA</td><td class="NLM_def"><p class="first last"><i>N</i>-isopropyl-<i>N</i>-methyl-<i>tert</i>-butylamine</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">nuclear receptor</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">PPT</td><td class="NLM_def"><p class="first last">propylpyrazole triol</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">progesterone receptor</p></td></tr><tr><td class="NLM_term">RAR</td><td class="NLM_def"><p class="first last">retinoic acid receptor</p></td></tr><tr><td class="NLM_term">RXR</td><td class="NLM_def"><p class="first last">retinoid X receptor</p></td></tr><tr><td class="NLM_term">SR</td><td class="NLM_def"><p class="first last">steroid receptor</p></td></tr><tr><td class="NLM_term">UAS</td><td class="NLM_def"><p class="first last">upstream activating sequences</p></td></tr><tr><td class="NLM_term">VDR</td><td class="NLM_def"><p class="first last">vitamin D receptor</p></td></tr></table><span class="title" id="d98286380e5779">Additional Notes</span><div class="NLM_fn" id="fncc"><sup>a</sup> <p class="last">Preparation of 5-Methylhexan-1-al: PCC (3.71 g, 17.21 mmol) was suspended in dry methylene chloride (40 mL). A solution of 5-methyl-1-hexanol (1 g, 8.61 mmol) in methylene chloride (15 mL) was then added in one portion to the stirred suspension to give a dark reaction mixture, which was stirred at room temperature overnight. Dry ether (60 mL) was added and then molecular sieve followed by stirring for 1 h. The supernatant liquid was decanted, and the insoluble residue was washed with dry ether (3 × 20 mL). The combined organic phases were passed through a short florisil column, and the solvent was removed in vacuo providing 370 mg (38%) of product, which was used without further purification and analysis in the next step.</p></div><div class="NLM_fn" id="fnd"><sup>b</sup> <p class="last">Preparation of 6-Methylheptan-1-al: PCC (2.89 g, 13.44 mmol) was suspended in dry methylene chloride (40 mL). A solution of 6-methyl-1-heptanol (1 g, 7.68 mmol) in methylene chloride (15 mL) was then added in one portion to the stirred suspension to give a dark reaction mixture, which was stirred at room temperature overnight. Dry ether (60 mL) was added and then molecular sieve followed by stirring for 1 h. The supernatant liquid was decanted, and the insoluble residue was washed with dry ether (3 × 20 mL). The combined organic phases were passed through a short florisil column, and the solvent was removed in vacuo providing 750 mg (76%) of product, which was used without further purification and analysis in the next step.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i102">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodds, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, W.</span></span> <span> </span><span class="NLM_article-title">Synthetic Strogenic Agents without the Phenanthrene Nucleus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1936</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">996</span>, <span class="refDoi"> DOI: 10.1038/137996a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1038%2F137996a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaA28XkvVagsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1936&pages=996&author=E.+C.+Doddsauthor=W.+Lawson&title=Synthetic+Strogenic+Agents+without+the+Phenanthrene+Nucleus&doi=10.1038%2F137996a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic estrogenic agents without the phenanthrene nucleus</span></div><div class="casAuthors">Dodds, E. C.; Lawson, Wilfrid</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1936</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">996</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The phenanthrene condensed-ring structure is not necessary for estrogenic activity.  A table of 14 synthetic substances is given, all except one showing 100% positive estrus responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgp6KB1NsIerVg90H21EOLACvtfcHk0ljiOdrn5fJCTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA28XkvVagsQ%253D%253D&md5=9991eb1f0557091ee8f4d26b2c9d99d3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F137996a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F137996a0%26sid%3Dliteratum%253Aachs%26aulast%3DDodds%26aufirst%3DE.%2BC.%26aulast%3DLawson%26aufirst%3DW.%26atitle%3DSynthetic%2520Strogenic%2520Agents%2520without%2520the%2520Phenanthrene%2520Nucleus%26jtitle%3DNature%26date%3D1936%26volume%3D137%26spage%3D996%26doi%3D10.1038%2F137996a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krust, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeltsch, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staub, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrace, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterfield, M.</span></span> <span> </span><span class="NLM_article-title">Cloning of the Human Estrogen Receptor CDNA</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">7889</span>– <span class="NLM_lpage">7893</span>, <span class="refDoi"> DOI: 10.1073/pnas.82.23.7889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.82.23.7889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=3865204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaL28XotlShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=7889-7893&author=P.+Walterauthor=S.+Greenauthor=G.+Greeneauthor=A.+Krustauthor=J.+M.+Bornertauthor=J.+M.+Jeltschauthor=A.+Staubauthor=E.+Jensenauthor=G.+Scraceauthor=M.+Waterfield&title=Cloning+of+the+Human+Estrogen+Receptor+CDNA&doi=10.1073%2Fpnas.82.23.7889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the human estrogen receptor cDNA</span></div><div class="casAuthors">Walter, Philippe; Green, Stephen; Greene, Geoffrey; Krust, Andree; Bornert, Jean Marc; Jeltsch, Jean Marc; Staub, Adrien; Jensen, Elwood; Scrace, Geoffrey; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7889-93</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Poly(A)+ RNA isolated from the human breast cancer cell line MCF-7 was fractionated by sucrose gradient centrifugation and fractions enriched in estrogen receptor (ER) mRNA were used to prep. randomly primed cDNA libraries in the λg10 and λg11 vectors.  Clones corresponding to ER sequence were isolated from both libraries after screening with either ER monoclonal antibodies (λg11) or synthetic oligonucleotide probes designed from 2 peptide sequences of purified ER (λg10).  Five cDNA clones were isolated by antibody screening, and 5 were isolated after screening with synthetic oligonucleotides.  The 2 largest ER cDNA clones, λOR3 (1.3 kilobase pairs) and λOR8 (2.1 kilobase pairs), isolated by using antibodies and oligonucleotides, resp., were able to enrich selectively for ER mRNA by hybrid-selection.  Further, λOR8 contains the DNA sequence expected from the 2 ER peptides and cross-hybridizes with each of the other ER cDNA clones.  These results demonstrate that the clones isolated correspond to the ER mRNA sequence.  Use of λOR8 as a hybridization probe revealed a single poly(A)+ RNA band of ≈6.2 kilobase pairs in the ER-contg. human breast cancer cell lines MCF-7 and T47D.  In contrast, no hybridization was seen in the human ER-neg. cell line HeLa.  The same probe hybridizes to a chicken gene that is expressed in oviduct tissue as a 7.5-kilobase-pair poly(A)+ RNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjx0upbPWKHrVg90H21EOLACvtfcHk0ljiOdrn5fJCTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XotlShsA%253D%253D&md5=bfb5de85940113236c09e1f34a785b75</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.23.7889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.23.7889%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DGreene%26aufirst%3DG.%26aulast%3DKrust%26aufirst%3DA.%26aulast%3DBornert%26aufirst%3DJ.%2BM.%26aulast%3DJeltsch%26aufirst%3DJ.%2BM.%26aulast%3DStaub%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DE.%26aulast%3DScrace%26aufirst%3DG.%26aulast%3DWaterfield%26aufirst%3DM.%26atitle%3DCloning%2520of%2520the%2520Human%2520Estrogen%2520Receptor%2520CDNA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1985%26volume%3D82%26spage%3D7889%26epage%3D7893%26doi%3D10.1073%2Fpnas.82.23.7889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korach, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couse, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindzey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimbro, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eddy, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliaccio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snedeker, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubahn, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schomberg, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. P.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor Gene Disruption: Molecular Characterization and Experimental and Clinical Phenotypes</span>. <i>Recent Prog. Horm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=8701078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2sXktFKisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1996&pages=159-186&author=K.+S.+Korachauthor=J.+F.+Couseauthor=S.+W.+Curtisauthor=T.+F.+Washburnauthor=J.+Lindzeyauthor=K.+S.+Kimbroauthor=E.+M.+Eddyauthor=S.+Migliaccioauthor=S.+M.+Snedekerauthor=D.+B.+Lubahnauthor=D.+W.+Schombergauthor=E.+P.+Smith&title=Estrogen+Receptor+Gene+Disruption%3A+Molecular+Characterization+and+Experimental+and+Clinical+Phenotypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes</span></div><div class="casAuthors">Korach, Kenneth S.; Couse, John F.; Curtis, Sylvia W.; Washburn, Todd F.; Lindzey, Jonathan; Kimbro, K. Sean; Eddy, Edward M.; Migliaccio, Silvia; Snedeker, Suzanne M.; Lubahn, Dennis B.; Schomberg, David W.; Smith, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">Recent Progress in Hormone Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-188</span>CODEN:
                <span class="NLM_cas:coden">RPHRA6</span>;
        ISSN:<span class="NLM_cas:issn">0079-9963</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review with 50 refs.  The estrogen receptor (ER) is thought to play a crucial role in the regulation of many life processes, including development, reprodn. and normal physiol.  Because there have been no known mutations of the estrogen receptor in normal tissue of humans and animals, its presence and tissue distribution is thought to be essential for survival.  Using the techniques of homologous recombination, the ER gene has been disrupted to produce a line of transgenic mice possessing the altered ER gene (ERKO).  The mouse ER gene was disrupted by inserting a 1.8-kb PGK-Neomycin sequence into exon 2, ∼280 bp downstream of the transcription start codon.  The correct targeting of the disruption was demonstrated by Southern blot anal. and PCR.  Western blot anal. of uterine prepns. from ERKO females showed no detectable ER protein.  Heterozygotes had one half the level of ER protein compared to wild-type animals.  Estrogen insensitivity was confirmed using estrogen agonists, estradiol, hydroxy tamoxifen, diethylstilbestrol treatment for 3 days which resulted in a 3-4-fold increase in uterine wet wt. and vaginal cornification in wild-type females, while ERKO mice were totally unresponsive.  These data were further supported by the failure of estrogen or EGF treatment to induce DNA synthesis in uterine tissue of similarly treated mice.  Lactoferrin, an estrogen-responsive gene in the uterus, was also assayed by Northern blot.  Wild-type mice treated with a single estradiol injection showed a 350-fold induction in lactoferrin mRNA, while ERKO females showed no detectable response.  Both male and female animals survive to adulthood with normal gross external phenotypes.  As expected, females are infertile and demonstrate hypoplastic uteri and hyperemic ovaries with no apparent corpora lutea.  Males are also infertile, with atrophy of the testes and seminiferous tubule dysmorphogenesis.  Although the reproductive capabilities have been altered with a dramatic effect on the gonads, prenatal development of the reproductive tracts of both sexes appear to be independent of an ER-mediated response.  Anal. of the mammary glands of the ERKO females at 4 mo of age showed a primitive ductal rudiment rather than the fully developed ductal tree seen in wild-type siblings.  Also absent were the terminal end buds seen during normal ductal morphogenesis.  Both sexes show a decrease in skeletal bone d., supporting a direct role for ER action in bone.  A single patient is described who is homozygous for a point mutation in the human ER gene at codon 157.  The mutation produces a truncation of the ER protein and results in estrogen insensitivity syndrome.  Most significant of the clin. findings are effects on skeletal bone d. and retarded bone age.  Findings from the patient and mice suggest that the absence of functional ER is not lethal.  Mutation in the ER gene is present in the human population.  Further characterization of the mice and identification of addnl. patients will be required to more fully understand the consequences of ER gene mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOffkuQ39uzrVg90H21EOLACvtfcHk0ljiOdrn5fJCTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFKisr0%253D&md5=b9f0b64fca403a8ac04eff2884ad258a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKorach%26aufirst%3DK.%2BS.%26aulast%3DCouse%26aufirst%3DJ.%2BF.%26aulast%3DCurtis%26aufirst%3DS.%2BW.%26aulast%3DWashburn%26aufirst%3DT.%2BF.%26aulast%3DLindzey%26aufirst%3DJ.%26aulast%3DKimbro%26aufirst%3DK.%2BS.%26aulast%3DEddy%26aufirst%3DE.%2BM.%26aulast%3DMigliaccio%26aufirst%3DS.%26aulast%3DSnedeker%26aufirst%3DS.%2BM.%26aulast%3DLubahn%26aufirst%3DD.%2BB.%26aulast%3DSchomberg%26aufirst%3DD.%2BW.%26aulast%3DSmith%26aufirst%3DE.%2BP.%26atitle%3DEstrogen%2520Receptor%2520Gene%2520Disruption%253A%2520Molecular%2520Characterization%2520and%2520Experimental%2520and%2520Clinical%2520Phenotypes%26jtitle%3DRecent%2520Prog.%2520Horm.%2520Res.%26date%3D1996%26volume%3D51%26spage%3D159%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">discussion 186–188.</p></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelto-Huikko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J. A.</span></span> <span> </span><span class="NLM_article-title">Cloning of a Novel Receptor Expressed in Rat Prostate and Ovary</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">5925</span>– <span class="NLM_lpage">5930</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.12.5925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.93.12.5925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=8650195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Ojs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=5925-5930&author=G.+G.+Kuiperauthor=E.+Enmarkauthor=M.+Pelto-Huikkoauthor=S.+Nilssonauthor=J.+A.+Gustafsson&title=Cloning+of+a+Novel+Receptor+Expressed+in+Rat+Prostate+and+Ovary&doi=10.1073%2Fpnas.93.12.5925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a novel estrogen receptor expressed in rat prostate and ovary</span></div><div class="casAuthors">Kuiper, George G. J. M.; Enmark, Eva; Pelto-Huikko, Markku; Nilsson, Stefan; Gustafsson, Jan-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5925-5930</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The authors have cloned a novel member of the nuclear receptor superfamily.  The cDNA of clone 29 was isolated from a rat prostate cDNA library and it encodes a protein of 485 amino acid residues with a calcd. mol. wt. of 54.2 kDa.  Clone 29 protein is unique in that it is highly homologous to the rat estrogen receptor (ER) protein, particularly in the DNA-binding domain (95%) and in the C-terminal ligand-binding domain (55%).  Expression of clone 29 in rat tissues was investigated by in situ hybridization and prominent expression was found in prostate and ovary.  In the prostate clone 29 is expressed in the epithelial cells of the secretory alveoli, whereas in the ovary the granulosa cells in primary, secondary, and mature follicles showed expression of clone 29.  Satn. ligand-binding anal. of in vitro synthesized clone 29 protein revealed a single binding component for 17β-estradiol (E2) and high affinity (Kd = 0.6 nM).  In ligand-competition expts. the binding affinity decreased in the order E2 > diethylstilbestrol > estriol > estrone > 5α-androstane-3β,17β-diol » testosterone = progesterone = corticosterone = 5α-androstane-3α,17β-diol.  In cotransfection expts. of Chinese hamster ovary cells with a clone 29 expression vector and an estrogen-regulated reporter gene, maximal stimulation (about 3-fold) of reporter gene activity was found during incubation with 10 nM of E2.  Neither progesterone, testosterone, dexamethasone, thyroid hormone, all-trans-retinoic acid, nor 5α-androstane-3α,17β-diol could stimulate reporter gene activity, whereas estrone and 5α-androstane-3β,17β-diol did.  The authors conclude that clone 29 cDNA encodes a novel rat ER, which they suggest be named rat ERβ to distinguish it from the previously cloned ER (ERα) from rat uterus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemRoHhjStjrVg90H21EOLACvtfcHk0lgKnUE84xi8DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Ojs7c%253D&md5=aa1c112de706d680f59afec3e77830b3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.12.5925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.12.5925%26sid%3Dliteratum%253Aachs%26aulast%3DKuiper%26aufirst%3DG.%2BG.%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DPelto-Huikko%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DGustafsson%26aufirst%3DJ.%2BA.%26atitle%3DCloning%2520of%2520a%2520Novel%2520Receptor%2520Expressed%2520in%2520Rat%2520Prostate%2520and%2520Ovary%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D5925%26epage%3D5930%26doi%3D10.1073%2Fpnas.93.12.5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäkelä, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treuter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tujague, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Estrogen Action</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1535</span>– <span class="NLM_lpage">1565</span>, <span class="refDoi"> DOI: 10.1152/physrev.2001.81.4.1535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1152%2Fphysrev.2001.81.4.1535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=11581496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD38XislCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=1535-1565&author=S.+Nilssonauthor=S.+M%C3%A4kel%C3%A4author=E.+Treuterauthor=M.+Tujagueauthor=J.+Thomsenauthor=G.+Anderssonauthor=E.+Enmarkauthor=K.+Petterssonauthor=M.+Warnerauthor=J.-%C3%85.+Gustafsson&title=Mechanisms+of+Estrogen+Action&doi=10.1152%2Fphysrev.2001.81.4.1535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of estrogen action</span></div><div class="casAuthors">Nilsson, Stefan; Makela, Sari; Treuter, Eckardt; Tujague, Michel; Thomsen, Jane; Andersson, Goran; Enmark, Eva; Pettersson, Katarina; Warner, Margaret; Gustafsson, Jan-Ake</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1535-1565</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Our appreciation of the physiol. functions of estrogens and the mechanisms through which estrogens bring about these functions has changed during the past decade.  Just as transgenic mice were produced in which estrogen receptors had been inactivated and we thought that we were about to understand the role of estrogen receptors in physiol. and pathol., it was found that there was not 1 but 2 distinct and functional estrogen receptors, now called ERα and ERβ.  Transgenic mice in which each of the receptors or both the receptors are inactive have revealed a much broader role for estrogens in the body than was previously thought.  This decade also saw the description of a male patient who had no functional ERα and whose continued bone growth clearly revealed an important function of estrogen in men.  The importance of estrogen in both males and females was also demonstrated in the lab. in transgenic mice in which the aromatase gene was inactivated.  Finally, crystal structures of the estrogen receptors with agonists and antagonists have revealed much about how ligand binding influences receptor conformation and how this conformation influences interaction of the receptor with coactivators or corepressors and hence dets. cellular response to ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxK-vrJTSDErVg90H21EOLACvtfcHk0lgKnUE84xi8DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislCqtw%253D%253D&md5=e3c660fbdf99d1b456486caabef516c8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.4.1535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.4.1535%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DS.%26aulast%3DTreuter%26aufirst%3DE.%26aulast%3DTujague%26aufirst%3DM.%26aulast%3DThomsen%26aufirst%3DJ.%26aulast%3DAndersson%26aufirst%3DG.%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DPettersson%26aufirst%3DK.%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26atitle%3DMechanisms%2520of%2520Estrogen%2520Action%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D1535%26epage%3D1565%26doi%3D10.1152%2Fphysrev.2001.81.4.1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heldring, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tujague, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ström, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treuter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptors: How Do They Signal and What Are Their Targets</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">931</span>, <span class="refDoi"> DOI: 10.1152/physrev.00026.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1152%2Fphysrev.00026.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=17615392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFGls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2007&pages=905-931&author=N.+Heldringauthor=A.+Pikeauthor=S.+Anderssonauthor=J.+Matthewsauthor=G.+Chengauthor=J.+Hartmanauthor=M.+Tujagueauthor=A.+Str%C3%B6mauthor=E.+Treuterauthor=M.+Warnerauthor=J.-%C3%85.+Gustafsson&title=Estrogen+Receptors%3A+How+Do+They+Signal+and+What+Are+Their+Targets&doi=10.1152%2Fphysrev.00026.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptors: how do they signal and what are their targets</span></div><div class="casAuthors">Heldring, Nina; Pike, Ashley; Andersson, Sandra; Matthews, Jason; Cheng, Guojun; Hartman, Johan; Tujague, Michel; Stroem, Anders; Treuter, Eckardt; Warner, Margaret; Gustafsson, Jan-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">905-931</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  During the past decade there has been a substantial advance in our understanding of estrogen signaling both from a clin. as well as a preclin. perspective.  Estrogen signaling is a balance between two opposing forces in the form of two distinct receptors (ERα and ERβ) and their splice variants.  The prospect that these two pathways can be selectively stimulated or inhibited with subtype-selective drugs constitutes new and promising therapeutic opportunities in clin. areas as diverse as hormone replacement, autoimmune diseases, prostate and breast cancer, and depression.  Mol. biol., biochem., and structural studies have generated information which is invaluable for the development of more selective and effective ER ligands.  We have also become aware that ERs do not function by themselves but require a no. of coregulatory proteins whose cell-specific expression explains some of the distinct cellular actions of estrogen.  Estrogen is an important morphogen, and many of its proliferative effects on the epithelial compartment of glands are mediated by growth factors secreted from the stromal compartment.  Thus understanding the cross-talk between growth factor and estrogen signaling is essential for understanding both normal and malignant growth.  In this review we focus on several of the interesting recent discoveries concerning estrogen receptors, on estrogen as a morphogen, and on the mol. mechanisms of anti-estrogen signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXhRpQBWMSFbVg90H21EOLACvtfcHk0lgKnUE84xi8DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFGls7k%253D&md5=207d16fa37d6b14483b9fe1002ce2646</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00026.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00026.2006%26sid%3Dliteratum%253Aachs%26aulast%3DHeldring%26aufirst%3DN.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DAndersson%26aufirst%3DS.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DHartman%26aufirst%3DJ.%26aulast%3DTujague%26aufirst%3DM.%26aulast%3DStr%25C3%25B6m%26aufirst%3DA.%26aulast%3DTreuter%26aufirst%3DE.%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26atitle%3DEstrogen%2520Receptors%253A%2520How%2520Do%2520They%2520Signal%2520and%2520What%2520Are%2520Their%2520Targets%26jtitle%3DPhysiol.%2520Rev.%26date%3D2007%26volume%3D87%26spage%3D905%26epage%3D931%26doi%3D10.1152%2Fphysrev.00026.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmeci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigel, R. J.</span></span> <span> </span><span class="NLM_article-title">Identification of a Gene (GPR30) with Homology to the G-Protein-Coupled Receptor Superfamily Associated with Estrogen Receptor Expression in Breast Cancer</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1006/geno.1997.4972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1006%2Fgeno.1997.4972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=9367686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2sXnsVejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=607-617&author=C.+Carmeciauthor=D.+A.+Thompsonauthor=H.+Z.+Ringauthor=U.+Franckeauthor=R.+J.+Weigel&title=Identification+of+a+Gene+%28GPR30%29+with+Homology+to+the+G-Protein-Coupled+Receptor+Superfamily+Associated+with+Estrogen+Receptor+Expression+in+Breast+Cancer&doi=10.1006%2Fgeno.1997.4972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer</span></div><div class="casAuthors">Carmeci, Charles; Thompson, Devon A.; Ring, Huijun Z.; Francke, Uta; Weigel, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">607-617</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Using the technique of differential cDNA library screening, a cDNA clone was isolated from an estrogen receptor (ER)-pos. breast carcinoma cell line (MCF7) cDNA library based upon the overexpression of this gene compared to an ER-neg. cell line (MDA-MB-231).  Sequence anal. of this clone detd. that it shared significant homol. to G-protein-coupled receptors.  This receptor, GPCR-Br, was abundantly expressed in the ER-pos. breast carcinoma cell lines MCF7, T-47D, and MDA-MB-361.  Expression was absent or minimal in the ER-neg. breast carcinoma cell lines BT-20, MDA-MB-231, and HBL-100.  GPCR-Br was ubiquitously expressed in human tissues examd. but was most abundant in placenta.  GPCR-Br expression was examd. in 11 primary breast carcinomas.  GPCR-Br was detected in all 4 ER-pos. tumors and only 1 of 7 ER-neg. tumors.  Based upon PCR anal. in hybrid cell lines, the gene for GPCR-Br (HGMW-approved symbol GPR30) was mapped to chromosome 7p22.  The pattern of expression of GPCR-Br indicates that this receptor may be involved in physiol. responses specific to hormonally responsive tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQz06vdDuObVg90H21EOLACvtfcHk0ljZWKx14UPwjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsVejsbo%253D&md5=831bb2d172786fe61c914e8e851d0735</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1997.4972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1997.4972%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeci%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DRing%26aufirst%3DH.%2BZ.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DWeigel%26aufirst%3DR.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520Gene%2520%2528GPR30%2529%2520with%2520Homology%2520to%2520the%2520G-Protein-Coupled%2520Receptor%2520Superfamily%2520Associated%2520with%2520Estrogen%2520Receptor%2520Expression%2520in%2520Breast%2520Cancer%26jtitle%3DGenomics%26date%3D1997%26volume%3D45%26spage%3D607%26epage%3D617%26doi%3D10.1006%2Fgeno.1997.4972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Revankar, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimino, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sklar, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arterburn, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prossnitz, E. R.</span></span> <span> </span><span class="NLM_article-title">A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">1625</span>– <span class="NLM_lpage">1630</span>, <span class="refDoi"> DOI: 10.1126/science.1106943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1126%2Fscience.1106943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=15705806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitV2is7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=1625-1630&author=C.+M.+Revankarauthor=D.+F.+Ciminoauthor=L.+A.+Sklarauthor=J.+B.+Arterburnauthor=E.+R.+Prossnitz&title=A+Transmembrane+Intracellular+Estrogen+Receptor+Mediates+Rapid+Cell+Signaling&doi=10.1126%2Fscience.1106943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling</span></div><div class="casAuthors">Revankar, Chetana M.; Cimino, Daniel F.; Sklar, Larry A.; Arterburn, Jeffrey B.; Prossnitz, Eric R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5715</span>),
    <span class="NLM_cas:pages">1625-1630</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The steroid hormone estrogen regulates many functionally unrelated processes in numerous tissues.  Although it is traditionally thought to control transcriptional activation through the classical nuclear estrogen receptors, it also initiates many rapid nongenomic signaling events.  We found that of all G protein-coupled receptors characterized to date, GPR30 is uniquely localized to the endoplasmic reticulum, where it specifically binds estrogen and fluorescent estrogen derivs.  Activating GPR30 by estrogen resulted in intracellular calcium mobilization and synthesis of phosphatidylinositol 3,4,5-trisphosphate in the nucleus.  Thus, GPR30 represents an intracellular transmembrane estrogen receptor that may contribute to normal estrogen physiol. as well as pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtnK3fSsNsrLVg90H21EOLACvtfcHk0ljZWKx14UPwjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitV2is7c%253D&md5=938d5a0422146eac0ace28da892d82ef</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106943%26sid%3Dliteratum%253Aachs%26aulast%3DRevankar%26aufirst%3DC.%2BM.%26aulast%3DCimino%26aufirst%3DD.%2BF.%26aulast%3DSklar%26aufirst%3DL.%2BA.%26aulast%3DArterburn%26aufirst%3DJ.%2BB.%26aulast%3DProssnitz%26aufirst%3DE.%2BR.%26atitle%3DA%2520Transmembrane%2520Intracellular%2520Estrogen%2520Receptor%2520Mediates%2520Rapid%2520Cell%2520Signaling%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D1625%26epage%3D1630%26doi%3D10.1126%2Fscience.1106943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, G. G. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandien, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häggblad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1210/endo.138.3.4979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fendo.138.3.4979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=9048584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2sXht1OksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1997&pages=863-870&author=G.+G.+J.+M.+Kuiperauthor=B.+Carlssonauthor=K.+Grandienauthor=E.+Enmarkauthor=J.+H%C3%A4ggbladauthor=S.+Nilssonauthor=J.-%C3%85.+Gustafsson&title=Comparison+of+the+Ligand+Binding+Specificity+and+Transcript+Tissue+Distribution+of+Estrogen+Receptors+%CE%B1+and+%CE%B2&doi=10.1210%2Fendo.138.3.4979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β</span></div><div class="casAuthors">Kuiper, George G. J. M.; Carlsson, Bo; Grandien, Kaj; Enmark, Eva; Haeggblad, Johan; Nilsson, Stefan; Gustafsson, Jan-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">863-870</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The rat estrogen receptor (ER) exists as two subtypes, ERα and ERβ, which differ in the C-terminal ligand-binding domain and in the N-terminal transactivation domain.  In this study we investigated the mRNA expression of both ER subtypes in rat tissues by RT-PCR and compared the ligand binding specificity of the ER subtypes.  Satn. ligand binding anal. of in vitro synthesized human ERα and rat ERβ protein revealed a single binding component for 16α-iodo-17β-estradiol with high affinity [dissocn. const. (Kd) = 0.1 nM for ERα protein and 0.4 nM for ERβ protein].  Most estrogenic substrates or estrogenic antagonists compete with 16α-[125I]iodo-17β-estradiol for binding to both ER subtypes in a very similar preference and degree; i.e., diethylstilbestrol > hexestrol > dienestrol > 4-OH-tamoxifen > 17β-estradiol > coumestrol, ICI-164384 > estrone, 17α-estradiol > nafoxidine, moxestrol > clomifene > estriol, 4-OH-estradiol > tamoxifen, 2-OH-estradiol, 5-androstene-3β-17β-diol, genistein for the ERα protein and dienestrol > 4-OH-tamoxifen > diethylstilbestrol > hexestrol > coumestrol, ICI-164384 > 17β-estradiol > estrone, genistein > estriol > nafoxidine, 5-androstene-3β,17β-diol > 17α-estradiol, clomifene, 2-OH-estradiol > 4-OH-estradiol, tamoxifen, moxestrol for the ERβ protein.  The rat tissue distribution and/or the relative level of ERα and ERβ expression seems to be quite different, i.e. moderate to high expression in uterus, testis, pituitary, ovary, kidney, epididymis, and adrenal for ERα and prostate, ovary, lung, bladder, brain, uterus, and testis for ERβ.  The described differences between the ER subtypes in relative ligand binding affinity and tissue distribution could contribute to the selective action of ER agonists and antagonists in different tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRnITtxbrCBLVg90H21EOLACvtfcHk0ljZWKx14UPwjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXht1OksrY%253D&md5=bb4d88e7ba9c878a79c711b3b0a5f92f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1210%2Fendo.138.3.4979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo.138.3.4979%26sid%3Dliteratum%253Aachs%26aulast%3DKuiper%26aufirst%3DG.%2BG.%2BJ.%2BM.%26aulast%3DCarlsson%26aufirst%3DB.%26aulast%3DGrandien%26aufirst%3DK.%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DH%25C3%25A4ggblad%26aufirst%3DJ.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26atitle%3DComparison%2520of%2520the%2520Ligand%2520Binding%2520Specificity%2520and%2520Transcript%2520Tissue%2520Distribution%2520of%2520Estrogen%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B2%26jtitle%3DEndocrinology%26date%3D1997%26volume%3D138%26spage%3D863%26epage%3D870%26doi%3D10.1210%2Fendo.138.3.4979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, K. J.</span>; <span class="NLM_string-name">Hewitt, S. C.</span>; <span class="NLM_string-name">Arao, Y.</span>; <span class="NLM_string-name">Korach, K. S.</span></span> <span> </span><span class="NLM_article-title">Estrogen Hormone Biology</span>. In  <i>Current Topics in Developmental Biology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, D.</span>; <span class="NLM_string-name">Tsai, S.</span></span>, Eds.; <span class="NLM_series">Nuclear Receptors in Development and Disease</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_year">2017</span>; Chapter 4; Vol.  <span class="NLM_volume">125</span>, pp  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">146</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fbs.ctdb.2016.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=109-146&author=K.+J.+Hamilton&author=S.+C.+Hewitt&author=Y.+Arao&author=K.+S.+Korachauthor=D.+Forrest&author=S.+Tsai&title=Current+Topics+in+Developmental+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fbs.ctdb.2016.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fbs.ctdb.2016.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DK.%2BJ.%26atitle%3DEstrogen%2520Hormone%2520Biology%26btitle%3DCurrent%2520Topics%2520in%2520Developmental%2520Biology%26aulast%3DForrest%26aufirst%3DD.%26pub%3DAcademic%2520Press%26date%3D2017%26volume%3D125%26spage%3D109%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budish, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, S. H.</span></span> <span> </span><span class="NLM_article-title">GPER–Novel Membrane Oestrogen Receptor</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1016</span>, <span class="refDoi"> DOI: 10.1042/CS20160114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1042%2FCS20160114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC28XotVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2016&pages=1005-1016&author=M.+A.+Zimmermanauthor=R.+A.+Budishauthor=S.+Kashyapauthor=S.+H.+Lindsey&title=GPER%E2%80%93Novel+Membrane+Oestrogen+Receptor&doi=10.1042%2FCS20160114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">GPER-novel membrane estrogen receptor</span></div><div class="casAuthors">Zimmerman, Margaret A.; Budish, Rebecca A.; Kashyap, Shreya; Lindsey, Sarah H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The recent discovery of the G protein-coupled estrogen receptor (GPER) presents new challenges and opportunities for understanding the physiol., pathophysiol. and pharmacol. of many diseases.  This review will focus on the expression and function of GPER in hypertension, kidney disease, atherosclerosis, vascular remodelling, heart failure, reprodn., metabolic disorders, cancer, environmental health and menopause.  Furthermore, this review will highlight the potential of GPER as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGtirrMoyBjrVg90H21EOLACvtfcHk0ljdZolvTCLwNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotVSrsLs%253D&md5=7404f65583d895b9ccc19505eb9a858b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1042%2FCS20160114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20160114%26sid%3Dliteratum%253Aachs%26aulast%3DZimmerman%26aufirst%3DM.%2BA.%26aulast%3DBudish%26aufirst%3DR.%2BA.%26aulast%3DKashyap%26aufirst%3DS.%26aulast%3DLindsey%26aufirst%3DS.%2BH.%26atitle%3DGPER%25E2%2580%2593Novel%2520Membrane%2520Oestrogen%2520Receptor%26jtitle%3DClin.%2520Sci.%26date%3D2016%26volume%3D130%26spage%3D1005%26epage%3D1016%26doi%3D10.1042%2FCS20160114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mäkelä, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savolainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aavik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myllärniemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taskinen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häyry, P.</span></span> <span> </span><span class="NLM_article-title">Differentiation between Vasculoprotective and Uterotrophic Effects of Ligands with Different Binding Affinities to Estrogen Receptors α and β</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">7077</span>– <span class="NLM_lpage">7082</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.12.7077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.96.12.7077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10359841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXks1WktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=7077-7082&author=S.+M%C3%A4kel%C3%A4author=H.+Savolainenauthor=E.+Aavikauthor=M.+Myll%C3%A4rniemiauthor=L.+Straussauthor=E.+Taskinenauthor=J.-%C3%85.+Gustafssonauthor=P.+H%C3%A4yry&title=Differentiation+between+Vasculoprotective+and+Uterotrophic+Effects+of+Ligands+with+Different+Binding+Affinities+to+Estrogen+Receptors+%CE%B1+and+%CE%B2&doi=10.1073%2Fpnas.96.12.7077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β</span></div><div class="casAuthors">Makela, Sari; Savolainen, Hanna; Aavik, Einari; Myllarniemi, Marjukka; Strauss, Leena; Taskinen, Eero; Gustafsson, Jan-Ake; Hayry, Pekka</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7077-7082</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Estrogen-based drug therapy in cardiovascular diseases has been difficult because it has not been possible to sep. the wanted vasculoprotective effect from the unwanted effects of the hormone to the reproductive system.  Here we demonstrate that, after endothelial denudation of rat carotid artery, the mRNA of the classical estrogen receptor (ER) is constitutively expressed at a low level, whereas the expression of the novel ER mRNA increases >40-fold.  Under in situ hybridization and immunohistochem., ERβ mRNA and protein colocalize with the smooth muscle cells in the media and neointima.  Treatment of ovariectomized female rats with the isoflavone phytoestrogen genistein, which shows 20-fold higher binding affinity to ERβ than to ERα, or with 17β-estradiol, which does not differentiate between the two receptors, provides similar dose-dependent vasculoprotective effect in rat carotid injury model.  In addn. in concn. <10 μM, both ligands are equally inhibitory to the replication and migration of smooth muscle cells in vitro.  However, only treatment with 17β-estradiol, but not with genistein, is accompanied with a dose-dependent uterotrophic effect.  The results suggest that preferential targeting to ERβ will provide vasculoprotective estrogen analogs devoid of effects to the reproductive system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpaaiArl5LrVg90H21EOLACvtfcHk0ljdZolvTCLwNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXks1WktbY%253D&md5=eac9076dd6e164de1216e54059d9782c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.12.7077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.12.7077%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DS.%26aulast%3DSavolainen%26aufirst%3DH.%26aulast%3DAavik%26aufirst%3DE.%26aulast%3DMyll%25C3%25A4rniemi%26aufirst%3DM.%26aulast%3DStrauss%26aufirst%3DL.%26aulast%3DTaskinen%26aufirst%3DE.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26aulast%3DH%25C3%25A4yry%26aufirst%3DP.%26atitle%3DDifferentiation%2520between%2520Vasculoprotective%2520and%2520Uterotrophic%2520Effects%2520of%2520Ligands%2520with%2520Different%2520Binding%2520Affinities%2520to%2520Estrogen%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D7077%26epage%3D7082%26doi%3D10.1073%2Fpnas.96.12.7077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filardo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span> <span> </span><span class="NLM_article-title">Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">624</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1210/en.2004-1064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fen.2004-1064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=15539556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotlWitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=624-632&author=P.+Thomasauthor=Y.+Pangauthor=E.+J.+Filardoauthor=J.+Dong&title=Identity+of+an+Estrogen+Membrane+Receptor+Coupled+to+a+G+Protein+in+Human+Breast+Cancer+Cells&doi=10.1210%2Fen.2004-1064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells</span></div><div class="casAuthors">Thomas, P.; Pang, Y.; Filardo, E. J.; Dong, J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">624-632</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Although nonclassical estrogen actions initiated at the cell surface have been described in many tissues, the identities of the membrane estrogen receptors (mERs) mediating these actions remain unclear.  Here we show that GPR30, an orphan receptor unrelated to nuclear estrogen receptors, has all the binding and signaling characteristics of a mER.  A high-affinity (dissocn. const. 2.7 nM), limited capacity, displaceable, single binding site specific for estrogens was detected in plasma membranes of SKBR3 breast cancer cells that express GPR30 but lack nuclear estrogen receptors.  Progesterone-induced increases and small interfering RNA-induced decreases in GPR30 expression in SKBR3 cells were accompanied by parallel changes in specific estradiol-17β (E2) binding.  Plasma membranes of human embryonic kidney 293 cells transfected with GPR30, but not those of untransfected cells, and human placental tissues that express GPR30 also displayed high-affinity, specific estrogen binding typical of mERs.  E2 treatment of transfected cell membranes caused activation of a stimulatory G protein that is directly coupled to the receptor, indicating GPR30 is a G protein-coupled receptor (GPCR), and also increased adenylyl cyclase activity.  The finding that the antiestrogens tamoxifen and ICI 182,780, and an environmental estrogen, ortho, para-dichlorodiphenyl-dichloroethylene (o,p'-DDE), have high binding affinities to the receptor and mimic the actions of E2 has important implications for both the development and treatment of estrogen-dependent breast cancer.  GPR30 is structurally unrelated to the recently discovered family of GPCR-like membrane progestin receptors.  The identification of a second distinct class of GPCR-like steroid membrane receptors suggests a widespread role for GPCRs in nonclassical steroid hormone actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5L9Qo-2sS4rVg90H21EOLACvtfcHk0ljJ78Jv9w1lnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotlWitw%253D%253D&md5=6870880ddbd84da144dc18d929707bcd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1210%2Fen.2004-1064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2004-1064%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DP.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DFilardo%26aufirst%3DE.%2BJ.%26aulast%3DDong%26aufirst%3DJ.%26atitle%3DIdentity%2520of%2520an%2520Estrogen%2520Membrane%2520Receptor%2520Coupled%2520to%2520a%2520G%2520Protein%2520in%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26spage%3D624%26epage%3D632%26doi%3D10.1210%2Fen.2004-1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lubahn, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couse, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korach, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smithies, O.</span></span> <span> </span><span class="NLM_article-title">Alteration of Reproductive Function but Not Prenatal Sexual Development after Insertional Disruption of the Mouse Estrogen Receptor Gene</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">11162</span>– <span class="NLM_lpage">11166</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.23.11162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.90.23.11162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=8248223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2cXks1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=11162-11166&author=D.+B.+Lubahnauthor=J.+S.+Moyerauthor=T.+S.+Goldingauthor=J.+F.+Couseauthor=K.+S.+Korachauthor=O.+Smithies&title=Alteration+of+Reproductive+Function+but+Not+Prenatal+Sexual+Development+after+Insertional+Disruption+of+the+Mouse+Estrogen+Receptor+Gene&doi=10.1073%2Fpnas.90.23.11162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene</span></div><div class="casAuthors">Lubahn, Dennis B.; Moyer, Jeffrey S.; Golding, Thomas S.; Couse, John F.; Korach, Kenneth S.; Smithies, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11162-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Estrogen receptor and its ligand, estradiol, have long been thought to be essential for survival, fertility, and female sexual differentiation and development.  Consistent with this proposed crucial role, no human estrogen receptor gene mutations are known, unlike the androgen receptor, where many loss of function mutations have been found.  The authors have generated mutant mice lacking responsiveness to estradiol by disrupting the estrogen receptor gene by gene targeting.  Both male and female animals survive to adulthood with normal gross external phenotypes.  Females are infertile; males have a decreased fertility.  Females have hypoplastic uteri and hyperemic ovaries with no detectable corpora lutea.  In adult wild-type and heterozygous females, 3-day estradiol treatment at 40 μg/kg stimulates a 3- to 4-fold increase in uterine wet wt. and alters vaginal cornification, but the uteri and vagina do not respond in the animals with the estrogen receptor gene disruption.  Prenatal male and female reproductive tract development can therefore occur in the absence of estradiol receptor-mediated responsiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhRWAK7AJWFLVg90H21EOLACvtfcHk0ljJ78Jv9w1lnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXks1ajsw%253D%253D&md5=bde5d2b52c3e2fda7c834175b3e61ca0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.23.11162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.23.11162%26sid%3Dliteratum%253Aachs%26aulast%3DLubahn%26aufirst%3DD.%2BB.%26aulast%3DMoyer%26aufirst%3DJ.%2BS.%26aulast%3DGolding%26aufirst%3DT.%2BS.%26aulast%3DCouse%26aufirst%3DJ.%2BF.%26aulast%3DKorach%26aufirst%3DK.%2BS.%26aulast%3DSmithies%26aufirst%3DO.%26atitle%3DAlteration%2520of%2520Reproductive%2520Function%2520but%2520Not%2520Prenatal%2520Sexual%2520Development%2520after%2520Insertional%2520Disruption%2520of%2520the%2520Mouse%2520Estrogen%2520Receptor%2520Gene%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D11162%26epage%3D11166%26doi%3D10.1073%2Fpnas.90.23.11162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krege, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couse, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korach, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smithies, O.</span></span> <span> </span><span class="NLM_article-title">Generation and Reproductive Phenotypes of Mice Lacking Estrogen Receptor β</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">15677</span>– <span class="NLM_lpage">15682</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.26.15677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.95.26.15677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=9861029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15677-15682&author=J.+H.+Kregeauthor=J.+B.+Hodginauthor=J.+F.+Couseauthor=E.+Enmarkauthor=M.+Warnerauthor=J.+F.+Mahlerauthor=M.+Sarauthor=K.+S.+Korachauthor=J.-%C3%85.+Gustafssonauthor=O.+Smithies&title=Generation+and+Reproductive+Phenotypes+of+Mice+Lacking+Estrogen+Receptor+%CE%B2&doi=10.1073%2Fpnas.95.26.15677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Generation and reproductive phenotypes of mice lacking estrogen receptor β</span></div><div class="casAuthors">Krege, John H.; Hodgin, Jeffrey B.; Couse, John F.; Enmark, Eva; Warner, Margaret; Mahler, Joel F.; Sar, Madhabananda; Korach, Kenneth S.; Gustafsson, Jan-Ake; Smithies, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15677-15682</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Estrogens influence the differentiation and maintenance of reproductive tissues and affect lipid metab. and bone remodeling.  Two estrogen receptors (ERs) have been identified to date, ERα and ERβ.  The authors previously generated and studied knockout mice lacking estrogen receptor α and reported severe reproductive and behavioral phenotypes including complete infertility of both male and female mice and absence of breast tissue development.  Here, the authors describe the generation of mice lacking estrogen receptor β (ERβ -/-) by insertion of a neomycin-resistance gene into exon 3 of the coding gene by using homologous recombination in embryonic stem cells.  Mice lacking this receptor develop normally and are indistinguishable grossly and histol. as young adults from their littermates.  RNA anal. and immunocytochem. show that tissues from ERβ -/- mice lack normal ERβ RNA and protein.  Breeding expts. with young, sexually mature females show that they are fertile and exhibit normal sexual behavior, but have fewer and smaller litters than wild-type mice.  Superovulation expts. indicate that this redn. in fertility is the result of reduced ovarian efficiency.  The mutant females have normal breast development and lactate normally.  Young, sexually mature male mice show no overt abnormalities and reproduce normally.  Older mutant males display signs of prostate and bladder hyperplasia.  Thus, ERβ is essential for normal ovulation efficiency but is not essential for female or male sexual differentiation, fertility, or lactation.  Future expts. are required to det. the role of ERβ in bone and cardiovascular homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUdPlJH7MDrVg90H21EOLACvtfcHk0lg3lzEcd2gsMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeiuw%253D%253D&md5=50cc5538ab791d52f280959e296d0e8d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15677%26sid%3Dliteratum%253Aachs%26aulast%3DKrege%26aufirst%3DJ.%2BH.%26aulast%3DHodgin%26aufirst%3DJ.%2BB.%26aulast%3DCouse%26aufirst%3DJ.%2BF.%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DMahler%26aufirst%3DJ.%2BF.%26aulast%3DSar%26aufirst%3DM.%26aulast%3DKorach%26aufirst%3DK.%2BS.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26aulast%3DSmithies%26aufirst%3DO.%26atitle%3DGeneration%2520and%2520Reproductive%2520Phenotypes%2520of%2520Mice%2520Lacking%2520Estrogen%2520Receptor%2520%25CE%25B2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D15677%26epage%3D15682%26doi%3D10.1073%2Fpnas.95.26.15677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prossnitz, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hathaway, H. J.</span></span> <span> </span><span class="NLM_article-title">What Have We Learned about GPER Function in Physiology and Disease from Knockout Mice?</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.jsbmb.2015.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.jsbmb.2015.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=26189910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1CkurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2015&pages=114-126&author=E.+R.+Prossnitzauthor=H.+J.+Hathaway&title=What+Have+We+Learned+about+GPER+Function+in+Physiology+and+Disease+from+Knockout+Mice%3F&doi=10.1016%2Fj.jsbmb.2015.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">What have we learned about GPER function in physiology and disease from knockout mice?</span></div><div class="casAuthors">Prossnitz, Eric R.; Hathaway, Helen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-126</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Estrogens, predominantly 17β-estradiol, exert diverse effects throughout the body in both normal and pathophysiol., during development and in reproductive, metabolic, endocrine, cardiovascular, nervous, musculoskeletal and immune systems.  Estrogen and its receptors also play important roles in carcinogenesis and therapy, particularly for breast cancer.  In addn. to the classical nuclear estrogen receptors (ERα and ERβ) that traditionally mediate predominantly genomic signaling, the G protein-coupled estrogen receptor GPER has become recognized as a crit. mediator of rapid signaling in response to estrogen.  Mouse models, and in particular knockout (KO) mice, represent an important approach to understand the functions of receptors in normal physiol. and disease.  Whereas ERα KO mice display multiple significant defects in reprodn. and mammary gland development, ERβ KO phenotypes are more limited, and GPER KO exhibit no reproductive deficits.  However, the study of GPER KO mice over the last six years has revealed that GPER deficiency results in multiple physiol. alterations including obesity, cardiovascular dysfunction, insulin resistance and glucose intolerance.  In addn., the lack of estrogen-mediated effects in numerous tissues of GPER KO mice, studied in vivo or ex vivo, including those of the cardiovascular, endocrine, nervous and immune systems, reveals GPER as a genuine mediator of estrogen action.  Importantly, GPER KO mice have also demonstrated roles for GPER in breast carcinogenesis and metastasis.  In combination with the supporting effects of GPER-selective ligands and GPER knockdown approaches, GPER KO mice demonstrate the therapeutic potential of targeting GPER activity in diseases as diverse as obesity, diabetes, multiple sclerosis, hypertension, atherosclerosis, myocardial infarction, stroke and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXPmJ2K7SChLVg90H21EOLACvtfcHk0lg3lzEcd2gsMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1CkurnN&md5=76ffa0a4124d62506b9add2f0459dd32</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2015.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2015.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DProssnitz%26aufirst%3DE.%2BR.%26aulast%3DHathaway%26aufirst%3DH.%2BJ.%26atitle%3DWhat%2520Have%2520We%2520Learned%2520about%2520GPER%2520Function%2520in%2520Physiology%2520and%2520Disease%2520from%2520Knockout%2520Mice%253F%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D153%26spage%3D114%26epage%3D126%26doi%3D10.1016%2Fj.jsbmb.2015.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. A.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor-β: Recent Lessons from in Vivo Studies</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1210/me.2005-0459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fme.2005-0459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=16556737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=1-13&author=H.+A.+Harris&title=Estrogen+Receptor-%CE%B2%3A+Recent+Lessons+from+in+Vivo+Studies&doi=10.1210%2Fme.2005-0459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor-β: recent lessons from in vivo studies</span></div><div class="casAuthors">Harris, Heather A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The unexpected discovery of a second form of the estrogen receptor (ER), designated ERβ, surprised and energized the field of estrogen research.  In the 9 yr since its identification, the remarkable efforts from academic and industrial scientists of many disciplines have made significant progress in elucidating its biol.  A powerful battery of tools, including knockout mice as well as a panel of receptor-selective agonists, has allowed an investigation into the role of ERβ.  To date, in vivo efficacy studies are limited to rodents.  Current data indicate that ERβ plays a minor role in mediating estrogen action in the uterus, on the hypothalamus/pituitary, the skeleton, and other classic estrogen target tissues.  However, a clear role for ERβ has been established in the ovary, cardiovascular system, and brain as well as in several animal models of inflammation including arthritis, endometriosis, inflammatory bowel disease, and sepsis.  The next phase of research will focus on elucidating, at a mol. level, how ERβ exerts these diverse effects and exploring the clin. utility of ERβ-selective agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-mcaoNu5iELVg90H21EOLACvtfcHk0lg3lzEcd2gsMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFOnsw%253D%253D&md5=f55e31161a74e96fa82518f7aac9e62f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0459%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DH.%2BA.%26atitle%3DEstrogen%2520Receptor-%25CE%25B2%253A%2520Recent%2520Lessons%2520from%2520in%2520Vivo%2520Studies%26jtitle%3DMol.%2520Endocrinol.%26date%3D2007%26volume%3D21%26spage%3D1%26epage%3D13%26doi%3D10.1210%2Fme.2005-0459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanholi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nalvarte, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-A.</span></span> <span> </span><span class="NLM_article-title">Ventral Prostate and Mammary Gland Phenotype in Mice with Complete Deletion of the ERβ Gene</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">4902</span>– <span class="NLM_lpage">4909</span>, <span class="refDoi"> DOI: 10.1073/pnas.1920478117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.1920478117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=32075916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVSrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=4902-4909&author=M.+Warnerauthor=W.+Wuauthor=L.+Montanholiauthor=I.+Nalvarteauthor=P.+Antonsonauthor=J.-A.+Gustafsson&title=Ventral+Prostate+and+Mammary+Gland+Phenotype+in+Mice+with+Complete+Deletion+of+the+ER%CE%B2+Gene&doi=10.1073%2Fpnas.1920478117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ventral prostate and mammary gland phenotype in mice with complete deletion of the ERβ gene</span></div><div class="casAuthors">Warner, Margaret; Wu, Wan-fu; Montanholi, Leticia; Nalvarte, Ivan; Antonson, Per; Gustafsson, Jan-Ake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4902-4909</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Disagreements about the phenotype of estrogen receptor β; (ERβ) knockout mouse, created by removing the DNA-binding domain of the ERβ; gene or interruption of the gene with a neocassette (Oliver Smithies ERβ knockout mice [ERβOS-/-]), prompted us to create an ERβ knockout mouse by deleting the ERβ gene with the use of CRISPR/Cas9 technol.  We confirmed that the ERβ gene was eliminated from the mouse genome and that no ERβ mRNA or protein was detectable in tissues of this mouse.  Overall the phenotype of the ventral prostate (VP) and mammary gland (MG) in ERβcrispr-/- mice was similar to, but more severe than, that in the ERβOS-/-mice.  In the VP of 6-mo-old ERβcrispr-/- mice there was epithelial hyperplasia, fibroplasia, inflammation, stromal overgrowth, and intraductal cancer-like lesions.  This was accompanied by an increase in Ki67 and P63 and loss in DACH1 and PURα, two androgen receptor (AR) repressors.  In the MG there was overexpression of estrogen receptor α and progesterone receptor, loss of collagen, increase in proliferation and expression of metalloproteases, and invasive epithelium.  Surprisingly, by 18 mo of age, the no. of hyperplastic foci was reduced, the ducts of the VP and MG became atrophic, and, in the VP, there was massive immune infiltration and massive desquamation of the luminal epithelial cells.  These changes were coincident with reduced levels of androgens in males and estrogens in females.  We conclude that ERβ is a tumor suppressor gene in the VP and MG where its loss increases the activity AR and ERα resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjOOOU8IzUurVg90H21EOLACvtfcHk0lg3lzEcd2gsMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVSrur0%253D&md5=5b9cf899ca7c8779041f68a6164349d1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1920478117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1920478117%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DMontanholi%26aufirst%3DL.%26aulast%3DNalvarte%26aufirst%3DI.%26aulast%3DAntonson%26aufirst%3DP.%26aulast%3DGustafsson%26aufirst%3DJ.-A.%26atitle%3DVentral%2520Prostate%2520and%2520Mammary%2520Gland%2520Phenotype%2520in%2520Mice%2520with%2520Complete%2520Deletion%2520of%2520the%2520ER%25CE%25B2%2520Gene%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2020%26volume%3D117%26spage%3D4902%26epage%3D4909%26doi%3D10.1073%2Fpnas.1920478117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marriner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, J. A.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor-β Potency-Selective Ligands: Structure–Activity Relationship Studies of Diarylpropionitriles and Their Acetylene and Polar Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">4230</span>– <span class="NLM_lpage">4251</span>, <span class="refDoi"> DOI: 10.1021/jm010254a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010254a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFagsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4230-4251&author=M.+J.+Meyersauthor=J.+Sunauthor=K.+E.+Carlsonauthor=G.+A.+Marrinerauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogen&title=Estrogen+Receptor-%CE%B2+Potency-Selective+Ligands%3A+Structure%E2%80%93Activity+Relationship+Studies+of+Diarylpropionitriles+and+Their+Acetylene+and+Polar+Analogues&doi=10.1021%2Fjm010254a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen Receptor-β Potency-Selective Ligands: Structure-Activity Relationship Studies of Diarylpropionitriles and Their Acetylene and Polar Analogues</span></div><div class="casAuthors">Meyers, Marvin J.; Sun, Jun; Carlson, Kathryn E.; Marriner, Gwendolyn A.; Katzenellenbogen, Benita S.; Katzenellenbogen, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4230-4251</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through an effort to develop novel ligands that have subtype selectivity for the estrogen receptors alpha (ERα) and beta (ERβ), we have found that 2,3-bis(4-hydroxyphenyl)propionitrile (DPN) acts as an agonist on both ER subtypes, but has a 70-fold higher relative binding affinity and 170-fold higher relative potency in transcription assays with ERβ than with ERα.  To investigate the ERβ affinity- and potency-selective character of this DPN further, we prepd. a series of DPN analogs in which both the ligand core and the arom. rings were modified by the repositioning of phenolic hydroxy groups and by the addn. of alkyl substituents and nitrile groups.  We also prepd. other series of DPN analogs in which the nitrile functionality was replaced with acetylene groups or polar functions, to mimic the linear geometry or polarity of the nitrile, resp.  To varying degrees, all of the analogs show preferential binding affinity for ERβ (i.e., they are ERβ affinity-selective), and many, but not all of them, are also more potent in activating transcription through ERβ than through ERα (i.e., they are ERβ potency-selective). meso-2,3-Bis(4-hydroxyphenyl)succinonitrile and dl-2,3-bis(4-hydroxyphenyl)succinonitrile are among the highest ERβ affinity-selective ligands, and they have an ERβ potency selectivity that is equiv. to that of DPN.  The acetylene analogs have higher binding affinities but somewhat lower selectivities than their nitrile counterparts.  The polar analogs have lower affinities, and only the fluorinated polar analogs have substantial affinity selectivities.  This study suggests that, in this series of ligands, the nitrile functionality is crit. to ERβ selectivity because it provides the optimal combination of linear geometry and polarity. Furthermore, the addn. of a second nitrile group β to the nitrile in DPN or the addn. of a Me substituent at an ortho position on the β-arom. ring increases the affinity and selectivity of these compds. for ERβ.  These ERβ-selective compds. may prove to be valuable tools in understanding the differences in structure and biol. function of ERα and ERβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK5qpvnjw6mLVg90H21EOLACvtfcHk0lgp-0TttCuCoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFagsr8%253D&md5=8fbf46c36aaf2ffcc9a8c44b15827bfe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm010254a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010254a%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DMarriner%26aufirst%3DG.%2BA.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DEstrogen%2520Receptor-%25CE%25B2%2520Potency-Selective%2520Ligands%253A%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520of%2520Diarylpropionitriles%2520and%2520Their%2520Acetylene%2520and%2520Polar%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4230%26epage%3D4251%26doi%3D10.1021%2Fjm010254a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coletta, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, J. A.</span></span> <span> </span><span class="NLM_article-title">Pyrazole Ligands: Structure–Affinity/Activity Relationships and Estrogen Receptor-α-Selective Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4934</span>– <span class="NLM_lpage">4947</span>, <span class="refDoi"> DOI: 10.1021/jm000170m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000170m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1yjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4934-4947&author=S.+R.+Staufferauthor=C.+J.+Colettaauthor=R.+Tedescoauthor=G.+Nishiguchiauthor=K.+Carlsonauthor=J.+Sunauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogen&title=Pyrazole+Ligands%3A+Structure%E2%80%93Affinity%2FActivity+Relationships+and+Estrogen+Receptor-%CE%B1-Selective+Agonists&doi=10.1021%2Fjm000170m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Ligands: Structure-Affinity/Activity Relationships and Estrogen Receptor-α-Selective Agonists</span></div><div class="casAuthors">Stauffer, Shaun R.; Coletta, Christopher J.; Tedesco, Rosanna; Nishiguchi, Gisele; Carlson, Kathryn; Sun, Jun; Katzenellenbogen, Benita S.; Katzenellenbogen, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4934-4947</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have found that certain tetrasubstituted pyrazoles are high-affinity ligands for the estrogen receptor (ER) and that one pyrazole is considerably more potent as an agonist on the ERα than on the ERβ subtype.  To investigate what substituent pattern provides optimal ER binding affinity and the greatest enhancement of potency as an ERα-selective agonist, we prepd. a no. of tetrasubstituted pyrazole analogs with defined variations at certain substituent positions.  Anal. of their binding affinity pattern shows that a C(4)-Pr substituent is optimal and that a p-hydroxyl group on the N(1)-Ph group also enhances affinity and selectivity for ERα.  The best compd. in this series, a propylpyrazole triol (I), binds to ERα with high affinity (ca. 50% that of estradiol), and it has a 410-fold binding affinity preference for ERα.  It also activates gene transcription only through ERα. Thus, this compd. represents the first ERα-specific agonist.  We investigated the mol. basis for the exceptional ERα binding affinity and potency selectivity of pyrazole I by a further study of structure-affinity relationships in this series and by mol. modeling.  These investigations suggest that the pyrazole triols prefer to bind to ERα with their C(3)-phenol in the estradiol A-ring binding pocket and that binding selectivity results from differences in the interaction of the pyrazole core and C(4)-Pr group with portions of the receptor where ERα has a smaller residue than ERβ.  These ER subtype-specific interactions and the ER subtype-selective ligands that can be derived from them should prove useful in defining those biol. activities in estrogen target cells that can be selectively activated through ERα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhsnWI9OqFlLVg90H21EOLACvtfcHk0lgp-0TttCuCoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1yjsbk%253D&md5=3bce249ad2d0eaf91aa4ad17ebffdd05</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm000170m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000170m%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DColetta%26aufirst%3DC.%2BJ.%26aulast%3DTedesco%26aufirst%3DR.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DCarlson%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DPyrazole%2520Ligands%253A%2520Structure%25E2%2580%2593Affinity%252FActivity%2520Relationships%2520and%2520Estrogen%2520Receptor-%25CE%25B1-Selective%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4934%26epage%3D4947%26doi%3D10.1021%2Fjm000170m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-A.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor β as a Pharmaceutical Target</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2016.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.tips.2016.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=27979317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKnu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=92-99&author=M.+Warnerauthor=B.+Huangauthor=J.-A.+Gustafsson&title=Estrogen+Receptor+%CE%B2+as+a+Pharmaceutical+Target&doi=10.1016%2Fj.tips.2016.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen Receptor β as a Pharmaceutical Target</span></div><div class="casAuthors">Warner, Margaret; Huang, Bo; Gustafsson, Jan-Ake</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-99</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A major issue in clin. endocrinol. today is how to use hormones to achieve the health benefits that they clearly can provide but avoid the neg. side effects, i.e., how to develop more precise medicines.  This problem of how to use hormones is pervasive in clin. endocrinol.  It is true for estrogen, progesterone, androgen, vitamin D, and thyroid hormone, and the problem is amplified in the case of new ligands for the more recently discovered nuclear receptors.  Selective targeting of hormone receptor subtypes is one attractive way to harness the beneficial effects of hormones while reducing unwanted side effects.  Here, we focus on estrogen receptor (ER)β, which has promise as a selective target in hormone replacement therapy, and in breast and prostate cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGhx9LQhVTbbVg90H21EOLACvtfcHk0lgp-0TttCuCoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKnu7jM&md5=976f8a25342bba055e9ba332c84f7ff2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2016.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2016.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DGustafsson%26aufirst%3DJ.-A.%26atitle%3DEstrogen%2520Receptor%2520%25CE%25B2%2520as%2520a%2520Pharmaceutical%2520Target%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26spage%3D92%26epage%3D99%26doi%3D10.1016%2Fj.tips.2016.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span> <span> </span><span class="NLM_article-title">Oestrogen Receptors – an Overview</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2796.1999.00545.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1046%2Fj.1365-2796.1999.00545.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10447781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlCmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1999&pages=133-138&author=E.+Enmarkauthor=J.-%C3%85.+Gustafsson&title=Oestrogen+Receptors+%E2%80%93+an+Overview&doi=10.1046%2Fj.1365-2796.1999.00545.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Oestrogen receptors - an overview</span></div><div class="casAuthors">Enmark, E.; Gustafsson, J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-138</span>CODEN:
                <span class="NLM_cas:coden">JINMEO</span>;
        ISSN:<span class="NLM_cas:issn">0954-6820</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 29 refs.  The estrogen receptor (ER) is a ligand-activated transcription factor that mediates the effects of the steroid hormone 17β-estradiol in both males and females.  Since the isolation and cloning of ER, the prevailing opinion has been that only one such receptor exists.  The finding of a second subtype of ER (ERβ) has caused considerable excitement and has forced endocrinologists to re-evaluate many aspects of the actions of estrogens.  In this article, the authors will try to summarize the current knowledge about the two estrogen receptor subtypes, with the emphasis on estrogen receptor β (ERβ), and to comment on the observations in mice lacking either receptor or the hormone itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpzEhOiQC5CLVg90H21EOLACvtfcHk0liVJRWwCdg3IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlCmtb8%253D&md5=731a0a091639714ccb2a4b8760eec5a6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2796.1999.00545.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2796.1999.00545.x%26sid%3Dliteratum%253Aachs%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26atitle%3DOestrogen%2520Receptors%2520%25E2%2580%2593%2520an%2520Overview%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D1999%26volume%3D246%26spage%3D133%26epage%3D138%26doi%3D10.1046%2Fj.1365-2796.1999.00545.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bapat, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonder, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frail, D. E.</span></span> <span> </span><span class="NLM_article-title">The Ligand Binding Profiles of Estrogen Receptors α and β Are Species Dependent</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1016/S0039-128X(01)00194-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2FS0039-128X%2801%2900194-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=11958794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslWgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=379-384&author=H.+A.+Harrisauthor=A.+R.+Bapatauthor=D.+S.+Gonderauthor=D.+E.+Frail&title=The+Ligand+Binding+Profiles+of+Estrogen+Receptors+%CE%B1+and+%CE%B2+Are+Species+Dependent&doi=10.1016%2FS0039-128X%2801%2900194-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The ligand binding profiles of estrogen receptors α and β are species dependent</span></div><div class="casAuthors">Harris, Heather A.; Bapat, Ashok R.; Gonder, Daniel S.; Frail, Donald E.</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Estrogens and selective estrogen receptor modulators are used for the treatment and prevention of conditions resulting from menopause.  Since estrogens exert their activity by binding to nuclear receptors, there is intense interest in developing new ligands for the two known estrogen receptor subtypes, ER-α and ER-β.  Characterization assays used to profile new estrogen receptor ligands often utilize receptors from different species, with the assumption that they behave identically.  To test this belief, we have profiled a no. of estrogens, other steroids, phytoestrogens and selective estrogen receptor modulators in a solid phase radioligand binding assay using recombinant protein for human, rat, and mouse ER-α and ER-β.  Certain compds. show species dependent binding preferences for ER-α or ER-β, leading to differences in receptor subtype selectivity.  The amino acids identified by crystallog. as lining the ligand binding cavity are the same among the three species, suggesting that as yet unidentified amino acids contribute to the structure of the binding site.  We conclude from this anal. that the ability of a compd. to selectively bind to a particular ER subtype can be species dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHFlegWTMkZbVg90H21EOLACvtfcHk0liVJRWwCdg3IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslWgs7g%253D&md5=7d8abb8e1b0083d859b19556dcfa4355</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0039-128X%2801%2900194-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0039-128X%252801%252900194-5%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DH.%2BA.%26aulast%3DBapat%26aufirst%3DA.%2BR.%26aulast%3DGonder%26aufirst%3DD.%2BS.%26aulast%3DFrail%26aufirst%3DD.%2BE.%26atitle%3DThe%2520Ligand%2520Binding%2520Profiles%2520of%2520Estrogen%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B2%2520Are%2520Species%2520Dependent%26jtitle%3DSteroids%26date%3D2002%26volume%3D67%26spage%3D379%26epage%3D384%26doi%3D10.1016%2FS0039-128X%2801%2900194-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coss, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. T.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor β Selective Nonsteroidal Estrogens: Seeking Clinical Indications</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1517/13543771003657164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1517%2F13543771003657164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=20302450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslamu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=507-534&author=M.+L.+Mohlerauthor=R.+Narayananauthor=C.+C.+Cossauthor=K.+Huauthor=Y.+Heauthor=Z.+Wuauthor=S.-S.+Hongauthor=D.+J.+Hwangauthor=D.+D.+Millerauthor=J.+T.+Dalton&title=Estrogen+Receptor+%CE%B2+Selective+Nonsteroidal+Estrogens%3A+Seeking+Clinical+Indications&doi=10.1517%2F13543771003657164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor β selective nonsteroidal estrogens: seeking clinical indications</span></div><div class="casAuthors">Mohler, Michael L.; Narayanan, Ramesh; Coss, Christopher C.; Hu, Kejiang; He, Yali; Wu, Zhongzhi; Hong, Seoung-Soo; Hwang, Dong Jin; Miller, Duane D.; Dalton, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-534</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Nonsteroidal estrogens have been known since the 1930s.  However, the relatively recent (1996) discovery of estrogen receptor subtype β (ERβ) suggested a possible paradigm shift away from SERM-like selectivity.  Selective ERβ agonism would potentially allow expansion of estrogenic targeting into new indications (discussed herein) currently precluded by the thrombogenic and hyperproliferative effects of nonselective estrogens.  Areas covered in this review: ERβ agonist design has been very successful.  Pharmacophores for ERβ selective nonsteroidal estrogens are generally diphenolic compds. that achieve an inter-phenolic distance and geometry similar to 17β-estradiol with few restraints on the nature of the element linking the phenols (or phenol mimetics).  The tremendously chemodiverse ERβ agonist patent literature is reviewed, segregating the agonists into structurally similar compds. based on their interphenolic linking elements.  What the reader will gain: A comprehensive understanding of the chemotype landscape of this field and an assessment of its maturation.  Take home message: Subtype selective ERβ agonist therapy seems very promising.  However, more clin. testing is needed to firmly establish its therapeutic potential.  At this point, ERβ is a promising target in search of an indication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQEw4HgBz_E7Vg90H21EOLACvtfcHk0liVJRWwCdg3IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslamu7w%253D&md5=43641194b70be56c763fdf4d8e836e88</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543771003657164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003657164%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DM.%2BL.%26aulast%3DNarayanan%26aufirst%3DR.%26aulast%3DCoss%26aufirst%3DC.%2BC.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DEstrogen%2520Receptor%2520%25CE%25B2%2520Selective%2520Nonsteroidal%2520Estrogens%253A%2520Seeking%2520Clinical%2520Indications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D507%26epage%3D534%26doi%3D10.1517%2F13543771003657164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manas, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collini, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. A.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-β Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5021</span>– <span class="NLM_lpage">5040</span>, <span class="refDoi"> DOI: 10.1021/jm049719y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049719y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt12gtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5021-5040&author=M.+S.+Malamasauthor=E.+S.+Manasauthor=R.+E.+McDevittauthor=I.+Gunawanauthor=Z.+B.+Xuauthor=M.+D.+Colliniauthor=C.+P.+Millerauthor=T.+Dinhauthor=R.+A.+Hendersonauthor=J.+C.+Keithauthor=H.+A.+Harris&title=Design+and+Synthesis+of+Aryl+Diphenolic+Azoles+as+Potent+and+Selective+Estrogen+Receptor-%CE%B2+Ligands&doi=10.1021%2Fjm049719y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-β Ligands</span></div><div class="casAuthors">Malamas, Michael S.; Manas, Eric S.; McDevitt, Robert E.; Gunawan, Iwan; Xu, Zhang B.; Collini, Michael D.; Miller, Chris P.; Dinh, Tam; Henderson, Ruth A.; Keith, James C., Jr.; Harris, Heather A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5021-5040</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New diphenolic azoles as highly selective estrogen receptor-β agonists are reported.  The more potent and selective analogs of these series have comparable binding affinities for ERβ as the natural ligand 17β-estradiol but are >100-fold selective over ERα.  The design strategy not only followed a traditional SAR approach but also was supported by X-ray structures of ERβ cocrystd. with various ligands as well as mol. modeling studies.  These strategies enabled the use of a single conservative residue substitution in the ligand-binding pocket, ERα Met421 → ERβ Ile373, to optimize ERβ selectivity.  The 7-position-substituted benzoxazoles were the most selective ligands of both azole series, with ERB-041 (I) being >200-fold selective for ERβ.  The majority of ERβ selective agonists tested that were at least ∼50-fold selective displayed a consistent in vivo profile: they were inactive in several models of classic estrogen action (uterotrophic, osteopenia, and vasomotor instability models) and yet were active in the HLA-B27 transgenic rat model of inflammatory bowel disease.  These data suggest that ERβ-selective agonists are devoid of classic estrogenic effects and may offer a novel therapy to treat certain inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4naT8lsva7LVg90H21EOLACvtfcHk0lhsH2lslcInsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt12gtrc%253D&md5=01c7d1d0fb71105c1adffeb5f0bc7d3b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm049719y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049719y%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DMcDevitt%26aufirst%3DR.%2BE.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DXu%26aufirst%3DZ.%2BB.%26aulast%3DCollini%26aufirst%3DM.%2BD.%26aulast%3DMiller%26aufirst%3DC.%2BP.%26aulast%3DDinh%26aufirst%3DT.%26aulast%3DHenderson%26aufirst%3DR.%2BA.%26aulast%3DKeith%26aufirst%3DJ.%2BC.%26aulast%3DHarris%26aufirst%3DH.%2BA.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Aryl%2520Diphenolic%2520Azoles%2520as%2520Potent%2520and%2520Selective%2520Estrogen%2520Receptor-%25CE%25B2%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5021%26epage%3D5040%26doi%3D10.1021%2Fjm049719y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roman-Blas, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castañeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero-Beaumont, G.</span></span> <span> </span><span class="NLM_article-title">Efficacy and Safety of a Selective Estrogen Receptor β Agonist, ERB-041, in Patients with Rheumatoid Arthritis: A 12-Week, Randomized, Placebo-Controlled, Phase II Study</span>. <i>Arthritis Care Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1588</span>– <span class="NLM_lpage">1593</span>, <span class="refDoi"> DOI: 10.1002/acr.20275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1002%2Facr.20275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2gu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1588-1593&author=J.+A.+Roman-Blasauthor=S.+Casta%C3%B1edaauthor=M.+Cutoloauthor=G.+Herrero-Beaumont&title=Efficacy+and+Safety+of+a+Selective+Estrogen+Receptor+%CE%B2+Agonist%2C+ERB-041%2C+in+Patients+with+Rheumatoid+Arthritis%3A+A+12-Week%2C+Randomized%2C+Placebo-Controlled%2C+Phase+II+Study&doi=10.1002%2Facr.20275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study</span></div><div class="casAuthors">Roman-Blas, Jorge A.; Castaneda, Santos; Cutolo, Maurizio; Herrero-Beaumont, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Care & Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1588-1593</span>CODEN:
                <span class="NLM_cas:coden">ARCREG</span>;
        ISSN:<span class="NLM_cas:issn">2151-464X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Selective estrogen receptor β (ERβ) agonists have demonstrated relevant antiinflammatory effects in different animal models.  This study aimed to compare the efficacy and safety of one of these agonists, ERB-041, in subjects with rheumatoid arthritis (RA).  Methods. A total of 291 patients with active RA receiving stable doses of methotrexate were randomized to receive 5, 25, or 75 mg of ERB-041 or placebo for 12 wk.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) at 12 wk.  Secondary end points included the ACR 50% improvement criteria (ACR50) and the ACR 70% improvement criteria (ACR70) responses, health outcomes measures, C-reactive protein (CRP) levels, and potential exposure-response relationships.  Medical history, phys. examn., and lab. values were obtained at screening, baseline, and weeks 2, 4, 8, and 12.  Results. No statistically significant difference for the ACR20 was found between the ERB-041 treatment and placebo groups (P = 0.518).  Nor was a significant difference obsd. for ACR50 and ACR70 responses, health outcomes measures, CRP levels, and overall incidence of adverse events among all groups.  Forty-four subjects (15.1%) discontinued the study and the rate of discontinuation was similar among the treatment groups.  The most commonly reported treatment-emergent adverse events were headache (7.6%), nausea (6.2%), infection (4.8%), and bronchitis (4.1%).  None of the adverse events was considered treatment related.  Conclusion. Although well tolerated and safe, ERB-041 failed to demonstrate antiinflammatory efficacy in RA patients, despite evidence of strong activity in preclin. arthritis models.  These results suggest that selective ERβ agonists would not have effects on regulating inflammatory response in RA.  Nevertheless, further studies are warranted to establish their efficacy in inflammatory arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozdzCHPRoW0bVg90H21EOLACvtfcHk0lhsH2lslcInsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2gu7rF&md5=b3b3d9966e0c841340d2077af7cb43e7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Facr.20275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Facr.20275%26sid%3Dliteratum%253Aachs%26aulast%3DRoman-Blas%26aufirst%3DJ.%2BA.%26aulast%3DCasta%25C3%25B1eda%26aufirst%3DS.%26aulast%3DCutolo%26aufirst%3DM.%26aulast%3DHerrero-Beaumont%26aufirst%3DG.%26atitle%3DEfficacy%2520and%2520Safety%2520of%2520a%2520Selective%2520Estrogen%2520Receptor%2520%25CE%25B2%2520Agonist%252C%2520ERB-041%252C%2520in%2520Patients%2520with%2520Rheumatoid%2520Arthritis%253A%2520A%252012-Week%252C%2520Randomized%252C%2520Placebo-Controlled%252C%2520Phase%2520II%2520Study%26jtitle%3DArthritis%2520Care%2520Res.%26date%3D2010%26volume%3D62%26spage%3D1588%26epage%3D1593%26doi%3D10.1002%2Facr.20275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norman, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borromeo, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugar, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durst, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montrose-Rafizadeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amos, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boodhoo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, V.</span></span> <span> </span><span class="NLM_article-title">Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6155</span>– <span class="NLM_lpage">6157</span>, <span class="refDoi"> DOI: 10.1021/jm060491j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060491j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFaitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6155-6157&author=B.+H.+Normanauthor=J.+A.+Dodgeauthor=T.+I.+Richardsonauthor=P.+S.+Borromeoauthor=C.+W.+Lugarauthor=S.+A.+Jonesauthor=K.+Chenauthor=Y.+Wangauthor=G.+L.+Durstauthor=R.+J.+Barrauthor=C.+Montrose-Rafizadehauthor=H.+E.+Osborneauthor=R.+M.+Amosauthor=S.+Guoauthor=A.+Boodhooauthor=V.+Krishnan&title=Benzopyrans+Are+Selective+Estrogen+Receptor+%CE%B2+Agonists+with+Novel+Activity+in+Models+of+Benign+Prostatic+Hyperplasia&doi=10.1021%2Fjm060491j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia</span></div><div class="casAuthors">Norman, Bryan H.; Dodge, Jeffrey A.; Richardson, Timothy I.; Borromeo, Peter S.; Lugar, Charles W.; Jones, Scott A.; Chen, Keyue; Wang, Yong; Durst, Gregory L.; Barr, Robert J.; Montrose-Rafizadeh, Chahrzad; Osborne, Harold E.; Amos, Robert M.; Guo, Sherry; Boodhoo, Amechand; Krishnan, Venkatesh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6155-6157</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzopyran selective estrogen receptor beta agonist-1 (SERBA-1) shows potent, selective binding and agonist function in estrogen receptor β (ERβ) in vitro assays.  X-ray crystal structures of SERBA-1 in ERα and β help explain obsd. β-selectivity of this ligand.  SERBA-1 in vivo demonstrates involution of the ventral prostate in CD-1 mice (ERβ effect), while having no effect on gonadal hormone levels (ERα effect) at 10× the efficacious dose, consistent with in vitro properties of this mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruukNvc0ncZ7Vg90H21EOLACvtfcHk0lhsH2lslcInsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFaitr8%253D&md5=8d57f3742a46fe2b1ff176186a6f5d08</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm060491j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060491j%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DB.%2BH.%26aulast%3DDodge%26aufirst%3DJ.%2BA.%26aulast%3DRichardson%26aufirst%3DT.%2BI.%26aulast%3DBorromeo%26aufirst%3DP.%2BS.%26aulast%3DLugar%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DS.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDurst%26aufirst%3DG.%2BL.%26aulast%3DBarr%26aufirst%3DR.%2BJ.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DOsborne%26aufirst%3DH.%2BE.%26aulast%3DAmos%26aufirst%3DR.%2BM.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DBoodhoo%26aufirst%3DA.%26aulast%3DKrishnan%26aufirst%3DV.%26atitle%3DBenzopyrans%2520Are%2520Selective%2520Estrogen%2520Receptor%2520%25CE%25B2%2520Agonists%2520with%2520Novel%2520Activity%2520in%2520Models%2520of%2520Benign%2520Prostatic%2520Hyperplasia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6155%26epage%3D6157%26doi%3D10.1021%2Fjm060491j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roehrborn, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spann, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serviss, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor Beta Agonist LY500307 Fails to Improve Symptoms in Men with Enlarged Prostate Secondary to Benign Prostatic Hypertrophy</span>. <i>Prostate Cancer Prostatic Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1038/pcan.2014.43</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1038%2Fpcan.2014.43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=25348255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVOnt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=43-48&author=C.+G.+Roehrbornauthor=M.+E.+Spannauthor=S.+L.+Myersauthor=C.+R.+Servissauthor=L.+Huauthor=Y.+Jin&title=Estrogen+Receptor+Beta+Agonist+LY500307+Fails+to+Improve+Symptoms+in+Men+with+Enlarged+Prostate+Secondary+to+Benign+Prostatic+Hypertrophy&doi=10.1038%2Fpcan.2014.43"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy</span></div><div class="casAuthors">Roehrborn, C. G.; Spann, M. E.; Myers, S. L.; Serviss, C. R.; Hu, L.; Jin, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Prostate Cancer and Prostatic Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">PCPDFW</span>;
        ISSN:<span class="NLM_cas:issn">1365-7852</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: To assess the efficacy and safety of LY500307, a selective estrogen receptor beta agonist, on lower urinary tract symptoms (LUTS) in patients with enlarged prostate secondary to BPH.  Methods: In a randomized, double-blind, placebo-controlled, parallel phase 2, efficacy and safety study, eligible patients with moderate to severe LUTS and prostatic enlargement (≥30 mL) were randomized to placebo or LY500307 at 1, 3, 10 and 25 mg once daily for 24 wk.  Primary efficacy end point was change in total International Prostate Symptoms Score (IPSS) after 24 wk.  Secondary end points included changes in total prostate vol. (TPV) that served as a proof of concept end point, as well as IPSS quality of life, max. peak urine flow rate (Qmax) and PSA and safety (adverse events, lab. test).  Results: A total of 414 patients were randomized when the study was terminated because of insufficient TPV redn., based on a priori defined interim anal.  The IPSS mean change from baseline to end point was -3.4±6.8 in the placebo group and -1.3±6.6, -2.6±7.0, -3.7±6.7 and -4.4±5.7 in the 1, 3, 10 and 25 mg LY500307-treated groups, resp. (P>0.05).  Similarly, no treatment effect was obsd. for any of the secondary efficacy measures.  Incidence of adverse events was comparable between treatment groups, and no clin. meaningful changes in lab. tests were obsd.  Conclusions: LY500307 was well tolerated in BPH patients with LUTS at doses up to 25 mg once daily for 24 wk.  The study was terminated early because of inadequate efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodCHIV5KoevLVg90H21EOLACvtfcHk0ljx0tO512PEYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVOnt73I&md5=a6fa7058d61630f48df3b35c5d637c70</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fpcan.2014.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fpcan.2014.43%26sid%3Dliteratum%253Aachs%26aulast%3DRoehrborn%26aufirst%3DC.%2BG.%26aulast%3DSpann%26aufirst%3DM.%2BE.%26aulast%3DMyers%26aufirst%3DS.%2BL.%26aulast%3DServiss%26aufirst%3DC.%2BR.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DY.%26atitle%3DEstrogen%2520Receptor%2520Beta%2520Agonist%2520LY500307%2520Fails%2520to%2520Improve%2520Symptoms%2520in%2520Men%2520with%2520Enlarged%2520Prostate%2520Secondary%2520to%2520Benign%2520Prostatic%2520Hypertrophy%26jtitle%3DProstate%2520Cancer%2520Prostatic%2520Dis.%26date%3D2015%26volume%3D18%26spage%3D43%26epage%3D48%26doi%3D10.1038%2Fpcan.2014.43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Breier, A.</span></span> <span> </span><span class="NLM_article-title">The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia—Full Text View—ClinicalTrials.gov</span>. <a href="https://clinicaltrials.gov/ct2/show/NCT01874756" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01874756</a> (accessed Apr 27, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=A.+Breier&title=The+Efficacy+and+Safety+of+a+Selective+Estrogen+Receptor+Beta+Agonist+%28LY500307%29+for+Negative+Symptoms+and+Cognitive+Impairment+Associated+With+Schizophrenia%E2%80%94Full+Text+View%E2%80%94ClinicalTrials.gov"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DBreier%26aufirst%3DA.%26atitle%3DThe%2520Efficacy%2520and%2520Safety%2520of%2520a%2520Selective%2520Estrogen%2520Receptor%2520Beta%2520Agonist%2520%2528LY500307%2529%2520for%2520Negative%2520Symptoms%2520and%2520Cognitive%2520Impairment%2520Associated%2520With%2520Schizophrenia%25E2%2580%2594Full%2520Text%2520View%25E2%2580%2594ClinicalTrials.gov%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span> </span><span class="NLM_article-title">Effects
of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced
Mood Symptoms in Women with Past Perimenopausal Depression—Tabular
View—ClinicalTrials.gov</span>. <a href="https://clinicaltrials.gov/ct2/show/record/NCT03689543" class="extLink">https://clinicaltrials.gov/ct2/show/record/NCT03689543</a> (accessed Apr 27, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Effects%0Aof+an+ER+Beta+Agonist+%28Lilly+Compound+LY500307%29+on+Estradiol-Withdrawal-Induced%0AMood+Symptoms+in+Women+with+Past+Perimenopausal+Depression%E2%80%94Tabular%0AView%E2%80%94ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Frecord%2FNCT03689543+%28accessed+Apr+27%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DEffects%250Aof%2520an%2520ER%2520Beta%2520Agonist%2520%2528Lilly%2520Compound%2520LY500307%2529%2520on%2520Estradiol-Withdrawal-Induced%250AMood%2520Symptoms%2520in%2520Women%2520with%2520Past%2520Perimenopausal%2520Depression%25E2%2580%2594Tabular%250AView%25E2%2580%2594ClinicalTrials.gov%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paterni, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minutolo, F.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor Ligands: A Patent Review Update</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1517/13543776.2013.805206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1517%2F13543776.2013.805206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=23713677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1247-1271&author=I.+Paterniauthor=S.+Bertiniauthor=C.+Granchiauthor=M.+Macchiaauthor=F.+Minutolo&title=Estrogen+Receptor+Ligands%3A+A+Patent+Review+Update&doi=10.1517%2F13543776.2013.805206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor ligands: a patent review update</span></div><div class="casAuthors">Paterni, Ilaria; Bertini, Simone; Granchi, Carlotta; Macchia, Marco; Minutolo, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1247-1271</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The role of estrogens is mostly mediated by two nuclear receptors (ERα and ERβ) and a membrane-assocd. G-protein (GPR30 or GPER), and it is not limited to reprodn., but it extends to the skeletal, cardiovascular and central nervous systems.  Various pathologies such as cancer, inflammatory, neurodegenerative and metabolic diseases are often assocd. with dysfunctions of the estrogenic system.  Therapeutic interventions by agents that affect the estrogenic signaling pathway might be useful in the treatment of many dissimilar diseases.  Areas covered: The massive chemodiversity of ER ligands, limited to patented small mols., is herein reviewed.  The reported compds. are classified on the basis of their chem. structures.  Non-steroidal derivs., which mostly consist of diphenolic compds., are further segregated into chem. classes based on their central scaffold.  Expert opinion: Estrogens have been used for almost a century and their earlier applications have concerned interventions in the female reproductive functions, as well as the treatment of some estrogen-dependent cancers and osteoporosis.  Since the discovery of ERβ in 1996, the patent literature has started to pay a progressively increasing attention to this newer receptor subtype, which holds promise as a target for new indications, most of which still need to be clin. validated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO4rnbfdD65LVg90H21EOLACvtfcHk0ljx0tO512PEYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fO&md5=6f747f7fccf0953fc64cd61b5f287dd6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.805206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.805206%26sid%3Dliteratum%253Aachs%26aulast%3DPaterni%26aufirst%3DI.%26aulast%3DBertini%26aufirst%3DS.%26aulast%3DGranchi%26aufirst%3DC.%26aulast%3DMacchia%26aufirst%3DM.%26aulast%3DMinutolo%26aufirst%3DF.%26atitle%3DEstrogen%2520Receptor%2520Ligands%253A%2520A%2520Patent%2520Review%2520Update%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1247%26epage%3D1271%26doi%3D10.1517%2F13543776.2013.805206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukasawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shudo, K.</span></span> <span> </span><span class="NLM_article-title">Potent Estrogenic Agonists Bearing Dicarba-<i>closo</i>-Dodecaborane as a Hydrophobic Pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1504</span>, <span class="refDoi"> DOI: 10.1021/jm9900725</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9900725" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXisVaqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1501-1504&author=Y.+Endoauthor=T.+Iijimaauthor=Y.+Yamakoshiauthor=M.+Yamaguchiauthor=H.+Fukasawaauthor=K.+Shudo&title=Potent+Estrogenic+Agonists+Bearing+Dicarba-closo-Dodecaborane+as+a+Hydrophobic+Pharmacophore&doi=10.1021%2Fjm9900725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Estrogenic Agonists Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore</span></div><div class="casAuthors">Endo, Yasuyuki; Iijima, Toru; Yamakoshi, Yuko; Yamaguchi, Mitsuhiro; Fukasawa, Hiroshi; Shudo, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1501-1504</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The novel carborane contg. mols., e.g. 1-(4-hydroxyphenyl)-1,12-dicarba-closo-dodecaborane, with potent estrogenic activity was developed.  The unique character of biol. active mols. contg. a carborane skeleton may give to unusual membrane transport characteristics and metab., compared with conventional active mols.  The superagonistic properties of the carborane-contg. compds. raise the possibility that structure-function studies could lead to the development of more selective estrogen agonists and antagonists, which could be useful as therapeutic agents for a wide variety of conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2AlXhU9tPobVg90H21EOLACvtfcHk0lj1F6k_LyxQNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVaqsbY%253D&md5=b487b1fcfa55e50d83a5cf96d8b357fa</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm9900725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9900725%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DIijima%26aufirst%3DT.%26aulast%3DYamakoshi%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DFukasawa%26aufirst%3DH.%26aulast%3DShudo%26aufirst%3DK.%26atitle%3DPotent%2520Estrogenic%2520Agonists%2520Bearing%2520Dicarba-closo-Dodecaborane%2520as%2520a%2520Hydrophobic%2520Pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1501%26epage%3D1504%26doi%3D10.1021%2Fjm9900725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barth, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span> <span> </span><span class="NLM_article-title">A Realistic Appraisal of Boron Neutron Capture Therapy as a Cancer Treatment Modality</span>. <i>Cancer Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>, <span class="NLM_elocation-id">36</span> <span class="refDoi"> DOI: 10.1186/s40880-018-0280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1186%2Fs40880-018-0280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=29914575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A280%3ADC%252BC1MbosFamuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&author=R.+F.+Barthauthor=Z.+Zhangauthor=T.+Liu&title=A+Realistic+Appraisal+of+Boron+Neutron+Capture+Therapy+as+a+Cancer+Treatment+Modality&doi=10.1186%2Fs40880-018-0280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A realistic appraisal of boron neutron capture therapy as a cancer treatment modality</span></div><div class="casAuthors">Barth Rolf F; Zhang Zizhu; Liu Tong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer communications (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Boron neutron capture therapy (BNCT) is a binary therapeutic modality based on the nuclear capture and fission reactions that occur when the stable isotope boron-10 is irradiated with neutrons to produce high-energy alpha particles and recoiling lithium-7 nuclei.  In this Commentary we will focus on a number of papers that were presented at a Symposium entitled "Current Clinical Status of Boron Neutron Capture Therapy and Paths to the Future", which was held in September 2017 at the China National Convention Center in Beijing.  Results were presented by clinicians from Japan, Finland, the United States, the China mainland and Taiwan, China who have been working in the multiple disciplines that are required for carrying out clinical BNCT.  The main focus was on the treatment of patients with malignant brain tumors, recurrent tumors of the head and neck region, and cutaneous melanomas.  The results obtained in treating these patients were reported in detail and, although most of the patients with brain tumors and head and neck cancer were not cured, there was evidence of some clinical efficacy.  Although there are a number of problems that must be addressed, further clinical studies to evaluate the efficacy of BNCT are warranted.  First, despite considerable effort by numerous investigators over the past 40 years, there still are only two boron-containing drugs in clinical use, L-boronophenylalanine (BPA) and sodium borocaptate (BSH).  Therefore, until new and more effective boron delivery agents are developed, efforts should be directed to improving the dosing and delivery of BPA and BSH.  Second, due to a variety of reasons, nuclear reactor-based BNCT has ended except for its use in the China mainland and Taiwan.  Therefore, the future of BNCT depends upon the results of the ongoing Phase II clinical trials that are being carried out in Japan and the soon to be initiated trials that will be carried out in Finland.  If the results obtained from these clinical trials are sufficiently promising, then BNCT will have a clear path to the future, especially for patients with the therapeutically challenging malignancies that in the past have been treated with reactor-based BNCT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-_cHN3uno-8K3uFsUIZtkfW6udTcc2eYVNg_45tsZ9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbosFamuw%253D%253D&md5=aaf7960e10efcae0cbdcaa5113ba2bda</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2Fs40880-018-0280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40880-018-0280-5%26sid%3Dliteratum%253Aachs%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DT.%26atitle%3DA%2520Realistic%2520Appraisal%2520of%2520Boron%2520Neutron%2520Capture%2520Therapy%2520as%2520a%2520Cancer%2520Treatment%2520Modality%26jtitle%3DCancer%2520Commun.%26date%3D2018%26volume%3D38%26doi%3D10.1186%2Fs40880-018-0280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soloway, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjarks, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnum, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, F.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codogni, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. G.</span></span> <span> </span><span class="NLM_article-title">The Chemistry of Neutron Capture Therapy</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1515</span>– <span class="NLM_lpage">1562</span>, <span class="refDoi"> DOI: 10.1021/cr941195u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr941195u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlygtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1998&pages=1515-1562&author=A.+H.+Solowayauthor=W.+Tjarksauthor=B.+A.+Barnumauthor=F.-G.+Rongauthor=R.+F.+Barthauthor=I.+M.+Codogniauthor=J.+G.+Wilson&title=The+Chemistry+of+Neutron+Capture+Therapy&doi=10.1021%2Fcr941195u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemistry of Neutron Capture Therapy</span></div><div class="casAuthors">Soloway, Albert H.; Tjarks, Werner; Barnum, Beverly A.; Rong, Feng-Guang; Barth, Rolf F.; Codogni, Iwona M.; Wilson, J. Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1515-1562</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 633 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQlar2oXrwMrVg90H21EOLACvtfcHk0lj1F6k_LyxQNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlygtL8%253D&md5=52bcd4d4e2f37833d76092e9a1867b3c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcr941195u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr941195u%26sid%3Dliteratum%253Aachs%26aulast%3DSoloway%26aufirst%3DA.%2BH.%26aulast%3DTjarks%26aufirst%3DW.%26aulast%3DBarnum%26aufirst%3DB.%2BA.%26aulast%3DRong%26aufirst%3DF.-G.%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DCodogni%26aufirst%3DI.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520Chemistry%2520of%2520Neutron%2520Capture%2520Therapy%26jtitle%3DChem.%2520Rev.%26date%3D1998%26volume%3D98%26spage%3D1515%26epage%3D1562%26doi%3D10.1021%2Fcr941195u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soloway, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Boron Compounds for Use in Neutron Capture Therapy of Brain Tumors. I. Animal Investigations</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=13915041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaF38Xks1al" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1961&pages=117-122&author=A.+H.+Solowayauthor=R.+L.+Wrightauthor=J.+R.+Messer&title=Evaluation+of+Boron+Compounds+for+Use+in+Neutron+Capture+Therapy+of+Brain+Tumors.+I.+Animal+Investigations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of boron compounds for use in neutron-capture therapy of brain tumors. I. Animal investigations</span></div><div class="casAuthors">Soloway, A. H.; Wright, R. L.; Messer, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-22</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">cf. CA 54, 1374d.-m-Boronosuccinanilic, 3-amino-4-carboxybenzeneboronic, m- and p-carboxybenzeneboronic, 2-nitrobenzene-l,4-diboronic, o-(2-carboxyacetamidoethyl)benzeneboronic, 2-acetamidobenzeneboronic, and m-ureidobenzeneboronic acids, p-boronophenylalanine, Na perhydrodecaborate, and boric acid were evaluated in mice with transplanted glioma (ependymoma) for toxicity.  The tumor-to-brain ratios and the concns. in various organ tissues were detd.  The 1st 2 compds. appeared promising and were studied further in cats by intravenous and intracarotid artery injection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ3NwRRVrpJbVg90H21EOLACvtfcHk0lj1F6k_LyxQNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38Xks1al&md5=e291c2430bd5f235a4b0f6e3a429a7d3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoloway%26aufirst%3DA.%2BH.%26aulast%3DWright%26aufirst%3DR.%2BL.%26aulast%3DMesser%26aufirst%3DJ.%2BR.%26atitle%3DEvaluation%2520of%2520Boron%2520Compounds%2520for%2520Use%2520in%2520Neutron%2520Capture%2520Therapy%2520of%2520Brain%2520Tumors.%2520I.%2520Animal%2520Investigations%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1961%26volume%3D134%26spage%3D117%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stockmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gozzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhnert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sárosi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey-Hawkins, E.</span></span> <span> </span><span class="NLM_article-title">New Keys for Old Locks: Carborane-Containing Drugs as Platforms for Mechanism-Based Therapies</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3497</span>– <span class="NLM_lpage">3512</span>, <span class="refDoi"> DOI: 10.1039/C9CS00197B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1039%2FC9CS00197B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=31214680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtF2nt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2019&pages=3497-3512&author=P.+Stockmannauthor=M.+Gozziauthor=R.+Kuhnertauthor=M.+B.+S%C3%A1rosiauthor=E.+Hey-Hawkins&title=New+Keys+for+Old+Locks%3A+Carborane-Containing+Drugs+as+Platforms+for+Mechanism-Based+Therapies&doi=10.1039%2FC9CS00197B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies</span></div><div class="casAuthors">Stockmann, Philipp; Gozzi, Marta; Kuhnert, Robert; Sarosi, Menyhart B.; Hey-Hawkins, Evamarie</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3497-3512</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Icosahedral carboranes in medicine are still an emerging class of compds. with potential beneficial applications in drug design.  These highly hydrophobic clusters are potential "new keys for old locks" which open up an exciting field of research for well-known, but challenging important therapeutic substrates, as demonstrated by the numerous examples discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOMBCVidtHL7Vg90H21EOLACvtfcHk0ljfY1qvlwn8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtF2nt7vI&md5=b2a1f1247161aeedf257cd807d2a30fd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2FC9CS00197B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9CS00197B%26sid%3Dliteratum%253Aachs%26aulast%3DStockmann%26aufirst%3DP.%26aulast%3DGozzi%26aufirst%3DM.%26aulast%3DKuhnert%26aufirst%3DR.%26aulast%3DS%25C3%25A1rosi%26aufirst%3DM.%2BB.%26aulast%3DHey-Hawkins%26aufirst%3DE.%26atitle%3DNew%2520Keys%2520for%2520Old%2520Locks%253A%2520Carborane-Containing%2520Drugs%2520as%2520Platforms%2520for%2520Mechanism-Based%2520Therapies%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2019%26volume%3D48%26spage%3D3497%26epage%3D3512%26doi%3D10.1039%2FC9CS00197B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leśnikowski, Z. J.</span></span> <span> </span><span class="NLM_article-title">Challenges and Opportunities for the Application of Boron Clusters in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7738</span>– <span class="NLM_lpage">7758</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01932</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFSgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7738-7758&author=Z.+J.+Le%C5%9Bnikowski&title=Challenges+and+Opportunities+for+the+Application+of+Boron+Clusters+in+Drug+Design&doi=10.1021%2Facs.jmedchem.5b01932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities for the Application of Boron Clusters in Drug Design</span></div><div class="casAuthors">Lesnikowski, Zbigniew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7738-7758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are two branches in boron medicinal chem.: the first focuses on single boron atom compds., and the second utilizes boron clusters.  Boron clusters and their heteroatom counterparts belong to the family of cage compds.  A subset of this extensive class of compds. includes dicarbadodecaboranes, which have the general formula C2B10H12, and their metal biscarboranyl complexes, metallacarboranes, with the formula [M(C2B10H12)2-2].  The unique properties of boron clusters have resulted in their utilization in applications such as in pharmacophores, as scaffolds in mol. construction, and as modulators of bioactive compds.  This Perspective presents an overview of the properties of boron clusters that are pertinent for drug discovery, recent applications in the design of various classes of drugs, and the potential use of boron clusters in the construction of new pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX92E97ik4ubVg90H21EOLACvtfcHk0ljfY1qvlwn8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFSgs7c%253D&md5=1d4c3720cdc649c5fc3de397bea15e83</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01932%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C5%259Bnikowski%26aufirst%3DZ.%2BJ.%26atitle%3DChallenges%2520and%2520Opportunities%2520for%2520the%2520Application%2520of%2520Boron%2520Clusters%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7738%26epage%3D7758%26doi%3D10.1021%2Facs.jmedchem.5b01932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leśnikowski, Z. J.</span></span> <span> </span><span class="NLM_article-title">What Are the Current Challenges with the Application of Boron Clusters to Drug Design?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">481</span>, <span class="refDoi"> DOI: 10.1080/17460441.2021.1867531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1080%2F17460441.2021.1867531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=33356654" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=481&author=Z.+J.+Le%C5%9Bnikowski&title=What+Are+the+Current+Challenges+with+the+Application+of+Boron+Clusters+to+Drug+Design%3F&doi=10.1080%2F17460441.2021.1867531"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1080%2F17460441.2021.1867531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2021.1867531%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C5%259Bnikowski%26aufirst%3DZ.%2BJ.%26atitle%3DWhat%2520Are%2520the%2520Current%2520Challenges%2520with%2520the%2520Application%2520of%2520Boron%2520Clusters%2520to%2520Drug%2520Design%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2020%26spage%3D481%26doi%3D10.1080%2F17460441.2021.1867531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedlák, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eignerová, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dračínský, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janoušek, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartůněk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotora, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of 17α-(Carboranylalkyl)Estradiols as Ligands for Estrogen Receptors α and β</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>747</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2013.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.jorganchem.2013.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKgsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=747&publication_year=2013&pages=178-183&author=D.+Sedl%C3%A1kauthor=B.+Eignerov%C3%A1author=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=Z.+Janou%C5%A1ekauthor=P.+Bart%C5%AFn%C4%9Bkauthor=M.+Kotora&title=Synthesis+and+Evaluation+of+17%CE%B1-%28Carboranylalkyl%29Estradiols+as+Ligands+for+Estrogen+Receptors+%CE%B1+and+%CE%B2&doi=10.1016%2Fj.jorganchem.2013.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 17α-(carboranylalkyl)estradiols as ligands for estrogen receptors α and β</span></div><div class="casAuthors">Sedlak, David; Eignerova, Barbara; Dracinsky, Martin; Janousek, Zbynek; Bartunek, Petr; Kotora, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">747</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178-183</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 17α-(carboranylalkyl)estradiols was synthesized using cross-metathesis reaction of 17α-allyl- and 17α-vinylestradiols with allylcarboranes catalyzed by Hoveyda-Grubbs 2nd generation catalyst.  The prepd. estradiol derivs. were tested in the panel of cell-based reporter assays including all steroid receptors.  The compds. mainly activated estrogen receptors α and β and tended to be weakly selective for ERα.  Besides ERα and ERβ, we have also detected a weak agonistic activity on AR and PR at micromolar concns.  We didn't observe any antagonistic effect with the exception of two receptors: GR and MR which were inhibited with some of the tested ligands.  However, the inhibition was detectable at concns. exceeding by far those needed to activate estrogen receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgH0Jo_HEdurVg90H21EOLACvtfcHk0ljfY1qvlwn8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKgsrrL&md5=30ff55174dd93879e3cdd196e1032c6a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2013.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2013.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DSedl%25C3%25A1k%26aufirst%3DD.%26aulast%3DEignerov%25C3%25A1%26aufirst%3DB.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DJanou%25C5%25A1ek%26aufirst%3DZ.%26aulast%3DBart%25C5%25AFn%25C4%259Bk%26aufirst%3DP.%26aulast%3DKotora%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%252017%25CE%25B1-%2528Carboranylalkyl%2529Estradiols%2520as%2520Ligands%2520for%2520Estrogen%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B2%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2013%26volume%3D747%26spage%3D178%26epage%3D183%26doi%3D10.1016%2Fj.jorganchem.2013.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eignerová, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlák, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dračínský, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartůněk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotora, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biochemical Characterization of a Series of 17α-Perfluoroalkylated Estradiols as Selective Ligands for Estrogen Receptor α</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6947</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1021/jm100563h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100563h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWlsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6947-6953&author=B.+Eignerov%C3%A1author=D.+Sedl%C3%A1kauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=P.+Bart%C5%AFn%C4%9Bkauthor=M.+Kotora&title=Synthesis+and+Biochemical+Characterization+of+a+Series+of+17%CE%B1-Perfluoroalkylated+Estradiols+as+Selective+Ligands+for+Estrogen+Receptor+%CE%B1&doi=10.1021%2Fjm100563h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biochemical Characterization of a Series of 17α-Perfluoroalkylated Estradiols as Selective Ligands for Estrogen Receptor α</span></div><div class="casAuthors">Eignerova, Barbara; Sedlak, David; Dracinsky, Martin; Bartunek, Petr; Kotora, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6947-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite intensive research efforts, the distinct biol. roles of two closely related estrogen receptors, ERα and ERβ, are only partially understood.  Therefore, ligands selective for either of two isotypes are useful research tools because they allow for exerting a desired subset of biol. effects mediated by only one of the receptors.  Here we report on the synthesis of a new class of potent and selective ligands for ERα represented by a series of 17α-substituted estradiols bearing lipophilic perfluoroalkyl chains.  These 17α-perfluoroalkylated estradiols were synthesized by Ru-catalyzed cross metathesis reactions of 17α-allyl- or 17α-vinylestradiols with perfluoroalkylpropenes.  Compds. were tested in both agonistic and antagonistic modes using a panel of stable steroid receptor reporter cell lines established in U2OS cells and consisting of ERα-LBD, ERβ-LBD, GR-LBD, and MR-LBD reporters.  Some of the compds. are potent and selective agonists of ERα, exhibiting weak partial to no detectable agonistic activity on ERβ.  Notably, I is the most ERα selective ligand of the prepd. compds. because it activates ERα but inhibits ERβ.  In addn., some compds. are pure agonists on ERα but show mixed agonistic/antagonistic profile on ERβ which is a typical pattern obsd. for selective estrogen receptor modulators (SERMs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1e_HTEHDqs7Vg90H21EOLACvtfcHk0lhxQZPGcHpsuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWlsb7E&md5=be45ac8fd4423d38ba410b2e080676fa</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm100563h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100563h%26sid%3Dliteratum%253Aachs%26aulast%3DEignerov%25C3%25A1%26aufirst%3DB.%26aulast%3DSedl%25C3%25A1k%26aufirst%3DD.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DBart%25C5%25AFn%25C4%259Bk%26aufirst%3DP.%26aulast%3DKotora%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biochemical%2520Characterization%2520of%2520a%2520Series%2520of%252017%25CE%25B1-Perfluoroalkylated%2520Estradiols%2520as%2520Selective%2520Ligands%2520for%2520Estrogen%2520Receptor%2520%25CE%25B1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6947%26epage%3D6953%26doi%3D10.1021%2Fjm100563h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedlák, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novák, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartůněk, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of 17α-Arylestradiols as Ligands for Estrogen Receptor α and β</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4290</span>– <span class="NLM_lpage">4294</span>, <span class="refDoi"> DOI: 10.1021/jm901898a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901898a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVyhuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4290-4294&author=D.+Sedl%C3%A1kauthor=P.+Nov%C3%A1kauthor=M.+Kotoraauthor=P.+Bart%C5%AFn%C4%9Bk&title=Synthesis+and+Evaluation+of+17%CE%B1-Arylestradiols+as+Ligands+for+Estrogen+Receptor+%CE%B1+and+%CE%B2&doi=10.1021%2Fjm901898a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of 17α-Arylestradiols as Ligands for Estrogen Receptor α and β</span></div><div class="casAuthors">Sedlak, David; Novak, Petr; Kotora, Martin; Bartunek, Petr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4290-4294</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To identify novel estrogen receptor ligands a series of substituted 17α-arylestradiols I [X = C(CO2Et)2, C(COMe)2, C(CO2Et)COMe, C(CO2Et)CN, NTs, O] were synthesized using the catalytic [2 + 2 + 2]-cyclotrimerization of 17α-ethynylestradiol with various 1,7-diynes HC≡CCH2XCH2C≡CH in the presence of Wilkinson's catalysts [Rh(PPh3)3Cl].  The compds. were subjected to competitive binding assays, cell-based luciferase reporter assays, and proliferation assays.  These expts. confirmed their estrogenic character and revealed some interesting properties like mixed partial/full agonism for ERα/ERβ and different selectivity as a result of differing potencies for either ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL62tciCB-mLVg90H21EOLACvtfcHk0lhxQZPGcHpsuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVyhuro%253D&md5=f1c7acaa44d748d6c5adc341290a79cb</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm901898a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901898a%26sid%3Dliteratum%253Aachs%26aulast%3DSedl%25C3%25A1k%26aufirst%3DD.%26aulast%3DNov%25C3%25A1k%26aufirst%3DP.%26aulast%3DKotora%26aufirst%3DM.%26aulast%3DBart%25C5%25AFn%25C4%259Bk%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%252017%25CE%25B1-Arylestradiols%2520as%2520Ligands%2520for%2520Estrogen%2520Receptor%2520%25CE%25B1%2520and%2520%25CE%25B2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4290%26epage%3D4294%26doi%3D10.1021%2Fjm901898a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span> <span> </span><span class="NLM_article-title">Utility of Boron Clusters for Drug Design. Relation between Estrogen Receptor Binding Affinity and Hydrophobicity of Phenols Bearing Various Types of Carboranyl Groups</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4089</span>– <span class="NLM_lpage">4092</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.bmcl.2003.08.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=14592514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVWrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4089-4092&author=Y.+Endoauthor=K.+Yamamotoauthor=H.+Kagechika&title=Utility+of+Boron+Clusters+for+Drug+Design.+Relation+between+Estrogen+Receptor+Binding+Affinity+and+Hydrophobicity+of+Phenols+Bearing+Various+Types+of+Carboranyl+Groups&doi=10.1016%2Fj.bmcl.2003.08.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of boron clusters for drug design. Relation between estrogen receptor binding affinity and hydrophobicity of phenols bearing various types of carboranyl groups</span></div><div class="casAuthors">Endo, Yasuyuki; Yamamoto, Keisuke; Kagechika, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4089-4092</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">High binding affinity for estrogen receptor and the appearance of estrogenic activity require a phenolic ring and an appropriate hydrophobic group adjacent to the phenolic ring.  A quant. structure-activity relationship anal. based on the values of logP and the pKa of the phenolic group showed that the hydrophobicity of these compds. is highly correlated to the estrogen receptor α (ERα)-binding affinity.  These results should be useful for application of these spherical boron clusters (dicarba-closo-dodecaboranes; carboranes) as hydrophobic pharmacophores in drug design, as well as for microscopic anal. of ER-ligand interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVjjBmIIp87Vg90H21EOLACvtfcHk0lhxQZPGcHpsuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVWrtrk%253D&md5=337630c26a43eb82c590ebb7b6cd8e15</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DUtility%2520of%2520Boron%2520Clusters%2520for%2520Drug%2520Design.%2520Relation%2520between%2520Estrogen%2520Receptor%2520Binding%2520Affinity%2520and%2520Hydrophobicity%2520of%2520Phenols%2520Bearing%2520Various%2520Types%2520of%2520Carboranyl%2520Groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D4089%26epage%3D4092%26doi%3D10.1016%2Fj.bmcl.2003.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukasawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itai, A.</span></span> <span> </span><span class="NLM_article-title">Potent Estrogen Agonists Based on Carborane as a Hydrophobic Skeletal Structure: A New Medicinal Application of Boron Clusters</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(01)00016-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2FS1074-5521%2801%2900016-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=11325590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1ahsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=341-355&author=Y.+Endoauthor=T.+Iijimaauthor=Y.+Yamakoshiauthor=H.+Fukasawaauthor=C.+Miyauraauthor=M.+Inadaauthor=A.+Kuboauthor=A.+Itai&title=Potent+Estrogen+Agonists+Based+on+Carborane+as+a+Hydrophobic+Skeletal+Structure%3A+A+New+Medicinal+Application+of+Boron+Clusters&doi=10.1016%2FS1074-5521%2801%2900016-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Potent estrogen agonists based on carborane as a hydrophobic skeletal structure: a new medicinal application of boron clusters</span></div><div class="casAuthors">Endo, Yasuyuki; Iijima, Toru; Yamakoshi, Yuko; Fukasawa, Hiroshi; Miyaura, Chisato; Inada, Masaki; Kubo, Asako; Itai, Akiko</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-355</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: Carboranes (dicarba-closo-dodecaboranes) are a class of carbon-contg. polyhedral boron-cluster compds. having remarkable thermal stability and exceptional hydrophobicity.  Applications of the unique structural and chem. properties offered by icosahedral carboranes in boron neutron capture therapy have received increasing attention over the past 30 yr.  However, these features of carboranes may allow another application as a hydrophobic pharmacophore in biol. active mols. that interact hydrophobically with receptors.  Results: We have designed candidate estrogen-receptor-binding compds. having carborane as a hydrophobic skeletal structure and synthesized them.  The most potent compd. bearing a carborane cage exhibited activity at least 10-fold greater than that of 17β-estradiol in the luciferase reporter gene assay.  Estrogen receptor-α-binding data for the compd. were consistent with the results of the luciferase reporter gene assay.  The compd. also showed potent in vivo effects on the recovery of uterine wt. and bone loss in ovariectomized mice.  Conclusion: Further development of the potent carborane-contg. estrogenic agonists described here, having a new skeletal structure and unique characteristics, should yield novel therapeutic agents, esp. selective estrogen receptor modulators.  Furthermore, the suitability of the spherical carborane cage for binding to the cavity of the estrogen receptor-α ligand-binding domain should provide a basis for a similar approach to developing novel ligands for other steroid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb6lTWB0tsRrVg90H21EOLACvtfcHk0ljN0x_sa6S9BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1ahsr4%253D&md5=1f1af2e8526772e69d711f538fc1d82d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900016-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900016-3%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DIijima%26aufirst%3DT.%26aulast%3DYamakoshi%26aufirst%3DY.%26aulast%3DFukasawa%26aufirst%3DH.%26aulast%3DMiyaura%26aufirst%3DC.%26aulast%3DInada%26aufirst%3DM.%26aulast%3DKubo%26aufirst%3DA.%26aulast%3DItai%26aufirst%3DA.%26atitle%3DPotent%2520Estrogen%2520Agonists%2520Based%2520on%2520Carborane%2520as%2520a%2520Hydrophobic%2520Skeletal%2520Structure%253A%2520A%2520New%2520Medicinal%2520Application%2520of%2520Boron%2520Clusters%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D341%26epage%3D355%26doi%3D10.1016%2FS1074-5521%2801%2900016-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaise, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Carborane-Containing Estrogen Receptor-Beta (ERβ)-Selective Ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4174</span>– <span class="NLM_lpage">4178</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.bmcl.2015.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=26298498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSlsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4174-4178&author=K.+Ohtaauthor=T.+Ogawaauthor=A.+Odaauthor=A.+Kaiseauthor=Y.+Endo&title=Design+and+Synthesis+of+Carborane-Containing+Estrogen+Receptor-Beta+%28ER%CE%B2%29-Selective+Ligands&doi=10.1016%2Fj.bmcl.2015.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of carborane-containing estrogen receptor-beta (ERβ)-selective ligands</span></div><div class="casAuthors">Ohta, Kiminori; Ogawa, Takumi; Oda, Akifumi; Kaise, Asako; Endo, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4174-4178</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Candidates for highly selective estrogen receptor-beta (ERβ) ligands were designed and synthesized based on carborane-contg. ER ligands as lead compds.  Among them, p-carboranylcyclohexanol derivs. 8a and 8b exhibited high ERβ selectivity in competitive binding assay: for example, 8a showed 56-fold selectivity for ERβ over ERα.  Docking studies of 8a and 8b with the ERα and ERβ ligand-binding domains (LBDs) suggested that the p-carborane cage of the ligands is located close to key amino acid residues that influence ER-subtype selectivity, i.e., Leu384 in the ERα LBD and Met336 in the ERβ LBD.  The p-carborane cage in 8a and 8b appears to play a crucial role in the increased ERβ selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe9IKuTiWQ27Vg90H21EOLACvtfcHk0ljN0x_sa6S9BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSlsLjF&md5=18ce9668981a0f26829a981d79f8addb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DT.%26aulast%3DOda%26aufirst%3DA.%26aulast%3DKaise%26aufirst%3DA.%26aulast%3DEndo%26aufirst%3DY.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Carborane-Containing%2520Estrogen%2520Receptor-Beta%2520%2528ER%25CE%25B2%2529-Selective%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4174%26epage%3D4178%26doi%3D10.1016%2Fj.bmcl.2015.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coult, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacBride, J. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, K.</span></span> <span> </span><span class="NLM_article-title">C-Arylation and C-Heteroarylation of Icosahedral Carboranes via Their Copper(I) Derivatives</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/0022-328X(93)83337-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2F0022-328X%2893%2983337-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2cXitFOktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=1993&pages=19-29&author=R.+Coultauthor=M.+A.+Foxauthor=W.+R.+Gillauthor=P.+L.+Herbertsonauthor=J.+A.+H.+MacBrideauthor=K.+Wade&title=C-Arylation+and+C-Heteroarylation+of+Icosahedral+Carboranes+via+Their+Copper%28I%29+Derivatives&doi=10.1016%2F0022-328X%2893%2983337-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">C-arylation and C-heteroarylation of icosahedral carboranes via their copper(I) derivatives</span></div><div class="casAuthors">Coult, Robert; Fox, Mark A.; Gill, Wendy R.; Herbertson, Penelope L.; MacBride, J. A. Hugh; Wade, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">19-29</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    </div><div class="casAbstract">Reaction between C-mono- or C,C'-di-copper(I) derivs. of 1,2-, 1,7-, or 1,12-dicarba-closo-dodecaborane(12) and aryl iodides in the presence of pyridine gives the corresponding C-mono- or C,C'-diaryl derivs. of 1,7- and 1,12-dicarba-closo-dodecaboranes(12); 1,2-dicarba-closo-dodecaborane(12) gives only the C-monoaryl product.  Cyclic or linear arylene coupled systems are obtained when di-iodoarenes are used.  Copper(I) derivs. may be generated from C-unsubstituted or C-monosubstituted carboranes using copper(I) t-butoxide when substituents incompatible with the use of C-lithio-intermediates are involved.  The C-copper(I) deriv. of 1,2-dicarba-closo-dodecaborane(12) gives 1,2-di-2'-pyridyl-1,2-dicarba-closo-dodecaborane(12) specifically with 2-bromopyridine.  The (inferred) intermediate mono-2-pyridyl-deriv., obtained independently from 2-ethynylpyridine and the di-Me sulfide complex of decaborane, gives 1-phenyl-2,2'-pyridyl-1,2-dicarba-closo-dodecaborane(12) upon conversion into its copper(I) deriv. and treatment with iododobenzene.  However, the copper(I) deriv. of 1-phenyl-1,2-dicarba-closo-dodecaborane(12) does not react to a significant extent with 2-bromopyridine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeCKX7XjIpibVg90H21EOLACvtfcHk0ljN0x_sa6S9BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitFOktbc%253D&md5=cbd713095584fc4dbaf5b88cee325275</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0022-328X%2893%2983337-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-328X%252893%252983337-U%26sid%3Dliteratum%253Aachs%26aulast%3DCoult%26aufirst%3DR.%26aulast%3DFox%26aufirst%3DM.%2BA.%26aulast%3DGill%26aufirst%3DW.%2BR.%26aulast%3DHerbertson%26aufirst%3DP.%2BL.%26aulast%3DMacBride%26aufirst%3DJ.%2BA.%2BH.%26aulast%3DWade%26aufirst%3DK.%26atitle%3DC-Arylation%2520and%2520C-Heteroarylation%2520of%2520Icosahedral%2520Carboranes%2520via%2520Their%2520Copper%2528I%2529%2520Derivatives%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1993%26volume%3D462%26spage%3D19%26epage%3D29%26doi%3D10.1016%2F0022-328X%2893%2983337-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakshi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V. K.</span></span> <span> </span><span class="NLM_article-title">A Stable and Easily Prepared Catalyst for the Enantioselective Reduction of Ketones. Applications to Multistep Syntheses</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">7925</span>– <span class="NLM_lpage">7926</span>, <span class="refDoi"> DOI: 10.1021/ja00259a075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00259a075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaL1cXnsFShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=7925-7926&author=E.+J.+Coreyauthor=R.+K.+Bakshiauthor=S.+Shibataauthor=C.+P.+Chenauthor=V.+K.+Singh&title=A+Stable+and+Easily+Prepared+Catalyst+for+the+Enantioselective+Reduction+of+Ketones.+Applications+to+Multistep+Syntheses&doi=10.1021%2Fja00259a075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A stable and easily prepared catalyst for the enantioselective reduction of ketones.  Applications to multistep syntheses</span></div><div class="casAuthors">Corey, E. J.; Bakshi, Raman K.; Shibata, Saizo; Chen, Chung Pin; Singh, Vinod K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7925-6</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The readily available and stable oxazaborolidine I is an excellent catalyst for the enantioselective redn. of a wide range of ketones.  The stereochem. course of the redn. is predictable and the secondary alcs. formed are generally produced with high enantioselectivity.  Use of I or its enantiomer provides outstanding control of stereochem. at C(15) in prostaglandin synthesis.  A general and highly enantioselective synthesis of trans-2,5-diarylfurans, potent antagonists of platelet activating factor, also illustrates the value of this enantioselective redn.  Both I and its enantiomer can be obtained from (±)-pyroglutamic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ6p262xrQBrVg90H21EOLACvtfcHk0lgDDHbspQ3Ibw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXnsFShtA%253D%253D&md5=4deaae8502b4e75f0744e46a9e774dec</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja00259a075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00259a075%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%2BP.%26aulast%3DSingh%26aufirst%3DV.%2BK.%26atitle%3DA%2520Stable%2520and%2520Easily%2520Prepared%2520Catalyst%2520for%2520the%2520Enantioselective%2520Reduction%2520of%2520Ketones.%2520Applications%2520to%2520Multistep%2520Syntheses%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26spage%3D7925%26epage%3D7926%26doi%3D10.1021%2Fja00259a075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dale, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, H. S.</span></span> <span> </span><span class="NLM_article-title">Nuclear Magnetic Resonance Enantiomer Regents. Configurational Correlations via Nuclear Magnetic Resonance Chemical Shifts of Diastereomeric Mandelate, O-Methylmandelate, and.Alpha.-Methoxy-.Alpha.-Trifluoromethylphenylacetate (MTPA) Esters</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1021/ja00783a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00783a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaE3sXotlOjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1973&pages=512-519&author=J.+A.+Daleauthor=H.+S.+Mosher&title=Nuclear+Magnetic+Resonance+Enantiomer+Regents.+Configurational+Correlations+via+Nuclear+Magnetic+Resonance+Chemical+Shifts+of+Diastereomeric+Mandelate%2C+O-Methylmandelate%2C+and.Alpha.-Methoxy-.Alpha.-Trifluoromethylphenylacetate+%28MTPA%29+Esters&doi=10.1021%2Fja00783a034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear magnetic resonance enantiomer regents.  Configurational correlations via nuclear magnetic resonance chemical shifts of diastereomeric mandelate, O-methylmandelate, and α-methoxy-α-trifluoromethylphenylacetate (MTPA) esters</span></div><div class="casAuthors">Dale, James A.; Mosher, Harry S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">512-19</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">An empirically derived correlation of configuration and NMR chem. shifts for diastereomeric mandelate, O-methylmandelate and α-methoxy-α-trifluoromethylphenylacetate esters has been developed and rationalized in terms of useful models.  These models have been successfully applied to over 40 examples.  The correlations involve the relative chem. shifts of the proton resonances from the groups attached to the carbinyl carbon of these diastereomeric esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpul_cMuRtNTLVg90H21EOLACvtfcHk0lgDDHbspQ3Ibw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXotlOjtw%253D%253D&md5=27a7f9c81b89c6b29ffed705dc4f689c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja00783a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00783a034%26sid%3Dliteratum%253Aachs%26aulast%3DDale%26aufirst%3DJ.%2BA.%26aulast%3DMosher%26aufirst%3DH.%2BS.%26atitle%3DNuclear%2520Magnetic%2520Resonance%2520Enantiomer%2520Regents.%2520Configurational%2520Correlations%2520via%2520Nuclear%2520Magnetic%2520Resonance%2520Chemical%2520Shifts%2520of%2520Diastereomeric%2520Mandelate%252C%2520O-Methylmandelate%252C%2520and.Alpha.-Methoxy-.Alpha.-Trifluoromethylphenylacetate%2520%2528MTPA%2529%2520Esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1973%26volume%3D95%26spage%3D512%26epage%3D519%26doi%3D10.1021%2Fja00783a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoye, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span> <span> </span><span class="NLM_article-title">Mosher Ester Analysis for the Determination of Absolute Configuration of Stereogenic (Chiral) Carbinol Carbons</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2451</span>– <span class="NLM_lpage">2458</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1038%2Fnprot.2007.354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=17947986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOksL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=2451-2458&author=T.+R.+Hoyeauthor=C.+S.+Jeffreyauthor=F.+Shao&title=Mosher+Ester+Analysis+for+the+Determination+of+Absolute+Configuration+of+Stereogenic+%28Chiral%29+Carbinol+Carbons&doi=10.1038%2Fnprot.2007.354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mosher ester analysis for the determination of absolute configuration of stereogenic (chiral) carbinol carbons</span></div><div class="casAuthors">Hoye, Thomas R.; Jeffrey, Christopher S.; Shao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2451-2458</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This protocol details the most commonly used NMR-based method for deducing the configuration of otherwise unknown stereogenic, secondary carbinol (alc.) centers (R1R2CHOH (or the analogous amines where OH is replaced by NH2)).  This 'Mosher ester anal.' relies on the fact that the protons in diastereomeric α-methoxy-α-trifluoromethylphenylacetic acid (MTPA) esters (i.e., those derived from conjugation of the carbinol under interrogation with MTPA) display different arrays of chem. shifts (δs) in their 1H NMR spectra.  The protocol consists of the following: (i) prepn. of each of the diastereomeric S- and R-MTPA esters and (ii) comparative (ΔδSR) anal. of the 1H NMR spectral data of these two esters.  By analyzing the sign of the difference in chem. shifts for a no. of analogous pairs of protons (the set of ΔδSR values) in the diastereomeric esters (or amides), the abs. configuration of the original carbinol (or amino) stereocenter can be reliably deduced.  A typical Mosher ester anal. requires approx. 4-6 h of active effort over a 1- to 2-d period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdQys4JRj4LVg90H21EOLACvtfcHk0lgDDHbspQ3Ibw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOksL3E&md5=741bb9fd8eb7c18c310196f298e5ea3f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.354%26sid%3Dliteratum%253Aachs%26aulast%3DHoye%26aufirst%3DT.%2BR.%26aulast%3DJeffrey%26aufirst%3DC.%2BS.%26aulast%3DShao%26aufirst%3DF.%26atitle%3DMosher%2520Ester%2520Analysis%2520for%2520the%2520Determination%2520of%2520Absolute%2520Configuration%2520of%2520Stereogenic%2520%2528Chiral%2529%2520Carbinol%2520Carbons%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D2451%26epage%3D2458%26doi%3D10.1038%2Fnprot.2007.354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Androgen Receptor Full Antagonists Bearing a P-Carborane Cage: Promising Ligands for Anti-Androgen Withdrawal Syndrome</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4917</span>– <span class="NLM_lpage">4926</span>, <span class="refDoi"> DOI: 10.1021/jm100316f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100316f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFaktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4917-4926&author=T.+Gotoauthor=K.+Ohtaauthor=S.+Fujiiauthor=S.+Ohtaauthor=Y.+Endo&title=Design+and+Synthesis+of+Androgen+Receptor+Full+Antagonists+Bearing+a+P-Carborane+Cage%3A+Promising+Ligands+for+Anti-Androgen+Withdrawal+Syndrome&doi=10.1021%2Fjm100316f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Androgen Receptor Full Antagonists Bearing a p-Carborane Cage: Promising Ligands for Anti-Androgen Withdrawal Syndrome</span></div><div class="casAuthors">Goto, Tokuhito; Ohta, Kiminori; Fujii, Shinya; Ohta, Shigeru; Endo, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4917-4926</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pure androgen receptor (AR) full antagonists are candidates to treat anti-androgen refractory prostate cancers.  We previously developed a carborane-contg. AR antagonist, 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaborane-1-yl)benzonitrile (BA341), which was more potent than hydroxyflutamide (4) but acted as an agonist toward LNCaP prostate cancer cells expressing T877A AR mutant.  Here, we designed and synthesized novel AR full antagonists, 3-[12-(1-hydroxy-2-Ar-ethyl)-1,12-dicarba-closo-dodecaborane-1-yl]benzonitrile (e.g., Ar = 4-XC6H4O, X = F 7b, MeO, NO2, NHCOMe and Ar = 4-XC6H4S, X = H, F 8b, MeO, NHCOMe, CF3 and Ar = 4-XC6H4SO2) structurally based upon the clin. used AR full antagonist (R)-bicalutamide (5) to test our hypothesis that the carborane cage is suitable as a hydrophobic pharmacophore for AR ligands.  7A and 8b showed good biol. profiles in AR binding and transactivation assays and dose-dependently inhibited the testosterone-induced proliferation of LNCaP cells, as well as SC-3 cells.  The IC50 values of compds. 7b and 8b were 3.8 × 10-7 and 4.2 × 10-7 M, resp. [5, 8.7 × 10-7 M].  Since compds. 7b and 8b did not show any agonistic activity in functional assays, they seem to be pure AR full antagonists and are therefore candidates for treatment of anti-androgen withdrawal syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC-PU3ZvWrSLVg90H21EOLACvtfcHk0lgDDHbspQ3Ibw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFaktbs%253D&md5=e1df86c4bdb95869f329aac6442419d7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm100316f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100316f%26sid%3Dliteratum%253Aachs%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DY.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Androgen%2520Receptor%2520Full%2520Antagonists%2520Bearing%2520a%2520P-Carborane%2520Cage%253A%2520Promising%2520Ligands%2520for%2520Anti-Androgen%2520Withdrawal%2520Syndrome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4917%26epage%3D4926%26doi%3D10.1021%2Fjm100316f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawahata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure, Docking Study and Structure–Activity Relationship of Carborane-Containing Androgen Receptor Antagonist 3-(12-Hydroxymethyl-1,12-Dicarba-<i>closo</i>-Dodecaboran-1-Yl)Benzonitrile</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3540</span>– <span class="NLM_lpage">3548</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.bmc.2011.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=21536446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFWmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3540-3548&author=K.+Ohtaauthor=T.+Gotoauthor=S.+Fujiiauthor=M.+Kawahataauthor=A.+Odaauthor=S.+Ohtaauthor=K.+Yamaguchiauthor=S.+Hironoauthor=Y.+Endo&title=Crystal+Structure%2C+Docking+Study+and+Structure%E2%80%93Activity+Relationship+of+Carborane-Containing+Androgen+Receptor+Antagonist+3-%2812-Hydroxymethyl-1%2C12-Dicarba-closo-Dodecaboran-1-Yl%29Benzonitrile&doi=10.1016%2Fj.bmc.2011.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecarboran-1-yl)benzonitrile</span></div><div class="casAuthors">Ohta, Kiminori; Goto, Tokuhito; Fujii, Shinya; Kawahata, Masatoshi; Oda, Akifumi; Ohta, Shigeru; Yamaguchi, Kentaro; Hirono, Shuichi; Endo, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3540-3548</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A potent androgen receptor (AR) antagonist, 3-(12-hydroxymethyl-1,12 dicarba-closo-dodecarboran-1-yl)benzonitrile (3a, BA341), contains a p-carborane cage as a hydrophobic pharmacophore.  We elucidated the structural properties of 3a by single-crystal x-ray diffraction anal. and conducted a docking study of 3a with hAR LBD.  The cyano group of 3a formed hydrogen bonds with Gln711 and Arg752 and the hydroxymethyl group did so with Asn705 and Thr877 in hAR LBD.  The bulky p-carborane cage was accommodated in the hydrophobic pocket of hAR LBD.  To understand the structure-activity relation around the hydroxymethyl group of 3a, we designed, synthesized, and evaluated the biol. activities of various novel AR ligands.  Since the biol. activities of carbonyl compds. 8a, 8b, and 8c were similar to or weaker than those of the parent hydroxyl compds. 3a, 7a, and 7b, it seems to be necessary to have not only a hydrogen bonding acceptor, but also a hydrogen bonding donor adjacent to the hydroxymethyl group of 3a for efficient interaction with hAR LBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxmUphWEEIirVg90H21EOLACvtfcHk0lj8Po6soivSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFWmt7Y%253D&md5=ad316a904afbef54577cf99651706340</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DKawahata%26aufirst%3DM.%26aulast%3DOda%26aufirst%3DA.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DY.%26atitle%3DCrystal%2520Structure%252C%2520Docking%2520Study%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Carborane-Containing%2520Androgen%2520Receptor%2520Antagonist%25203-%252812-Hydroxymethyl-1%252C12-Dicarba-closo-Dodecaboran-1-Yl%2529Benzonitrile%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3540%26epage%3D3548%26doi%3D10.1016%2Fj.bmc.2011.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anzenbacher, P.</span>; <span class="NLM_string-name">Zanger, U. M.</span></span>, Eds.  <i>Metabolism of Drugs and Other Xenobiotics</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">John Wiley & Sons, Ltd.</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1002%2F9783527630905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Anzenbacher&author=U.+M.+Zanger&title=Metabolism+of+Drugs+and+Other+Xenobiotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F9783527630905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527630905%26sid%3Dliteratum%253Aachs%26aulast%3DAnzenbacher%26aufirst%3DP.%26btitle%3DMetabolism%2520of%2520Drugs%2520and%2520Other%2520Xenobiotics%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conney, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Oxidative Metabolites of 17β-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3398</span>, <span class="refDoi"> DOI: 10.1210/en.2003-0192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fen.2003-0192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=12865317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=3382-3398&author=A.+J.+Leeauthor=M.+X.+Caiauthor=P.+E.+Thomasauthor=A.+H.+Conneyauthor=B.+T.+Zhu&title=Characterization+of+the+Oxidative+Metabolites+of+17%CE%B2-Estradiol+and+Estrone+Formed+by+15+Selectively+Expressed+Human+Cytochrome+P450+Isoforms&doi=10.1210%2Fen.2003-0192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms</span></div><div class="casAuthors">Lee, Anthony J.; Cai, May Xiaoxin; Thomas, Paul E.; Conney, Allan H.; Zhu, Bao Ting</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3398</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">We systematically characterized the oxidative metabolites of 17β-estradiol and estrone formed by 15 human cytochrome P 450 (CYP) isoforms.  CYP1A1 had high activity for 17β-estradiol 2-hydroxylation, followed by 15α-, 6α-, 4-, and 7α-hydroxylation.  However, when estrone was the substrate, CYP1A1 formed more 4-hydroxyestrone than 15α- or 6α-hydroxyestrone, with 2-hydroxyestrone as the major metabolite.  CYP1A2 had the highest activity for the 2-hydroxylation of both 17β-estradiol and estrone, although it also had considerable activity for their 4-hydroxylation (9-13% of 2-hydroxylation).  CYP1B1 mainly catalyzed the formation of catechol estrogens, with 4-hydroxyestrogens predominant.  CYP2A6, 2B6, 2C8, 2C9, 2C19, and 2D6 each showed a varying degree of low catalytic activity for estrogen 2-hydroxylation, whereas CYP2C18 and CYP2E1 did not show any detectable estrogen-hydroxylating activity.  CYP3A4 had strong activity for the formation of 2-hydroxyestradiol, followed by 4-hydroxyestradiol and an unknown polar metabolite, and small amts. of 16α- and 16β-hydroxyestrogens were also formed.  The ratio of 4- to 2-hydroxylation of 17β-estradiol or estrone with CYP3A4 was 0.22 or 0.51, resp.  CYP3A5 had similar catalytic activity for the formation of 2- and 4-hydroxyestrogens.  Notably, CYP3A5 had an unusually high ratio of 4- to 2-hydroxylation of 17β-estradiol or estrone (0.53 or 1.26, resp.).  CYP3A4 and 3A5 also catalyzed the formation of nonpolar estrogen metabolite peaks (chromatog. less polar than estrone).  CYP3A7 had a distinct catalytic activity for the 16α-hydroxylation of estrone, but not 17β-estradiol.  CYP4A11 had little catalytic activity for the metab. of 17β-estradiol and estrone.  In conclusion, many human CYP isoforms are involved in the oxidative metab. of 17β-estradiol and estrone, with a varying degree of catalytic activity and distinct regioselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5q2Y1i5eYsrVg90H21EOLACvtfcHk0lj8Po6soivSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGjsb0%253D&md5=dc77411de262647d6fcf0c28c27d66e7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1210%2Fen.2003-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2003-0192%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DCai%26aufirst%3DM.%2BX.%26aulast%3DThomas%26aufirst%3DP.%2BE.%26aulast%3DConney%26aufirst%3DA.%2BH.%26aulast%3DZhu%26aufirst%3DB.%2BT.%26atitle%3DCharacterization%2520of%2520the%2520Oxidative%2520Metabolites%2520of%252017%25CE%25B2-Estradiol%2520and%2520Estrone%2520Formed%2520by%252015%2520Selectively%2520Expressed%2520Human%2520Cytochrome%2520P450%2520Isoforms%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D3382%26epage%3D3398%26doi%3D10.1210%2Fen.2003-0192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yano, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wester, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoch, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span> <span> </span><span class="NLM_article-title">The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">38091</span>– <span class="NLM_lpage">38094</span>, <span class="refDoi"> DOI: 10.1074/jbc.C400293200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1074%2Fjbc.C400293200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=15258162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1Oqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=38091-38094&author=J.+K.+Yanoauthor=M.+R.+Westerauthor=G.+A.+Schochauthor=K.+J.+Griffinauthor=C.+D.+Stoutauthor=E.+F.+Johnson&title=The+Structure+of+Human+Microsomal+Cytochrome+P450+3A4+Determined+by+X-ray+Crystallography+to+2.05-%C3%85+Resolution&doi=10.1074%2Fjbc.C400293200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution</span></div><div class="casAuthors">Yano, Jason K.; Wester, Michael R.; Schoch, Guillaume A.; Griffin, Keith J.; Stout, C. David; Johnson, Eric F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">38091-38094</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The structure of P 450 3A4 was detd. by x-ray crystallog. to 2.05-Å resoln.  P 450 3A4 catalyzes the metabolic clearance of a large no. of clin. used drugs, and a no. of adverse drug-drug interactions reflect the inhibition or induction of the enzyme.  P 450 3A4 exhibits a relatively large substrate-binding cavity that is consistent with its capacity to oxidize bulky substrates such as cyclosporin, statins, taxanes, and macrolide antibiotics.  Family 3A P450s also exhibit unusual kinetic characteristics that suggest simultaneous occupancy by smaller substrates.  Although the active site vol. is similar to that of P 450 2C8 (PDB code: 1PQ2), the shape of the active site cavity differs considerably due to differences in the folding and packing of portions of the protein that form the cavity.  Compared with P 450 2C8, the active site cavity of 3A4 is much larger near the heme iron.  The lower constraints on the motions of small substrates near the site of oxygen activation may diminish the efficiency of substrate oxidn., which may in turn be improved by space restrictions imposed by the presence of a second substrate mol.  The structure of P 450 3A4 should facilitate a better understanding of the substrate selectivity of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpOI8NmLt-drVg90H21EOLACvtfcHk0lhOOn5s33i_Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1Oqs7c%253D&md5=59a8fa760069d365165ddeeb9e4081d4</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C400293200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C400293200%26sid%3Dliteratum%253Aachs%26aulast%3DYano%26aufirst%3DJ.%2BK.%26aulast%3DWester%26aufirst%3DM.%2BR.%26aulast%3DSchoch%26aufirst%3DG.%2BA.%26aulast%3DGriffin%26aufirst%3DK.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26atitle%3DThe%2520Structure%2520of%2520Human%2520Microsomal%2520Cytochrome%2520P450%25203A4%2520Determined%2520by%2520X-ray%2520Crystallography%2520to%25202.05-%25C3%2585%2520Resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D38091%26epage%3D38094%26doi%3D10.1074%2Fjbc.C400293200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anzenbacherová, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzenbacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, R.</span></span> <span> </span><span class="NLM_article-title">Flexibility and Stability of the Structure of Cytochromes P450 3A4 and BM-3</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">2916</span>– <span class="NLM_lpage">2920</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.2000.01305.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1046%2Fj.1432-1327.2000.01305.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10806389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1Gjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=2916-2920&author=E.+Anzenbacherov%C3%A1author=N.+Becauthor=P.+Anzenbacherauthor=J.+Hudecekauthor=P.+Soucekauthor=C.+Jungauthor=A.+W.+Munroauthor=R.+Lange&title=Flexibility+and+Stability+of+the+Structure+of+Cytochromes+P450+3A4+and+BM-3&doi=10.1046%2Fj.1432-1327.2000.01305.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3</span></div><div class="casAuthors">Anzenbacherova, Eva; Bec, Nicole; Anzenbacher, Pavel; Hudecek, Jiri; Soucek, Pavel; Jung, Christiane; Munro, Andrew W.; Lange, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2916-2920</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The flexibility of the structure and compressibility of the resp. active site of cytochromes P 450 3A4 (CYP3A4) and BM-3 (CYP102) were studied using absorption spectroscopy in the UV and visual regions.  Conformational changes in the overall protein structures of both CYP3A4 and CYP102 due to the effects of temp. and pressure are reversible.  However, the enzymes differ in the properties of their active sites.  The CYP3A4 enzyme denatures to the inactive P420 form relatively easy, at 3000 bar over half is converted to P420.  The compressibility of its active site is lower than that of CYP102 and is greater with the substrate bound, which is in line with the obsd. lack of a stabilizing effect of the substrate on its conformation under pressure.  In contrast, CYP102, although having the most compressible active site among the P450s, possesses a structure that does not denature easily to the inactive (P420) form under pressure.  In this respect, it resembles the P 450 isolated from acidothermophilic archaebacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4IkUTFriMV7Vg90H21EOLACvtfcHk0lhOOn5s33i_Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1Gjs7w%253D&md5=9e358cae19770cf66d9ec8cd6ffe595e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01305.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01305.x%26sid%3Dliteratum%253Aachs%26aulast%3DAnzenbacherov%25C3%25A1%26aufirst%3DE.%26aulast%3DBec%26aufirst%3DN.%26aulast%3DAnzenbacher%26aufirst%3DP.%26aulast%3DHudecek%26aufirst%3DJ.%26aulast%3DSoucek%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DC.%26aulast%3DMunro%26aufirst%3DA.%2BW.%26aulast%3DLange%26aufirst%3DR.%26atitle%3DFlexibility%2520and%2520Stability%2520of%2520the%2520Structure%2520of%2520Cytochromes%2520P450%25203A4%2520and%2520BM-3%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D2916%26epage%3D2920%26doi%3D10.1046%2Fj.1432-1327.2000.01305.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leathurby, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mewshaw, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharode, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzolf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komm, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneker, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frail, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, J. C.</span></span> <span> </span><span class="NLM_article-title">Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">4241</span>– <span class="NLM_lpage">4249</span>, <span class="refDoi"> DOI: 10.1210/en.2003-0550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fen.2003-0550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=14500559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Srt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=4241-4249&author=H.+A.+Harrisauthor=L.+M.+Albertauthor=Y.+Leathurbyauthor=M.+S.+Malamasauthor=R.+E.+Mewshawauthor=C.+P.+Millerauthor=Y.+P.+Kharodeauthor=J.+Marzolfauthor=B.+S.+Kommauthor=R.+C.+Winnekerauthor=D.+E.+Frailauthor=R.+A.+Hendersonauthor=Y.+Zhuauthor=J.+C.+Keith&title=Evaluation+of+an+Estrogen+Receptor-%CE%B2+Agonist+in+Animal+Models+of+Human+Disease&doi=10.1210%2Fen.2003-0550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of an estrogen receptor-β agonist in animal models of human disease</span></div><div class="casAuthors">Harris, Heather A.; Albert, Leo M.; Leathurby, Yelena; Malamas, Michael S.; Mewshaw, Richard E.; Miller, Chris P.; Kharode, Yogendra P.; Marzolf, James; Komm, Barry S.; Winneker, Richard C.; Frail, Donald E.; Henderson, Ruth A.; Zhu, Yuan; Keith, James C., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4241-4249</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The discovery of a second estrogen receptor (ER), called ERβ, in 1996 sparked intense interest within the scientific community to discover its role in mediating estrogen action.  However, despite more than 6 yr of research into the function of this receptor, its physiol. role in mediating estrogen action remains unclear and controversial.  We have developed a series of highly selective agonists for ERβ and have characterized their activity in several clin. relevant rodent models of human disease.  The activity of one such compd., ERB-041, is reported here.  We conclude from these studies that ERβ does not mediate the bone-sparing activity of estrogen on the rat skeleton and that it does not affect ovulation or ovariectomy-induced wt. gain.  In addn., these compds. are nonuterotrophic and nonmammotrophic.  However, ERB-041 has a dramatic beneficial effect in the HLA-B27 transgenic rat model of inflammatory bowel disease and the Lewis rat adjuvant-induced arthritis model.  Daily oral doses as low as 1 mg/kg reverse the chronic diarrhea of HLA-B27 transgenic rats and dramatically improve histol. disease scores in the colon.  The same dosing regimen in the therapeutic adjuvant-induced arthritis model reduces joint scores from 12 (maximal inflammation) to 1 over a period of 10 d.  Synovitis and Mankin (articular cartilage) histol. scores are also significantly lowered (50-75%).  These data suggest that one function of ERβ may be to modulate the immune response, and that ERβ-selective ligands may be therapeutically useful agents to treat chronic intestinal and joint inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcqFZcYmicf7Vg90H21EOLACvtfcHk0lhOOn5s33i_Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Srt7o%253D&md5=ed1255fd36790a7b9bc665624e5a4619</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1210%2Fen.2003-0550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2003-0550%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DH.%2BA.%26aulast%3DAlbert%26aufirst%3DL.%2BM.%26aulast%3DLeathurby%26aufirst%3DY.%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DMiller%26aufirst%3DC.%2BP.%26aulast%3DKharode%26aufirst%3DY.%2BP.%26aulast%3DMarzolf%26aufirst%3DJ.%26aulast%3DKomm%26aufirst%3DB.%2BS.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26aulast%3DFrail%26aufirst%3DD.%2BE.%26aulast%3DHenderson%26aufirst%3DR.%2BA.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DKeith%26aufirst%3DJ.%2BC.%26atitle%3DEvaluation%2520of%2520an%2520Estrogen%2520Receptor-%25CE%25B2%2520Agonist%2520in%2520Animal%2520Models%2520of%2520Human%2520Disease%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D4241%26epage%3D4249%26doi%3D10.1210%2Fen.2003-0550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulmer, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherden, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bercaw, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, K. I.</span></span> <span> </span><span class="NLM_article-title">NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2176</span>– <span class="NLM_lpage">2179</span>, <span class="refDoi"> DOI: 10.1021/om100106e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om100106e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslKms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=2176-2179&author=G.+R.+Fulmerauthor=A.+J.+M.+Millerauthor=N.+H.+Sherdenauthor=H.+E.+Gottliebauthor=A.+Nudelmanauthor=B.+M.+Stoltzauthor=J.+E.+Bercawauthor=K.+I.+Goldberg&title=NMR+Chemical+Shifts+of+Trace+Impurities%3A+Common+Laboratory+Solvents%2C+Organics%2C+and+Gases+in+Deuterated+Solvents+Relevant+to+the+Organometallic+Chemist&doi=10.1021%2Fom100106e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist</span></div><div class="casAuthors">Fulmer, Gregory R.; Miller, Alexander J. M.; Sherden, Nathaniel H.; Gottlieb, Hugo E.; Nudelman, Abraham; Stoltz, Brian M.; Bercaw, John E.; Goldberg, Karen I.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2176-2179</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tables of 1H and 13C NMR chem. shifts have been compiled for common org. compds. often used as reagents or found as products or contaminants in deuterated org. solvents.  Building upon the work of Gottlieb, Kotlyar, and Nudelman in the Journal of Org. Chem., signals for common impurities are now reported in addnl. NMR solvents (tetrahydrofuran-d8, toluene-d8, dichloromethane-d2, chlorobenzene-d5, and 2,2,2-trifluoroethanol-d3) which are frequently used in organometallic labs.  Chem. shifts for other orgs. which are often used as reagents or internal stds. or are found as products in organometallic chem. are also reported for all the listed solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3GGHumCq_P7Vg90H21EOLACvtfcHk0lhOOn5s33i_Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslKms7Y%253D&md5=53317e05fe3be77fe7de48d8fe1fb8b7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fom100106e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom100106e%26sid%3Dliteratum%253Aachs%26aulast%3DFulmer%26aufirst%3DG.%2BR.%26aulast%3DMiller%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DSherden%26aufirst%3DN.%2BH.%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DStoltz%26aufirst%3DB.%2BM.%26aulast%3DBercaw%26aufirst%3DJ.%2BE.%26aulast%3DGoldberg%26aufirst%3DK.%2BI.%26atitle%3DNMR%2520Chemical%2520Shifts%2520of%2520Trace%2520Impurities%253A%2520Common%2520Laboratory%2520Solvents%252C%2520Organics%252C%2520and%2520Gases%2520in%2520Deuterated%2520Solvents%2520Relevant%2520to%2520the%2520Organometallic%2520Chemist%26jtitle%3DOrganometallics%26date%3D2010%26volume%3D29%26spage%3D2176%26epage%3D2179%26doi%3D10.1021%2Fom100106e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thirumamagal, B. T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyaya, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsamuel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golightly, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jehning, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backer, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjarks, W.</span></span> <span> </span><span class="NLM_article-title">Receptor-Targeted Liposomal Delivery of Boron-Containing Cholesterol Mimics for Boron Neutron Capture Therapy (BNCT)</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1141</span>– <span class="NLM_lpage">1150</span>, <span class="refDoi"> DOI: 10.1021/bc060075d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc060075d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2ltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=1141-1150&author=B.+T.+S.+Thirumamagalauthor=X.+B.+Zhaoauthor=A.+K.+Bandyopadhyayaauthor=J.+Johnsamuelauthor=R.+Tiwariauthor=D.+W.+Golightlyauthor=V.+Patelauthor=B.+T.+Jehningauthor=M.+V.+Backerauthor=R.+F.+Barthauthor=R.+J.+Leeauthor=J.+M.+Backerauthor=W.+Tjarks&title=Receptor-Targeted+Liposomal+Delivery+of+Boron-Containing+Cholesterol+Mimics+for+Boron+Neutron+Capture+Therapy+%28BNCT%29&doi=10.1021%2Fbc060075d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor-Targeted Liposomal Delivery of Boron-Containing Cholesterol Mimics for Boron Neutron Capture Therapy (BNCT)</span></div><div class="casAuthors">Thirumamagal, B. T. S.; Zhao, Xiaobin B.; Bandyopadhyaya, Achintya K.; Narayanasamy, Sureshbabu; Johnsamuel, Jayaseharan; Tiwari, Rohit; Golightly, Danold W.; Patel, Vimalkumar; Jehning, Brian T.; Backer, Marina V.; Barth, Rolf F.; Lee, Robert J.; Backer, Joseph M.; Tjarks, Werner</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1141-1150</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liposomes have been a main focus of tumor-selective boron delivery strategies in boron neutron capture therapy (BNCT), a binary method for the treatment of cancer that is based on the nuclear reaction between boron atoms and low-energy thermal neutrons.  Three novel carboranyl cholesterol derivs. were prepd. as lipid bilayer components for the construction of nontargeted and receptor-targeted boronated liposomes for BNCT.  A major structural feature of these novel boronated cholesterol mimics is the replacement of the B and the C ring of cholesterol with a carborane cluster.  Computational analyses indicated that all three boronated compds. have structural features and physicochem. properties that are very similar to those of cholesterol.  One of the synthesized boronated cholesterol mimics was stably incorporated into non-, folate receptor (FR)-, and vascular endothelial growth factor receptor-2 (VEGFR-2)-targeted liposomes.  No major differences were found in appearance, size distribution, and lamellarity between conventional dipalmitoylphosphatidylcholine (DPPC)/cholesterol liposomes, nontargeted, and FR-targeted liposomal formulations of this carboranyl cholesterol deriv.  FR-targeted boronated liposomes were taken up extensively in FR overexpressing KB cells in vitro, and the uptake was effectively blocked in the presence of free folate.  In contrast, a boronated cholesterol mimic incorporated into nontargeted liposomes showed significantly lower cellular uptake.  There was no apparent in vitro cytotoxicity in FR overexpressing KB cells and VEGFR-2 overexpressing 293/KDR cells when these were incubated with boronated FR- and (VEGFR-2)-targeted liposomes, resp., although the former accumulated extensively in KB cells and the latter effectively interacted with VEGFR-2 by causing autophosphorylation and protecting 293/KDR cells from SLT (Shiga-like toxin)-VEGF cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTeLUOoPO0-LVg90H21EOLACvtfcHk0ljSFAplzmsbRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2ltbs%253D&md5=4a6a65107118389c48d5ee8233e563f8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbc060075d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060075d%26sid%3Dliteratum%253Aachs%26aulast%3DThirumamagal%26aufirst%3DB.%2BT.%2BS.%26aulast%3DZhao%26aufirst%3DX.%2BB.%26aulast%3DBandyopadhyaya%26aufirst%3DA.%2BK.%26aulast%3DJohnsamuel%26aufirst%3DJ.%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DGolightly%26aufirst%3DD.%2BW.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DJehning%26aufirst%3DB.%2BT.%26aulast%3DBacker%26aufirst%3DM.%2BV.%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DBacker%26aufirst%3DJ.%2BM.%26aulast%3DTjarks%26aufirst%3DW.%26atitle%3DReceptor-Targeted%2520Liposomal%2520Delivery%2520of%2520Boron-Containing%2520Cholesterol%2520Mimics%2520for%2520Boron%2520Neutron%2520Capture%2520Therapy%2520%2528BNCT%2529%26jtitle%3DBioconjugate%2520Chem.%26date%3D2006%26volume%3D17%26spage%3D1141%26epage%3D1150%26doi%3D10.1021%2Fbc060075d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Nonsteroidal Progesterone Receptor Antagonists Based on C,C′-Diphenylcarborane Scaffold as a Hydrophobic Pharmacophore</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.ejmech.2014.07.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=25036787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=264-277&author=S.+Fujiiauthor=A.+Yamadaauthor=E.+Nakanoauthor=Y.+Takeuchiauthor=S.+Moriauthor=H.+Masunoauthor=H.+Kagechika&title=Design+and+Synthesis+of+Nonsteroidal+Progesterone+Receptor+Antagonists+Based+on+C%2CC%E2%80%B2-Diphenylcarborane+Scaffold+as+a+Hydrophobic+Pharmacophore&doi=10.1016%2Fj.ejmech.2014.07.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of nonsteroidal progesterone receptor antagonists based on C,C'-diphenylcarborane scaffold as a hydrophobic pharmacophore</span></div><div class="casAuthors">Fujii, Shinya; Yamada, Ayumi; Nakano, Eiichi; Takeuchi, Yuki; Mori, Shuichi; Masuno, Hiroyuki; Kagechika, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">264-277</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The progesterone receptor (PR) plays important roles in multiple physiol. processes, including female reprodn.  Here, we report the synthesis of nonsteroidal PR antagonists contg. a boron cluster as the hydrophobic core.  We found that 1,7-diphenyl-meta-carborane was the preferred substructure among the three carborane isomers.  One compd. was a potent PR antagonist (IC50: 29 nM).  Another compd. also exhibited potent activity (IC50: 93 nM), and did not bind to androgen receptor, glucocorticoid receptor or mineralocorticoid receptor.  These compds. may be useful for investigating potential clin. applications of PR modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogJLt5FaVnb7Vg90H21EOLACvtfcHk0ljSFAplzmsbRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7bF&md5=5b524301e7d8a908c6848a54652d2dc5</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DA.%26aulast%3DNakano%26aufirst%3DE.%26aulast%3DTakeuchi%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DMasuno%26aufirst%3DH.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Nonsteroidal%2520Progesterone%2520Receptor%2520Antagonists%2520Based%2520on%2520C%252CC%25E2%2580%25B2-Diphenylcarborane%2520Scaffold%2520as%2520a%2520Hydrophobic%2520Pharmacophore%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D264%26epage%3D277%26doi%3D10.1016%2Fj.ejmech.2014.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedlak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paguio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartunek, P.</span></span> <span> </span><span class="NLM_article-title">Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.2174/138620711795222446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.2174%2F138620711795222446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=21375502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslagtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=248-266&author=D.+Sedlakauthor=A.+Paguioauthor=P.+Bartunek&title=Two+Panels+of+Steroid+Receptor+Luciferase+Reporter+Cell+Lines+for+Compound+Profiling&doi=10.2174%2F138620711795222446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Two panels of steroid receptor luciferase reporter cell lines for compound profiling</span></div><div class="casAuthors">Sedlak, David; Paguio, Aileen; Bartunek, Petr</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">248-266</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Steroid hormone receptors represent a major target in drug discovery.  As ligand inducible transcription factors, their activity can be modulated by small lipophilic mols.  Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroid receptor activity (U2OS).  The panels contain reporter cell lines for estrogen receptors α and β, androgen, glucocorticoid, mineralocorticoid, and progesterone receptors.  In the first panel, the activation of either synthetic, steroid response elements contg. promoter or viral promoter is mediated by full-length steroid receptors.  The second panel is based on the expression of the chimeric receptor, which was created by the replacement of the N-terminal part of the mol. by Gal4 DBD and that binds to multiple UAS sites in the reporter promoter.  Both panels were extensively characterized by profiling 28 ligands in dose response manner in agonist and antagonist mode.  We have analyzed and compared the responses to tested ligands from both panels and concluded that in general both systems generated similar qual. response in terms of potency, efficacy, partial agonism/antagonism, mixed agonistic/antagonistic profiles and the rank of potencies was well conserved between both panels.  However, we have also identified some artifacts introduced by the Gal4/LBD reporter assays in contrast to their full-length receptor reporter counterparts.  Keeping in mind the advantages and drawbacks of each reporter format, these cell lines represent powerful and selective tools for profiling large compd. libraries (HTS) and for detailed study of mechanisms by which compds. exert their biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOMFFn8pEkmbVg90H21EOLACvtfcHk0lhutBt7Z8fAmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslagtL8%253D&md5=0a021e26cec2615f445f7b3d18625c39</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.2174%2F138620711795222446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620711795222446%26sid%3Dliteratum%253Aachs%26aulast%3DSedlak%26aufirst%3DD.%26aulast%3DPaguio%26aufirst%3DA.%26aulast%3DBartunek%26aufirst%3DP.%26atitle%3DTwo%2520Panels%2520of%2520Steroid%2520Receptor%2520Luciferase%2520Reporter%2520Cell%2520Lines%2520for%2520Compound%2520Profiling%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2011%26volume%3D14%26spage%3D248%26epage%3D266%26doi%3D10.2174%2F138620711795222446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the Inhibition Constant (KI) and the Concentration of Inhibitor Which Causes 50 per Cent Inhibition (I50) of an Enzymatic Reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+Inhibition+Constant+%28KI%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+per+Cent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520Inhibition%2520Constant%2520%2528KI%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">Enzymatic Analysis of CDNA-Expressed Human CYP1A1, CYP1A2, and CYP1B1 with 7-Ethoxyresorufin as Substrate</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">90</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=85-90&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DT.%2BK.%2BH.%26atitle%3DEnzymatic%2520Analysis%2520of%2520CDNA-Expressed%2520Human%2520CYP1A1%252C%2520CYP1A2%252C%2520and%2520CYP1B1%2520with%25207-Ethoxyresorufin%2520as%2520Substrate%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souček, P.</span></span> <span> </span><span class="NLM_article-title">Novel Sensitive High-Performance Liquid Chromatographic Method for Assay of Coumarin 7-Hydroxylation</span>. <i>J. Chromatogr. B: Biomed. Sci. Appl.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>734</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/S0378-4347(99)00325-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2FS0378-4347%2899%2900325-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10574186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXns1Ghtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=734&publication_year=1999&pages=23-29&author=P.+Sou%C4%8Dek&title=Novel+Sensitive+High-Performance+Liquid+Chromatographic+Method+for+Assay+of+Coumarin+7-Hydroxylation&doi=10.1016%2FS0378-4347%2899%2900325-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation</span></div><div class="casAuthors">Soucek, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Biomedical Sciences and Applications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">734</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">JCBBEP</span>;
        ISSN:<span class="NLM_cas:issn">0378-4347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">In this paper, a novel HPLC-based method with fluorometric detection of coumarin 7-hydroxylase is presented.  The described method provides a time-effective, more sensitive and specific alternative to the previously used spectrofluorometric assay.  Using the developed method, metab. of coumarin in 11 samples of human liver microsomes was evaluated and 1790±690 pmol/min/nmol cytochrome P 450 (CYP) activity was found.  Kinetic parameters and linearity of coumarin 7-hydroxylation were studied in a reconstituted system consisting of recombinant CYP2A6 expressed in Escherichia coli, rat NADPH-CYP reductase and usual components.  It was found that a 3.5 to 30 min time of incubation is suitable for estn. of coumarin 7-hydroxylase activity.  Obsd. Km and Vmax values in the CYP2A6 reconstituted system were 1.48±0.37 μM and 3360±180 pmol product/min/nmol CYP, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpprm2RYIioLbVg90H21EOLACvtfcHk0lhutBt7Z8fAmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1Ghtbw%253D&md5=313b3ef1e8521fa185c493775b679005</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0378-4347%2899%2900325-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-4347%252899%252900325-4%26sid%3Dliteratum%253Aachs%26aulast%3DSou%25C4%258Dek%26aufirst%3DP.%26atitle%3DNovel%2520Sensitive%2520High-Performance%2520Liquid%2520Chromatographic%2520Method%2520for%2520Assay%2520of%2520Coumarin%25207-Hydroxylation%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Biomed.%2520Sci.%2520Appl.%26date%3D1999%26volume%3D734%26spage%3D23%26epage%3D29%26doi%3D10.1016%2FS0378-4347%2899%2900325-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donato, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castell, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Lechón, M. J.</span></span> <span> </span><span class="NLM_article-title">Fluorescence-Based Assays for Screening Nine Cytochrome P450 (P450) Activities in Intact Cells Expressing Individual Human P450 Enzymes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1124/dmd.32.7.699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1124%2Fdmd.32.7.699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=15205384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlWqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=699-706&author=M.+T.+Donatoauthor=N.+Jim%C3%A9nezauthor=J.+V.+Castellauthor=M.+J.+G%C3%B3mez-Lech%C3%B3n&title=Fluorescence-Based+Assays+for+Screening+Nine+Cytochrome+P450+%28P450%29+Activities+in+Intact+Cells+Expressing+Individual+Human+P450+Enzymes&doi=10.1124%2Fdmd.32.7.699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes</span></div><div class="casAuthors">Donato, M. Teresa; Jimenez, Nuria; Castell, Jose V.; Gomez-Lechon, M. Jose</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">699-706</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Here, the authors describe a battery of fluorescence assays for rapid measurement in intact cells of the activity of 9 cytochromes P 450 (P 450) isoforms involved in drug metab.  The assays are based on the direct incubation of monolayers of cells expressing individual P 450 enzymes with a fluorogenic substrate followed by fluorometric quantification of the product formed and released into incubation medium.  For each individual P 450 activity, different fluorescent probes were examd., and the one showing the best properties (highest metabolic rates, lowest background fluorescence) was selected: 3-cyano-7-ethoxycoumarin for CYP1A2 and CYP2C19, coumarin for CYP2A6, 7-ethoxy-4-trifluoromethylcoumarin for CYP2B6, dibenzylfluorescein for CYP2C8, 7-methoxy-4-trifluoromethylcoumarin (MFC) for CYP2C9 and CYP2E1, 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin for CYP2D6, and 7-benzyloxy-4-trifluoromethylcoumarin for CYP3A4.  The fluorescence-based assays were highly sensitive and allowed the simultaneous measurement of a large no. of samples using plate readers, thus enhancing sample throughput.  The major advantages over high-throughput assays in subcellular fractions were that, as living cells were used, manual handling and enzyme damage were minimized, the endoplasmic reticulum of the cells remained intact, exogenous cofactors or NADPH-regenerating systems were not required, and transport processes were maintained.  These assays could be applied to preliminary screening of inhibitory effects of new drugs on individual P 450 enzymes.  After comparison of the results obtained using the fluorescent probes in intact P 450-expressing cells and those obtained using the HPLC-based selective assays in the same cells, in primary human hepatocytes, or in human liver microsomes, a fairly good agreement was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDn89BZzSJtrVg90H21EOLACvtfcHk0lgonqWJQpuZ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlWqt7k%253D&md5=10a4fda9a830c33436a8b2373e3af799</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.7.699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.7.699%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DM.%2BT.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DN.%26aulast%3DCastell%26aufirst%3DJ.%2BV.%26aulast%3DG%25C3%25B3mez-Lech%25C3%25B3n%26aufirst%3DM.%2BJ.%26atitle%3DFluorescence-Based%2520Assays%2520for%2520Screening%2520Nine%2520Cytochrome%2520P450%2520%2528P450%2529%2520Activities%2520in%2520Intact%2520Cells%2520Expressing%2520Individual%2520Human%2520P450%2520Enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D699%26epage%3D706%26doi%3D10.1124%2Fdmd.32.7.699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi, C. L.</span>; <span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">High-Performance Liquid Chromatography Analysis of CYP2C8-Catalyzed Paclitaxel 6α-Hydroxylation</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">107</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=103-107&author=C.+L.+Crespi&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DHigh-Performance%2520Liquid%2520Chromatography%2520Analysis%2520of%2520CYP2C8-Catalyzed%2520Paclitaxel%25206%25CE%25B1-Hydroxylation%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D103%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi, C. L.</span>; <span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">Determination of CYP2C9-Catalyzed Diclofenac 4′-Hydroxylation by High-Performance Liquid Chromatography</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">113</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=109-113&author=C.+L.+Crespi&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DDetermination%2520of%2520CYP2C9-Catalyzed%2520Diclofenac%25204%25E2%2580%25B2-Hydroxylation%2520by%2520High-Performance%2520Liquid%2520Chromatography%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D109%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi, C. L.</span>; <span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">CYP2C19-Mediated (S)-Mephenytoin 4′-Hydroxylation Assayed by High-Performance Liquid Chromatography With Radiometric Detection</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">119</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=115-119&author=C.+L.+Crespi&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DCYP2C19-Mediated%2520%2528S%2529-Mephenytoin%25204%25E2%2580%25B2-Hydroxylation%2520Assayed%2520by%2520High-Performance%2520Liquid%2520Chromatography%2520With%2520Radiometric%2520Detection%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D115%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi, C. L.</span>; <span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">CYP2D6-Dependent Bufuralol 1′-Hydroxylation Assayed by Reverse-Phase Ion-Pair High-Performance Liquid Chromatography With Fluorescence Detection</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">125</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=121-125&author=C.+L.+Crespi&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DCYP2D6-Dependent%2520Bufuralol%25201%25E2%2580%25B2-Hydroxylation%2520Assayed%2520by%2520Reverse-Phase%2520Ion-Pair%2520High-Performance%2520Liquid%2520Chromatography%2520With%2520Fluorescence%2520Detection%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D121%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, D.</span>; <span class="NLM_string-name">Menez, J.-F.</span>; <span class="NLM_string-name">Berthou, F.</span></span> <span> </span><span class="NLM_article-title">[12] Chlorzoxazone: An in Vitro and in Vivo Substrate Probe for Liver CYP2E1</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span>; <span class="NLM_string-name">Waterman, M. R.</span></span>, Eds.; <span class="NLM_series">Cytochrome P450, Part B</span>; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">1996</span>; Vol.  <span class="NLM_volume">272</span>, pp  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">123</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=115-123&author=D.+Lucas&author=J.-F.+Menez&author=F.+Berthouauthor=E.+F.+Johnson&author=M.+R.+Waterman&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DD.%26atitle%3D%255B12%255D%2520Chlorzoxazone%253A%2520An%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Substrate%2520Probe%2520for%2520Liver%2520CYP2E1%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26pub%3DAcademic%2520Press%26date%3D1996%26volume%3D272%26spage%3D115%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D.</span></span> <span> </span><span class="NLM_article-title">Inhibition and Kinetics of Cytochrome P4503A Activity in Microsomes from Rat, Human, and Cdna-Expressed Human Cytochrome P450</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">940</span>– <span class="NLM_lpage">947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=8886602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK28XlvV2itrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1996&pages=940-947&author=A.+Ghosalauthor=H.+Satohauthor=P.+E.+Thomasauthor=E.+Bushauthor=D.+Moore&title=Inhibition+and+Kinetics+of+Cytochrome+P4503A+Activity+in+Microsomes+from+Rat%2C+Human%2C+and+Cdna-Expressed+Human+Cytochrome+P450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450</span></div><div class="casAuthors">Ghosal, Anima; Satoh, Hiroko; Thomas, Paul E.; Bush, Ernest; Moore, David</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">940-947</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Midazolam (MDZ) is metabolized in human liver microsomes by the cytochrome P 450 (CYP) 3A subfamily to 1'-hydroxy (1'-OH) and 4-hydroxy (4-OH) metabolites.  MDZ is metabolized in the rat primarily to 4-OH MDZ, 1'-OH MDZ, and 1',4-dihydroxy (1',4-diOH) MDZ.  The kinetics of 4-OH and 1'-OH metabolite formation were detd. using hepatic microsomes from control, Ro 23-7637 and dexamethasone-treated male rats.  KM values for the major metabolite, 4-OH MDZ, were 24.5, 43.1, and 32.8 μM, and the corresponding Vmax values were 5.9, 28.9, and 13 nmol/mg/min for the control, DEX, and Ro 23-7637-treated animals, resp.  KM values for 1'-hydroxylation of MDZ (the major metabolite) after incubation with human liver microsomes from three individuals were 5.57, 2.50, and 3.56 μM, and the corresponding Vmax values were 4.38, 0.49, and 0.19 nmol/mg/min, resp.  In parallel studies using cDNA-expressed human CYP3A4 microsomes, the KM for 1'-OH formation was 1.56 μM, and the corresponding Vmax was 0.16 nmol/mg/min.  MDZ was not metabolized by cDNA-expressed human CYP2D6, CYP2E1, or CYP1A2, thus confirming that these isoforms were not responsible for its biotransformation.  The formation of 1',4-diOH metabolite in rat and 1'-OH formation in cDNA-expressed human CYP3A4 microsomes showed a decrease in velocity at high substrate concns.  Inhibition studies showed that MDZ hydroxylation was strongly inhibited by ketoconazole and Ro 23-7637 in rat, human, and cDNA-expressed human CYP3A4 microsomes.  α-Naphthoflavone stimulated 1'-OH metabolite formation in human and cDNA-expressed human CYP3A4 microsomes at low concn. (10 μM).  Naringenin, a flavonoid present in grapefruit juice, also inhibited MDZ metab. in human liver microsomes.  Immunoinhibition studies revealed that polyclonal anti-rat CYP3A2 antibody inhibited MDZ metab. 80-90% in rat, human, and cDNA-expressed human CYP3A4 microsomes, thus suggesting that members of the CYP3A4 subfamily were involved in the metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZdr6TvfGpHLVg90H21EOLACvtfcHk0lh0EMDbZBHABw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvV2itrg%253D&md5=fb95979ee683d0166e6159ccd3bee9e2</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhosal%26aufirst%3DA.%26aulast%3DSatoh%26aufirst%3DH.%26aulast%3DThomas%26aufirst%3DP.%2BE.%26aulast%3DBush%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DD.%26atitle%3DInhibition%2520and%2520Kinetics%2520of%2520Cytochrome%2520P4503A%2520Activity%2520in%2520Microsomes%2520from%2520Rat%252C%2520Human%252C%2520and%2520Cdna-Expressed%2520Human%2520Cytochrome%2520P450%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1996%26volume%3D24%26spage%3D940%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kronbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, U. A.</span></span> <span> </span><span class="NLM_article-title">Oxidation of Midazolam and Triazolam by Human Liver Cytochrome P450IIIA4</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=2787473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaL1MXlt1Kgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1989&pages=89-96&author=T.+Kronbachauthor=D.+Mathysauthor=M.+Umenoauthor=F.+J.+Gonzalezauthor=U.+A.+Meyer&title=Oxidation+of+Midazolam+and+Triazolam+by+Human+Liver+Cytochrome+P450IIIA4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4</span></div><div class="casAuthors">Kronbach, Thomas; Mathys, Daniel; Umeno, Morio; Gonzalez, Frank J.; Meyer, Urs A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The metab. of midazolam and triazolam to their 1'-hydroxy and 4-hydroxy metabolites was studied in microsomes of human livers.  The formation of both metabolites was inhibited >90% by an antiserum directed against a pregnenolone 16α-carbonitrile-inducible cytochrome P 450 (P450PCN1) of rat liver.  Moreover, midazolam hydroxylase activity was immunopptd. from solubilized human microsomes with polyclonal antibodies against rat P450PCN1 and the closely related human isoenzyme P450NF.  A close correlation was obsd. between the amt. of protein detected in immunoblots with these antibodies and the midazolam or triazolam or triazolam hydroxylase activity.  The formation of both metabolites of midazolam was inhibited by triacetyloleandomycin, a known inhibitor of cytochromes P 450 of the IIIA family.  Direct evidence that P450IIIA4 catalyzes the metab. of midazolam was provided through the use of cDNA-directed expression.  Monkey COS cells transfected with human P450PCN1 cDNA were able to catalyze both the 1'- and the 4-hydroxylation of midazolam.  The metab. of midazolam and triazolam in human liver is apparently predominantly mediated by cytochrome P450IIIA4.  Two of 15 human livers expressed a 2nd immunoreactive microsomal protein of higher apparent mol. wt. and were more active in midazolam 1'-hydroxylation.  The data also provide evidence that the marked interindividual variation in the response to these widely used benzodiazepine drugs is due to variable hepatic metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXjW8xpvlfmLVg90H21EOLACvtfcHk0lh0EMDbZBHABw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlt1Kgu7g%253D&md5=6ecf9fc3682977542e46d9a32be16f21</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKronbach%26aufirst%3DT.%26aulast%3DMathys%26aufirst%3DD.%26aulast%3DUmeno%26aufirst%3DM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DMeyer%26aufirst%3DU.%2BA.%26atitle%3DOxidation%2520of%2520Midazolam%2520and%2520Triazolam%2520by%2520Human%2520Liver%2520Cytochrome%2520P450IIIA4%26jtitle%3DMol.%2520Pharmacol.%26date%3D1989%26volume%3D36%26spage%3D89%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Estrogen receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Alkyl- and Hydroxyalkyl-Substituted Carboranes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) <i>n</i>-BuLi, dimethoxyethane (1,2-DME), −78 or 0 °C; (b) BBr<sub>3</sub>, CH<sub>2</sub>CI<sub>2</sub>, 0 °C to room temperature (RT).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Ketone <b>9</b> and <i>S</i> and <i>R</i> Enantiomers <b>7</b> and <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) PCC, CH<sub>2</sub>Cl<sub>2</sub>; (b) BH<sub>3</sub>·THF, (<i>S</i>)-2-Me-CBS, RT; (c) BH<sub>3</sub>·THF, (<i>R</i>)-2-Me-CBS, RT; (d) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to RT.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Phenyl Compound <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) <i>n</i>-Hexylmagnesium bromide, Et<sub>2</sub>O, 0 °C; (b) PCC, CH<sub>2</sub>CI<sub>2</sub>; (c) BH<sub>3</sub>·THF, (<i>R</i>)-2-Me-CBS, 0 °C; (d) 1-dodecanethiol, <i>N</i>-methylpyrrolidinone (NMP), NaOH, 100 °C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Cyclohexyl Compound <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>I, acetone, reflux; (b) (methoxymethyl)triphenylphosphonium chloride, LiHMDS, THF; 2 N HCI; (c) hexylmagnesium bromide, Et<sub>2</sub>O, 0 °C; (d) PCC, CH<sub>2</sub>CI<sub>2</sub>; (e) BH<sub>3</sub>·THF, (<i>R</i>)-2-Me-CBS, 0°C; (f) 1-dodecanethiol, NMP, NaOH, 100 °C.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of [2.2.2]Bicyclic Compound <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Br<sub>2</sub>, dichloromethane (DCM), HgO; (b) AICI<sub>3</sub>, benzene, (c) LiAIH<sub>4</sub>, Et<sub>2</sub>O; (d) PCC, NaHCO<sub>3</sub>, NaOAc, CH<sub>2</sub>CI<sub>2</sub>; (e) hexylmagnesium bromide, Et<sub>2</sub>O; (f) AgOAc, Br<sub>2</sub>, CHCI<sub>3</sub>; (g) PCC, CH<sub>2</sub>CI<sub>2</sub>; (h) BH<sub>3</sub>·THF, (<i>R</i>)-2-Me-CBS 0 °C; (i) benzaldehyde oxime, Cs<sub>2</sub>CO<sub>3</sub>, RockPhos Pd G3.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>28</b> and <b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) <i>n</i>-BuLi, 1,2-DME, −78 or 0 °C, 1-heptanal; (b) BBr<sub>3</sub>, CH<sub>2</sub>CI<sub>2</sub>, 0 °C to RT.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Ligand selectivity for ERβ increases with elongation of the side hydrocarbon chain. <b>BE120</b>, <b>3g</b>, and <b>8</b> were tested in ERα (dashed line) and ERβ (solid line) transactivation assays in the concentration range between 10 μM and 1 pM, in triplicates and activities were expressed relative to 100 nM 17β-estradiol set to 100%. Increasing length of the carboranes’ side hydrocarbon chain is accompanied with decreasing potency in both ERα and ERβ reporter assays and by increasing selectivity for ERβ (blue: nonselective, green: 10–100× selective, red: selectivity >100×).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/medium/jm1c00555_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Activities of the carboranes’ compound library on steroid receptors. (A) Compounds were profiled at 1 μM in the selective luciferase reporter assays for the agonistic and (B) antagonistic activities for steroid receptors. The activity is expressed relative to maximal activity induced by reference compound or as a fold induction compared to untreated cells for control assay (MMTV reporter alone, dark red dots). Cell viability in U2OS cells was used as a control experiment for the antagonistic activities and is expressed in a scale of 0–100% relative to dimethyl sulfoxide (DMSO)-treated cells (green dots).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00555/20210629/images/large/jm1c00555_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00555&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i102">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodds, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, W.</span></span> <span> </span><span class="NLM_article-title">Synthetic Strogenic Agents without the Phenanthrene Nucleus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1936</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">996</span>, <span class="refDoi"> DOI: 10.1038/137996a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1038%2F137996a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaA28XkvVagsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1936&pages=996&author=E.+C.+Doddsauthor=W.+Lawson&title=Synthetic+Strogenic+Agents+without+the+Phenanthrene+Nucleus&doi=10.1038%2F137996a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic estrogenic agents without the phenanthrene nucleus</span></div><div class="casAuthors">Dodds, E. C.; Lawson, Wilfrid</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1936</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">996</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The phenanthrene condensed-ring structure is not necessary for estrogenic activity.  A table of 14 synthetic substances is given, all except one showing 100% positive estrus responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgp6KB1NsIerVg90H21EOLACvtfcHk0liddr10md4wxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA28XkvVagsQ%253D%253D&md5=9991eb1f0557091ee8f4d26b2c9d99d3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F137996a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F137996a0%26sid%3Dliteratum%253Aachs%26aulast%3DDodds%26aufirst%3DE.%2BC.%26aulast%3DLawson%26aufirst%3DW.%26atitle%3DSynthetic%2520Strogenic%2520Agents%2520without%2520the%2520Phenanthrene%2520Nucleus%26jtitle%3DNature%26date%3D1936%26volume%3D137%26spage%3D996%26doi%3D10.1038%2F137996a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krust, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeltsch, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staub, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrace, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterfield, M.</span></span> <span> </span><span class="NLM_article-title">Cloning of the Human Estrogen Receptor CDNA</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">7889</span>– <span class="NLM_lpage">7893</span>, <span class="refDoi"> DOI: 10.1073/pnas.82.23.7889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.82.23.7889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=3865204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaL28XotlShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=7889-7893&author=P.+Walterauthor=S.+Greenauthor=G.+Greeneauthor=A.+Krustauthor=J.+M.+Bornertauthor=J.+M.+Jeltschauthor=A.+Staubauthor=E.+Jensenauthor=G.+Scraceauthor=M.+Waterfield&title=Cloning+of+the+Human+Estrogen+Receptor+CDNA&doi=10.1073%2Fpnas.82.23.7889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of the human estrogen receptor cDNA</span></div><div class="casAuthors">Walter, Philippe; Green, Stephen; Greene, Geoffrey; Krust, Andree; Bornert, Jean Marc; Jeltsch, Jean Marc; Staub, Adrien; Jensen, Elwood; Scrace, Geoffrey; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7889-93</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Poly(A)+ RNA isolated from the human breast cancer cell line MCF-7 was fractionated by sucrose gradient centrifugation and fractions enriched in estrogen receptor (ER) mRNA were used to prep. randomly primed cDNA libraries in the λg10 and λg11 vectors.  Clones corresponding to ER sequence were isolated from both libraries after screening with either ER monoclonal antibodies (λg11) or synthetic oligonucleotide probes designed from 2 peptide sequences of purified ER (λg10).  Five cDNA clones were isolated by antibody screening, and 5 were isolated after screening with synthetic oligonucleotides.  The 2 largest ER cDNA clones, λOR3 (1.3 kilobase pairs) and λOR8 (2.1 kilobase pairs), isolated by using antibodies and oligonucleotides, resp., were able to enrich selectively for ER mRNA by hybrid-selection.  Further, λOR8 contains the DNA sequence expected from the 2 ER peptides and cross-hybridizes with each of the other ER cDNA clones.  These results demonstrate that the clones isolated correspond to the ER mRNA sequence.  Use of λOR8 as a hybridization probe revealed a single poly(A)+ RNA band of ≈6.2 kilobase pairs in the ER-contg. human breast cancer cell lines MCF-7 and T47D.  In contrast, no hybridization was seen in the human ER-neg. cell line HeLa.  The same probe hybridizes to a chicken gene that is expressed in oviduct tissue as a 7.5-kilobase-pair poly(A)+ RNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjx0upbPWKHrVg90H21EOLACvtfcHk0liddr10md4wxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XotlShsA%253D%253D&md5=bfb5de85940113236c09e1f34a785b75</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.23.7889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.23.7889%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DGreene%26aufirst%3DG.%26aulast%3DKrust%26aufirst%3DA.%26aulast%3DBornert%26aufirst%3DJ.%2BM.%26aulast%3DJeltsch%26aufirst%3DJ.%2BM.%26aulast%3DStaub%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DE.%26aulast%3DScrace%26aufirst%3DG.%26aulast%3DWaterfield%26aufirst%3DM.%26atitle%3DCloning%2520of%2520the%2520Human%2520Estrogen%2520Receptor%2520CDNA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1985%26volume%3D82%26spage%3D7889%26epage%3D7893%26doi%3D10.1073%2Fpnas.82.23.7889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korach, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couse, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindzey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimbro, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eddy, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliaccio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snedeker, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubahn, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schomberg, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. P.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor Gene Disruption: Molecular Characterization and Experimental and Clinical Phenotypes</span>. <i>Recent Prog. Horm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=8701078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2sXktFKisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1996&pages=159-186&author=K.+S.+Korachauthor=J.+F.+Couseauthor=S.+W.+Curtisauthor=T.+F.+Washburnauthor=J.+Lindzeyauthor=K.+S.+Kimbroauthor=E.+M.+Eddyauthor=S.+Migliaccioauthor=S.+M.+Snedekerauthor=D.+B.+Lubahnauthor=D.+W.+Schombergauthor=E.+P.+Smith&title=Estrogen+Receptor+Gene+Disruption%3A+Molecular+Characterization+and+Experimental+and+Clinical+Phenotypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes</span></div><div class="casAuthors">Korach, Kenneth S.; Couse, John F.; Curtis, Sylvia W.; Washburn, Todd F.; Lindzey, Jonathan; Kimbro, K. Sean; Eddy, Edward M.; Migliaccio, Silvia; Snedeker, Suzanne M.; Lubahn, Dennis B.; Schomberg, David W.; Smith, Eric P.</div><div class="citationInfo"><span class="NLM_cas:title">Recent Progress in Hormone Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">159-188</span>CODEN:
                <span class="NLM_cas:coden">RPHRA6</span>;
        ISSN:<span class="NLM_cas:issn">0079-9963</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review with 50 refs.  The estrogen receptor (ER) is thought to play a crucial role in the regulation of many life processes, including development, reprodn. and normal physiol.  Because there have been no known mutations of the estrogen receptor in normal tissue of humans and animals, its presence and tissue distribution is thought to be essential for survival.  Using the techniques of homologous recombination, the ER gene has been disrupted to produce a line of transgenic mice possessing the altered ER gene (ERKO).  The mouse ER gene was disrupted by inserting a 1.8-kb PGK-Neomycin sequence into exon 2, ∼280 bp downstream of the transcription start codon.  The correct targeting of the disruption was demonstrated by Southern blot anal. and PCR.  Western blot anal. of uterine prepns. from ERKO females showed no detectable ER protein.  Heterozygotes had one half the level of ER protein compared to wild-type animals.  Estrogen insensitivity was confirmed using estrogen agonists, estradiol, hydroxy tamoxifen, diethylstilbestrol treatment for 3 days which resulted in a 3-4-fold increase in uterine wet wt. and vaginal cornification in wild-type females, while ERKO mice were totally unresponsive.  These data were further supported by the failure of estrogen or EGF treatment to induce DNA synthesis in uterine tissue of similarly treated mice.  Lactoferrin, an estrogen-responsive gene in the uterus, was also assayed by Northern blot.  Wild-type mice treated with a single estradiol injection showed a 350-fold induction in lactoferrin mRNA, while ERKO females showed no detectable response.  Both male and female animals survive to adulthood with normal gross external phenotypes.  As expected, females are infertile and demonstrate hypoplastic uteri and hyperemic ovaries with no apparent corpora lutea.  Males are also infertile, with atrophy of the testes and seminiferous tubule dysmorphogenesis.  Although the reproductive capabilities have been altered with a dramatic effect on the gonads, prenatal development of the reproductive tracts of both sexes appear to be independent of an ER-mediated response.  Anal. of the mammary glands of the ERKO females at 4 mo of age showed a primitive ductal rudiment rather than the fully developed ductal tree seen in wild-type siblings.  Also absent were the terminal end buds seen during normal ductal morphogenesis.  Both sexes show a decrease in skeletal bone d., supporting a direct role for ER action in bone.  A single patient is described who is homozygous for a point mutation in the human ER gene at codon 157.  The mutation produces a truncation of the ER protein and results in estrogen insensitivity syndrome.  Most significant of the clin. findings are effects on skeletal bone d. and retarded bone age.  Findings from the patient and mice suggest that the absence of functional ER is not lethal.  Mutation in the ER gene is present in the human population.  Further characterization of the mice and identification of addnl. patients will be required to more fully understand the consequences of ER gene mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOffkuQ39uzrVg90H21EOLACvtfcHk0liddr10md4wxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFKisr0%253D&md5=b9f0b64fca403a8ac04eff2884ad258a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKorach%26aufirst%3DK.%2BS.%26aulast%3DCouse%26aufirst%3DJ.%2BF.%26aulast%3DCurtis%26aufirst%3DS.%2BW.%26aulast%3DWashburn%26aufirst%3DT.%2BF.%26aulast%3DLindzey%26aufirst%3DJ.%26aulast%3DKimbro%26aufirst%3DK.%2BS.%26aulast%3DEddy%26aufirst%3DE.%2BM.%26aulast%3DMigliaccio%26aufirst%3DS.%26aulast%3DSnedeker%26aufirst%3DS.%2BM.%26aulast%3DLubahn%26aufirst%3DD.%2BB.%26aulast%3DSchomberg%26aufirst%3DD.%2BW.%26aulast%3DSmith%26aufirst%3DE.%2BP.%26atitle%3DEstrogen%2520Receptor%2520Gene%2520Disruption%253A%2520Molecular%2520Characterization%2520and%2520Experimental%2520and%2520Clinical%2520Phenotypes%26jtitle%3DRecent%2520Prog.%2520Horm.%2520Res.%26date%3D1996%26volume%3D51%26spage%3D159%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">discussion 186–188.</p></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelto-Huikko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J. A.</span></span> <span> </span><span class="NLM_article-title">Cloning of a Novel Receptor Expressed in Rat Prostate and Ovary</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">5925</span>– <span class="NLM_lpage">5930</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.12.5925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.93.12.5925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=8650195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Ojs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=5925-5930&author=G.+G.+Kuiperauthor=E.+Enmarkauthor=M.+Pelto-Huikkoauthor=S.+Nilssonauthor=J.+A.+Gustafsson&title=Cloning+of+a+Novel+Receptor+Expressed+in+Rat+Prostate+and+Ovary&doi=10.1073%2Fpnas.93.12.5925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a novel estrogen receptor expressed in rat prostate and ovary</span></div><div class="casAuthors">Kuiper, George G. J. M.; Enmark, Eva; Pelto-Huikko, Markku; Nilsson, Stefan; Gustafsson, Jan-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5925-5930</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The authors have cloned a novel member of the nuclear receptor superfamily.  The cDNA of clone 29 was isolated from a rat prostate cDNA library and it encodes a protein of 485 amino acid residues with a calcd. mol. wt. of 54.2 kDa.  Clone 29 protein is unique in that it is highly homologous to the rat estrogen receptor (ER) protein, particularly in the DNA-binding domain (95%) and in the C-terminal ligand-binding domain (55%).  Expression of clone 29 in rat tissues was investigated by in situ hybridization and prominent expression was found in prostate and ovary.  In the prostate clone 29 is expressed in the epithelial cells of the secretory alveoli, whereas in the ovary the granulosa cells in primary, secondary, and mature follicles showed expression of clone 29.  Satn. ligand-binding anal. of in vitro synthesized clone 29 protein revealed a single binding component for 17β-estradiol (E2) and high affinity (Kd = 0.6 nM).  In ligand-competition expts. the binding affinity decreased in the order E2 > diethylstilbestrol > estriol > estrone > 5α-androstane-3β,17β-diol » testosterone = progesterone = corticosterone = 5α-androstane-3α,17β-diol.  In cotransfection expts. of Chinese hamster ovary cells with a clone 29 expression vector and an estrogen-regulated reporter gene, maximal stimulation (about 3-fold) of reporter gene activity was found during incubation with 10 nM of E2.  Neither progesterone, testosterone, dexamethasone, thyroid hormone, all-trans-retinoic acid, nor 5α-androstane-3α,17β-diol could stimulate reporter gene activity, whereas estrone and 5α-androstane-3β,17β-diol did.  The authors conclude that clone 29 cDNA encodes a novel rat ER, which they suggest be named rat ERβ to distinguish it from the previously cloned ER (ERα) from rat uterus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemRoHhjStjrVg90H21EOLACvtfcHk0ljisBEPEGOiXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Ojs7c%253D&md5=aa1c112de706d680f59afec3e77830b3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.12.5925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.12.5925%26sid%3Dliteratum%253Aachs%26aulast%3DKuiper%26aufirst%3DG.%2BG.%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DPelto-Huikko%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DGustafsson%26aufirst%3DJ.%2BA.%26atitle%3DCloning%2520of%2520a%2520Novel%2520Receptor%2520Expressed%2520in%2520Rat%2520Prostate%2520and%2520Ovary%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D5925%26epage%3D5930%26doi%3D10.1073%2Fpnas.93.12.5925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mäkelä, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treuter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tujague, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Estrogen Action</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1535</span>– <span class="NLM_lpage">1565</span>, <span class="refDoi"> DOI: 10.1152/physrev.2001.81.4.1535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1152%2Fphysrev.2001.81.4.1535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=11581496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD38XislCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=1535-1565&author=S.+Nilssonauthor=S.+M%C3%A4kel%C3%A4author=E.+Treuterauthor=M.+Tujagueauthor=J.+Thomsenauthor=G.+Anderssonauthor=E.+Enmarkauthor=K.+Petterssonauthor=M.+Warnerauthor=J.-%C3%85.+Gustafsson&title=Mechanisms+of+Estrogen+Action&doi=10.1152%2Fphysrev.2001.81.4.1535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of estrogen action</span></div><div class="casAuthors">Nilsson, Stefan; Makela, Sari; Treuter, Eckardt; Tujague, Michel; Thomsen, Jane; Andersson, Goran; Enmark, Eva; Pettersson, Katarina; Warner, Margaret; Gustafsson, Jan-Ake</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1535-1565</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Our appreciation of the physiol. functions of estrogens and the mechanisms through which estrogens bring about these functions has changed during the past decade.  Just as transgenic mice were produced in which estrogen receptors had been inactivated and we thought that we were about to understand the role of estrogen receptors in physiol. and pathol., it was found that there was not 1 but 2 distinct and functional estrogen receptors, now called ERα and ERβ.  Transgenic mice in which each of the receptors or both the receptors are inactive have revealed a much broader role for estrogens in the body than was previously thought.  This decade also saw the description of a male patient who had no functional ERα and whose continued bone growth clearly revealed an important function of estrogen in men.  The importance of estrogen in both males and females was also demonstrated in the lab. in transgenic mice in which the aromatase gene was inactivated.  Finally, crystal structures of the estrogen receptors with agonists and antagonists have revealed much about how ligand binding influences receptor conformation and how this conformation influences interaction of the receptor with coactivators or corepressors and hence dets. cellular response to ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxK-vrJTSDErVg90H21EOLACvtfcHk0ljisBEPEGOiXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislCqtw%253D%253D&md5=e3c660fbdf99d1b456486caabef516c8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.4.1535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.4.1535%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DS.%26aulast%3DTreuter%26aufirst%3DE.%26aulast%3DTujague%26aufirst%3DM.%26aulast%3DThomsen%26aufirst%3DJ.%26aulast%3DAndersson%26aufirst%3DG.%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DPettersson%26aufirst%3DK.%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26atitle%3DMechanisms%2520of%2520Estrogen%2520Action%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D1535%26epage%3D1565%26doi%3D10.1152%2Fphysrev.2001.81.4.1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heldring, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tujague, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ström, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treuter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptors: How Do They Signal and What Are Their Targets</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">931</span>, <span class="refDoi"> DOI: 10.1152/physrev.00026.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1152%2Fphysrev.00026.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=17615392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFGls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2007&pages=905-931&author=N.+Heldringauthor=A.+Pikeauthor=S.+Anderssonauthor=J.+Matthewsauthor=G.+Chengauthor=J.+Hartmanauthor=M.+Tujagueauthor=A.+Str%C3%B6mauthor=E.+Treuterauthor=M.+Warnerauthor=J.-%C3%85.+Gustafsson&title=Estrogen+Receptors%3A+How+Do+They+Signal+and+What+Are+Their+Targets&doi=10.1152%2Fphysrev.00026.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptors: how do they signal and what are their targets</span></div><div class="casAuthors">Heldring, Nina; Pike, Ashley; Andersson, Sandra; Matthews, Jason; Cheng, Guojun; Hartman, Johan; Tujague, Michel; Stroem, Anders; Treuter, Eckardt; Warner, Margaret; Gustafsson, Jan-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">905-931</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  During the past decade there has been a substantial advance in our understanding of estrogen signaling both from a clin. as well as a preclin. perspective.  Estrogen signaling is a balance between two opposing forces in the form of two distinct receptors (ERα and ERβ) and their splice variants.  The prospect that these two pathways can be selectively stimulated or inhibited with subtype-selective drugs constitutes new and promising therapeutic opportunities in clin. areas as diverse as hormone replacement, autoimmune diseases, prostate and breast cancer, and depression.  Mol. biol., biochem., and structural studies have generated information which is invaluable for the development of more selective and effective ER ligands.  We have also become aware that ERs do not function by themselves but require a no. of coregulatory proteins whose cell-specific expression explains some of the distinct cellular actions of estrogen.  Estrogen is an important morphogen, and many of its proliferative effects on the epithelial compartment of glands are mediated by growth factors secreted from the stromal compartment.  Thus understanding the cross-talk between growth factor and estrogen signaling is essential for understanding both normal and malignant growth.  In this review we focus on several of the interesting recent discoveries concerning estrogen receptors, on estrogen as a morphogen, and on the mol. mechanisms of anti-estrogen signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXhRpQBWMSFbVg90H21EOLACvtfcHk0ljisBEPEGOiXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFGls7k%253D&md5=207d16fa37d6b14483b9fe1002ce2646</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00026.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00026.2006%26sid%3Dliteratum%253Aachs%26aulast%3DHeldring%26aufirst%3DN.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DAndersson%26aufirst%3DS.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DHartman%26aufirst%3DJ.%26aulast%3DTujague%26aufirst%3DM.%26aulast%3DStr%25C3%25B6m%26aufirst%3DA.%26aulast%3DTreuter%26aufirst%3DE.%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26atitle%3DEstrogen%2520Receptors%253A%2520How%2520Do%2520They%2520Signal%2520and%2520What%2520Are%2520Their%2520Targets%26jtitle%3DPhysiol.%2520Rev.%26date%3D2007%26volume%3D87%26spage%3D905%26epage%3D931%26doi%3D10.1152%2Fphysrev.00026.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmeci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ring, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigel, R. J.</span></span> <span> </span><span class="NLM_article-title">Identification of a Gene (GPR30) with Homology to the G-Protein-Coupled Receptor Superfamily Associated with Estrogen Receptor Expression in Breast Cancer</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">607</span>– <span class="NLM_lpage">617</span>, <span class="refDoi"> DOI: 10.1006/geno.1997.4972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1006%2Fgeno.1997.4972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=9367686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2sXnsVejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1997&pages=607-617&author=C.+Carmeciauthor=D.+A.+Thompsonauthor=H.+Z.+Ringauthor=U.+Franckeauthor=R.+J.+Weigel&title=Identification+of+a+Gene+%28GPR30%29+with+Homology+to+the+G-Protein-Coupled+Receptor+Superfamily+Associated+with+Estrogen+Receptor+Expression+in+Breast+Cancer&doi=10.1006%2Fgeno.1997.4972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer</span></div><div class="casAuthors">Carmeci, Charles; Thompson, Devon A.; Ring, Huijun Z.; Francke, Uta; Weigel, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">607-617</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Using the technique of differential cDNA library screening, a cDNA clone was isolated from an estrogen receptor (ER)-pos. breast carcinoma cell line (MCF7) cDNA library based upon the overexpression of this gene compared to an ER-neg. cell line (MDA-MB-231).  Sequence anal. of this clone detd. that it shared significant homol. to G-protein-coupled receptors.  This receptor, GPCR-Br, was abundantly expressed in the ER-pos. breast carcinoma cell lines MCF7, T-47D, and MDA-MB-361.  Expression was absent or minimal in the ER-neg. breast carcinoma cell lines BT-20, MDA-MB-231, and HBL-100.  GPCR-Br was ubiquitously expressed in human tissues examd. but was most abundant in placenta.  GPCR-Br expression was examd. in 11 primary breast carcinomas.  GPCR-Br was detected in all 4 ER-pos. tumors and only 1 of 7 ER-neg. tumors.  Based upon PCR anal. in hybrid cell lines, the gene for GPCR-Br (HGMW-approved symbol GPR30) was mapped to chromosome 7p22.  The pattern of expression of GPCR-Br indicates that this receptor may be involved in physiol. responses specific to hormonally responsive tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQz06vdDuObVg90H21EOLACvtfcHk0litAQ0rkrZ8zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsVejsbo%253D&md5=831bb2d172786fe61c914e8e851d0735</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1997.4972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1997.4972%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeci%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DRing%26aufirst%3DH.%2BZ.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DWeigel%26aufirst%3DR.%2BJ.%26atitle%3DIdentification%2520of%2520a%2520Gene%2520%2528GPR30%2529%2520with%2520Homology%2520to%2520the%2520G-Protein-Coupled%2520Receptor%2520Superfamily%2520Associated%2520with%2520Estrogen%2520Receptor%2520Expression%2520in%2520Breast%2520Cancer%26jtitle%3DGenomics%26date%3D1997%26volume%3D45%26spage%3D607%26epage%3D617%26doi%3D10.1006%2Fgeno.1997.4972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Revankar, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimino, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sklar, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arterburn, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prossnitz, E. R.</span></span> <span> </span><span class="NLM_article-title">A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">1625</span>– <span class="NLM_lpage">1630</span>, <span class="refDoi"> DOI: 10.1126/science.1106943</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1126%2Fscience.1106943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=15705806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitV2is7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=1625-1630&author=C.+M.+Revankarauthor=D.+F.+Ciminoauthor=L.+A.+Sklarauthor=J.+B.+Arterburnauthor=E.+R.+Prossnitz&title=A+Transmembrane+Intracellular+Estrogen+Receptor+Mediates+Rapid+Cell+Signaling&doi=10.1126%2Fscience.1106943"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling</span></div><div class="casAuthors">Revankar, Chetana M.; Cimino, Daniel F.; Sklar, Larry A.; Arterburn, Jeffrey B.; Prossnitz, Eric R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5715</span>),
    <span class="NLM_cas:pages">1625-1630</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The steroid hormone estrogen regulates many functionally unrelated processes in numerous tissues.  Although it is traditionally thought to control transcriptional activation through the classical nuclear estrogen receptors, it also initiates many rapid nongenomic signaling events.  We found that of all G protein-coupled receptors characterized to date, GPR30 is uniquely localized to the endoplasmic reticulum, where it specifically binds estrogen and fluorescent estrogen derivs.  Activating GPR30 by estrogen resulted in intracellular calcium mobilization and synthesis of phosphatidylinositol 3,4,5-trisphosphate in the nucleus.  Thus, GPR30 represents an intracellular transmembrane estrogen receptor that may contribute to normal estrogen physiol. as well as pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtnK3fSsNsrLVg90H21EOLACvtfcHk0litAQ0rkrZ8zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitV2is7c%253D&md5=938d5a0422146eac0ace28da892d82ef</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106943%26sid%3Dliteratum%253Aachs%26aulast%3DRevankar%26aufirst%3DC.%2BM.%26aulast%3DCimino%26aufirst%3DD.%2BF.%26aulast%3DSklar%26aufirst%3DL.%2BA.%26aulast%3DArterburn%26aufirst%3DJ.%2BB.%26aulast%3DProssnitz%26aufirst%3DE.%2BR.%26atitle%3DA%2520Transmembrane%2520Intracellular%2520Estrogen%2520Receptor%2520Mediates%2520Rapid%2520Cell%2520Signaling%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D1625%26epage%3D1630%26doi%3D10.1126%2Fscience.1106943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, G. G. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandien, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häggblad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">863</span>– <span class="NLM_lpage">870</span>, <span class="refDoi"> DOI: 10.1210/endo.138.3.4979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fendo.138.3.4979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=9048584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2sXht1OksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1997&pages=863-870&author=G.+G.+J.+M.+Kuiperauthor=B.+Carlssonauthor=K.+Grandienauthor=E.+Enmarkauthor=J.+H%C3%A4ggbladauthor=S.+Nilssonauthor=J.-%C3%85.+Gustafsson&title=Comparison+of+the+Ligand+Binding+Specificity+and+Transcript+Tissue+Distribution+of+Estrogen+Receptors+%CE%B1+and+%CE%B2&doi=10.1210%2Fendo.138.3.4979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β</span></div><div class="casAuthors">Kuiper, George G. J. M.; Carlsson, Bo; Grandien, Kaj; Enmark, Eva; Haeggblad, Johan; Nilsson, Stefan; Gustafsson, Jan-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">863-870</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The rat estrogen receptor (ER) exists as two subtypes, ERα and ERβ, which differ in the C-terminal ligand-binding domain and in the N-terminal transactivation domain.  In this study we investigated the mRNA expression of both ER subtypes in rat tissues by RT-PCR and compared the ligand binding specificity of the ER subtypes.  Satn. ligand binding anal. of in vitro synthesized human ERα and rat ERβ protein revealed a single binding component for 16α-iodo-17β-estradiol with high affinity [dissocn. const. (Kd) = 0.1 nM for ERα protein and 0.4 nM for ERβ protein].  Most estrogenic substrates or estrogenic antagonists compete with 16α-[125I]iodo-17β-estradiol for binding to both ER subtypes in a very similar preference and degree; i.e., diethylstilbestrol > hexestrol > dienestrol > 4-OH-tamoxifen > 17β-estradiol > coumestrol, ICI-164384 > estrone, 17α-estradiol > nafoxidine, moxestrol > clomifene > estriol, 4-OH-estradiol > tamoxifen, 2-OH-estradiol, 5-androstene-3β-17β-diol, genistein for the ERα protein and dienestrol > 4-OH-tamoxifen > diethylstilbestrol > hexestrol > coumestrol, ICI-164384 > 17β-estradiol > estrone, genistein > estriol > nafoxidine, 5-androstene-3β,17β-diol > 17α-estradiol, clomifene, 2-OH-estradiol > 4-OH-estradiol, tamoxifen, moxestrol for the ERβ protein.  The rat tissue distribution and/or the relative level of ERα and ERβ expression seems to be quite different, i.e. moderate to high expression in uterus, testis, pituitary, ovary, kidney, epididymis, and adrenal for ERα and prostate, ovary, lung, bladder, brain, uterus, and testis for ERβ.  The described differences between the ER subtypes in relative ligand binding affinity and tissue distribution could contribute to the selective action of ER agonists and antagonists in different tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRnITtxbrCBLVg90H21EOLACvtfcHk0litAQ0rkrZ8zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXht1OksrY%253D&md5=bb4d88e7ba9c878a79c711b3b0a5f92f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1210%2Fendo.138.3.4979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo.138.3.4979%26sid%3Dliteratum%253Aachs%26aulast%3DKuiper%26aufirst%3DG.%2BG.%2BJ.%2BM.%26aulast%3DCarlsson%26aufirst%3DB.%26aulast%3DGrandien%26aufirst%3DK.%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DH%25C3%25A4ggblad%26aufirst%3DJ.%26aulast%3DNilsson%26aufirst%3DS.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26atitle%3DComparison%2520of%2520the%2520Ligand%2520Binding%2520Specificity%2520and%2520Transcript%2520Tissue%2520Distribution%2520of%2520Estrogen%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B2%26jtitle%3DEndocrinology%26date%3D1997%26volume%3D138%26spage%3D863%26epage%3D870%26doi%3D10.1210%2Fendo.138.3.4979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, K. J.</span>; <span class="NLM_string-name">Hewitt, S. C.</span>; <span class="NLM_string-name">Arao, Y.</span>; <span class="NLM_string-name">Korach, K. S.</span></span> <span> </span><span class="NLM_article-title">Estrogen Hormone Biology</span>. In  <i>Current Topics in Developmental Biology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, D.</span>; <span class="NLM_string-name">Tsai, S.</span></span>, Eds.; <span class="NLM_series">Nuclear Receptors in Development and Disease</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_year">2017</span>; Chapter 4; Vol.  <span class="NLM_volume">125</span>, pp  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">146</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fbs.ctdb.2016.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=109-146&author=K.+J.+Hamilton&author=S.+C.+Hewitt&author=Y.+Arao&author=K.+S.+Korachauthor=D.+Forrest&author=S.+Tsai&title=Current+Topics+in+Developmental+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fbs.ctdb.2016.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fbs.ctdb.2016.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DK.%2BJ.%26atitle%3DEstrogen%2520Hormone%2520Biology%26btitle%3DCurrent%2520Topics%2520in%2520Developmental%2520Biology%26aulast%3DForrest%26aufirst%3DD.%26pub%3DAcademic%2520Press%26date%3D2017%26volume%3D125%26spage%3D109%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budish, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, S. H.</span></span> <span> </span><span class="NLM_article-title">GPER–Novel Membrane Oestrogen Receptor</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">1005</span>– <span class="NLM_lpage">1016</span>, <span class="refDoi"> DOI: 10.1042/CS20160114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1042%2FCS20160114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC28XotVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2016&pages=1005-1016&author=M.+A.+Zimmermanauthor=R.+A.+Budishauthor=S.+Kashyapauthor=S.+H.+Lindsey&title=GPER%E2%80%93Novel+Membrane+Oestrogen+Receptor&doi=10.1042%2FCS20160114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">GPER-novel membrane estrogen receptor</span></div><div class="casAuthors">Zimmerman, Margaret A.; Budish, Rebecca A.; Kashyap, Shreya; Lindsey, Sarah H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1005-1016</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The recent discovery of the G protein-coupled estrogen receptor (GPER) presents new challenges and opportunities for understanding the physiol., pathophysiol. and pharmacol. of many diseases.  This review will focus on the expression and function of GPER in hypertension, kidney disease, atherosclerosis, vascular remodelling, heart failure, reprodn., metabolic disorders, cancer, environmental health and menopause.  Furthermore, this review will highlight the potential of GPER as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGtirrMoyBjrVg90H21EOLACvtfcHk0lhQdKWqmCBf5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotVSrsLs%253D&md5=7404f65583d895b9ccc19505eb9a858b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1042%2FCS20160114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20160114%26sid%3Dliteratum%253Aachs%26aulast%3DZimmerman%26aufirst%3DM.%2BA.%26aulast%3DBudish%26aufirst%3DR.%2BA.%26aulast%3DKashyap%26aufirst%3DS.%26aulast%3DLindsey%26aufirst%3DS.%2BH.%26atitle%3DGPER%25E2%2580%2593Novel%2520Membrane%2520Oestrogen%2520Receptor%26jtitle%3DClin.%2520Sci.%26date%3D2016%26volume%3D130%26spage%3D1005%26epage%3D1016%26doi%3D10.1042%2FCS20160114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mäkelä, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savolainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aavik, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myllärniemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taskinen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häyry, P.</span></span> <span> </span><span class="NLM_article-title">Differentiation between Vasculoprotective and Uterotrophic Effects of Ligands with Different Binding Affinities to Estrogen Receptors α and β</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">7077</span>– <span class="NLM_lpage">7082</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.12.7077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.96.12.7077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10359841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXks1WktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=7077-7082&author=S.+M%C3%A4kel%C3%A4author=H.+Savolainenauthor=E.+Aavikauthor=M.+Myll%C3%A4rniemiauthor=L.+Straussauthor=E.+Taskinenauthor=J.-%C3%85.+Gustafssonauthor=P.+H%C3%A4yry&title=Differentiation+between+Vasculoprotective+and+Uterotrophic+Effects+of+Ligands+with+Different+Binding+Affinities+to+Estrogen+Receptors+%CE%B1+and+%CE%B2&doi=10.1073%2Fpnas.96.12.7077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β</span></div><div class="casAuthors">Makela, Sari; Savolainen, Hanna; Aavik, Einari; Myllarniemi, Marjukka; Strauss, Leena; Taskinen, Eero; Gustafsson, Jan-Ake; Hayry, Pekka</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7077-7082</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Estrogen-based drug therapy in cardiovascular diseases has been difficult because it has not been possible to sep. the wanted vasculoprotective effect from the unwanted effects of the hormone to the reproductive system.  Here we demonstrate that, after endothelial denudation of rat carotid artery, the mRNA of the classical estrogen receptor (ER) is constitutively expressed at a low level, whereas the expression of the novel ER mRNA increases >40-fold.  Under in situ hybridization and immunohistochem., ERβ mRNA and protein colocalize with the smooth muscle cells in the media and neointima.  Treatment of ovariectomized female rats with the isoflavone phytoestrogen genistein, which shows 20-fold higher binding affinity to ERβ than to ERα, or with 17β-estradiol, which does not differentiate between the two receptors, provides similar dose-dependent vasculoprotective effect in rat carotid injury model.  In addn. in concn. <10 μM, both ligands are equally inhibitory to the replication and migration of smooth muscle cells in vitro.  However, only treatment with 17β-estradiol, but not with genistein, is accompanied with a dose-dependent uterotrophic effect.  The results suggest that preferential targeting to ERβ will provide vasculoprotective estrogen analogs devoid of effects to the reproductive system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpaaiArl5LrVg90H21EOLACvtfcHk0lhQdKWqmCBf5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXks1WktbY%253D&md5=eac9076dd6e164de1216e54059d9782c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.12.7077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.12.7077%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DS.%26aulast%3DSavolainen%26aufirst%3DH.%26aulast%3DAavik%26aufirst%3DE.%26aulast%3DMyll%25C3%25A4rniemi%26aufirst%3DM.%26aulast%3DStrauss%26aufirst%3DL.%26aulast%3DTaskinen%26aufirst%3DE.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26aulast%3DH%25C3%25A4yry%26aufirst%3DP.%26atitle%3DDifferentiation%2520between%2520Vasculoprotective%2520and%2520Uterotrophic%2520Effects%2520of%2520Ligands%2520with%2520Different%2520Binding%2520Affinities%2520to%2520Estrogen%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D7077%26epage%3D7082%26doi%3D10.1073%2Fpnas.96.12.7077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filardo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span> <span> </span><span class="NLM_article-title">Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">624</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1210/en.2004-1064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fen.2004-1064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=15539556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotlWitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=624-632&author=P.+Thomasauthor=Y.+Pangauthor=E.+J.+Filardoauthor=J.+Dong&title=Identity+of+an+Estrogen+Membrane+Receptor+Coupled+to+a+G+Protein+in+Human+Breast+Cancer+Cells&doi=10.1210%2Fen.2004-1064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells</span></div><div class="casAuthors">Thomas, P.; Pang, Y.; Filardo, E. J.; Dong, J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">624-632</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Although nonclassical estrogen actions initiated at the cell surface have been described in many tissues, the identities of the membrane estrogen receptors (mERs) mediating these actions remain unclear.  Here we show that GPR30, an orphan receptor unrelated to nuclear estrogen receptors, has all the binding and signaling characteristics of a mER.  A high-affinity (dissocn. const. 2.7 nM), limited capacity, displaceable, single binding site specific for estrogens was detected in plasma membranes of SKBR3 breast cancer cells that express GPR30 but lack nuclear estrogen receptors.  Progesterone-induced increases and small interfering RNA-induced decreases in GPR30 expression in SKBR3 cells were accompanied by parallel changes in specific estradiol-17β (E2) binding.  Plasma membranes of human embryonic kidney 293 cells transfected with GPR30, but not those of untransfected cells, and human placental tissues that express GPR30 also displayed high-affinity, specific estrogen binding typical of mERs.  E2 treatment of transfected cell membranes caused activation of a stimulatory G protein that is directly coupled to the receptor, indicating GPR30 is a G protein-coupled receptor (GPCR), and also increased adenylyl cyclase activity.  The finding that the antiestrogens tamoxifen and ICI 182,780, and an environmental estrogen, ortho, para-dichlorodiphenyl-dichloroethylene (o,p'-DDE), have high binding affinities to the receptor and mimic the actions of E2 has important implications for both the development and treatment of estrogen-dependent breast cancer.  GPR30 is structurally unrelated to the recently discovered family of GPCR-like membrane progestin receptors.  The identification of a second distinct class of GPCR-like steroid membrane receptors suggests a widespread role for GPCRs in nonclassical steroid hormone actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5L9Qo-2sS4rVg90H21EOLACvtfcHk0lhQdKWqmCBf5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotlWitw%253D%253D&md5=6870880ddbd84da144dc18d929707bcd</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1210%2Fen.2004-1064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2004-1064%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DP.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DFilardo%26aufirst%3DE.%2BJ.%26aulast%3DDong%26aufirst%3DJ.%26atitle%3DIdentity%2520of%2520an%2520Estrogen%2520Membrane%2520Receptor%2520Coupled%2520to%2520a%2520G%2520Protein%2520in%2520Human%2520Breast%2520Cancer%2520Cells%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26spage%3D624%26epage%3D632%26doi%3D10.1210%2Fen.2004-1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lubahn, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golding, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couse, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korach, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smithies, O.</span></span> <span> </span><span class="NLM_article-title">Alteration of Reproductive Function but Not Prenatal Sexual Development after Insertional Disruption of the Mouse Estrogen Receptor Gene</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">11162</span>– <span class="NLM_lpage">11166</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.23.11162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.90.23.11162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=8248223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2cXks1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=11162-11166&author=D.+B.+Lubahnauthor=J.+S.+Moyerauthor=T.+S.+Goldingauthor=J.+F.+Couseauthor=K.+S.+Korachauthor=O.+Smithies&title=Alteration+of+Reproductive+Function+but+Not+Prenatal+Sexual+Development+after+Insertional+Disruption+of+the+Mouse+Estrogen+Receptor+Gene&doi=10.1073%2Fpnas.90.23.11162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene</span></div><div class="casAuthors">Lubahn, Dennis B.; Moyer, Jeffrey S.; Golding, Thomas S.; Couse, John F.; Korach, Kenneth S.; Smithies, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11162-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Estrogen receptor and its ligand, estradiol, have long been thought to be essential for survival, fertility, and female sexual differentiation and development.  Consistent with this proposed crucial role, no human estrogen receptor gene mutations are known, unlike the androgen receptor, where many loss of function mutations have been found.  The authors have generated mutant mice lacking responsiveness to estradiol by disrupting the estrogen receptor gene by gene targeting.  Both male and female animals survive to adulthood with normal gross external phenotypes.  Females are infertile; males have a decreased fertility.  Females have hypoplastic uteri and hyperemic ovaries with no detectable corpora lutea.  In adult wild-type and heterozygous females, 3-day estradiol treatment at 40 μg/kg stimulates a 3- to 4-fold increase in uterine wet wt. and alters vaginal cornification, but the uteri and vagina do not respond in the animals with the estrogen receptor gene disruption.  Prenatal male and female reproductive tract development can therefore occur in the absence of estradiol receptor-mediated responsiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhRWAK7AJWFLVg90H21EOLACvtfcHk0lj-oxcNqD_fVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXks1ajsw%253D%253D&md5=bde5d2b52c3e2fda7c834175b3e61ca0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.23.11162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.23.11162%26sid%3Dliteratum%253Aachs%26aulast%3DLubahn%26aufirst%3DD.%2BB.%26aulast%3DMoyer%26aufirst%3DJ.%2BS.%26aulast%3DGolding%26aufirst%3DT.%2BS.%26aulast%3DCouse%26aufirst%3DJ.%2BF.%26aulast%3DKorach%26aufirst%3DK.%2BS.%26aulast%3DSmithies%26aufirst%3DO.%26atitle%3DAlteration%2520of%2520Reproductive%2520Function%2520but%2520Not%2520Prenatal%2520Sexual%2520Development%2520after%2520Insertional%2520Disruption%2520of%2520the%2520Mouse%2520Estrogen%2520Receptor%2520Gene%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D11162%26epage%3D11166%26doi%3D10.1073%2Fpnas.90.23.11162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krege, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgin, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couse, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahler, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korach, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smithies, O.</span></span> <span> </span><span class="NLM_article-title">Generation and Reproductive Phenotypes of Mice Lacking Estrogen Receptor β</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">15677</span>– <span class="NLM_lpage">15682</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.26.15677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.95.26.15677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=9861029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15677-15682&author=J.+H.+Kregeauthor=J.+B.+Hodginauthor=J.+F.+Couseauthor=E.+Enmarkauthor=M.+Warnerauthor=J.+F.+Mahlerauthor=M.+Sarauthor=K.+S.+Korachauthor=J.-%C3%85.+Gustafssonauthor=O.+Smithies&title=Generation+and+Reproductive+Phenotypes+of+Mice+Lacking+Estrogen+Receptor+%CE%B2&doi=10.1073%2Fpnas.95.26.15677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Generation and reproductive phenotypes of mice lacking estrogen receptor β</span></div><div class="casAuthors">Krege, John H.; Hodgin, Jeffrey B.; Couse, John F.; Enmark, Eva; Warner, Margaret; Mahler, Joel F.; Sar, Madhabananda; Korach, Kenneth S.; Gustafsson, Jan-Ake; Smithies, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15677-15682</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Estrogens influence the differentiation and maintenance of reproductive tissues and affect lipid metab. and bone remodeling.  Two estrogen receptors (ERs) have been identified to date, ERα and ERβ.  The authors previously generated and studied knockout mice lacking estrogen receptor α and reported severe reproductive and behavioral phenotypes including complete infertility of both male and female mice and absence of breast tissue development.  Here, the authors describe the generation of mice lacking estrogen receptor β (ERβ -/-) by insertion of a neomycin-resistance gene into exon 3 of the coding gene by using homologous recombination in embryonic stem cells.  Mice lacking this receptor develop normally and are indistinguishable grossly and histol. as young adults from their littermates.  RNA anal. and immunocytochem. show that tissues from ERβ -/- mice lack normal ERβ RNA and protein.  Breeding expts. with young, sexually mature females show that they are fertile and exhibit normal sexual behavior, but have fewer and smaller litters than wild-type mice.  Superovulation expts. indicate that this redn. in fertility is the result of reduced ovarian efficiency.  The mutant females have normal breast development and lactate normally.  Young, sexually mature male mice show no overt abnormalities and reproduce normally.  Older mutant males display signs of prostate and bladder hyperplasia.  Thus, ERβ is essential for normal ovulation efficiency but is not essential for female or male sexual differentiation, fertility, or lactation.  Future expts. are required to det. the role of ERβ in bone and cardiovascular homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUdPlJH7MDrVg90H21EOLACvtfcHk0lj-oxcNqD_fVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeiuw%253D%253D&md5=50cc5538ab791d52f280959e296d0e8d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15677%26sid%3Dliteratum%253Aachs%26aulast%3DKrege%26aufirst%3DJ.%2BH.%26aulast%3DHodgin%26aufirst%3DJ.%2BB.%26aulast%3DCouse%26aufirst%3DJ.%2BF.%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DMahler%26aufirst%3DJ.%2BF.%26aulast%3DSar%26aufirst%3DM.%26aulast%3DKorach%26aufirst%3DK.%2BS.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26aulast%3DSmithies%26aufirst%3DO.%26atitle%3DGeneration%2520and%2520Reproductive%2520Phenotypes%2520of%2520Mice%2520Lacking%2520Estrogen%2520Receptor%2520%25CE%25B2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D15677%26epage%3D15682%26doi%3D10.1073%2Fpnas.95.26.15677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prossnitz, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hathaway, H. J.</span></span> <span> </span><span class="NLM_article-title">What Have We Learned about GPER Function in Physiology and Disease from Knockout Mice?</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.jsbmb.2015.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.jsbmb.2015.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=26189910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1CkurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2015&pages=114-126&author=E.+R.+Prossnitzauthor=H.+J.+Hathaway&title=What+Have+We+Learned+about+GPER+Function+in+Physiology+and+Disease+from+Knockout+Mice%3F&doi=10.1016%2Fj.jsbmb.2015.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">What have we learned about GPER function in physiology and disease from knockout mice?</span></div><div class="casAuthors">Prossnitz, Eric R.; Hathaway, Helen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-126</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Estrogens, predominantly 17β-estradiol, exert diverse effects throughout the body in both normal and pathophysiol., during development and in reproductive, metabolic, endocrine, cardiovascular, nervous, musculoskeletal and immune systems.  Estrogen and its receptors also play important roles in carcinogenesis and therapy, particularly for breast cancer.  In addn. to the classical nuclear estrogen receptors (ERα and ERβ) that traditionally mediate predominantly genomic signaling, the G protein-coupled estrogen receptor GPER has become recognized as a crit. mediator of rapid signaling in response to estrogen.  Mouse models, and in particular knockout (KO) mice, represent an important approach to understand the functions of receptors in normal physiol. and disease.  Whereas ERα KO mice display multiple significant defects in reprodn. and mammary gland development, ERβ KO phenotypes are more limited, and GPER KO exhibit no reproductive deficits.  However, the study of GPER KO mice over the last six years has revealed that GPER deficiency results in multiple physiol. alterations including obesity, cardiovascular dysfunction, insulin resistance and glucose intolerance.  In addn., the lack of estrogen-mediated effects in numerous tissues of GPER KO mice, studied in vivo or ex vivo, including those of the cardiovascular, endocrine, nervous and immune systems, reveals GPER as a genuine mediator of estrogen action.  Importantly, GPER KO mice have also demonstrated roles for GPER in breast carcinogenesis and metastasis.  In combination with the supporting effects of GPER-selective ligands and GPER knockdown approaches, GPER KO mice demonstrate the therapeutic potential of targeting GPER activity in diseases as diverse as obesity, diabetes, multiple sclerosis, hypertension, atherosclerosis, myocardial infarction, stroke and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXPmJ2K7SChLVg90H21EOLACvtfcHk0lj-oxcNqD_fVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1CkurnN&md5=76ffa0a4124d62506b9add2f0459dd32</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2015.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2015.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DProssnitz%26aufirst%3DE.%2BR.%26aulast%3DHathaway%26aufirst%3DH.%2BJ.%26atitle%3DWhat%2520Have%2520We%2520Learned%2520about%2520GPER%2520Function%2520in%2520Physiology%2520and%2520Disease%2520from%2520Knockout%2520Mice%253F%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D153%26spage%3D114%26epage%3D126%26doi%3D10.1016%2Fj.jsbmb.2015.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. A.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor-β: Recent Lessons from in Vivo Studies</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1210/me.2005-0459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fme.2005-0459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=16556737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=1-13&author=H.+A.+Harris&title=Estrogen+Receptor-%CE%B2%3A+Recent+Lessons+from+in+Vivo+Studies&doi=10.1210%2Fme.2005-0459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor-β: recent lessons from in vivo studies</span></div><div class="casAuthors">Harris, Heather A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The unexpected discovery of a second form of the estrogen receptor (ER), designated ERβ, surprised and energized the field of estrogen research.  In the 9 yr since its identification, the remarkable efforts from academic and industrial scientists of many disciplines have made significant progress in elucidating its biol.  A powerful battery of tools, including knockout mice as well as a panel of receptor-selective agonists, has allowed an investigation into the role of ERβ.  To date, in vivo efficacy studies are limited to rodents.  Current data indicate that ERβ plays a minor role in mediating estrogen action in the uterus, on the hypothalamus/pituitary, the skeleton, and other classic estrogen target tissues.  However, a clear role for ERβ has been established in the ovary, cardiovascular system, and brain as well as in several animal models of inflammation including arthritis, endometriosis, inflammatory bowel disease, and sepsis.  The next phase of research will focus on elucidating, at a mol. level, how ERβ exerts these diverse effects and exploring the clin. utility of ERβ-selective agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-mcaoNu5iELVg90H21EOLACvtfcHk0lhqMm0DhpZuQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFOnsw%253D%253D&md5=f55e31161a74e96fa82518f7aac9e62f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1210%2Fme.2005-0459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2005-0459%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DH.%2BA.%26atitle%3DEstrogen%2520Receptor-%25CE%25B2%253A%2520Recent%2520Lessons%2520from%2520in%2520Vivo%2520Studies%26jtitle%3DMol.%2520Endocrinol.%26date%3D2007%26volume%3D21%26spage%3D1%26epage%3D13%26doi%3D10.1210%2Fme.2005-0459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanholi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nalvarte, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-A.</span></span> <span> </span><span class="NLM_article-title">Ventral Prostate and Mammary Gland Phenotype in Mice with Complete Deletion of the ERβ Gene</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">4902</span>– <span class="NLM_lpage">4909</span>, <span class="refDoi"> DOI: 10.1073/pnas.1920478117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1073%2Fpnas.1920478117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=32075916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVSrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=4902-4909&author=M.+Warnerauthor=W.+Wuauthor=L.+Montanholiauthor=I.+Nalvarteauthor=P.+Antonsonauthor=J.-A.+Gustafsson&title=Ventral+Prostate+and+Mammary+Gland+Phenotype+in+Mice+with+Complete+Deletion+of+the+ER%CE%B2+Gene&doi=10.1073%2Fpnas.1920478117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ventral prostate and mammary gland phenotype in mice with complete deletion of the ERβ gene</span></div><div class="casAuthors">Warner, Margaret; Wu, Wan-fu; Montanholi, Leticia; Nalvarte, Ivan; Antonson, Per; Gustafsson, Jan-Ake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4902-4909</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Disagreements about the phenotype of estrogen receptor β; (ERβ) knockout mouse, created by removing the DNA-binding domain of the ERβ; gene or interruption of the gene with a neocassette (Oliver Smithies ERβ knockout mice [ERβOS-/-]), prompted us to create an ERβ knockout mouse by deleting the ERβ gene with the use of CRISPR/Cas9 technol.  We confirmed that the ERβ gene was eliminated from the mouse genome and that no ERβ mRNA or protein was detectable in tissues of this mouse.  Overall the phenotype of the ventral prostate (VP) and mammary gland (MG) in ERβcrispr-/- mice was similar to, but more severe than, that in the ERβOS-/-mice.  In the VP of 6-mo-old ERβcrispr-/- mice there was epithelial hyperplasia, fibroplasia, inflammation, stromal overgrowth, and intraductal cancer-like lesions.  This was accompanied by an increase in Ki67 and P63 and loss in DACH1 and PURα, two androgen receptor (AR) repressors.  In the MG there was overexpression of estrogen receptor α and progesterone receptor, loss of collagen, increase in proliferation and expression of metalloproteases, and invasive epithelium.  Surprisingly, by 18 mo of age, the no. of hyperplastic foci was reduced, the ducts of the VP and MG became atrophic, and, in the VP, there was massive immune infiltration and massive desquamation of the luminal epithelial cells.  These changes were coincident with reduced levels of androgens in males and estrogens in females.  We conclude that ERβ is a tumor suppressor gene in the VP and MG where its loss increases the activity AR and ERα resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjOOOU8IzUurVg90H21EOLACvtfcHk0lhqMm0DhpZuQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVSrur0%253D&md5=5b9cf899ca7c8779041f68a6164349d1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1920478117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1920478117%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DMontanholi%26aufirst%3DL.%26aulast%3DNalvarte%26aufirst%3DI.%26aulast%3DAntonson%26aufirst%3DP.%26aulast%3DGustafsson%26aufirst%3DJ.-A.%26atitle%3DVentral%2520Prostate%2520and%2520Mammary%2520Gland%2520Phenotype%2520in%2520Mice%2520with%2520Complete%2520Deletion%2520of%2520the%2520ER%25CE%25B2%2520Gene%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2020%26volume%3D117%26spage%3D4902%26epage%3D4909%26doi%3D10.1073%2Fpnas.1920478117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marriner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, J. A.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor-β Potency-Selective Ligands: Structure–Activity Relationship Studies of Diarylpropionitriles and Their Acetylene and Polar Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">4230</span>– <span class="NLM_lpage">4251</span>, <span class="refDoi"> DOI: 10.1021/jm010254a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010254a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFagsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4230-4251&author=M.+J.+Meyersauthor=J.+Sunauthor=K.+E.+Carlsonauthor=G.+A.+Marrinerauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogen&title=Estrogen+Receptor-%CE%B2+Potency-Selective+Ligands%3A+Structure%E2%80%93Activity+Relationship+Studies+of+Diarylpropionitriles+and+Their+Acetylene+and+Polar+Analogues&doi=10.1021%2Fjm010254a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen Receptor-β Potency-Selective Ligands: Structure-Activity Relationship Studies of Diarylpropionitriles and Their Acetylene and Polar Analogues</span></div><div class="casAuthors">Meyers, Marvin J.; Sun, Jun; Carlson, Kathryn E.; Marriner, Gwendolyn A.; Katzenellenbogen, Benita S.; Katzenellenbogen, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4230-4251</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through an effort to develop novel ligands that have subtype selectivity for the estrogen receptors alpha (ERα) and beta (ERβ), we have found that 2,3-bis(4-hydroxyphenyl)propionitrile (DPN) acts as an agonist on both ER subtypes, but has a 70-fold higher relative binding affinity and 170-fold higher relative potency in transcription assays with ERβ than with ERα.  To investigate the ERβ affinity- and potency-selective character of this DPN further, we prepd. a series of DPN analogs in which both the ligand core and the arom. rings were modified by the repositioning of phenolic hydroxy groups and by the addn. of alkyl substituents and nitrile groups.  We also prepd. other series of DPN analogs in which the nitrile functionality was replaced with acetylene groups or polar functions, to mimic the linear geometry or polarity of the nitrile, resp.  To varying degrees, all of the analogs show preferential binding affinity for ERβ (i.e., they are ERβ affinity-selective), and many, but not all of them, are also more potent in activating transcription through ERβ than through ERα (i.e., they are ERβ potency-selective). meso-2,3-Bis(4-hydroxyphenyl)succinonitrile and dl-2,3-bis(4-hydroxyphenyl)succinonitrile are among the highest ERβ affinity-selective ligands, and they have an ERβ potency selectivity that is equiv. to that of DPN.  The acetylene analogs have higher binding affinities but somewhat lower selectivities than their nitrile counterparts.  The polar analogs have lower affinities, and only the fluorinated polar analogs have substantial affinity selectivities.  This study suggests that, in this series of ligands, the nitrile functionality is crit. to ERβ selectivity because it provides the optimal combination of linear geometry and polarity. Furthermore, the addn. of a second nitrile group β to the nitrile in DPN or the addn. of a Me substituent at an ortho position on the β-arom. ring increases the affinity and selectivity of these compds. for ERβ.  These ERβ-selective compds. may prove to be valuable tools in understanding the differences in structure and biol. function of ERα and ERβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK5qpvnjw6mLVg90H21EOLACvtfcHk0lhqMm0DhpZuQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFagsr8%253D&md5=8fbf46c36aaf2ffcc9a8c44b15827bfe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm010254a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010254a%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DMarriner%26aufirst%3DG.%2BA.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DEstrogen%2520Receptor-%25CE%25B2%2520Potency-Selective%2520Ligands%253A%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520of%2520Diarylpropionitriles%2520and%2520Their%2520Acetylene%2520and%2520Polar%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4230%26epage%3D4251%26doi%3D10.1021%2Fjm010254a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coletta, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, J. A.</span></span> <span> </span><span class="NLM_article-title">Pyrazole Ligands: Structure–Affinity/Activity Relationships and Estrogen Receptor-α-Selective Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4934</span>– <span class="NLM_lpage">4947</span>, <span class="refDoi"> DOI: 10.1021/jm000170m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000170m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1yjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4934-4947&author=S.+R.+Staufferauthor=C.+J.+Colettaauthor=R.+Tedescoauthor=G.+Nishiguchiauthor=K.+Carlsonauthor=J.+Sunauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogen&title=Pyrazole+Ligands%3A+Structure%E2%80%93Affinity%2FActivity+Relationships+and+Estrogen+Receptor-%CE%B1-Selective+Agonists&doi=10.1021%2Fjm000170m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Ligands: Structure-Affinity/Activity Relationships and Estrogen Receptor-α-Selective Agonists</span></div><div class="casAuthors">Stauffer, Shaun R.; Coletta, Christopher J.; Tedesco, Rosanna; Nishiguchi, Gisele; Carlson, Kathryn; Sun, Jun; Katzenellenbogen, Benita S.; Katzenellenbogen, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4934-4947</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have found that certain tetrasubstituted pyrazoles are high-affinity ligands for the estrogen receptor (ER) and that one pyrazole is considerably more potent as an agonist on the ERα than on the ERβ subtype.  To investigate what substituent pattern provides optimal ER binding affinity and the greatest enhancement of potency as an ERα-selective agonist, we prepd. a no. of tetrasubstituted pyrazole analogs with defined variations at certain substituent positions.  Anal. of their binding affinity pattern shows that a C(4)-Pr substituent is optimal and that a p-hydroxyl group on the N(1)-Ph group also enhances affinity and selectivity for ERα.  The best compd. in this series, a propylpyrazole triol (I), binds to ERα with high affinity (ca. 50% that of estradiol), and it has a 410-fold binding affinity preference for ERα.  It also activates gene transcription only through ERα. Thus, this compd. represents the first ERα-specific agonist.  We investigated the mol. basis for the exceptional ERα binding affinity and potency selectivity of pyrazole I by a further study of structure-affinity relationships in this series and by mol. modeling.  These investigations suggest that the pyrazole triols prefer to bind to ERα with their C(3)-phenol in the estradiol A-ring binding pocket and that binding selectivity results from differences in the interaction of the pyrazole core and C(4)-Pr group with portions of the receptor where ERα has a smaller residue than ERβ.  These ER subtype-specific interactions and the ER subtype-selective ligands that can be derived from them should prove useful in defining those biol. activities in estrogen target cells that can be selectively activated through ERα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhsnWI9OqFlLVg90H21EOLACvtfcHk0liQT-fbIfwogA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1yjsbk%253D&md5=3bce249ad2d0eaf91aa4ad17ebffdd05</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm000170m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000170m%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DColetta%26aufirst%3DC.%2BJ.%26aulast%3DTedesco%26aufirst%3DR.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DCarlson%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DPyrazole%2520Ligands%253A%2520Structure%25E2%2580%2593Affinity%252FActivity%2520Relationships%2520and%2520Estrogen%2520Receptor-%25CE%25B1-Selective%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4934%26epage%3D4947%26doi%3D10.1021%2Fjm000170m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-A.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor β as a Pharmaceutical Target</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2016.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.tips.2016.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=27979317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKnu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=92-99&author=M.+Warnerauthor=B.+Huangauthor=J.-A.+Gustafsson&title=Estrogen+Receptor+%CE%B2+as+a+Pharmaceutical+Target&doi=10.1016%2Fj.tips.2016.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen Receptor β as a Pharmaceutical Target</span></div><div class="casAuthors">Warner, Margaret; Huang, Bo; Gustafsson, Jan-Ake</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-99</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A major issue in clin. endocrinol. today is how to use hormones to achieve the health benefits that they clearly can provide but avoid the neg. side effects, i.e., how to develop more precise medicines.  This problem of how to use hormones is pervasive in clin. endocrinol.  It is true for estrogen, progesterone, androgen, vitamin D, and thyroid hormone, and the problem is amplified in the case of new ligands for the more recently discovered nuclear receptors.  Selective targeting of hormone receptor subtypes is one attractive way to harness the beneficial effects of hormones while reducing unwanted side effects.  Here, we focus on estrogen receptor (ER)β, which has promise as a selective target in hormone replacement therapy, and in breast and prostate cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGhx9LQhVTbbVg90H21EOLACvtfcHk0liQT-fbIfwogA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKnu7jM&md5=976f8a25342bba055e9ba332c84f7ff2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2016.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2016.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DGustafsson%26aufirst%3DJ.-A.%26atitle%3DEstrogen%2520Receptor%2520%25CE%25B2%2520as%2520a%2520Pharmaceutical%2520Target%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26spage%3D92%26epage%3D99%26doi%3D10.1016%2Fj.tips.2016.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enmark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-Å.</span></span> <span> </span><span class="NLM_article-title">Oestrogen Receptors – an Overview</span>. <i>J. Intern. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>246</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">138</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2796.1999.00545.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1046%2Fj.1365-2796.1999.00545.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10447781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlCmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=1999&pages=133-138&author=E.+Enmarkauthor=J.-%C3%85.+Gustafsson&title=Oestrogen+Receptors+%E2%80%93+an+Overview&doi=10.1046%2Fj.1365-2796.1999.00545.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Oestrogen receptors - an overview</span></div><div class="casAuthors">Enmark, E.; Gustafsson, J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Internal Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-138</span>CODEN:
                <span class="NLM_cas:coden">JINMEO</span>;
        ISSN:<span class="NLM_cas:issn">0954-6820</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 29 refs.  The estrogen receptor (ER) is a ligand-activated transcription factor that mediates the effects of the steroid hormone 17β-estradiol in both males and females.  Since the isolation and cloning of ER, the prevailing opinion has been that only one such receptor exists.  The finding of a second subtype of ER (ERβ) has caused considerable excitement and has forced endocrinologists to re-evaluate many aspects of the actions of estrogens.  In this article, the authors will try to summarize the current knowledge about the two estrogen receptor subtypes, with the emphasis on estrogen receptor β (ERβ), and to comment on the observations in mice lacking either receptor or the hormone itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpzEhOiQC5CLVg90H21EOLACvtfcHk0liQT-fbIfwogA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlCmtb8%253D&md5=731a0a091639714ccb2a4b8760eec5a6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2796.1999.00545.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2796.1999.00545.x%26sid%3Dliteratum%253Aachs%26aulast%3DEnmark%26aufirst%3DE.%26aulast%3DGustafsson%26aufirst%3DJ.-%25C3%2585.%26atitle%3DOestrogen%2520Receptors%2520%25E2%2580%2593%2520an%2520Overview%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D1999%26volume%3D246%26spage%3D133%26epage%3D138%26doi%3D10.1046%2Fj.1365-2796.1999.00545.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bapat, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonder, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frail, D. E.</span></span> <span> </span><span class="NLM_article-title">The Ligand Binding Profiles of Estrogen Receptors α and β Are Species Dependent</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1016/S0039-128X(01)00194-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2FS0039-128X%2801%2900194-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=11958794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD38XhslWgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=379-384&author=H.+A.+Harrisauthor=A.+R.+Bapatauthor=D.+S.+Gonderauthor=D.+E.+Frail&title=The+Ligand+Binding+Profiles+of+Estrogen+Receptors+%CE%B1+and+%CE%B2+Are+Species+Dependent&doi=10.1016%2FS0039-128X%2801%2900194-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The ligand binding profiles of estrogen receptors α and β are species dependent</span></div><div class="casAuthors">Harris, Heather A.; Bapat, Ashok R.; Gonder, Daniel S.; Frail, Donald E.</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Estrogens and selective estrogen receptor modulators are used for the treatment and prevention of conditions resulting from menopause.  Since estrogens exert their activity by binding to nuclear receptors, there is intense interest in developing new ligands for the two known estrogen receptor subtypes, ER-α and ER-β.  Characterization assays used to profile new estrogen receptor ligands often utilize receptors from different species, with the assumption that they behave identically.  To test this belief, we have profiled a no. of estrogens, other steroids, phytoestrogens and selective estrogen receptor modulators in a solid phase radioligand binding assay using recombinant protein for human, rat, and mouse ER-α and ER-β.  Certain compds. show species dependent binding preferences for ER-α or ER-β, leading to differences in receptor subtype selectivity.  The amino acids identified by crystallog. as lining the ligand binding cavity are the same among the three species, suggesting that as yet unidentified amino acids contribute to the structure of the binding site.  We conclude from this anal. that the ability of a compd. to selectively bind to a particular ER subtype can be species dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHFlegWTMkZbVg90H21EOLACvtfcHk0liQT-fbIfwogA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhslWgs7g%253D&md5=7d8abb8e1b0083d859b19556dcfa4355</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0039-128X%2801%2900194-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0039-128X%252801%252900194-5%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DH.%2BA.%26aulast%3DBapat%26aufirst%3DA.%2BR.%26aulast%3DGonder%26aufirst%3DD.%2BS.%26aulast%3DFrail%26aufirst%3DD.%2BE.%26atitle%3DThe%2520Ligand%2520Binding%2520Profiles%2520of%2520Estrogen%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B2%2520Are%2520Species%2520Dependent%26jtitle%3DSteroids%26date%3D2002%26volume%3D67%26spage%3D379%26epage%3D384%26doi%3D10.1016%2FS0039-128X%2801%2900194-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coss, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalton, J. T.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor β Selective Nonsteroidal Estrogens: Seeking Clinical Indications</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1517/13543771003657164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1517%2F13543771003657164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=20302450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslamu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=507-534&author=M.+L.+Mohlerauthor=R.+Narayananauthor=C.+C.+Cossauthor=K.+Huauthor=Y.+Heauthor=Z.+Wuauthor=S.-S.+Hongauthor=D.+J.+Hwangauthor=D.+D.+Millerauthor=J.+T.+Dalton&title=Estrogen+Receptor+%CE%B2+Selective+Nonsteroidal+Estrogens%3A+Seeking+Clinical+Indications&doi=10.1517%2F13543771003657164"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor β selective nonsteroidal estrogens: seeking clinical indications</span></div><div class="casAuthors">Mohler, Michael L.; Narayanan, Ramesh; Coss, Christopher C.; Hu, Kejiang; He, Yali; Wu, Zhongzhi; Hong, Seoung-Soo; Hwang, Dong Jin; Miller, Duane D.; Dalton, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-534</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Nonsteroidal estrogens have been known since the 1930s.  However, the relatively recent (1996) discovery of estrogen receptor subtype β (ERβ) suggested a possible paradigm shift away from SERM-like selectivity.  Selective ERβ agonism would potentially allow expansion of estrogenic targeting into new indications (discussed herein) currently precluded by the thrombogenic and hyperproliferative effects of nonselective estrogens.  Areas covered in this review: ERβ agonist design has been very successful.  Pharmacophores for ERβ selective nonsteroidal estrogens are generally diphenolic compds. that achieve an inter-phenolic distance and geometry similar to 17β-estradiol with few restraints on the nature of the element linking the phenols (or phenol mimetics).  The tremendously chemodiverse ERβ agonist patent literature is reviewed, segregating the agonists into structurally similar compds. based on their interphenolic linking elements.  What the reader will gain: A comprehensive understanding of the chemotype landscape of this field and an assessment of its maturation.  Take home message: Subtype selective ERβ agonist therapy seems very promising.  However, more clin. testing is needed to firmly establish its therapeutic potential.  At this point, ERβ is a promising target in search of an indication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQEw4HgBz_E7Vg90H21EOLACvtfcHk0ljgbLy4n0ttwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslamu7w%253D&md5=43641194b70be56c763fdf4d8e836e88</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543771003657164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003657164%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DM.%2BL.%26aulast%3DNarayanan%26aufirst%3DR.%26aulast%3DCoss%26aufirst%3DC.%2BC.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DEstrogen%2520Receptor%2520%25CE%25B2%2520Selective%2520Nonsteroidal%2520Estrogens%253A%2520Seeking%2520Clinical%2520Indications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D507%26epage%3D534%26doi%3D10.1517%2F13543771003657164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manas, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDevitt, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collini, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. A.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-β Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5021</span>– <span class="NLM_lpage">5040</span>, <span class="refDoi"> DOI: 10.1021/jm049719y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049719y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt12gtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5021-5040&author=M.+S.+Malamasauthor=E.+S.+Manasauthor=R.+E.+McDevittauthor=I.+Gunawanauthor=Z.+B.+Xuauthor=M.+D.+Colliniauthor=C.+P.+Millerauthor=T.+Dinhauthor=R.+A.+Hendersonauthor=J.+C.+Keithauthor=H.+A.+Harris&title=Design+and+Synthesis+of+Aryl+Diphenolic+Azoles+as+Potent+and+Selective+Estrogen+Receptor-%CE%B2+Ligands&doi=10.1021%2Fjm049719y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Aryl Diphenolic Azoles as Potent and Selective Estrogen Receptor-β Ligands</span></div><div class="casAuthors">Malamas, Michael S.; Manas, Eric S.; McDevitt, Robert E.; Gunawan, Iwan; Xu, Zhang B.; Collini, Michael D.; Miller, Chris P.; Dinh, Tam; Henderson, Ruth A.; Keith, James C., Jr.; Harris, Heather A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5021-5040</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New diphenolic azoles as highly selective estrogen receptor-β agonists are reported.  The more potent and selective analogs of these series have comparable binding affinities for ERβ as the natural ligand 17β-estradiol but are >100-fold selective over ERα.  The design strategy not only followed a traditional SAR approach but also was supported by X-ray structures of ERβ cocrystd. with various ligands as well as mol. modeling studies.  These strategies enabled the use of a single conservative residue substitution in the ligand-binding pocket, ERα Met421 → ERβ Ile373, to optimize ERβ selectivity.  The 7-position-substituted benzoxazoles were the most selective ligands of both azole series, with ERB-041 (I) being >200-fold selective for ERβ.  The majority of ERβ selective agonists tested that were at least ∼50-fold selective displayed a consistent in vivo profile: they were inactive in several models of classic estrogen action (uterotrophic, osteopenia, and vasomotor instability models) and yet were active in the HLA-B27 transgenic rat model of inflammatory bowel disease.  These data suggest that ERβ-selective agonists are devoid of classic estrogenic effects and may offer a novel therapy to treat certain inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4naT8lsva7LVg90H21EOLACvtfcHk0ljgbLy4n0ttwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt12gtrc%253D&md5=01c7d1d0fb71105c1adffeb5f0bc7d3b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm049719y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049719y%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DMcDevitt%26aufirst%3DR.%2BE.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DXu%26aufirst%3DZ.%2BB.%26aulast%3DCollini%26aufirst%3DM.%2BD.%26aulast%3DMiller%26aufirst%3DC.%2BP.%26aulast%3DDinh%26aufirst%3DT.%26aulast%3DHenderson%26aufirst%3DR.%2BA.%26aulast%3DKeith%26aufirst%3DJ.%2BC.%26aulast%3DHarris%26aufirst%3DH.%2BA.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Aryl%2520Diphenolic%2520Azoles%2520as%2520Potent%2520and%2520Selective%2520Estrogen%2520Receptor-%25CE%25B2%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5021%26epage%3D5040%26doi%3D10.1021%2Fjm049719y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roman-Blas, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castañeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutolo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero-Beaumont, G.</span></span> <span> </span><span class="NLM_article-title">Efficacy and Safety of a Selective Estrogen Receptor β Agonist, ERB-041, in Patients with Rheumatoid Arthritis: A 12-Week, Randomized, Placebo-Controlled, Phase II Study</span>. <i>Arthritis Care Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1588</span>– <span class="NLM_lpage">1593</span>, <span class="refDoi"> DOI: 10.1002/acr.20275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1002%2Facr.20275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2gu7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1588-1593&author=J.+A.+Roman-Blasauthor=S.+Casta%C3%B1edaauthor=M.+Cutoloauthor=G.+Herrero-Beaumont&title=Efficacy+and+Safety+of+a+Selective+Estrogen+Receptor+%CE%B2+Agonist%2C+ERB-041%2C+in+Patients+with+Rheumatoid+Arthritis%3A+A+12-Week%2C+Randomized%2C+Placebo-Controlled%2C+Phase+II+Study&doi=10.1002%2Facr.20275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study</span></div><div class="casAuthors">Roman-Blas, Jorge A.; Castaneda, Santos; Cutolo, Maurizio; Herrero-Beaumont, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Care & Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1588-1593</span>CODEN:
                <span class="NLM_cas:coden">ARCREG</span>;
        ISSN:<span class="NLM_cas:issn">2151-464X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Selective estrogen receptor β (ERβ) agonists have demonstrated relevant antiinflammatory effects in different animal models.  This study aimed to compare the efficacy and safety of one of these agonists, ERB-041, in subjects with rheumatoid arthritis (RA).  Methods. A total of 291 patients with active RA receiving stable doses of methotrexate were randomized to receive 5, 25, or 75 mg of ERB-041 or placebo for 12 wk.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) at 12 wk.  Secondary end points included the ACR 50% improvement criteria (ACR50) and the ACR 70% improvement criteria (ACR70) responses, health outcomes measures, C-reactive protein (CRP) levels, and potential exposure-response relationships.  Medical history, phys. examn., and lab. values were obtained at screening, baseline, and weeks 2, 4, 8, and 12.  Results. No statistically significant difference for the ACR20 was found between the ERB-041 treatment and placebo groups (P = 0.518).  Nor was a significant difference obsd. for ACR50 and ACR70 responses, health outcomes measures, CRP levels, and overall incidence of adverse events among all groups.  Forty-four subjects (15.1%) discontinued the study and the rate of discontinuation was similar among the treatment groups.  The most commonly reported treatment-emergent adverse events were headache (7.6%), nausea (6.2%), infection (4.8%), and bronchitis (4.1%).  None of the adverse events was considered treatment related.  Conclusion. Although well tolerated and safe, ERB-041 failed to demonstrate antiinflammatory efficacy in RA patients, despite evidence of strong activity in preclin. arthritis models.  These results suggest that selective ERβ agonists would not have effects on regulating inflammatory response in RA.  Nevertheless, further studies are warranted to establish their efficacy in inflammatory arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozdzCHPRoW0bVg90H21EOLACvtfcHk0lg0TwDSutY3vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2gu7rF&md5=b3b3d9966e0c841340d2077af7cb43e7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Facr.20275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Facr.20275%26sid%3Dliteratum%253Aachs%26aulast%3DRoman-Blas%26aufirst%3DJ.%2BA.%26aulast%3DCasta%25C3%25B1eda%26aufirst%3DS.%26aulast%3DCutolo%26aufirst%3DM.%26aulast%3DHerrero-Beaumont%26aufirst%3DG.%26atitle%3DEfficacy%2520and%2520Safety%2520of%2520a%2520Selective%2520Estrogen%2520Receptor%2520%25CE%25B2%2520Agonist%252C%2520ERB-041%252C%2520in%2520Patients%2520with%2520Rheumatoid%2520Arthritis%253A%2520A%252012-Week%252C%2520Randomized%252C%2520Placebo-Controlled%252C%2520Phase%2520II%2520Study%26jtitle%3DArthritis%2520Care%2520Res.%26date%3D2010%26volume%3D62%26spage%3D1588%26epage%3D1593%26doi%3D10.1002%2Facr.20275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norman, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borromeo, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugar, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durst, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montrose-Rafizadeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amos, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boodhoo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, V.</span></span> <span> </span><span class="NLM_article-title">Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6155</span>– <span class="NLM_lpage">6157</span>, <span class="refDoi"> DOI: 10.1021/jm060491j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060491j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFaitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6155-6157&author=B.+H.+Normanauthor=J.+A.+Dodgeauthor=T.+I.+Richardsonauthor=P.+S.+Borromeoauthor=C.+W.+Lugarauthor=S.+A.+Jonesauthor=K.+Chenauthor=Y.+Wangauthor=G.+L.+Durstauthor=R.+J.+Barrauthor=C.+Montrose-Rafizadehauthor=H.+E.+Osborneauthor=R.+M.+Amosauthor=S.+Guoauthor=A.+Boodhooauthor=V.+Krishnan&title=Benzopyrans+Are+Selective+Estrogen+Receptor+%CE%B2+Agonists+with+Novel+Activity+in+Models+of+Benign+Prostatic+Hyperplasia&doi=10.1021%2Fjm060491j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia</span></div><div class="casAuthors">Norman, Bryan H.; Dodge, Jeffrey A.; Richardson, Timothy I.; Borromeo, Peter S.; Lugar, Charles W.; Jones, Scott A.; Chen, Keyue; Wang, Yong; Durst, Gregory L.; Barr, Robert J.; Montrose-Rafizadeh, Chahrzad; Osborne, Harold E.; Amos, Robert M.; Guo, Sherry; Boodhoo, Amechand; Krishnan, Venkatesh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6155-6157</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzopyran selective estrogen receptor beta agonist-1 (SERBA-1) shows potent, selective binding and agonist function in estrogen receptor β (ERβ) in vitro assays.  X-ray crystal structures of SERBA-1 in ERα and β help explain obsd. β-selectivity of this ligand.  SERBA-1 in vivo demonstrates involution of the ventral prostate in CD-1 mice (ERβ effect), while having no effect on gonadal hormone levels (ERα effect) at 10× the efficacious dose, consistent with in vitro properties of this mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruukNvc0ncZ7Vg90H21EOLACvtfcHk0lg0TwDSutY3vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFaitr8%253D&md5=8d57f3742a46fe2b1ff176186a6f5d08</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm060491j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060491j%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DB.%2BH.%26aulast%3DDodge%26aufirst%3DJ.%2BA.%26aulast%3DRichardson%26aufirst%3DT.%2BI.%26aulast%3DBorromeo%26aufirst%3DP.%2BS.%26aulast%3DLugar%26aufirst%3DC.%2BW.%26aulast%3DJones%26aufirst%3DS.%2BA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDurst%26aufirst%3DG.%2BL.%26aulast%3DBarr%26aufirst%3DR.%2BJ.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DOsborne%26aufirst%3DH.%2BE.%26aulast%3DAmos%26aufirst%3DR.%2BM.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DBoodhoo%26aufirst%3DA.%26aulast%3DKrishnan%26aufirst%3DV.%26atitle%3DBenzopyrans%2520Are%2520Selective%2520Estrogen%2520Receptor%2520%25CE%25B2%2520Agonists%2520with%2520Novel%2520Activity%2520in%2520Models%2520of%2520Benign%2520Prostatic%2520Hyperplasia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6155%26epage%3D6157%26doi%3D10.1021%2Fjm060491j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roehrborn, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spann, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serviss, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor Beta Agonist LY500307 Fails to Improve Symptoms in Men with Enlarged Prostate Secondary to Benign Prostatic Hypertrophy</span>. <i>Prostate Cancer Prostatic Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1038/pcan.2014.43</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1038%2Fpcan.2014.43" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=25348255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVOnt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=43-48&author=C.+G.+Roehrbornauthor=M.+E.+Spannauthor=S.+L.+Myersauthor=C.+R.+Servissauthor=L.+Huauthor=Y.+Jin&title=Estrogen+Receptor+Beta+Agonist+LY500307+Fails+to+Improve+Symptoms+in+Men+with+Enlarged+Prostate+Secondary+to+Benign+Prostatic+Hypertrophy&doi=10.1038%2Fpcan.2014.43"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy</span></div><div class="casAuthors">Roehrborn, C. G.; Spann, M. E.; Myers, S. L.; Serviss, C. R.; Hu, L.; Jin, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Prostate Cancer and Prostatic Diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">PCPDFW</span>;
        ISSN:<span class="NLM_cas:issn">1365-7852</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: To assess the efficacy and safety of LY500307, a selective estrogen receptor beta agonist, on lower urinary tract symptoms (LUTS) in patients with enlarged prostate secondary to BPH.  Methods: In a randomized, double-blind, placebo-controlled, parallel phase 2, efficacy and safety study, eligible patients with moderate to severe LUTS and prostatic enlargement (≥30 mL) were randomized to placebo or LY500307 at 1, 3, 10 and 25 mg once daily for 24 wk.  Primary efficacy end point was change in total International Prostate Symptoms Score (IPSS) after 24 wk.  Secondary end points included changes in total prostate vol. (TPV) that served as a proof of concept end point, as well as IPSS quality of life, max. peak urine flow rate (Qmax) and PSA and safety (adverse events, lab. test).  Results: A total of 414 patients were randomized when the study was terminated because of insufficient TPV redn., based on a priori defined interim anal.  The IPSS mean change from baseline to end point was -3.4±6.8 in the placebo group and -1.3±6.6, -2.6±7.0, -3.7±6.7 and -4.4±5.7 in the 1, 3, 10 and 25 mg LY500307-treated groups, resp. (P>0.05).  Similarly, no treatment effect was obsd. for any of the secondary efficacy measures.  Incidence of adverse events was comparable between treatment groups, and no clin. meaningful changes in lab. tests were obsd.  Conclusions: LY500307 was well tolerated in BPH patients with LUTS at doses up to 25 mg once daily for 24 wk.  The study was terminated early because of inadequate efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodCHIV5KoevLVg90H21EOLACvtfcHk0lg0TwDSutY3vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVOnt73I&md5=a6fa7058d61630f48df3b35c5d637c70</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fpcan.2014.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fpcan.2014.43%26sid%3Dliteratum%253Aachs%26aulast%3DRoehrborn%26aufirst%3DC.%2BG.%26aulast%3DSpann%26aufirst%3DM.%2BE.%26aulast%3DMyers%26aufirst%3DS.%2BL.%26aulast%3DServiss%26aufirst%3DC.%2BR.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DY.%26atitle%3DEstrogen%2520Receptor%2520Beta%2520Agonist%2520LY500307%2520Fails%2520to%2520Improve%2520Symptoms%2520in%2520Men%2520with%2520Enlarged%2520Prostate%2520Secondary%2520to%2520Benign%2520Prostatic%2520Hypertrophy%26jtitle%3DProstate%2520Cancer%2520Prostatic%2520Dis.%26date%3D2015%26volume%3D18%26spage%3D43%26epage%3D48%26doi%3D10.1038%2Fpcan.2014.43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Breier, A.</span></span> <span> </span><span class="NLM_article-title">The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia—Full Text View—ClinicalTrials.gov</span>. <a href="https://clinicaltrials.gov/ct2/show/NCT01874756" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01874756</a> (accessed Apr 27, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=A.+Breier&title=The+Efficacy+and+Safety+of+a+Selective+Estrogen+Receptor+Beta+Agonist+%28LY500307%29+for+Negative+Symptoms+and+Cognitive+Impairment+Associated+With+Schizophrenia%E2%80%94Full+Text+View%E2%80%94ClinicalTrials.gov"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DBreier%26aufirst%3DA.%26atitle%3DThe%2520Efficacy%2520and%2520Safety%2520of%2520a%2520Selective%2520Estrogen%2520Receptor%2520Beta%2520Agonist%2520%2528LY500307%2529%2520for%2520Negative%2520Symptoms%2520and%2520Cognitive%2520Impairment%2520Associated%2520With%2520Schizophrenia%25E2%2580%2594Full%2520Text%2520View%25E2%2580%2594ClinicalTrials.gov%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span> </span><span class="NLM_article-title">Effects
of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced
Mood Symptoms in Women with Past Perimenopausal Depression—Tabular
View—ClinicalTrials.gov</span>. <a href="https://clinicaltrials.gov/ct2/show/record/NCT03689543" class="extLink">https://clinicaltrials.gov/ct2/show/record/NCT03689543</a> (accessed Apr 27, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Effects%0Aof+an+ER+Beta+Agonist+%28Lilly+Compound+LY500307%29+on+Estradiol-Withdrawal-Induced%0AMood+Symptoms+in+Women+with+Past+Perimenopausal+Depression%E2%80%94Tabular%0AView%E2%80%94ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Frecord%2FNCT03689543+%28accessed+Apr+27%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DEffects%250Aof%2520an%2520ER%2520Beta%2520Agonist%2520%2528Lilly%2520Compound%2520LY500307%2529%2520on%2520Estradiol-Withdrawal-Induced%250AMood%2520Symptoms%2520in%2520Women%2520with%2520Past%2520Perimenopausal%2520Depression%25E2%2580%2594Tabular%250AView%25E2%2580%2594ClinicalTrials.gov%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paterni, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minutolo, F.</span></span> <span> </span><span class="NLM_article-title">Estrogen Receptor Ligands: A Patent Review Update</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1517/13543776.2013.805206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1517%2F13543776.2013.805206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=23713677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1247-1271&author=I.+Paterniauthor=S.+Bertiniauthor=C.+Granchiauthor=M.+Macchiaauthor=F.+Minutolo&title=Estrogen+Receptor+Ligands%3A+A+Patent+Review+Update&doi=10.1517%2F13543776.2013.805206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen receptor ligands: a patent review update</span></div><div class="casAuthors">Paterni, Ilaria; Bertini, Simone; Granchi, Carlotta; Macchia, Marco; Minutolo, Filippo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1247-1271</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The role of estrogens is mostly mediated by two nuclear receptors (ERα and ERβ) and a membrane-assocd. G-protein (GPR30 or GPER), and it is not limited to reprodn., but it extends to the skeletal, cardiovascular and central nervous systems.  Various pathologies such as cancer, inflammatory, neurodegenerative and metabolic diseases are often assocd. with dysfunctions of the estrogenic system.  Therapeutic interventions by agents that affect the estrogenic signaling pathway might be useful in the treatment of many dissimilar diseases.  Areas covered: The massive chemodiversity of ER ligands, limited to patented small mols., is herein reviewed.  The reported compds. are classified on the basis of their chem. structures.  Non-steroidal derivs., which mostly consist of diphenolic compds., are further segregated into chem. classes based on their central scaffold.  Expert opinion: Estrogens have been used for almost a century and their earlier applications have concerned interventions in the female reproductive functions, as well as the treatment of some estrogen-dependent cancers and osteoporosis.  Since the discovery of ERβ in 1996, the patent literature has started to pay a progressively increasing attention to this newer receptor subtype, which holds promise as a target for new indications, most of which still need to be clin. validated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO4rnbfdD65LVg90H21EOLACvtfcHk0liezc0S8XHqmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyns7fO&md5=6f747f7fccf0953fc64cd61b5f287dd6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.805206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.805206%26sid%3Dliteratum%253Aachs%26aulast%3DPaterni%26aufirst%3DI.%26aulast%3DBertini%26aufirst%3DS.%26aulast%3DGranchi%26aufirst%3DC.%26aulast%3DMacchia%26aufirst%3DM.%26aulast%3DMinutolo%26aufirst%3DF.%26atitle%3DEstrogen%2520Receptor%2520Ligands%253A%2520A%2520Patent%2520Review%2520Update%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D1247%26epage%3D1271%26doi%3D10.1517%2F13543776.2013.805206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukasawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shudo, K.</span></span> <span> </span><span class="NLM_article-title">Potent Estrogenic Agonists Bearing Dicarba-<i>closo</i>-Dodecaborane as a Hydrophobic Pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1504</span>, <span class="refDoi"> DOI: 10.1021/jm9900725</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9900725" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXisVaqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1501-1504&author=Y.+Endoauthor=T.+Iijimaauthor=Y.+Yamakoshiauthor=M.+Yamaguchiauthor=H.+Fukasawaauthor=K.+Shudo&title=Potent+Estrogenic+Agonists+Bearing+Dicarba-closo-Dodecaborane+as+a+Hydrophobic+Pharmacophore&doi=10.1021%2Fjm9900725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Estrogenic Agonists Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore</span></div><div class="casAuthors">Endo, Yasuyuki; Iijima, Toru; Yamakoshi, Yuko; Yamaguchi, Mitsuhiro; Fukasawa, Hiroshi; Shudo, Koichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1501-1504</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The novel carborane contg. mols., e.g. 1-(4-hydroxyphenyl)-1,12-dicarba-closo-dodecaborane, with potent estrogenic activity was developed.  The unique character of biol. active mols. contg. a carborane skeleton may give to unusual membrane transport characteristics and metab., compared with conventional active mols.  The superagonistic properties of the carborane-contg. compds. raise the possibility that structure-function studies could lead to the development of more selective estrogen agonists and antagonists, which could be useful as therapeutic agents for a wide variety of conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2AlXhU9tPobVg90H21EOLACvtfcHk0liezc0S8XHqmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVaqsbY%253D&md5=b487b1fcfa55e50d83a5cf96d8b357fa</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm9900725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9900725%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DIijima%26aufirst%3DT.%26aulast%3DYamakoshi%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DM.%26aulast%3DFukasawa%26aufirst%3DH.%26aulast%3DShudo%26aufirst%3DK.%26atitle%3DPotent%2520Estrogenic%2520Agonists%2520Bearing%2520Dicarba-closo-Dodecaborane%2520as%2520a%2520Hydrophobic%2520Pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1501%26epage%3D1504%26doi%3D10.1021%2Fjm9900725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barth, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span> <span> </span><span class="NLM_article-title">A Realistic Appraisal of Boron Neutron Capture Therapy as a Cancer Treatment Modality</span>. <i>Cancer Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>, <span class="NLM_elocation-id">36</span> <span class="refDoi"> DOI: 10.1186/s40880-018-0280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1186%2Fs40880-018-0280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=29914575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A280%3ADC%252BC1MbosFamuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&author=R.+F.+Barthauthor=Z.+Zhangauthor=T.+Liu&title=A+Realistic+Appraisal+of+Boron+Neutron+Capture+Therapy+as+a+Cancer+Treatment+Modality&doi=10.1186%2Fs40880-018-0280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A realistic appraisal of boron neutron capture therapy as a cancer treatment modality</span></div><div class="casAuthors">Barth Rolf F; Zhang Zizhu; Liu Tong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer communications (London, England)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Boron neutron capture therapy (BNCT) is a binary therapeutic modality based on the nuclear capture and fission reactions that occur when the stable isotope boron-10 is irradiated with neutrons to produce high-energy alpha particles and recoiling lithium-7 nuclei.  In this Commentary we will focus on a number of papers that were presented at a Symposium entitled "Current Clinical Status of Boron Neutron Capture Therapy and Paths to the Future", which was held in September 2017 at the China National Convention Center in Beijing.  Results were presented by clinicians from Japan, Finland, the United States, the China mainland and Taiwan, China who have been working in the multiple disciplines that are required for carrying out clinical BNCT.  The main focus was on the treatment of patients with malignant brain tumors, recurrent tumors of the head and neck region, and cutaneous melanomas.  The results obtained in treating these patients were reported in detail and, although most of the patients with brain tumors and head and neck cancer were not cured, there was evidence of some clinical efficacy.  Although there are a number of problems that must be addressed, further clinical studies to evaluate the efficacy of BNCT are warranted.  First, despite considerable effort by numerous investigators over the past 40 years, there still are only two boron-containing drugs in clinical use, L-boronophenylalanine (BPA) and sodium borocaptate (BSH).  Therefore, until new and more effective boron delivery agents are developed, efforts should be directed to improving the dosing and delivery of BPA and BSH.  Second, due to a variety of reasons, nuclear reactor-based BNCT has ended except for its use in the China mainland and Taiwan.  Therefore, the future of BNCT depends upon the results of the ongoing Phase II clinical trials that are being carried out in Japan and the soon to be initiated trials that will be carried out in Finland.  If the results obtained from these clinical trials are sufficiently promising, then BNCT will have a clear path to the future, especially for patients with the therapeutically challenging malignancies that in the past have been treated with reactor-based BNCT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-_cHN3uno-8K3uFsUIZtkfW6udTcc2eavTXCoXzgiErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbosFamuw%253D%253D&md5=aaf7960e10efcae0cbdcaa5113ba2bda</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2Fs40880-018-0280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40880-018-0280-5%26sid%3Dliteratum%253Aachs%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DT.%26atitle%3DA%2520Realistic%2520Appraisal%2520of%2520Boron%2520Neutron%2520Capture%2520Therapy%2520as%2520a%2520Cancer%2520Treatment%2520Modality%26jtitle%3DCancer%2520Commun.%26date%3D2018%26volume%3D38%26doi%3D10.1186%2Fs40880-018-0280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soloway, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjarks, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnum, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, F.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codogni, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. G.</span></span> <span> </span><span class="NLM_article-title">The Chemistry of Neutron Capture Therapy</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1515</span>– <span class="NLM_lpage">1562</span>, <span class="refDoi"> DOI: 10.1021/cr941195u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr941195u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlygtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1998&pages=1515-1562&author=A.+H.+Solowayauthor=W.+Tjarksauthor=B.+A.+Barnumauthor=F.-G.+Rongauthor=R.+F.+Barthauthor=I.+M.+Codogniauthor=J.+G.+Wilson&title=The+Chemistry+of+Neutron+Capture+Therapy&doi=10.1021%2Fcr941195u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The Chemistry of Neutron Capture Therapy</span></div><div class="casAuthors">Soloway, Albert H.; Tjarks, Werner; Barnum, Beverly A.; Rong, Feng-Guang; Barth, Rolf F.; Codogni, Iwona M.; Wilson, J. Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1515-1562</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 633 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQlar2oXrwMrVg90H21EOLACvtfcHk0liwgmVkr564TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlygtL8%253D&md5=52bcd4d4e2f37833d76092e9a1867b3c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcr941195u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr941195u%26sid%3Dliteratum%253Aachs%26aulast%3DSoloway%26aufirst%3DA.%2BH.%26aulast%3DTjarks%26aufirst%3DW.%26aulast%3DBarnum%26aufirst%3DB.%2BA.%26aulast%3DRong%26aufirst%3DF.-G.%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DCodogni%26aufirst%3DI.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BG.%26atitle%3DThe%2520Chemistry%2520of%2520Neutron%2520Capture%2520Therapy%26jtitle%3DChem.%2520Rev.%26date%3D1998%26volume%3D98%26spage%3D1515%26epage%3D1562%26doi%3D10.1021%2Fcr941195u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soloway, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, J. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Boron Compounds for Use in Neutron Capture Therapy of Brain Tumors. I. Animal Investigations</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">117</span>– <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=13915041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaF38Xks1al" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=1961&pages=117-122&author=A.+H.+Solowayauthor=R.+L.+Wrightauthor=J.+R.+Messer&title=Evaluation+of+Boron+Compounds+for+Use+in+Neutron+Capture+Therapy+of+Brain+Tumors.+I.+Animal+Investigations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of boron compounds for use in neutron-capture therapy of brain tumors. I. Animal investigations</span></div><div class="casAuthors">Soloway, A. H.; Wright, R. L.; Messer, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117-22</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">cf. CA 54, 1374d.-m-Boronosuccinanilic, 3-amino-4-carboxybenzeneboronic, m- and p-carboxybenzeneboronic, 2-nitrobenzene-l,4-diboronic, o-(2-carboxyacetamidoethyl)benzeneboronic, 2-acetamidobenzeneboronic, and m-ureidobenzeneboronic acids, p-boronophenylalanine, Na perhydrodecaborate, and boric acid were evaluated in mice with transplanted glioma (ependymoma) for toxicity.  The tumor-to-brain ratios and the concns. in various organ tissues were detd.  The 1st 2 compds. appeared promising and were studied further in cats by intravenous and intracarotid artery injection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ3NwRRVrpJbVg90H21EOLACvtfcHk0liwgmVkr564TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38Xks1al&md5=e291c2430bd5f235a4b0f6e3a429a7d3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoloway%26aufirst%3DA.%2BH.%26aulast%3DWright%26aufirst%3DR.%2BL.%26aulast%3DMesser%26aufirst%3DJ.%2BR.%26atitle%3DEvaluation%2520of%2520Boron%2520Compounds%2520for%2520Use%2520in%2520Neutron%2520Capture%2520Therapy%2520of%2520Brain%2520Tumors.%2520I.%2520Animal%2520Investigations%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1961%26volume%3D134%26spage%3D117%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stockmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gozzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhnert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sárosi, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey-Hawkins, E.</span></span> <span> </span><span class="NLM_article-title">New Keys for Old Locks: Carborane-Containing Drugs as Platforms for Mechanism-Based Therapies</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3497</span>– <span class="NLM_lpage">3512</span>, <span class="refDoi"> DOI: 10.1039/C9CS00197B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1039%2FC9CS00197B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=31214680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtF2nt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2019&pages=3497-3512&author=P.+Stockmannauthor=M.+Gozziauthor=R.+Kuhnertauthor=M.+B.+S%C3%A1rosiauthor=E.+Hey-Hawkins&title=New+Keys+for+Old+Locks%3A+Carborane-Containing+Drugs+as+Platforms+for+Mechanism-Based+Therapies&doi=10.1039%2FC9CS00197B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New keys for old locks: carborane-containing drugs as platforms for mechanism-based therapies</span></div><div class="casAuthors">Stockmann, Philipp; Gozzi, Marta; Kuhnert, Robert; Sarosi, Menyhart B.; Hey-Hawkins, Evamarie</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3497-3512</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Icosahedral carboranes in medicine are still an emerging class of compds. with potential beneficial applications in drug design.  These highly hydrophobic clusters are potential "new keys for old locks" which open up an exciting field of research for well-known, but challenging important therapeutic substrates, as demonstrated by the numerous examples discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOMBCVidtHL7Vg90H21EOLACvtfcHk0liwgmVkr564TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtF2nt7vI&md5=b2a1f1247161aeedf257cd807d2a30fd</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2FC9CS00197B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9CS00197B%26sid%3Dliteratum%253Aachs%26aulast%3DStockmann%26aufirst%3DP.%26aulast%3DGozzi%26aufirst%3DM.%26aulast%3DKuhnert%26aufirst%3DR.%26aulast%3DS%25C3%25A1rosi%26aufirst%3DM.%2BB.%26aulast%3DHey-Hawkins%26aufirst%3DE.%26atitle%3DNew%2520Keys%2520for%2520Old%2520Locks%253A%2520Carborane-Containing%2520Drugs%2520as%2520Platforms%2520for%2520Mechanism-Based%2520Therapies%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2019%26volume%3D48%26spage%3D3497%26epage%3D3512%26doi%3D10.1039%2FC9CS00197B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leśnikowski, Z. J.</span></span> <span> </span><span class="NLM_article-title">Challenges and Opportunities for the Application of Boron Clusters in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7738</span>– <span class="NLM_lpage">7758</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01932</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFSgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7738-7758&author=Z.+J.+Le%C5%9Bnikowski&title=Challenges+and+Opportunities+for+the+Application+of+Boron+Clusters+in+Drug+Design&doi=10.1021%2Facs.jmedchem.5b01932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities for the Application of Boron Clusters in Drug Design</span></div><div class="casAuthors">Lesnikowski, Zbigniew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7738-7758</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There are two branches in boron medicinal chem.: the first focuses on single boron atom compds., and the second utilizes boron clusters.  Boron clusters and their heteroatom counterparts belong to the family of cage compds.  A subset of this extensive class of compds. includes dicarbadodecaboranes, which have the general formula C2B10H12, and their metal biscarboranyl complexes, metallacarboranes, with the formula [M(C2B10H12)2-2].  The unique properties of boron clusters have resulted in their utilization in applications such as in pharmacophores, as scaffolds in mol. construction, and as modulators of bioactive compds.  This Perspective presents an overview of the properties of boron clusters that are pertinent for drug discovery, recent applications in the design of various classes of drugs, and the potential use of boron clusters in the construction of new pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX92E97ik4ubVg90H21EOLACvtfcHk0ljt1yHmXbWVFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFSgs7c%253D&md5=1d4c3720cdc649c5fc3de397bea15e83</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01932%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C5%259Bnikowski%26aufirst%3DZ.%2BJ.%26atitle%3DChallenges%2520and%2520Opportunities%2520for%2520the%2520Application%2520of%2520Boron%2520Clusters%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7738%26epage%3D7758%26doi%3D10.1021%2Facs.jmedchem.5b01932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leśnikowski, Z. J.</span></span> <span> </span><span class="NLM_article-title">What Are the Current Challenges with the Application of Boron Clusters to Drug Design?</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">481</span>, <span class="refDoi"> DOI: 10.1080/17460441.2021.1867531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1080%2F17460441.2021.1867531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=33356654" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=481&author=Z.+J.+Le%C5%9Bnikowski&title=What+Are+the+Current+Challenges+with+the+Application+of+Boron+Clusters+to+Drug+Design%3F&doi=10.1080%2F17460441.2021.1867531"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1080%2F17460441.2021.1867531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2021.1867531%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C5%259Bnikowski%26aufirst%3DZ.%2BJ.%26atitle%3DWhat%2520Are%2520the%2520Current%2520Challenges%2520with%2520the%2520Application%2520of%2520Boron%2520Clusters%2520to%2520Drug%2520Design%253F%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2020%26spage%3D481%26doi%3D10.1080%2F17460441.2021.1867531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedlák, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eignerová, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dračínský, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janoušek, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartůněk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotora, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of 17α-(Carboranylalkyl)Estradiols as Ligands for Estrogen Receptors α and β</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>747</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1016/j.jorganchem.2013.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.jorganchem.2013.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKgsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=747&publication_year=2013&pages=178-183&author=D.+Sedl%C3%A1kauthor=B.+Eignerov%C3%A1author=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=Z.+Janou%C5%A1ekauthor=P.+Bart%C5%AFn%C4%9Bkauthor=M.+Kotora&title=Synthesis+and+Evaluation+of+17%CE%B1-%28Carboranylalkyl%29Estradiols+as+Ligands+for+Estrogen+Receptors+%CE%B1+and+%CE%B2&doi=10.1016%2Fj.jorganchem.2013.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 17α-(carboranylalkyl)estradiols as ligands for estrogen receptors α and β</span></div><div class="casAuthors">Sedlak, David; Eignerova, Barbara; Dracinsky, Martin; Janousek, Zbynek; Bartunek, Petr; Kotora, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">747</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178-183</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 17α-(carboranylalkyl)estradiols was synthesized using cross-metathesis reaction of 17α-allyl- and 17α-vinylestradiols with allylcarboranes catalyzed by Hoveyda-Grubbs 2nd generation catalyst.  The prepd. estradiol derivs. were tested in the panel of cell-based reporter assays including all steroid receptors.  The compds. mainly activated estrogen receptors α and β and tended to be weakly selective for ERα.  Besides ERα and ERβ, we have also detected a weak agonistic activity on AR and PR at micromolar concns.  We didn't observe any antagonistic effect with the exception of two receptors: GR and MR which were inhibited with some of the tested ligands.  However, the inhibition was detectable at concns. exceeding by far those needed to activate estrogen receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgH0Jo_HEdurVg90H21EOLACvtfcHk0ljt1yHmXbWVFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKgsrrL&md5=30ff55174dd93879e3cdd196e1032c6a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jorganchem.2013.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jorganchem.2013.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DSedl%25C3%25A1k%26aufirst%3DD.%26aulast%3DEignerov%25C3%25A1%26aufirst%3DB.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DJanou%25C5%25A1ek%26aufirst%3DZ.%26aulast%3DBart%25C5%25AFn%25C4%259Bk%26aufirst%3DP.%26aulast%3DKotora%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%252017%25CE%25B1-%2528Carboranylalkyl%2529Estradiols%2520as%2520Ligands%2520for%2520Estrogen%2520Receptors%2520%25CE%25B1%2520and%2520%25CE%25B2%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D2013%26volume%3D747%26spage%3D178%26epage%3D183%26doi%3D10.1016%2Fj.jorganchem.2013.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eignerová, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlák, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dračínský, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartůněk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotora, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biochemical Characterization of a Series of 17α-Perfluoroalkylated Estradiols as Selective Ligands for Estrogen Receptor α</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">6947</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1021/jm100563h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100563h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWlsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6947-6953&author=B.+Eignerov%C3%A1author=D.+Sedl%C3%A1kauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=P.+Bart%C5%AFn%C4%9Bkauthor=M.+Kotora&title=Synthesis+and+Biochemical+Characterization+of+a+Series+of+17%CE%B1-Perfluoroalkylated+Estradiols+as+Selective+Ligands+for+Estrogen+Receptor+%CE%B1&doi=10.1021%2Fjm100563h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biochemical Characterization of a Series of 17α-Perfluoroalkylated Estradiols as Selective Ligands for Estrogen Receptor α</span></div><div class="casAuthors">Eignerova, Barbara; Sedlak, David; Dracinsky, Martin; Bartunek, Petr; Kotora, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6947-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite intensive research efforts, the distinct biol. roles of two closely related estrogen receptors, ERα and ERβ, are only partially understood.  Therefore, ligands selective for either of two isotypes are useful research tools because they allow for exerting a desired subset of biol. effects mediated by only one of the receptors.  Here we report on the synthesis of a new class of potent and selective ligands for ERα represented by a series of 17α-substituted estradiols bearing lipophilic perfluoroalkyl chains.  These 17α-perfluoroalkylated estradiols were synthesized by Ru-catalyzed cross metathesis reactions of 17α-allyl- or 17α-vinylestradiols with perfluoroalkylpropenes.  Compds. were tested in both agonistic and antagonistic modes using a panel of stable steroid receptor reporter cell lines established in U2OS cells and consisting of ERα-LBD, ERβ-LBD, GR-LBD, and MR-LBD reporters.  Some of the compds. are potent and selective agonists of ERα, exhibiting weak partial to no detectable agonistic activity on ERβ.  Notably, I is the most ERα selective ligand of the prepd. compds. because it activates ERα but inhibits ERβ.  In addn., some compds. are pure agonists on ERα but show mixed agonistic/antagonistic profile on ERβ which is a typical pattern obsd. for selective estrogen receptor modulators (SERMs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1e_HTEHDqs7Vg90H21EOLACvtfcHk0ljt1yHmXbWVFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWlsb7E&md5=be45ac8fd4423d38ba410b2e080676fa</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm100563h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100563h%26sid%3Dliteratum%253Aachs%26aulast%3DEignerov%25C3%25A1%26aufirst%3DB.%26aulast%3DSedl%25C3%25A1k%26aufirst%3DD.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DBart%25C5%25AFn%25C4%259Bk%26aufirst%3DP.%26aulast%3DKotora%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520Biochemical%2520Characterization%2520of%2520a%2520Series%2520of%252017%25CE%25B1-Perfluoroalkylated%2520Estradiols%2520as%2520Selective%2520Ligands%2520for%2520Estrogen%2520Receptor%2520%25CE%25B1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6947%26epage%3D6953%26doi%3D10.1021%2Fjm100563h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedlák, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novák, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartůněk, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of 17α-Arylestradiols as Ligands for Estrogen Receptor α and β</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4290</span>– <span class="NLM_lpage">4294</span>, <span class="refDoi"> DOI: 10.1021/jm901898a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901898a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVyhuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4290-4294&author=D.+Sedl%C3%A1kauthor=P.+Nov%C3%A1kauthor=M.+Kotoraauthor=P.+Bart%C5%AFn%C4%9Bk&title=Synthesis+and+Evaluation+of+17%CE%B1-Arylestradiols+as+Ligands+for+Estrogen+Receptor+%CE%B1+and+%CE%B2&doi=10.1021%2Fjm901898a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of 17α-Arylestradiols as Ligands for Estrogen Receptor α and β</span></div><div class="casAuthors">Sedlak, David; Novak, Petr; Kotora, Martin; Bartunek, Petr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4290-4294</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To identify novel estrogen receptor ligands a series of substituted 17α-arylestradiols I [X = C(CO2Et)2, C(COMe)2, C(CO2Et)COMe, C(CO2Et)CN, NTs, O] were synthesized using the catalytic [2 + 2 + 2]-cyclotrimerization of 17α-ethynylestradiol with various 1,7-diynes HC≡CCH2XCH2C≡CH in the presence of Wilkinson's catalysts [Rh(PPh3)3Cl].  The compds. were subjected to competitive binding assays, cell-based luciferase reporter assays, and proliferation assays.  These expts. confirmed their estrogenic character and revealed some interesting properties like mixed partial/full agonism for ERα/ERβ and different selectivity as a result of differing potencies for either ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL62tciCB-mLVg90H21EOLACvtfcHk0lhvc4UOXodPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVyhuro%253D&md5=f1c7acaa44d748d6c5adc341290a79cb</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm901898a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901898a%26sid%3Dliteratum%253Aachs%26aulast%3DSedl%25C3%25A1k%26aufirst%3DD.%26aulast%3DNov%25C3%25A1k%26aufirst%3DP.%26aulast%3DKotora%26aufirst%3DM.%26aulast%3DBart%25C5%25AFn%25C4%259Bk%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%252017%25CE%25B1-Arylestradiols%2520as%2520Ligands%2520for%2520Estrogen%2520Receptor%2520%25CE%25B1%2520and%2520%25CE%25B2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4290%26epage%3D4294%26doi%3D10.1021%2Fjm901898a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span> <span> </span><span class="NLM_article-title">Utility of Boron Clusters for Drug Design. Relation between Estrogen Receptor Binding Affinity and Hydrophobicity of Phenols Bearing Various Types of Carboranyl Groups</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4089</span>– <span class="NLM_lpage">4092</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.08.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.bmcl.2003.08.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=14592514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVWrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4089-4092&author=Y.+Endoauthor=K.+Yamamotoauthor=H.+Kagechika&title=Utility+of+Boron+Clusters+for+Drug+Design.+Relation+between+Estrogen+Receptor+Binding+Affinity+and+Hydrophobicity+of+Phenols+Bearing+Various+Types+of+Carboranyl+Groups&doi=10.1016%2Fj.bmcl.2003.08.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of boron clusters for drug design. Relation between estrogen receptor binding affinity and hydrophobicity of phenols bearing various types of carboranyl groups</span></div><div class="casAuthors">Endo, Yasuyuki; Yamamoto, Keisuke; Kagechika, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4089-4092</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">High binding affinity for estrogen receptor and the appearance of estrogenic activity require a phenolic ring and an appropriate hydrophobic group adjacent to the phenolic ring.  A quant. structure-activity relationship anal. based on the values of logP and the pKa of the phenolic group showed that the hydrophobicity of these compds. is highly correlated to the estrogen receptor α (ERα)-binding affinity.  These results should be useful for application of these spherical boron clusters (dicarba-closo-dodecaboranes; carboranes) as hydrophobic pharmacophores in drug design, as well as for microscopic anal. of ER-ligand interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYVjjBmIIp87Vg90H21EOLACvtfcHk0lhvc4UOXodPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVWrtrk%253D&md5=337630c26a43eb82c590ebb7b6cd8e15</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.08.039%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DUtility%2520of%2520Boron%2520Clusters%2520for%2520Drug%2520Design.%2520Relation%2520between%2520Estrogen%2520Receptor%2520Binding%2520Affinity%2520and%2520Hydrophobicity%2520of%2520Phenols%2520Bearing%2520Various%2520Types%2520of%2520Carboranyl%2520Groups%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D4089%26epage%3D4092%26doi%3D10.1016%2Fj.bmcl.2003.08.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukasawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itai, A.</span></span> <span> </span><span class="NLM_article-title">Potent Estrogen Agonists Based on Carborane as a Hydrophobic Skeletal Structure: A New Medicinal Application of Boron Clusters</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(01)00016-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2FS1074-5521%2801%2900016-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=11325590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1ahsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=341-355&author=Y.+Endoauthor=T.+Iijimaauthor=Y.+Yamakoshiauthor=H.+Fukasawaauthor=C.+Miyauraauthor=M.+Inadaauthor=A.+Kuboauthor=A.+Itai&title=Potent+Estrogen+Agonists+Based+on+Carborane+as+a+Hydrophobic+Skeletal+Structure%3A+A+New+Medicinal+Application+of+Boron+Clusters&doi=10.1016%2FS1074-5521%2801%2900016-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Potent estrogen agonists based on carborane as a hydrophobic skeletal structure: a new medicinal application of boron clusters</span></div><div class="casAuthors">Endo, Yasuyuki; Iijima, Toru; Yamakoshi, Yuko; Fukasawa, Hiroshi; Miyaura, Chisato; Inada, Masaki; Kubo, Asako; Itai, Akiko</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-355</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: Carboranes (dicarba-closo-dodecaboranes) are a class of carbon-contg. polyhedral boron-cluster compds. having remarkable thermal stability and exceptional hydrophobicity.  Applications of the unique structural and chem. properties offered by icosahedral carboranes in boron neutron capture therapy have received increasing attention over the past 30 yr.  However, these features of carboranes may allow another application as a hydrophobic pharmacophore in biol. active mols. that interact hydrophobically with receptors.  Results: We have designed candidate estrogen-receptor-binding compds. having carborane as a hydrophobic skeletal structure and synthesized them.  The most potent compd. bearing a carborane cage exhibited activity at least 10-fold greater than that of 17β-estradiol in the luciferase reporter gene assay.  Estrogen receptor-α-binding data for the compd. were consistent with the results of the luciferase reporter gene assay.  The compd. also showed potent in vivo effects on the recovery of uterine wt. and bone loss in ovariectomized mice.  Conclusion: Further development of the potent carborane-contg. estrogenic agonists described here, having a new skeletal structure and unique characteristics, should yield novel therapeutic agents, esp. selective estrogen receptor modulators.  Furthermore, the suitability of the spherical carborane cage for binding to the cavity of the estrogen receptor-α ligand-binding domain should provide a basis for a similar approach to developing novel ligands for other steroid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb6lTWB0tsRrVg90H21EOLACvtfcHk0lhvc4UOXodPEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1ahsr4%253D&md5=1f1af2e8526772e69d711f538fc1d82d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2801%2900016-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252801%252900016-3%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DIijima%26aufirst%3DT.%26aulast%3DYamakoshi%26aufirst%3DY.%26aulast%3DFukasawa%26aufirst%3DH.%26aulast%3DMiyaura%26aufirst%3DC.%26aulast%3DInada%26aufirst%3DM.%26aulast%3DKubo%26aufirst%3DA.%26aulast%3DItai%26aufirst%3DA.%26atitle%3DPotent%2520Estrogen%2520Agonists%2520Based%2520on%2520Carborane%2520as%2520a%2520Hydrophobic%2520Skeletal%2520Structure%253A%2520A%2520New%2520Medicinal%2520Application%2520of%2520Boron%2520Clusters%26jtitle%3DChem.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D341%26epage%3D355%26doi%3D10.1016%2FS1074-5521%2801%2900016-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaise, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Carborane-Containing Estrogen Receptor-Beta (ERβ)-Selective Ligands</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4174</span>– <span class="NLM_lpage">4178</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.bmcl.2015.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=26298498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSlsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4174-4178&author=K.+Ohtaauthor=T.+Ogawaauthor=A.+Odaauthor=A.+Kaiseauthor=Y.+Endo&title=Design+and+Synthesis+of+Carborane-Containing+Estrogen+Receptor-Beta+%28ER%CE%B2%29-Selective+Ligands&doi=10.1016%2Fj.bmcl.2015.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of carborane-containing estrogen receptor-beta (ERβ)-selective ligands</span></div><div class="casAuthors">Ohta, Kiminori; Ogawa, Takumi; Oda, Akifumi; Kaise, Asako; Endo, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4174-4178</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Candidates for highly selective estrogen receptor-beta (ERβ) ligands were designed and synthesized based on carborane-contg. ER ligands as lead compds.  Among them, p-carboranylcyclohexanol derivs. 8a and 8b exhibited high ERβ selectivity in competitive binding assay: for example, 8a showed 56-fold selectivity for ERβ over ERα.  Docking studies of 8a and 8b with the ERα and ERβ ligand-binding domains (LBDs) suggested that the p-carborane cage of the ligands is located close to key amino acid residues that influence ER-subtype selectivity, i.e., Leu384 in the ERα LBD and Met336 in the ERβ LBD.  The p-carborane cage in 8a and 8b appears to play a crucial role in the increased ERβ selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe9IKuTiWQ27Vg90H21EOLACvtfcHk0ljQqqOpmxCg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSlsLjF&md5=18ce9668981a0f26829a981d79f8addb</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DT.%26aulast%3DOda%26aufirst%3DA.%26aulast%3DKaise%26aufirst%3DA.%26aulast%3DEndo%26aufirst%3DY.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Carborane-Containing%2520Estrogen%2520Receptor-Beta%2520%2528ER%25CE%25B2%2529-Selective%2520Ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4174%26epage%3D4178%26doi%3D10.1016%2Fj.bmcl.2015.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coult, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gill, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbertson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacBride, J. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, K.</span></span> <span> </span><span class="NLM_article-title">C-Arylation and C-Heteroarylation of Icosahedral Carboranes via Their Copper(I) Derivatives</span>. <i>J. Organomet. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>462</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/0022-328X(93)83337-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2F0022-328X%2893%2983337-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK2cXitFOktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=1993&pages=19-29&author=R.+Coultauthor=M.+A.+Foxauthor=W.+R.+Gillauthor=P.+L.+Herbertsonauthor=J.+A.+H.+MacBrideauthor=K.+Wade&title=C-Arylation+and+C-Heteroarylation+of+Icosahedral+Carboranes+via+Their+Copper%28I%29+Derivatives&doi=10.1016%2F0022-328X%2893%2983337-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">C-arylation and C-heteroarylation of icosahedral carboranes via their copper(I) derivatives</span></div><div class="casAuthors">Coult, Robert; Fox, Mark A.; Gill, Wendy R.; Herbertson, Penelope L.; MacBride, J. A. Hugh; Wade, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">19-29</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    </div><div class="casAbstract">Reaction between C-mono- or C,C'-di-copper(I) derivs. of 1,2-, 1,7-, or 1,12-dicarba-closo-dodecaborane(12) and aryl iodides in the presence of pyridine gives the corresponding C-mono- or C,C'-diaryl derivs. of 1,7- and 1,12-dicarba-closo-dodecaboranes(12); 1,2-dicarba-closo-dodecaborane(12) gives only the C-monoaryl product.  Cyclic or linear arylene coupled systems are obtained when di-iodoarenes are used.  Copper(I) derivs. may be generated from C-unsubstituted or C-monosubstituted carboranes using copper(I) t-butoxide when substituents incompatible with the use of C-lithio-intermediates are involved.  The C-copper(I) deriv. of 1,2-dicarba-closo-dodecaborane(12) gives 1,2-di-2'-pyridyl-1,2-dicarba-closo-dodecaborane(12) specifically with 2-bromopyridine.  The (inferred) intermediate mono-2-pyridyl-deriv., obtained independently from 2-ethynylpyridine and the di-Me sulfide complex of decaborane, gives 1-phenyl-2,2'-pyridyl-1,2-dicarba-closo-dodecaborane(12) upon conversion into its copper(I) deriv. and treatment with iododobenzene.  However, the copper(I) deriv. of 1-phenyl-1,2-dicarba-closo-dodecaborane(12) does not react to a significant extent with 2-bromopyridine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeCKX7XjIpibVg90H21EOLACvtfcHk0ljQqqOpmxCg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitFOktbc%253D&md5=cbd713095584fc4dbaf5b88cee325275</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0022-328X%2893%2983337-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-328X%252893%252983337-U%26sid%3Dliteratum%253Aachs%26aulast%3DCoult%26aufirst%3DR.%26aulast%3DFox%26aufirst%3DM.%2BA.%26aulast%3DGill%26aufirst%3DW.%2BR.%26aulast%3DHerbertson%26aufirst%3DP.%2BL.%26aulast%3DMacBride%26aufirst%3DJ.%2BA.%2BH.%26aulast%3DWade%26aufirst%3DK.%26atitle%3DC-Arylation%2520and%2520C-Heteroarylation%2520of%2520Icosahedral%2520Carboranes%2520via%2520Their%2520Copper%2528I%2529%2520Derivatives%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1993%26volume%3D462%26spage%3D19%26epage%3D29%26doi%3D10.1016%2F0022-328X%2893%2983337-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakshi, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V. K.</span></span> <span> </span><span class="NLM_article-title">A Stable and Easily Prepared Catalyst for the Enantioselective Reduction of Ketones. Applications to Multistep Syntheses</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">7925</span>– <span class="NLM_lpage">7926</span>, <span class="refDoi"> DOI: 10.1021/ja00259a075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00259a075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaL1cXnsFShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=7925-7926&author=E.+J.+Coreyauthor=R.+K.+Bakshiauthor=S.+Shibataauthor=C.+P.+Chenauthor=V.+K.+Singh&title=A+Stable+and+Easily+Prepared+Catalyst+for+the+Enantioselective+Reduction+of+Ketones.+Applications+to+Multistep+Syntheses&doi=10.1021%2Fja00259a075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A stable and easily prepared catalyst for the enantioselective reduction of ketones.  Applications to multistep syntheses</span></div><div class="casAuthors">Corey, E. J.; Bakshi, Raman K.; Shibata, Saizo; Chen, Chung Pin; Singh, Vinod K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7925-6</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The readily available and stable oxazaborolidine I is an excellent catalyst for the enantioselective redn. of a wide range of ketones.  The stereochem. course of the redn. is predictable and the secondary alcs. formed are generally produced with high enantioselectivity.  Use of I or its enantiomer provides outstanding control of stereochem. at C(15) in prostaglandin synthesis.  A general and highly enantioselective synthesis of trans-2,5-diarylfurans, potent antagonists of platelet activating factor, also illustrates the value of this enantioselective redn.  Both I and its enantiomer can be obtained from (±)-pyroglutamic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ6p262xrQBrVg90H21EOLACvtfcHk0ljQqqOpmxCg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXnsFShtA%253D%253D&md5=4deaae8502b4e75f0744e46a9e774dec</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja00259a075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00259a075%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DBakshi%26aufirst%3DR.%2BK.%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%2BP.%26aulast%3DSingh%26aufirst%3DV.%2BK.%26atitle%3DA%2520Stable%2520and%2520Easily%2520Prepared%2520Catalyst%2520for%2520the%2520Enantioselective%2520Reduction%2520of%2520Ketones.%2520Applications%2520to%2520Multistep%2520Syntheses%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26spage%3D7925%26epage%3D7926%26doi%3D10.1021%2Fja00259a075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dale, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, H. S.</span></span> <span> </span><span class="NLM_article-title">Nuclear Magnetic Resonance Enantiomer Regents. Configurational Correlations via Nuclear Magnetic Resonance Chemical Shifts of Diastereomeric Mandelate, O-Methylmandelate, and.Alpha.-Methoxy-.Alpha.-Trifluoromethylphenylacetate (MTPA) Esters</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1021/ja00783a034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00783a034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaE3sXotlOjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1973&pages=512-519&author=J.+A.+Daleauthor=H.+S.+Mosher&title=Nuclear+Magnetic+Resonance+Enantiomer+Regents.+Configurational+Correlations+via+Nuclear+Magnetic+Resonance+Chemical+Shifts+of+Diastereomeric+Mandelate%2C+O-Methylmandelate%2C+and.Alpha.-Methoxy-.Alpha.-Trifluoromethylphenylacetate+%28MTPA%29+Esters&doi=10.1021%2Fja00783a034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear magnetic resonance enantiomer regents.  Configurational correlations via nuclear magnetic resonance chemical shifts of diastereomeric mandelate, O-methylmandelate, and α-methoxy-α-trifluoromethylphenylacetate (MTPA) esters</span></div><div class="casAuthors">Dale, James A.; Mosher, Harry S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">512-19</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">An empirically derived correlation of configuration and NMR chem. shifts for diastereomeric mandelate, O-methylmandelate and α-methoxy-α-trifluoromethylphenylacetate esters has been developed and rationalized in terms of useful models.  These models have been successfully applied to over 40 examples.  The correlations involve the relative chem. shifts of the proton resonances from the groups attached to the carbinyl carbon of these diastereomeric esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpul_cMuRtNTLVg90H21EOLACvtfcHk0ljQqqOpmxCg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXotlOjtw%253D%253D&md5=27a7f9c81b89c6b29ffed705dc4f689c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja00783a034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00783a034%26sid%3Dliteratum%253Aachs%26aulast%3DDale%26aufirst%3DJ.%2BA.%26aulast%3DMosher%26aufirst%3DH.%2BS.%26atitle%3DNuclear%2520Magnetic%2520Resonance%2520Enantiomer%2520Regents.%2520Configurational%2520Correlations%2520via%2520Nuclear%2520Magnetic%2520Resonance%2520Chemical%2520Shifts%2520of%2520Diastereomeric%2520Mandelate%252C%2520O-Methylmandelate%252C%2520and.Alpha.-Methoxy-.Alpha.-Trifluoromethylphenylacetate%2520%2528MTPA%2529%2520Esters%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1973%26volume%3D95%26spage%3D512%26epage%3D519%26doi%3D10.1021%2Fja00783a034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoye, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, F.</span></span> <span> </span><span class="NLM_article-title">Mosher Ester Analysis for the Determination of Absolute Configuration of Stereogenic (Chiral) Carbinol Carbons</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2451</span>– <span class="NLM_lpage">2458</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1038%2Fnprot.2007.354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=17947986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOksL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=2451-2458&author=T.+R.+Hoyeauthor=C.+S.+Jeffreyauthor=F.+Shao&title=Mosher+Ester+Analysis+for+the+Determination+of+Absolute+Configuration+of+Stereogenic+%28Chiral%29+Carbinol+Carbons&doi=10.1038%2Fnprot.2007.354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Mosher ester analysis for the determination of absolute configuration of stereogenic (chiral) carbinol carbons</span></div><div class="casAuthors">Hoye, Thomas R.; Jeffrey, Christopher S.; Shao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2451-2458</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This protocol details the most commonly used NMR-based method for deducing the configuration of otherwise unknown stereogenic, secondary carbinol (alc.) centers (R1R2CHOH (or the analogous amines where OH is replaced by NH2)).  This 'Mosher ester anal.' relies on the fact that the protons in diastereomeric α-methoxy-α-trifluoromethylphenylacetic acid (MTPA) esters (i.e., those derived from conjugation of the carbinol under interrogation with MTPA) display different arrays of chem. shifts (δs) in their 1H NMR spectra.  The protocol consists of the following: (i) prepn. of each of the diastereomeric S- and R-MTPA esters and (ii) comparative (ΔδSR) anal. of the 1H NMR spectral data of these two esters.  By analyzing the sign of the difference in chem. shifts for a no. of analogous pairs of protons (the set of ΔδSR values) in the diastereomeric esters (or amides), the abs. configuration of the original carbinol (or amino) stereocenter can be reliably deduced.  A typical Mosher ester anal. requires approx. 4-6 h of active effort over a 1- to 2-d period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdQys4JRj4LVg90H21EOLACvtfcHk0ljoaUFbRAa8sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOksL3E&md5=741bb9fd8eb7c18c310196f298e5ea3f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.354%26sid%3Dliteratum%253Aachs%26aulast%3DHoye%26aufirst%3DT.%2BR.%26aulast%3DJeffrey%26aufirst%3DC.%2BS.%26aulast%3DShao%26aufirst%3DF.%26atitle%3DMosher%2520Ester%2520Analysis%2520for%2520the%2520Determination%2520of%2520Absolute%2520Configuration%2520of%2520Stereogenic%2520%2528Chiral%2529%2520Carbinol%2520Carbons%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D2451%26epage%3D2458%26doi%3D10.1038%2Fnprot.2007.354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Androgen Receptor Full Antagonists Bearing a P-Carborane Cage: Promising Ligands for Anti-Androgen Withdrawal Syndrome</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">4917</span>– <span class="NLM_lpage">4926</span>, <span class="refDoi"> DOI: 10.1021/jm100316f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100316f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFaktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4917-4926&author=T.+Gotoauthor=K.+Ohtaauthor=S.+Fujiiauthor=S.+Ohtaauthor=Y.+Endo&title=Design+and+Synthesis+of+Androgen+Receptor+Full+Antagonists+Bearing+a+P-Carborane+Cage%3A+Promising+Ligands+for+Anti-Androgen+Withdrawal+Syndrome&doi=10.1021%2Fjm100316f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Androgen Receptor Full Antagonists Bearing a p-Carborane Cage: Promising Ligands for Anti-Androgen Withdrawal Syndrome</span></div><div class="casAuthors">Goto, Tokuhito; Ohta, Kiminori; Fujii, Shinya; Ohta, Shigeru; Endo, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4917-4926</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pure androgen receptor (AR) full antagonists are candidates to treat anti-androgen refractory prostate cancers.  We previously developed a carborane-contg. AR antagonist, 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecaborane-1-yl)benzonitrile (BA341), which was more potent than hydroxyflutamide (4) but acted as an agonist toward LNCaP prostate cancer cells expressing T877A AR mutant.  Here, we designed and synthesized novel AR full antagonists, 3-[12-(1-hydroxy-2-Ar-ethyl)-1,12-dicarba-closo-dodecaborane-1-yl]benzonitrile (e.g., Ar = 4-XC6H4O, X = F 7b, MeO, NO2, NHCOMe and Ar = 4-XC6H4S, X = H, F 8b, MeO, NHCOMe, CF3 and Ar = 4-XC6H4SO2) structurally based upon the clin. used AR full antagonist (R)-bicalutamide (5) to test our hypothesis that the carborane cage is suitable as a hydrophobic pharmacophore for AR ligands.  7A and 8b showed good biol. profiles in AR binding and transactivation assays and dose-dependently inhibited the testosterone-induced proliferation of LNCaP cells, as well as SC-3 cells.  The IC50 values of compds. 7b and 8b were 3.8 × 10-7 and 4.2 × 10-7 M, resp. [5, 8.7 × 10-7 M].  Since compds. 7b and 8b did not show any agonistic activity in functional assays, they seem to be pure AR full antagonists and are therefore candidates for treatment of anti-androgen withdrawal syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC-PU3ZvWrSLVg90H21EOLACvtfcHk0ljoaUFbRAa8sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFaktbs%253D&md5=e1df86c4bdb95869f329aac6442419d7</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm100316f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100316f%26sid%3Dliteratum%253Aachs%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DY.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Androgen%2520Receptor%2520Full%2520Antagonists%2520Bearing%2520a%2520P-Carborane%2520Cage%253A%2520Promising%2520Ligands%2520for%2520Anti-Androgen%2520Withdrawal%2520Syndrome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4917%26epage%3D4926%26doi%3D10.1021%2Fjm100316f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawahata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure, Docking Study and Structure–Activity Relationship of Carborane-Containing Androgen Receptor Antagonist 3-(12-Hydroxymethyl-1,12-Dicarba-<i>closo</i>-Dodecaboran-1-Yl)Benzonitrile</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3540</span>– <span class="NLM_lpage">3548</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.bmc.2011.04.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=21536446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFWmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3540-3548&author=K.+Ohtaauthor=T.+Gotoauthor=S.+Fujiiauthor=M.+Kawahataauthor=A.+Odaauthor=S.+Ohtaauthor=K.+Yamaguchiauthor=S.+Hironoauthor=Y.+Endo&title=Crystal+Structure%2C+Docking+Study+and+Structure%E2%80%93Activity+Relationship+of+Carborane-Containing+Androgen+Receptor+Antagonist+3-%2812-Hydroxymethyl-1%2C12-Dicarba-closo-Dodecaboran-1-Yl%29Benzonitrile&doi=10.1016%2Fj.bmc.2011.04.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure, docking study and structure-activity relationship of carborane-containing androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closo-dodecarboran-1-yl)benzonitrile</span></div><div class="casAuthors">Ohta, Kiminori; Goto, Tokuhito; Fujii, Shinya; Kawahata, Masatoshi; Oda, Akifumi; Ohta, Shigeru; Yamaguchi, Kentaro; Hirono, Shuichi; Endo, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3540-3548</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A potent androgen receptor (AR) antagonist, 3-(12-hydroxymethyl-1,12 dicarba-closo-dodecarboran-1-yl)benzonitrile (3a, BA341), contains a p-carborane cage as a hydrophobic pharmacophore.  We elucidated the structural properties of 3a by single-crystal x-ray diffraction anal. and conducted a docking study of 3a with hAR LBD.  The cyano group of 3a formed hydrogen bonds with Gln711 and Arg752 and the hydroxymethyl group did so with Asn705 and Thr877 in hAR LBD.  The bulky p-carborane cage was accommodated in the hydrophobic pocket of hAR LBD.  To understand the structure-activity relation around the hydroxymethyl group of 3a, we designed, synthesized, and evaluated the biol. activities of various novel AR ligands.  Since the biol. activities of carbonyl compds. 8a, 8b, and 8c were similar to or weaker than those of the parent hydroxyl compds. 3a, 7a, and 7b, it seems to be necessary to have not only a hydrogen bonding acceptor, but also a hydrogen bonding donor adjacent to the hydroxymethyl group of 3a for efficient interaction with hAR LBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxmUphWEEIirVg90H21EOLACvtfcHk0ljoaUFbRAa8sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFWmt7Y%253D&md5=ad316a904afbef54577cf99651706340</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DKawahata%26aufirst%3DM.%26aulast%3DOda%26aufirst%3DA.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DY.%26atitle%3DCrystal%2520Structure%252C%2520Docking%2520Study%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520of%2520Carborane-Containing%2520Androgen%2520Receptor%2520Antagonist%25203-%252812-Hydroxymethyl-1%252C12-Dicarba-closo-Dodecaboran-1-Yl%2529Benzonitrile%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3540%26epage%3D3548%26doi%3D10.1016%2Fj.bmc.2011.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anzenbacher, P.</span>; <span class="NLM_string-name">Zanger, U. M.</span></span>, Eds.  <i>Metabolism of Drugs and Other Xenobiotics</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">John Wiley & Sons, Ltd.</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1002%2F9783527630905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Anzenbacher&author=U.+M.+Zanger&title=Metabolism+of+Drugs+and+Other+Xenobiotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F9783527630905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527630905%26sid%3Dliteratum%253Aachs%26aulast%3DAnzenbacher%26aufirst%3DP.%26btitle%3DMetabolism%2520of%2520Drugs%2520and%2520Other%2520Xenobiotics%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conney, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Oxidative Metabolites of 17β-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">3382</span>– <span class="NLM_lpage">3398</span>, <span class="refDoi"> DOI: 10.1210/en.2003-0192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fen.2003-0192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=12865317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=3382-3398&author=A.+J.+Leeauthor=M.+X.+Caiauthor=P.+E.+Thomasauthor=A.+H.+Conneyauthor=B.+T.+Zhu&title=Characterization+of+the+Oxidative+Metabolites+of+17%CE%B2-Estradiol+and+Estrone+Formed+by+15+Selectively+Expressed+Human+Cytochrome+P450+Isoforms&doi=10.1210%2Fen.2003-0192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms</span></div><div class="casAuthors">Lee, Anthony J.; Cai, May Xiaoxin; Thomas, Paul E.; Conney, Allan H.; Zhu, Bao Ting</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3382-3398</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">We systematically characterized the oxidative metabolites of 17β-estradiol and estrone formed by 15 human cytochrome P 450 (CYP) isoforms.  CYP1A1 had high activity for 17β-estradiol 2-hydroxylation, followed by 15α-, 6α-, 4-, and 7α-hydroxylation.  However, when estrone was the substrate, CYP1A1 formed more 4-hydroxyestrone than 15α- or 6α-hydroxyestrone, with 2-hydroxyestrone as the major metabolite.  CYP1A2 had the highest activity for the 2-hydroxylation of both 17β-estradiol and estrone, although it also had considerable activity for their 4-hydroxylation (9-13% of 2-hydroxylation).  CYP1B1 mainly catalyzed the formation of catechol estrogens, with 4-hydroxyestrogens predominant.  CYP2A6, 2B6, 2C8, 2C9, 2C19, and 2D6 each showed a varying degree of low catalytic activity for estrogen 2-hydroxylation, whereas CYP2C18 and CYP2E1 did not show any detectable estrogen-hydroxylating activity.  CYP3A4 had strong activity for the formation of 2-hydroxyestradiol, followed by 4-hydroxyestradiol and an unknown polar metabolite, and small amts. of 16α- and 16β-hydroxyestrogens were also formed.  The ratio of 4- to 2-hydroxylation of 17β-estradiol or estrone with CYP3A4 was 0.22 or 0.51, resp.  CYP3A5 had similar catalytic activity for the formation of 2- and 4-hydroxyestrogens.  Notably, CYP3A5 had an unusually high ratio of 4- to 2-hydroxylation of 17β-estradiol or estrone (0.53 or 1.26, resp.).  CYP3A4 and 3A5 also catalyzed the formation of nonpolar estrogen metabolite peaks (chromatog. less polar than estrone).  CYP3A7 had a distinct catalytic activity for the 16α-hydroxylation of estrone, but not 17β-estradiol.  CYP4A11 had little catalytic activity for the metab. of 17β-estradiol and estrone.  In conclusion, many human CYP isoforms are involved in the oxidative metab. of 17β-estradiol and estrone, with a varying degree of catalytic activity and distinct regioselectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5q2Y1i5eYsrVg90H21EOLACvtfcHk0lhoSTN1wXF-8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGjsb0%253D&md5=dc77411de262647d6fcf0c28c27d66e7</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1210%2Fen.2003-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2003-0192%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BJ.%26aulast%3DCai%26aufirst%3DM.%2BX.%26aulast%3DThomas%26aufirst%3DP.%2BE.%26aulast%3DConney%26aufirst%3DA.%2BH.%26aulast%3DZhu%26aufirst%3DB.%2BT.%26atitle%3DCharacterization%2520of%2520the%2520Oxidative%2520Metabolites%2520of%252017%25CE%25B2-Estradiol%2520and%2520Estrone%2520Formed%2520by%252015%2520Selectively%2520Expressed%2520Human%2520Cytochrome%2520P450%2520Isoforms%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D3382%26epage%3D3398%26doi%3D10.1210%2Fen.2003-0192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yano, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wester, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoch, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span> <span> </span><span class="NLM_article-title">The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">38091</span>– <span class="NLM_lpage">38094</span>, <span class="refDoi"> DOI: 10.1074/jbc.C400293200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1074%2Fjbc.C400293200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=15258162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1Oqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=38091-38094&author=J.+K.+Yanoauthor=M.+R.+Westerauthor=G.+A.+Schochauthor=K.+J.+Griffinauthor=C.+D.+Stoutauthor=E.+F.+Johnson&title=The+Structure+of+Human+Microsomal+Cytochrome+P450+3A4+Determined+by+X-ray+Crystallography+to+2.05-%C3%85+Resolution&doi=10.1074%2Fjbc.C400293200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution</span></div><div class="casAuthors">Yano, Jason K.; Wester, Michael R.; Schoch, Guillaume A.; Griffin, Keith J.; Stout, C. David; Johnson, Eric F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">38091-38094</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The structure of P 450 3A4 was detd. by x-ray crystallog. to 2.05-Å resoln.  P 450 3A4 catalyzes the metabolic clearance of a large no. of clin. used drugs, and a no. of adverse drug-drug interactions reflect the inhibition or induction of the enzyme.  P 450 3A4 exhibits a relatively large substrate-binding cavity that is consistent with its capacity to oxidize bulky substrates such as cyclosporin, statins, taxanes, and macrolide antibiotics.  Family 3A P450s also exhibit unusual kinetic characteristics that suggest simultaneous occupancy by smaller substrates.  Although the active site vol. is similar to that of P 450 2C8 (PDB code: 1PQ2), the shape of the active site cavity differs considerably due to differences in the folding and packing of portions of the protein that form the cavity.  Compared with P 450 2C8, the active site cavity of 3A4 is much larger near the heme iron.  The lower constraints on the motions of small substrates near the site of oxygen activation may diminish the efficiency of substrate oxidn., which may in turn be improved by space restrictions imposed by the presence of a second substrate mol.  The structure of P 450 3A4 should facilitate a better understanding of the substrate selectivity of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpOI8NmLt-drVg90H21EOLACvtfcHk0lhoSTN1wXF-8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1Oqs7c%253D&md5=59a8fa760069d365165ddeeb9e4081d4</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C400293200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C400293200%26sid%3Dliteratum%253Aachs%26aulast%3DYano%26aufirst%3DJ.%2BK.%26aulast%3DWester%26aufirst%3DM.%2BR.%26aulast%3DSchoch%26aufirst%3DG.%2BA.%26aulast%3DGriffin%26aufirst%3DK.%2BJ.%26aulast%3DStout%26aufirst%3DC.%2BD.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26atitle%3DThe%2520Structure%2520of%2520Human%2520Microsomal%2520Cytochrome%2520P450%25203A4%2520Determined%2520by%2520X-ray%2520Crystallography%2520to%25202.05-%25C3%2585%2520Resolution%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D38091%26epage%3D38094%26doi%3D10.1074%2Fjbc.C400293200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anzenbacherová, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bec, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzenbacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudecek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, R.</span></span> <span> </span><span class="NLM_article-title">Flexibility and Stability of the Structure of Cytochromes P450 3A4 and BM-3</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">2916</span>– <span class="NLM_lpage">2920</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.2000.01305.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1046%2Fj.1432-1327.2000.01305.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10806389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1Gjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=2916-2920&author=E.+Anzenbacherov%C3%A1author=N.+Becauthor=P.+Anzenbacherauthor=J.+Hudecekauthor=P.+Soucekauthor=C.+Jungauthor=A.+W.+Munroauthor=R.+Lange&title=Flexibility+and+Stability+of+the+Structure+of+Cytochromes+P450+3A4+and+BM-3&doi=10.1046%2Fj.1432-1327.2000.01305.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Flexibility and stability of the structure of cytochromes P450 3A4 and BM-3</span></div><div class="casAuthors">Anzenbacherova, Eva; Bec, Nicole; Anzenbacher, Pavel; Hudecek, Jiri; Soucek, Pavel; Jung, Christiane; Munro, Andrew W.; Lange, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2916-2920</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The flexibility of the structure and compressibility of the resp. active site of cytochromes P 450 3A4 (CYP3A4) and BM-3 (CYP102) were studied using absorption spectroscopy in the UV and visual regions.  Conformational changes in the overall protein structures of both CYP3A4 and CYP102 due to the effects of temp. and pressure are reversible.  However, the enzymes differ in the properties of their active sites.  The CYP3A4 enzyme denatures to the inactive P420 form relatively easy, at 3000 bar over half is converted to P420.  The compressibility of its active site is lower than that of CYP102 and is greater with the substrate bound, which is in line with the obsd. lack of a stabilizing effect of the substrate on its conformation under pressure.  In contrast, CYP102, although having the most compressible active site among the P450s, possesses a structure that does not denature easily to the inactive (P420) form under pressure.  In this respect, it resembles the P 450 isolated from acidothermophilic archaebacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4IkUTFriMV7Vg90H21EOLACvtfcHk0lhoSTN1wXF-8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1Gjs7w%253D&md5=9e358cae19770cf66d9ec8cd6ffe595e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01305.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01305.x%26sid%3Dliteratum%253Aachs%26aulast%3DAnzenbacherov%25C3%25A1%26aufirst%3DE.%26aulast%3DBec%26aufirst%3DN.%26aulast%3DAnzenbacher%26aufirst%3DP.%26aulast%3DHudecek%26aufirst%3DJ.%26aulast%3DSoucek%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DC.%26aulast%3DMunro%26aufirst%3DA.%2BW.%26aulast%3DLange%26aufirst%3DR.%26atitle%3DFlexibility%2520and%2520Stability%2520of%2520the%2520Structure%2520of%2520Cytochromes%2520P450%25203A4%2520and%2520BM-3%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D2916%26epage%3D2920%26doi%3D10.1046%2Fj.1432-1327.2000.01305.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leathurby, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mewshaw, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharode, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzolf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komm, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneker, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frail, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, J. C.</span></span> <span> </span><span class="NLM_article-title">Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">4241</span>– <span class="NLM_lpage">4249</span>, <span class="refDoi"> DOI: 10.1210/en.2003-0550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1210%2Fen.2003-0550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=14500559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Srt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=4241-4249&author=H.+A.+Harrisauthor=L.+M.+Albertauthor=Y.+Leathurbyauthor=M.+S.+Malamasauthor=R.+E.+Mewshawauthor=C.+P.+Millerauthor=Y.+P.+Kharodeauthor=J.+Marzolfauthor=B.+S.+Kommauthor=R.+C.+Winnekerauthor=D.+E.+Frailauthor=R.+A.+Hendersonauthor=Y.+Zhuauthor=J.+C.+Keith&title=Evaluation+of+an+Estrogen+Receptor-%CE%B2+Agonist+in+Animal+Models+of+Human+Disease&doi=10.1210%2Fen.2003-0550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of an estrogen receptor-β agonist in animal models of human disease</span></div><div class="casAuthors">Harris, Heather A.; Albert, Leo M.; Leathurby, Yelena; Malamas, Michael S.; Mewshaw, Richard E.; Miller, Chris P.; Kharode, Yogendra P.; Marzolf, James; Komm, Barry S.; Winneker, Richard C.; Frail, Donald E.; Henderson, Ruth A.; Zhu, Yuan; Keith, James C., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4241-4249</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The discovery of a second estrogen receptor (ER), called ERβ, in 1996 sparked intense interest within the scientific community to discover its role in mediating estrogen action.  However, despite more than 6 yr of research into the function of this receptor, its physiol. role in mediating estrogen action remains unclear and controversial.  We have developed a series of highly selective agonists for ERβ and have characterized their activity in several clin. relevant rodent models of human disease.  The activity of one such compd., ERB-041, is reported here.  We conclude from these studies that ERβ does not mediate the bone-sparing activity of estrogen on the rat skeleton and that it does not affect ovulation or ovariectomy-induced wt. gain.  In addn., these compds. are nonuterotrophic and nonmammotrophic.  However, ERB-041 has a dramatic beneficial effect in the HLA-B27 transgenic rat model of inflammatory bowel disease and the Lewis rat adjuvant-induced arthritis model.  Daily oral doses as low as 1 mg/kg reverse the chronic diarrhea of HLA-B27 transgenic rats and dramatically improve histol. disease scores in the colon.  The same dosing regimen in the therapeutic adjuvant-induced arthritis model reduces joint scores from 12 (maximal inflammation) to 1 over a period of 10 d.  Synovitis and Mankin (articular cartilage) histol. scores are also significantly lowered (50-75%).  These data suggest that one function of ERβ may be to modulate the immune response, and that ERβ-selective ligands may be therapeutically useful agents to treat chronic intestinal and joint inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcqFZcYmicf7Vg90H21EOLACvtfcHk0lgTiOF1VP5BZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Srt7o%253D&md5=ed1255fd36790a7b9bc665624e5a4619</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1210%2Fen.2003-0550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2003-0550%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DH.%2BA.%26aulast%3DAlbert%26aufirst%3DL.%2BM.%26aulast%3DLeathurby%26aufirst%3DY.%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DMiller%26aufirst%3DC.%2BP.%26aulast%3DKharode%26aufirst%3DY.%2BP.%26aulast%3DMarzolf%26aufirst%3DJ.%26aulast%3DKomm%26aufirst%3DB.%2BS.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26aulast%3DFrail%26aufirst%3DD.%2BE.%26aulast%3DHenderson%26aufirst%3DR.%2BA.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DKeith%26aufirst%3DJ.%2BC.%26atitle%3DEvaluation%2520of%2520an%2520Estrogen%2520Receptor-%25CE%25B2%2520Agonist%2520in%2520Animal%2520Models%2520of%2520Human%2520Disease%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D4241%26epage%3D4249%26doi%3D10.1210%2Fen.2003-0550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fulmer, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherden, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bercaw, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, K. I.</span></span> <span> </span><span class="NLM_article-title">NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2176</span>– <span class="NLM_lpage">2179</span>, <span class="refDoi"> DOI: 10.1021/om100106e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om100106e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslKms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=2176-2179&author=G.+R.+Fulmerauthor=A.+J.+M.+Millerauthor=N.+H.+Sherdenauthor=H.+E.+Gottliebauthor=A.+Nudelmanauthor=B.+M.+Stoltzauthor=J.+E.+Bercawauthor=K.+I.+Goldberg&title=NMR+Chemical+Shifts+of+Trace+Impurities%3A+Common+Laboratory+Solvents%2C+Organics%2C+and+Gases+in+Deuterated+Solvents+Relevant+to+the+Organometallic+Chemist&doi=10.1021%2Fom100106e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist</span></div><div class="casAuthors">Fulmer, Gregory R.; Miller, Alexander J. M.; Sherden, Nathaniel H.; Gottlieb, Hugo E.; Nudelman, Abraham; Stoltz, Brian M.; Bercaw, John E.; Goldberg, Karen I.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2176-2179</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tables of 1H and 13C NMR chem. shifts have been compiled for common org. compds. often used as reagents or found as products or contaminants in deuterated org. solvents.  Building upon the work of Gottlieb, Kotlyar, and Nudelman in the Journal of Org. Chem., signals for common impurities are now reported in addnl. NMR solvents (tetrahydrofuran-d8, toluene-d8, dichloromethane-d2, chlorobenzene-d5, and 2,2,2-trifluoroethanol-d3) which are frequently used in organometallic labs.  Chem. shifts for other orgs. which are often used as reagents or internal stds. or are found as products in organometallic chem. are also reported for all the listed solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3GGHumCq_P7Vg90H21EOLACvtfcHk0lgTiOF1VP5BZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslKms7Y%253D&md5=53317e05fe3be77fe7de48d8fe1fb8b7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fom100106e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom100106e%26sid%3Dliteratum%253Aachs%26aulast%3DFulmer%26aufirst%3DG.%2BR.%26aulast%3DMiller%26aufirst%3DA.%2BJ.%2BM.%26aulast%3DSherden%26aufirst%3DN.%2BH.%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DNudelman%26aufirst%3DA.%26aulast%3DStoltz%26aufirst%3DB.%2BM.%26aulast%3DBercaw%26aufirst%3DJ.%2BE.%26aulast%3DGoldberg%26aufirst%3DK.%2BI.%26atitle%3DNMR%2520Chemical%2520Shifts%2520of%2520Trace%2520Impurities%253A%2520Common%2520Laboratory%2520Solvents%252C%2520Organics%252C%2520and%2520Gases%2520in%2520Deuterated%2520Solvents%2520Relevant%2520to%2520the%2520Organometallic%2520Chemist%26jtitle%3DOrganometallics%26date%3D2010%26volume%3D29%26spage%3D2176%26epage%3D2179%26doi%3D10.1021%2Fom100106e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thirumamagal, B. T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyaya, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnsamuel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golightly, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jehning, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backer, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barth, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjarks, W.</span></span> <span> </span><span class="NLM_article-title">Receptor-Targeted Liposomal Delivery of Boron-Containing Cholesterol Mimics for Boron Neutron Capture Therapy (BNCT)</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1141</span>– <span class="NLM_lpage">1150</span>, <span class="refDoi"> DOI: 10.1021/bc060075d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc060075d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2ltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=1141-1150&author=B.+T.+S.+Thirumamagalauthor=X.+B.+Zhaoauthor=A.+K.+Bandyopadhyayaauthor=J.+Johnsamuelauthor=R.+Tiwariauthor=D.+W.+Golightlyauthor=V.+Patelauthor=B.+T.+Jehningauthor=M.+V.+Backerauthor=R.+F.+Barthauthor=R.+J.+Leeauthor=J.+M.+Backerauthor=W.+Tjarks&title=Receptor-Targeted+Liposomal+Delivery+of+Boron-Containing+Cholesterol+Mimics+for+Boron+Neutron+Capture+Therapy+%28BNCT%29&doi=10.1021%2Fbc060075d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor-Targeted Liposomal Delivery of Boron-Containing Cholesterol Mimics for Boron Neutron Capture Therapy (BNCT)</span></div><div class="casAuthors">Thirumamagal, B. T. S.; Zhao, Xiaobin B.; Bandyopadhyaya, Achintya K.; Narayanasamy, Sureshbabu; Johnsamuel, Jayaseharan; Tiwari, Rohit; Golightly, Danold W.; Patel, Vimalkumar; Jehning, Brian T.; Backer, Marina V.; Barth, Rolf F.; Lee, Robert J.; Backer, Joseph M.; Tjarks, Werner</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1141-1150</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liposomes have been a main focus of tumor-selective boron delivery strategies in boron neutron capture therapy (BNCT), a binary method for the treatment of cancer that is based on the nuclear reaction between boron atoms and low-energy thermal neutrons.  Three novel carboranyl cholesterol derivs. were prepd. as lipid bilayer components for the construction of nontargeted and receptor-targeted boronated liposomes for BNCT.  A major structural feature of these novel boronated cholesterol mimics is the replacement of the B and the C ring of cholesterol with a carborane cluster.  Computational analyses indicated that all three boronated compds. have structural features and physicochem. properties that are very similar to those of cholesterol.  One of the synthesized boronated cholesterol mimics was stably incorporated into non-, folate receptor (FR)-, and vascular endothelial growth factor receptor-2 (VEGFR-2)-targeted liposomes.  No major differences were found in appearance, size distribution, and lamellarity between conventional dipalmitoylphosphatidylcholine (DPPC)/cholesterol liposomes, nontargeted, and FR-targeted liposomal formulations of this carboranyl cholesterol deriv.  FR-targeted boronated liposomes were taken up extensively in FR overexpressing KB cells in vitro, and the uptake was effectively blocked in the presence of free folate.  In contrast, a boronated cholesterol mimic incorporated into nontargeted liposomes showed significantly lower cellular uptake.  There was no apparent in vitro cytotoxicity in FR overexpressing KB cells and VEGFR-2 overexpressing 293/KDR cells when these were incubated with boronated FR- and (VEGFR-2)-targeted liposomes, resp., although the former accumulated extensively in KB cells and the latter effectively interacted with VEGFR-2 by causing autophosphorylation and protecting 293/KDR cells from SLT (Shiga-like toxin)-VEGF cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTeLUOoPO0-LVg90H21EOLACvtfcHk0lgxTl8p0DLrog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2ltbs%253D&md5=4a6a65107118389c48d5ee8233e563f8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fbc060075d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc060075d%26sid%3Dliteratum%253Aachs%26aulast%3DThirumamagal%26aufirst%3DB.%2BT.%2BS.%26aulast%3DZhao%26aufirst%3DX.%2BB.%26aulast%3DBandyopadhyaya%26aufirst%3DA.%2BK.%26aulast%3DJohnsamuel%26aufirst%3DJ.%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DGolightly%26aufirst%3DD.%2BW.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DJehning%26aufirst%3DB.%2BT.%26aulast%3DBacker%26aufirst%3DM.%2BV.%26aulast%3DBarth%26aufirst%3DR.%2BF.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DBacker%26aufirst%3DJ.%2BM.%26aulast%3DTjarks%26aufirst%3DW.%26atitle%3DReceptor-Targeted%2520Liposomal%2520Delivery%2520of%2520Boron-Containing%2520Cholesterol%2520Mimics%2520for%2520Boron%2520Neutron%2520Capture%2520Therapy%2520%2528BNCT%2529%26jtitle%3DBioconjugate%2520Chem.%26date%3D2006%26volume%3D17%26spage%3D1141%26epage%3D1150%26doi%3D10.1021%2Fbc060075d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kagechika, H.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Nonsteroidal Progesterone Receptor Antagonists Based on C,C′-Diphenylcarborane Scaffold as a Hydrophobic Pharmacophore</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2Fj.ejmech.2014.07.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=25036787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=264-277&author=S.+Fujiiauthor=A.+Yamadaauthor=E.+Nakanoauthor=Y.+Takeuchiauthor=S.+Moriauthor=H.+Masunoauthor=H.+Kagechika&title=Design+and+Synthesis+of+Nonsteroidal+Progesterone+Receptor+Antagonists+Based+on+C%2CC%E2%80%B2-Diphenylcarborane+Scaffold+as+a+Hydrophobic+Pharmacophore&doi=10.1016%2Fj.ejmech.2014.07.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of nonsteroidal progesterone receptor antagonists based on C,C'-diphenylcarborane scaffold as a hydrophobic pharmacophore</span></div><div class="casAuthors">Fujii, Shinya; Yamada, Ayumi; Nakano, Eiichi; Takeuchi, Yuki; Mori, Shuichi; Masuno, Hiroyuki; Kagechika, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">264-277</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The progesterone receptor (PR) plays important roles in multiple physiol. processes, including female reprodn.  Here, we report the synthesis of nonsteroidal PR antagonists contg. a boron cluster as the hydrophobic core.  We found that 1,7-diphenyl-meta-carborane was the preferred substructure among the three carborane isomers.  One compd. was a potent PR antagonist (IC50: 29 nM).  Another compd. also exhibited potent activity (IC50: 93 nM), and did not bind to androgen receptor, glucocorticoid receptor or mineralocorticoid receptor.  These compds. may be useful for investigating potential clin. applications of PR modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogJLt5FaVnb7Vg90H21EOLACvtfcHk0lgxTl8p0DLrog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7bF&md5=5b524301e7d8a908c6848a54652d2dc5</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DA.%26aulast%3DNakano%26aufirst%3DE.%26aulast%3DTakeuchi%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DMasuno%26aufirst%3DH.%26aulast%3DKagechika%26aufirst%3DH.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Nonsteroidal%2520Progesterone%2520Receptor%2520Antagonists%2520Based%2520on%2520C%252CC%25E2%2580%25B2-Diphenylcarborane%2520Scaffold%2520as%2520a%2520Hydrophobic%2520Pharmacophore%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D264%26epage%3D277%26doi%3D10.1016%2Fj.ejmech.2014.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sedlak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paguio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartunek, P.</span></span> <span> </span><span class="NLM_article-title">Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.2174/138620711795222446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.2174%2F138620711795222446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=21375502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslagtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=248-266&author=D.+Sedlakauthor=A.+Paguioauthor=P.+Bartunek&title=Two+Panels+of+Steroid+Receptor+Luciferase+Reporter+Cell+Lines+for+Compound+Profiling&doi=10.2174%2F138620711795222446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Two panels of steroid receptor luciferase reporter cell lines for compound profiling</span></div><div class="casAuthors">Sedlak, David; Paguio, Aileen; Bartunek, Petr</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">248-266</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Steroid hormone receptors represent a major target in drug discovery.  As ligand inducible transcription factors, their activity can be modulated by small lipophilic mols.  Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroid receptor activity (U2OS).  The panels contain reporter cell lines for estrogen receptors α and β, androgen, glucocorticoid, mineralocorticoid, and progesterone receptors.  In the first panel, the activation of either synthetic, steroid response elements contg. promoter or viral promoter is mediated by full-length steroid receptors.  The second panel is based on the expression of the chimeric receptor, which was created by the replacement of the N-terminal part of the mol. by Gal4 DBD and that binds to multiple UAS sites in the reporter promoter.  Both panels were extensively characterized by profiling 28 ligands in dose response manner in agonist and antagonist mode.  We have analyzed and compared the responses to tested ligands from both panels and concluded that in general both systems generated similar qual. response in terms of potency, efficacy, partial agonism/antagonism, mixed agonistic/antagonistic profiles and the rank of potencies was well conserved between both panels.  However, we have also identified some artifacts introduced by the Gal4/LBD reporter assays in contrast to their full-length receptor reporter counterparts.  Keeping in mind the advantages and drawbacks of each reporter format, these cell lines represent powerful and selective tools for profiling large compd. libraries (HTS) and for detailed study of mechanisms by which compds. exert their biol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOMFFn8pEkmbVg90H21EOLACvtfcHk0lgxTl8p0DLrog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslagtL8%253D&md5=0a021e26cec2615f445f7b3d18625c39</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.2174%2F138620711795222446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620711795222446%26sid%3Dliteratum%253Aachs%26aulast%3DSedlak%26aufirst%3DD.%26aulast%3DPaguio%26aufirst%3DA.%26aulast%3DBartunek%26aufirst%3DP.%26atitle%3DTwo%2520Panels%2520of%2520Steroid%2520Receptor%2520Luciferase%2520Reporter%2520Cell%2520Lines%2520for%2520Compound%2520Profiling%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2011%26volume%3D14%26spage%3D248%26epage%3D266%26doi%3D10.2174%2F138620711795222446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung-Chi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prusoff, W. H.</span></span> <span> </span><span class="NLM_article-title">Relationship between the Inhibition Constant (KI) and the Concentration of Inhibitor Which Causes 50 per Cent Inhibition (I50) of an Enzymatic Reaction</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3099</span>– <span class="NLM_lpage">3108</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=4202581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=C.+Yung-Chiauthor=W.+H.+Prusoff&title=Relationship+between+the+Inhibition+Constant+%28KI%29+and+the+Concentration+of+Inhibitor+Which+Causes+50+per+Cent+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DYung-Chi%26aufirst%3DC.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520Inhibition%2520Constant%2520%2528KI%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">Enzymatic Analysis of CDNA-Expressed Human CYP1A1, CYP1A2, and CYP1B1 with 7-Ethoxyresorufin as Substrate</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">90</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=85-90&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DT.%2BK.%2BH.%26atitle%3DEnzymatic%2520Analysis%2520of%2520CDNA-Expressed%2520Human%2520CYP1A1%252C%2520CYP1A2%252C%2520and%2520CYP1B1%2520with%25207-Ethoxyresorufin%2520as%2520Substrate%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souček, P.</span></span> <span> </span><span class="NLM_article-title">Novel Sensitive High-Performance Liquid Chromatographic Method for Assay of Coumarin 7-Hydroxylation</span>. <i>J. Chromatogr. B: Biomed. Sci. Appl.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>734</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/S0378-4347(99)00325-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1016%2FS0378-4347%2899%2900325-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10574186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK1MXns1Ghtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=734&publication_year=1999&pages=23-29&author=P.+Sou%C4%8Dek&title=Novel+Sensitive+High-Performance+Liquid+Chromatographic+Method+for+Assay+of+Coumarin+7-Hydroxylation&doi=10.1016%2FS0378-4347%2899%2900325-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation</span></div><div class="casAuthors">Soucek, Pavel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Biomedical Sciences and Applications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">734</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">JCBBEP</span>;
        ISSN:<span class="NLM_cas:issn">0378-4347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">In this paper, a novel HPLC-based method with fluorometric detection of coumarin 7-hydroxylase is presented.  The described method provides a time-effective, more sensitive and specific alternative to the previously used spectrofluorometric assay.  Using the developed method, metab. of coumarin in 11 samples of human liver microsomes was evaluated and 1790±690 pmol/min/nmol cytochrome P 450 (CYP) activity was found.  Kinetic parameters and linearity of coumarin 7-hydroxylation were studied in a reconstituted system consisting of recombinant CYP2A6 expressed in Escherichia coli, rat NADPH-CYP reductase and usual components.  It was found that a 3.5 to 30 min time of incubation is suitable for estn. of coumarin 7-hydroxylase activity.  Obsd. Km and Vmax values in the CYP2A6 reconstituted system were 1.48±0.37 μM and 3360±180 pmol product/min/nmol CYP, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpprm2RYIioLbVg90H21EOLACvtfcHk0liZfingdk1f6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXns1Ghtbw%253D&md5=313b3ef1e8521fa185c493775b679005</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0378-4347%2899%2900325-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-4347%252899%252900325-4%26sid%3Dliteratum%253Aachs%26aulast%3DSou%25C4%258Dek%26aufirst%3DP.%26atitle%3DNovel%2520Sensitive%2520High-Performance%2520Liquid%2520Chromatographic%2520Method%2520for%2520Assay%2520of%2520Coumarin%25207-Hydroxylation%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Biomed.%2520Sci.%2520Appl.%26date%3D1999%26volume%3D734%26spage%3D23%26epage%3D29%26doi%3D10.1016%2FS0378-4347%2899%2900325-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donato, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castell, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Lechón, M. J.</span></span> <span> </span><span class="NLM_article-title">Fluorescence-Based Assays for Screening Nine Cytochrome P450 (P450) Activities in Intact Cells Expressing Individual Human P450 Enzymes</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1124/dmd.32.7.699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=10.1124%2Fdmd.32.7.699" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=15205384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlWqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=699-706&author=M.+T.+Donatoauthor=N.+Jim%C3%A9nezauthor=J.+V.+Castellauthor=M.+J.+G%C3%B3mez-Lech%C3%B3n&title=Fluorescence-Based+Assays+for+Screening+Nine+Cytochrome+P450+%28P450%29+Activities+in+Intact+Cells+Expressing+Individual+Human+P450+Enzymes&doi=10.1124%2Fdmd.32.7.699"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes</span></div><div class="casAuthors">Donato, M. Teresa; Jimenez, Nuria; Castell, Jose V.; Gomez-Lechon, M. Jose</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">699-706</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Here, the authors describe a battery of fluorescence assays for rapid measurement in intact cells of the activity of 9 cytochromes P 450 (P 450) isoforms involved in drug metab.  The assays are based on the direct incubation of monolayers of cells expressing individual P 450 enzymes with a fluorogenic substrate followed by fluorometric quantification of the product formed and released into incubation medium.  For each individual P 450 activity, different fluorescent probes were examd., and the one showing the best properties (highest metabolic rates, lowest background fluorescence) was selected: 3-cyano-7-ethoxycoumarin for CYP1A2 and CYP2C19, coumarin for CYP2A6, 7-ethoxy-4-trifluoromethylcoumarin for CYP2B6, dibenzylfluorescein for CYP2C8, 7-methoxy-4-trifluoromethylcoumarin (MFC) for CYP2C9 and CYP2E1, 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin for CYP2D6, and 7-benzyloxy-4-trifluoromethylcoumarin for CYP3A4.  The fluorescence-based assays were highly sensitive and allowed the simultaneous measurement of a large no. of samples using plate readers, thus enhancing sample throughput.  The major advantages over high-throughput assays in subcellular fractions were that, as living cells were used, manual handling and enzyme damage were minimized, the endoplasmic reticulum of the cells remained intact, exogenous cofactors or NADPH-regenerating systems were not required, and transport processes were maintained.  These assays could be applied to preliminary screening of inhibitory effects of new drugs on individual P 450 enzymes.  After comparison of the results obtained using the fluorescent probes in intact P 450-expressing cells and those obtained using the HPLC-based selective assays in the same cells, in primary human hepatocytes, or in human liver microsomes, a fairly good agreement was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDn89BZzSJtrVg90H21EOLACvtfcHk0liZfingdk1f6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlWqt7k%253D&md5=10a4fda9a830c33436a8b2373e3af799</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.7.699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.7.699%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DM.%2BT.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DN.%26aulast%3DCastell%26aufirst%3DJ.%2BV.%26aulast%3DG%25C3%25B3mez-Lech%25C3%25B3n%26aufirst%3DM.%2BJ.%26atitle%3DFluorescence-Based%2520Assays%2520for%2520Screening%2520Nine%2520Cytochrome%2520P450%2520%2528P450%2529%2520Activities%2520in%2520Intact%2520Cells%2520Expressing%2520Individual%2520Human%2520P450%2520Enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D699%26epage%3D706%26doi%3D10.1124%2Fdmd.32.7.699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi, C. L.</span>; <span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">High-Performance Liquid Chromatography Analysis of CYP2C8-Catalyzed Paclitaxel 6α-Hydroxylation</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">107</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=103-107&author=C.+L.+Crespi&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DHigh-Performance%2520Liquid%2520Chromatography%2520Analysis%2520of%2520CYP2C8-Catalyzed%2520Paclitaxel%25206%25CE%25B1-Hydroxylation%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D103%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi, C. L.</span>; <span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">Determination of CYP2C9-Catalyzed Diclofenac 4′-Hydroxylation by High-Performance Liquid Chromatography</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">113</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=109-113&author=C.+L.+Crespi&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DDetermination%2520of%2520CYP2C9-Catalyzed%2520Diclofenac%25204%25E2%2580%25B2-Hydroxylation%2520by%2520High-Performance%2520Liquid%2520Chromatography%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D109%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi, C. L.</span>; <span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">CYP2C19-Mediated (S)-Mephenytoin 4′-Hydroxylation Assayed by High-Performance Liquid Chromatography With Radiometric Detection</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">119</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=115-119&author=C.+L.+Crespi&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DCYP2C19-Mediated%2520%2528S%2529-Mephenytoin%25204%25E2%2580%25B2-Hydroxylation%2520Assayed%2520by%2520High-Performance%2520Liquid%2520Chromatography%2520With%2520Radiometric%2520Detection%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D115%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crespi, C. L.</span>; <span class="NLM_string-name">Chang, T. K. H.</span>; <span class="NLM_string-name">Waxman, D. J.</span></span> <span> </span><span class="NLM_article-title">CYP2D6-Dependent Bufuralol 1′-Hydroxylation Assayed by Reverse-Phase Ion-Pair High-Performance Liquid Chromatography With Fluorescence Detection</span>. In  <i>Cytochrome P450 Protocols</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, I. R.</span>; <span class="NLM_string-name">Shephard, E. A.</span></span>, Eds.; <span class="NLM_series">Methods in Molecular Biology</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">125</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=121-125&author=C.+L.+Crespi&author=T.+K.+H.+Chang&author=D.+J.+Waxmanauthor=I.+R.+Phillips&author=E.+A.+Shephard&title=Cytochrome+P450+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCrespi%26aufirst%3DC.%2BL.%26atitle%3DCYP2D6-Dependent%2520Bufuralol%25201%25E2%2580%25B2-Hydroxylation%2520Assayed%2520by%2520Reverse-Phase%2520Ion-Pair%2520High-Performance%2520Liquid%2520Chromatography%2520With%2520Fluorescence%2520Detection%26btitle%3DCytochrome%2520P450%2520Protocols%26aulast%3DPhillips%26aufirst%3DI.%2BR.%26pub%3DHumana%2520Press%26date%3D2006%26spage%3D121%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, D.</span>; <span class="NLM_string-name">Menez, J.-F.</span>; <span class="NLM_string-name">Berthou, F.</span></span> <span> </span><span class="NLM_article-title">[12] Chlorzoxazone: An in Vitro and in Vivo Substrate Probe for Liver CYP2E1</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span>; <span class="NLM_string-name">Waterman, M. R.</span></span>, Eds.; <span class="NLM_series">Cytochrome P450, Part B</span>; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">1996</span>; Vol.  <span class="NLM_volume">272</span>, pp  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">123</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=115-123&author=D.+Lucas&author=J.-F.+Menez&author=F.+Berthouauthor=E.+F.+Johnson&author=M.+R.+Waterman&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DD.%26atitle%3D%255B12%255D%2520Chlorzoxazone%253A%2520An%2520in%2520Vitro%2520and%2520in%2520Vivo%2520Substrate%2520Probe%2520for%2520Liver%2520CYP2E1%26btitle%3DMethods%2520in%2520Enzymology%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26pub%3DAcademic%2520Press%26date%3D1996%26volume%3D272%26spage%3D115%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D.</span></span> <span> </span><span class="NLM_article-title">Inhibition and Kinetics of Cytochrome P4503A Activity in Microsomes from Rat, Human, and Cdna-Expressed Human Cytochrome P450</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">940</span>– <span class="NLM_lpage">947</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=8886602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaK28XlvV2itrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1996&pages=940-947&author=A.+Ghosalauthor=H.+Satohauthor=P.+E.+Thomasauthor=E.+Bushauthor=D.+Moore&title=Inhibition+and+Kinetics+of+Cytochrome+P4503A+Activity+in+Microsomes+from+Rat%2C+Human%2C+and+Cdna-Expressed+Human+Cytochrome+P450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450</span></div><div class="casAuthors">Ghosal, Anima; Satoh, Hiroko; Thomas, Paul E.; Bush, Ernest; Moore, David</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">940-947</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Midazolam (MDZ) is metabolized in human liver microsomes by the cytochrome P 450 (CYP) 3A subfamily to 1'-hydroxy (1'-OH) and 4-hydroxy (4-OH) metabolites.  MDZ is metabolized in the rat primarily to 4-OH MDZ, 1'-OH MDZ, and 1',4-dihydroxy (1',4-diOH) MDZ.  The kinetics of 4-OH and 1'-OH metabolite formation were detd. using hepatic microsomes from control, Ro 23-7637 and dexamethasone-treated male rats.  KM values for the major metabolite, 4-OH MDZ, were 24.5, 43.1, and 32.8 μM, and the corresponding Vmax values were 5.9, 28.9, and 13 nmol/mg/min for the control, DEX, and Ro 23-7637-treated animals, resp.  KM values for 1'-hydroxylation of MDZ (the major metabolite) after incubation with human liver microsomes from three individuals were 5.57, 2.50, and 3.56 μM, and the corresponding Vmax values were 4.38, 0.49, and 0.19 nmol/mg/min, resp.  In parallel studies using cDNA-expressed human CYP3A4 microsomes, the KM for 1'-OH formation was 1.56 μM, and the corresponding Vmax was 0.16 nmol/mg/min.  MDZ was not metabolized by cDNA-expressed human CYP2D6, CYP2E1, or CYP1A2, thus confirming that these isoforms were not responsible for its biotransformation.  The formation of 1',4-diOH metabolite in rat and 1'-OH formation in cDNA-expressed human CYP3A4 microsomes showed a decrease in velocity at high substrate concns.  Inhibition studies showed that MDZ hydroxylation was strongly inhibited by ketoconazole and Ro 23-7637 in rat, human, and cDNA-expressed human CYP3A4 microsomes.  α-Naphthoflavone stimulated 1'-OH metabolite formation in human and cDNA-expressed human CYP3A4 microsomes at low concn. (10 μM).  Naringenin, a flavonoid present in grapefruit juice, also inhibited MDZ metab. in human liver microsomes.  Immunoinhibition studies revealed that polyclonal anti-rat CYP3A2 antibody inhibited MDZ metab. 80-90% in rat, human, and cDNA-expressed human CYP3A4 microsomes, thus suggesting that members of the CYP3A4 subfamily were involved in the metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZdr6TvfGpHLVg90H21EOLACvtfcHk0lh2dAWbdgjaZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvV2itrg%253D&md5=fb95979ee683d0166e6159ccd3bee9e2</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhosal%26aufirst%3DA.%26aulast%3DSatoh%26aufirst%3DH.%26aulast%3DThomas%26aufirst%3DP.%2BE.%26aulast%3DBush%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DD.%26atitle%3DInhibition%2520and%2520Kinetics%2520of%2520Cytochrome%2520P4503A%2520Activity%2520in%2520Microsomes%2520from%2520Rat%252C%2520Human%252C%2520and%2520Cdna-Expressed%2520Human%2520Cytochrome%2520P450%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1996%26volume%3D24%26spage%3D940%26epage%3D947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kronbach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, U. A.</span></span> <span> </span><span class="NLM_article-title">Oxidation of Midazolam and Triazolam by Human Liver Cytochrome P450IIIA4</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=2787473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;key=1%3ACAS%3A528%3ADyaL1MXlt1Kgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1989&pages=89-96&author=T.+Kronbachauthor=D.+Mathysauthor=M.+Umenoauthor=F.+J.+Gonzalezauthor=U.+A.+Meyer&title=Oxidation+of+Midazolam+and+Triazolam+by+Human+Liver+Cytochrome+P450IIIA4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4</span></div><div class="casAuthors">Kronbach, Thomas; Mathys, Daniel; Umeno, Morio; Gonzalez, Frank J.; Meyer, Urs A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-96</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">The metab. of midazolam and triazolam to their 1'-hydroxy and 4-hydroxy metabolites was studied in microsomes of human livers.  The formation of both metabolites was inhibited >90% by an antiserum directed against a pregnenolone 16α-carbonitrile-inducible cytochrome P 450 (P450PCN1) of rat liver.  Moreover, midazolam hydroxylase activity was immunopptd. from solubilized human microsomes with polyclonal antibodies against rat P450PCN1 and the closely related human isoenzyme P450NF.  A close correlation was obsd. between the amt. of protein detected in immunoblots with these antibodies and the midazolam or triazolam or triazolam hydroxylase activity.  The formation of both metabolites of midazolam was inhibited by triacetyloleandomycin, a known inhibitor of cytochromes P 450 of the IIIA family.  Direct evidence that P450IIIA4 catalyzes the metab. of midazolam was provided through the use of cDNA-directed expression.  Monkey COS cells transfected with human P450PCN1 cDNA were able to catalyze both the 1'- and the 4-hydroxylation of midazolam.  The metab. of midazolam and triazolam in human liver is apparently predominantly mediated by cytochrome P450IIIA4.  Two of 15 human livers expressed a 2nd immunoreactive microsomal protein of higher apparent mol. wt. and were more active in midazolam 1'-hydroxylation.  The data also provide evidence that the marked interindividual variation in the response to these widely used benzodiazepine drugs is due to variable hepatic metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXjW8xpvlfmLVg90H21EOLACvtfcHk0lh2dAWbdgjaZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlt1Kgu7g%253D&md5=6ecf9fc3682977542e46d9a32be16f21</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKronbach%26aufirst%3DT.%26aulast%3DMathys%26aufirst%3DD.%26aulast%3DUmeno%26aufirst%3DM.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26aulast%3DMeyer%26aufirst%3DU.%2BA.%26atitle%3DOxidation%2520of%2520Midazolam%2520and%2520Triazolam%2520by%2520Human%2520Liver%2520Cytochrome%2520P450IIIA4%26jtitle%3DMol.%2520Pharmacol.%26date%3D1989%26volume%3D36%26spage%3D89%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i97"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00555">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71767"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00555?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00555</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Activity profiles of library compounds in cell-based reporter assays for nuclear receptors; methods and experimental conditions for cytochrome P450 enzyme assays; and NMR and MS spectra and HPLC chromatograms (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_001.pdf">jm1c00555_si_001.pdf (9.81 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00555/suppl_file/jm1c00555_si_002.csv">jm1c00555_si_002.csv (9.79 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00555&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00555%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-13%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00555" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679985bd1bda3291","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
